<!DOCTYPE html>
<html lang="en" class="no-js">
    <head>
        <meta charset="UTF-8">
        <meta http-equiv="X-UA-Compatible" content="IE=edge">
        <meta name="applicable-device" content="pc,mobile">
        <meta name="viewport" content="width=device-width, initial-scale=1">
        
        
        
            <meta name="robots" content="max-image-preview:large">
            <meta name="access" content="Yes">

        
        <meta name="360-site-verification" content="1268d79b5e96aecf3ff2a7dac04ad990" />

        <title>GLP-1 receptor agonists in delirium and encephalopathies: a neuroprotective scoping review | Discover Medicine</title>

        
            
    
    <meta name="twitter:site" content="@SpringerLink"/>
    <meta name="twitter:card" content="summary_large_image"/>
    <meta name="twitter:image:alt" content="Content cover image"/>
    <meta name="twitter:title" content="GLP-1 receptor agonists in delirium and encephalopathies: a neuroprotective scoping review"/>
    <meta name="twitter:description" content="Discover Medicine - Delirium and encephalopathy are frequent causes of hospitalization leading to functional disability and cognitive impairment. Recent studies have suggested that glucagon-like..."/>
    <meta name="twitter:image" content="https://static-content.springer.com/image/art%3A10.1007%2Fs44337-025-00428-0/MediaObjects/44337_2025_428_Figa_HTML.png"/>
    <meta name="journal_id" content="44337"/>
    <meta name="dc.title" content="GLP-1 receptor agonists in delirium and encephalopathies: a neuroprotective scoping review"/>
    <meta name="dc.source" content="Discover Medicine 2025 2:1"/>
    <meta name="dc.format" content="text/html"/>
    <meta name="dc.publisher" content="Springer"/>
    <meta name="dc.date" content="2025-07-31"/>
    <meta name="dc.type" content="ReviewPaper"/>
    <meta name="dc.language" content="En"/>
    <meta name="dc.copyright" content="2025 This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply"/>
    <meta name="dc.rights" content="2025 This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply"/>
    <meta name="dc.rightsAgent" content="journalpermissions@springernature.com"/>
    <meta name="dc.description" content="Delirium and encephalopathy are frequent causes of hospitalization leading to functional disability and cognitive impairment. Recent studies have suggested that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may protect against neurodegeneration in conditions such as Alzheimer&#39;s dementia and Parkinson&#8217;s disease. However, there is limited literature on their benefits in delirium and encephalopathy. This scoping review explores the mechanisms of GLP-1 RAs in relation to delirium and encephalopathy based on animal studies, and presents current clinical evidence on their potential benefits for managing these neurological disorders. A literature search was conducted on PubMed, Embase, Google Scholar,Web of Science, and APA PsycInfo using search terms related to GLP-1 RAs, delirium, and encephalopathy, in which GLP-1 RAs may have potential benefits. In accordance with the Prisma-Scr guidelines, a total of 38 articles were included in the scoping review. This review focuses on several key brain dysfunctions in which GLP-1 RAs may offer potential benefits. These include postoperative delirium, sepsis-associated encephalopathy, hepatic encephalopathy, hypoxia-induced encephalopathy, diabetic encephalopathy, and alcohol withdrawal syndrome. Both preclinical and clinical studies suggest that GLP-1 RAs may provide neuroprotective benefits, including anti-apoptotic, anti-inflammatory, and cognitive-enhancing properties. These neuroprotective effects are supported by the molecular and pathophysiological pathways that could serve as potential targets for GLP-1 RAs. GLP-1 RAs may offer neuroprotective benefits in patients with postoperative delirium and encephalopathies.. Cellular benefits involve pathophysiological or molecular pathways that are shared with other biological systems. While the current evidence is based on preclinical and clinical studies, more research involving human subjects is needed to clarify the role of GLP-1 RAs in various brain dysfunctions."/>
    <meta name="prism.issn" content="3004-8885"/>
    <meta name="prism.publicationName" content="Discover Medicine"/>
    <meta name="prism.publicationDate" content="2025-07-31"/>
    <meta name="prism.volume" content="2"/>
    <meta name="prism.number" content="1"/>
    <meta name="prism.section" content="ReviewPaper"/>
    <meta name="prism.startingPage" content="1"/>
    <meta name="prism.endingPage" content="18"/>
    <meta name="prism.copyright" content="2025 This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply"/>
    <meta name="prism.rightsAgent" content="journalpermissions@springernature.com"/>
    <meta name="prism.url" content="https://link.springer.com/article/10.1007/s44337-025-00428-0"/>
    <meta name="prism.doi" content="doi:10.1007/s44337-025-00428-0"/>
    <meta name="citation_pdf_url" content="https://link.springer.com/content/pdf/10.1007/s44337-025-00428-0.pdf"/>
    <meta name="citation_fulltext_html_url" content="https://link.springer.com/article/10.1007/s44337-025-00428-0"/>
    <meta name="citation_journal_title" content="Discover Medicine"/>
    <meta name="citation_journal_abbrev" content="Discov Med"/>
    <meta name="citation_publisher" content="Springer Nature Singapore"/>
    <meta name="citation_issn" content="3004-8885"/>
    <meta name="citation_title" content="GLP-1 receptor agonists in delirium and encephalopathies: a neuroprotective scoping review"/>
    <meta name="citation_volume" content="2"/>
    <meta name="citation_issue" content="1"/>
    <meta name="citation_publication_date" content="2025/12"/>
    <meta name="citation_online_date" content="2025/07/31"/>
    <meta name="citation_firstpage" content="1"/>
    <meta name="citation_lastpage" content="18"/>
    <meta name="citation_article_type" content="Review"/>
    <meta name="citation_fulltext_world_readable" content=""/>
    <meta name="citation_language" content="en"/>
    <meta name="dc.identifier" content="doi:10.1007/s44337-025-00428-0"/>
    <meta name="DOI" content="10.1007/s44337-025-00428-0"/>
    <meta name="size" content="250780"/>
    <meta name="citation_doi" content="10.1007/s44337-025-00428-0"/>
    <meta name="citation_springer_api_url" content="http://api.springer.com/xmldata/jats?q=doi:10.1007/s44337-025-00428-0&amp;api_key="/>
    <meta name="description" content="Delirium and encephalopathy are frequent causes of hospitalization leading to functional disability and cognitive impairment. Recent studies have suggested"/>
    <meta name="dc.creator" content="Mercado, Francisco"/>
    <meta name="dc.creator" content="Kop, Michaela"/>
    <meta name="dc.creator" content="Trinh, Michelle"/>
    <meta name="dc.subject" content="Biomedicine, general"/>
    <meta name="dc.subject" content="Medicine/Public Health, general"/>
    <meta name="citation_reference" content="citation_journal_title=BioMed Cent; citation_title=A clinical perspective of sepsis-associated delirium; citation_author=R Tsuruta, Y Oda; citation_publication_date=2016; citation_doi=10.1186/s40560-016-0145-4; citation_id=CR1"/>
    <meta name="citation_reference" content="citation_journal_title=Lippincott Williams Wilkins; citation_title=Encephalopathy of infection and systemic inflammation; citation_author=GB Young; citation_volume=30; citation_issue=5; citation_publication_date=2013; citation_pages=454-461; citation_doi=10.1097/wnp.0b013e3182a73d83; citation_id=CR2"/>
    <meta name="citation_reference" content="citation_journal_title=Elsevier; citation_title=Delirium in elderly people; citation_author=SK Inouye, RG Westendorp, JS Saczynski; citation_volume=383; citation_issue=9920; citation_publication_date=2013; citation_pages=911-922; citation_doi=10.1016/s0140-6736(13)60688-1; citation_id=CR3"/>
    <meta name="citation_reference" content="citation_journal_title=Insights; citation_title=Encephalopathy: a comprehensive case series of five patients with MRI; citation_author=R Gupta, S Shrinuvasan; citation_publication_date=2024; citation_doi=10.36106/ijsr/8114421; citation_id=CR4"/>
    <meta name="citation_reference" content="citation_journal_title=Springer Sci Media; citation_title=Updated nomenclature of delirium and acute encephalopathy; citation_author=AJC Slooter, RD Stevens; citation_volume=33; citation_issue=3; citation_publication_date=2020; citation_pages=864-864; citation_doi=10.1007/s12028-020-01074-3; citation_id=CR5"/>
    <meta name="citation_reference" content="citation_journal_title=Publ Libr Sci; citation_title=Liver diseases as a novel risk factor for delirium in the ICU&#8211;delirium and hepatic encephalopathy are two distinct entities; citation_author=A Denk; citation_publication_date=2022; citation_doi=10.1371/journal.pone.0276914; citation_id=CR6"/>
    <meta name="citation_reference" content="citation_title=Casting light on the links between delirium, infection, and dementia risk; citation_publication_date=2024; citation_id=CR7; citation_author=C Dunne; citation_author=SS Dunne; citation_publisher=Elsevier"/>
    <meta name="citation_reference" content="citation_journal_title=Front Media; citation_title=Delirium from the gliocentric perspective; citation_author=A Sfera, C Osorio, A Price, R Gradini, MA Cummings; citation_volume=9; citation_publication_date=2015; citation_pages=171-171; citation_doi=10.3389/fncel.2015.00171; citation_id=CR8"/>
    <meta name="citation_reference" content="citation_journal_title=Lippincott Williams Wilkins; citation_title=Outcomes of early delirium diagnosis after general anesthesia in the elderly; citation_author=KJ Neufeld; citation_volume=117; citation_issue=2; citation_publication_date=2013; citation_pages=471-478; citation_doi=10.1213/ane.0b013e3182973650; citation_id=CR9"/>
    <meta name="citation_reference" content="M. E. Wilcox, N. E. Brummel, K. Archer, E. W. Ely, J. C. Jackson, and R. O. Hopkins, &#8220;Cognitive Dysfunction in ICU Patients: Risk Factors, Predictors, and Rehabilitation Interventions.&#8221; United States: by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins, Sep. 2013. 
                  https://journals.lww.com/ccmjournal/abstract/2013/09001/cognitive_dysfunction_in_icu_patients__risk.8.aspx
                  
                "/>
    <meta name="citation_reference" content="citation_journal_title=BMJ; citation_title=Delirium as a predictor of mortality in US medicare beneficiaries discharged from the emergency department: a national claims-level analysis up to 12 months; citation_author=J Israni, A Lesser, T Kent, KJ Ko; citation_publication_date=2018; citation_doi=10.1136/bmjopen-2017-021258; citation_id=CR11"/>
    <meta name="citation_reference" content="citation_journal_title=Wiley; citation_title=Delirium during postacute nursing home admission and risk for adverse outcomes; citation_author=CM Kosar, KS Thomas, SK Inouye, V Mor; citation_volume=65; citation_issue=7; citation_publication_date=2017; citation_pages=1470-1475; citation_doi=10.1111/jgs.14823; citation_id=CR12"/>
    <meta name="citation_reference" content="citation_journal_title=Lippincott Williams &amp; Wilkins; citation_title=Metabolic encephalopathies in the critical care unit; citation_author=J Frontera; citation_volume=18; citation_publication_date=2012; citation_pages=611-639; citation_doi=10.1212/01.con.0000415431.07019.c2; citation_id=CR13"/>
    <meta name="citation_reference" content="citation_journal_title=MA Healthc; citation_title=Management of delirium; citation_author=TR Nicholson, M Henderson; citation_volume=70; citation_issue=4; citation_publication_date=2009; citation_pages=217-221; citation_doi=10.12968/hmed.2009.70.4.41625; citation_id=CR14"/>
    <meta name="citation_reference" content="M. Cascella, M. Fiore, S. Leone, D. Carbone, and R. D. Napoli. Current controversies and future perspectives on treatment of intensive care unit delirium in adults,&#8221; vol. 8, no. 3. pp. 18&#8211;27, Jun. 2019. 
                  https://doi.org/10.5492/wjccm.v8.i3.18
                  
                ."/>
    <meta name="citation_reference" content="citation_journal_title=J Gerontol Geriatr; citation_title=The GLP-1 receptor agonist exendin-4 modulates hippocampal NMDA-receptor signaling in aged rats and improves cognitive impairment in diabetic elderly patients; citation_author=AD Romano, R Villani, M Sangineto, T Cassano, G Serviddio; citation_volume=70; citation_issue=2; citation_publication_date=2022; citation_pages=1-7; citation_doi=10.36150/2499-6564-N474; citation_id=CR16"/>
    <meta name="citation_reference" content="citation_journal_title=Dove Med Press; citation_title=Potential roles of glucagon-like peptide-1 and its analogues in dementia targeting impaired insulin secretion and neurodegeneration; citation_author=S Mehan, S Bhalla, EM Siddiqui, N Sharma, A Shandilya, A Khan; citation_volume=12; citation_publication_date=2022; citation_pages=31-59; citation_doi=10.2147/dnnd.s247153; citation_id=CR17"/>
    <meta name="citation_reference" content="citation_journal_title=Wiley; citation_title=Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders; citation_author=I Salcedo, D Tweedie, Y Li, NH Greig; citation_volume=166; citation_issue=5; citation_publication_date=2012; citation_pages=1586-1599; citation_doi=10.1111/j.1476-5381.2012.01971.x; citation_id=CR18"/>
    <meta name="citation_reference" content="citation_journal_title=Eur J Pharmacol; citation_title=Intranasal exendin-4 modifies necroptosis-mediated innate immune response to combat septic encephalopathy in rats: role of mTORC1 in immunogenic and tolerogenic cell demise; citation_author=DA Zaky, DM Abdallah, HS El-Abhar; citation_volume=961; citation_publication_date=2023; citation_doi=10.1016/j.ejphar.2023.176191; citation_id=CR19"/>
    <meta name="citation_reference" content="j. p. h. wilding@liverpool. ac. uk B. Emily Brown Daniel J. Cuthbertson, John P. Wilding, &#8220;Newer GLP-1 receptor agonists and obesity-diabetes,&#8221; vol. undefined, no. undefined. Feb. 2018. 
                  https://www.sciencedirect.com/science/article/pii/S0196978117303789
                  
                "/>
    <meta name="citation_reference" content="K. Tran et al. Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes. s10, no. 4, pp. 178&#8211;188, Jun. 2017."/>
    <meta name="citation_reference" content="S. L. D. Y. L. Lee. Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes. Korea (South): The Korean Society of Pediatric Endocrinology. 
                  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401818/
                  
                "/>
    <meta name="citation_reference" content="citation_journal_title=Wiley; citation_title=GLP-1 receptor agonists: nonglycemic clinical effects in weight loss and beyond; citation_author=DH Ryan, A Acosta; citation_volume=23; citation_issue=6; citation_publication_date=2015; citation_pages=1119-1129; citation_doi=10.1002/oby.21107; citation_id=CR23"/>
    <meta name="citation_reference" content="citation_journal_title=Am Diabetes Assoc; citation_title=Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes; citation_author=JB Buse, RR Henry, J Han, DDH Kim, M Fineman, A Baron; citation_volume=27; citation_issue=11; citation_publication_date=2004; citation_pages=2628-2635; citation_doi=10.2337/diacare.27.11.2628; citation_id=CR24"/>
    <meta name="citation_reference" content="H. W. Rodbard. 2018. The Clinical Impact of GLP 1 Receptor Agonists in Type 2 Diabetes Focus on the Long Acting Analogs. Mary Ann Liebert Inc. 
                  https://doi.org/10.1089/dia.2018.0103
                  
                ."/>
    <meta name="citation_reference" content="citation_journal_title=SAGE Publ; citation_title=GLP-1 receptor agonists: a review of head-to-head clinical studies; citation_author=JM Trujillo, W Nuffer, SL Ellis; citation_volume=6; citation_issue=1; citation_publication_date=2014; citation_pages=19-28; citation_doi=10.1177/2042018814559725; citation_id=CR26"/>
    <meta name="citation_reference" content="citation_journal_title=Neurology; citation_title=Delirium disorder: integrating delirium and acute encephalopathy; citation_author=MA Oldham, RG Holloway; citation_volume=95; citation_issue=4; citation_publication_date=2020; citation_pages=173-178; citation_doi=10.1212/WNL.0000000000009949; citation_id=CR27"/>
    <meta name="citation_reference" content="citation_journal_title=Elsevier BV; citation_title=Postoperative delirium in the PACU and intensive care unit; citation_author=N Theuerkauf, U Guenther, C Putensen; citation_volume=2; citation_issue=4; citation_publication_date=2012; citation_pages=148-155; citation_doi=10.1016/j.tacc.2012.03.002; citation_id=CR28"/>
    <meta name="citation_reference" content="T. Fong, S. Tulebaev, and S. Inouye. Delirium in elderly adults: diagnosis, prevention and treatment. 2009. 
                  https://doi.org/10.1038/nrneurol.2009.24
                  
                ."/>
    <meta name="citation_reference" content="citation_journal_title=Switzerland AGInter J Mol Sci; citation_title=GLP-1a: going beyond traditional use; citation_author=LF Laurindo, SM Barbalho, EL Guiguer; citation_publication_date=2022; citation_doi=10.3390/ijms23020739; citation_id=CR30"/>
    <meta name="citation_reference" content="citation_journal_title=Psychopharmacology; citation_title=Liraglutide ameliorates delirium-like behaviors of aged mice undergoing cardiac surgery by mitigating microglia activation via promoting mitophagy; citation_author=M Jia, X Lv, T Zhu, J-C Shen, W-X Liu, J-J Yang; citation_volume=241; citation_issue=4; citation_publication_date=2024; citation_pages=687-698; citation_doi=10.1007/s00213-023-06492-7; citation_id=CR31"/>
    <meta name="citation_reference" content="citation_journal_title=Neurochem Res; citation_title=Liraglutide reduces alcohol consumption, anxiety, memory impairment, and synapse loss in alcohol dependent mice; citation_author=W Liu, Z Wang, W Wang, Z Wang, Y Xing, C H&#246;lscher; citation_volume=49; citation_issue=4; citation_publication_date=2024; citation_pages=1061-1075; citation_doi=10.1007/s11064-023-04093-6; citation_id=CR32"/>
    <meta name="citation_reference" content="citation_journal_title=IOS Press; citation_title=The neuroprotection of liraglutide on Alzheimer-like learning and memory impairment by modulating the hyperphosphorylation of tau and neurofilament proteins and insulin signaling pathways in mice; citation_author=H Xiong; citation_volume=37; citation_issue=3; citation_publication_date=2013; citation_pages=623-635; citation_doi=10.3233/jad-130584; citation_id=CR33"/>
    <meta name="citation_reference" content="citation_journal_title=Cell Mol Biol; citation_title=Liraglutide nano-preparation on perioperative neurocognitive dysfunction in aged mice; citation_author=J Zhang; citation_volume=68; citation_issue=3; citation_publication_date=2022; citation_pages=356-364; citation_doi=10.14715/cmb/2022.68.3.39; citation_id=CR34"/>
    <meta name="citation_reference" content="citation_journal_title=Front Aging Neurosci; citation_title=Biomarkers of postoperative delirium and cognitive dysfunction; citation_author=G Androsova, R Krause, G Winterer, R Schneider; citation_publication_date=2015; citation_doi=10.3389/fnagi.2015.00112; citation_id=CR35"/>
    <meta name="citation_reference" content="citation_journal_title=J Clin Med; citation_title=The role of stress hyperglycemia on delirium onset; citation_author=E Lagonigro, A Pansini, P Mone, G Guerra, K Komici, C Fantini; citation_volume=14; citation_issue=2; citation_publication_date=2025; citation_pages=407; citation_doi=10.3390/jcm14020407; citation_id=CR36"/>
    <meta name="citation_reference" content="citation_journal_title=J Perianesth Nurs; citation_title=Perioperative implications of glucagon-like peptide-1 receptor agonists; citation_author=RC Wolfe; citation_volume=39; citation_issue=6; citation_publication_date=2024; citation_pages=1108-1110; citation_doi=10.1016/j.jopan.2024.09.022; citation_id=CR37"/>
    <meta name="citation_reference" content="A. H. Hulst. Glucose control therapies in the perioperative period. 
                  https://hdl.handle.net/11245.1/9f8b3eed-fbd4-4d84-96aa-593b390f447c
                  
                "/>
    <meta name="citation_reference" content="citation_journal_title=SAGE Publ; citation_title=Glycemic variability in type 2 diabetes mellitus and acute coronary syndrome: liraglutide compared with insulin glargine: a pilot study; citation_author=MID Olmo-Garc&#237;a; citation_publication_date=2020; citation_doi=10.1177/0300060520926063; citation_id=CR39"/>
    <meta name="citation_reference" content="citation_journal_title=Elsevier BV; citation_title=Dysregulation of the immune response in severe sepsis; citation_author=MR Pinsky; citation_volume=328; citation_issue=4; citation_publication_date=2004; citation_pages=220-229; citation_doi=10.1097/00000441-200410000-00005; citation_id=CR40"/>
    <meta name="citation_reference" content="citation_journal_title=Elsevier BV; citation_title=Mechanisms of organ dysfunction in sepsis; citation_author=R Pool, H G&#243;mez, JA Kellum; citation_volume=34; citation_issue=1; citation_publication_date=2017; citation_pages=63-80; citation_doi=10.1016/j.ccc.2017.08.003; citation_id=CR41"/>
    <meta name="citation_reference" content="citation_journal_title=BioMed Central; citation_title=The spectrum of sepsis-associated encephalopathy: a clinical perspective; citation_author=R Sonneville; citation_publication_date=2013; citation_doi=10.1186/s13054-023-04655-8; citation_id=CR42"/>
    <meta name="citation_reference" content="citation_journal_title=Lippincott Williams Wilkins; citation_title=Neurological complications of sepsis; citation_author=S Piva, M Bertoni, N Gitti, F Rasulo, N Latronico; citation_volume=29; citation_issue=2; citation_publication_date=2023; citation_pages=75-84; citation_doi=10.1097/mcc.0000000000001022; citation_id=CR43"/>
    <meta name="citation_reference" content="citation_journal_title=Mol Neurobiol; citation_title=Long-term cognitive outcomes after sepsis: a translational systematic review; citation_author=T Barichello; citation_volume=56; citation_publication_date=2019; citation_pages=186-251; citation_doi=10.1007/s12035-018-1048-2; citation_id=CR44"/>
    <meta name="citation_reference" content="citation_journal_title=Front Pharmacol; citation_title=GLP-1 receptor: a new target for sepsis; citation_author=F Yang; citation_volume=12; citation_publication_date=2021; citation_doi=10.3389/fphar.2021.706908; citation_id=CR45"/>
    <meta name="citation_reference" content="citation_journal_title=Mol Neurobiol; citation_title=Brain-defective insulin signaling is associated to late cognitive impairment in post-septic mice; citation_author=FS Neves; citation_volume=55; citation_issue=1; citation_publication_date=2018; citation_pages=435-444; citation_doi=10.1007/s12035-016-0307-3; citation_id=CR46"/>
    <meta name="citation_reference" content="citation_journal_title=Exp Neurol; citation_title=Activation of glucagon-like peptide-1 receptor in microglia exerts protective effects against sepsis-induced encephalopathy via attenuating endoplasmic reticulum stress-associated inflammation and apoptosis in a mouse model of sepsis; citation_author=H Yi; citation_volume=363; citation_publication_date=2023; citation_doi=10.1016/j.expneurol.2023.114348; citation_id=CR47"/>
    <meta name="citation_reference" content="citation_journal_title=Front Media; citation_title=Liraglutide activates mTORC1 signaling and AMPA receptors in rat hippocampal neurons under toxic conditions; citation_author=SW Park; citation_publication_date=2018; citation_doi=10.3389/fnins.2018.00756; citation_id=CR48"/>
    <meta name="citation_reference" content="citation_title=Autophagy, a guardian against neurodegeneration; citation_publication_date=2010; citation_id=CR49; citation_author=M Garc&#305;&#769;a Arencibia; citation_author=WE Hochfeld; citation_author=PC Toh; citation_author=DC Rubinsztein; citation_publisher=Elsevier"/>
    <meta name="citation_reference" content="citation_journal_title=IntechOpen; citation_title=Astrocyte pathophysiology in liver disease; citation_author=C P&#233;rez-Monter, A Torre-Delgadillo; citation_publication_date=2018; citation_doi=10.5772/intechopen.72506; citation_id=CR50"/>
    <meta name="citation_reference" content="citation_journal_title=Dove Med Press; citation_title=Hepatic encephalopathy: current challenges and future prospects; citation_author=M Swaminathan, M Ellul, T Cross; citation_publication_date=2018; citation_doi=10.2147/hmer.s118964; citation_id=CR51"/>
    <meta name="citation_reference" content="S. Elwir and R. S. Rahimi. Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options. pp. 1&#8211;10, May 2017. 
                  https://doi.org/10.14218/jcth.2016.00069
                  
                ."/>
    <meta name="citation_reference" content="citation_journal_title=Wiley; citation_title=Hepatic encephalopathy: diagnosis and management; citation_author=P Amodio; citation_volume=38; citation_issue=6; citation_publication_date=2018; citation_pages=966-975; citation_doi=10.1111/liv.13752; citation_id=CR53"/>
    <meta name="citation_reference" content="citation_journal_title=Adis Springer Healthcare; citation_title=Impact of hepatic encephalopathy in cirrhosis on quality-of-life issues; citation_author=S Montagnese, JS Bajaj; citation_volume=79; citation_publication_date=2019; citation_pages=11-16; citation_doi=10.1007/s40265-018-1019-y; citation_id=CR54"/>
    <meta name="citation_reference" content="citation_journal_title=Am J Gastroenterol; citation_title=Semaglutide reduces cognitive dysfunction in experimental non-alcoholic steatohepatitis through anti-inflammatory and neuroprotective effects; citation_author=K Kj&#230;rgaard; citation_volume=118; citation_issue=9; citation_publication_date=2023; citation_pages=S28-S29; citation_doi=10.14309/01.ajg.0000948452.01988.0c; citation_id=CR55"/>
    <meta name="citation_reference" content="citation_journal_title=Aliment Pharmacol Ther; citation_title=Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease cirrhosis and type 2 diabetes; citation_author=MI Elsaid; citation_volume=59; citation_issue=9; citation_publication_date=2024; citation_pages=1096-1110; citation_doi=10.1111/apt.17925; citation_id=CR56"/>
    <meta name="citation_reference" content="citation_journal_title=J Gastroenterol Hepatol; citation_title=Influence of glucagon-like peptide-1 receptor agonists on hepatic events in type 2 diabetes: a systematic review and meta-analysis; citation_author=PRC Passos, VOC Filho, MM Noronha, EB Hyppolito, EF Saldanha, RV Motta; citation_publication_date=2024; citation_doi=10.1111/jgh.16752; citation_id=CR57"/>
    <meta name="citation_reference" content="citation_journal_title=Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc; citation_title=Glucagon-like peptide-1 receptor agonist use in patients with liver cirrhosis and type 2 diabetes; citation_author=F-S Yen; citation_volume=22; citation_issue=6; citation_publication_date=2024; citation_pages=1255-1264.e18; citation_doi=10.1016/j.cgh.2023.06.004; citation_id=CR58"/>
    <meta name="citation_reference" content="citation_journal_title=Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc; citation_title=Glucagon-like peptide-1 receptor agonists and hepatic decompensation events in patients with cirrhosis and diabetes; citation_author=TG Simon, E Patorno, S Schneeweiss; citation_volume=20; citation_issue=6; citation_publication_date=2022; citation_pages=1382-1393.e19; citation_doi=10.1016/j.cgh.2021.07.010; citation_id=CR59"/>
    <meta name="citation_reference" content="citation_journal_title=Gastroenterology; citation_title=Glycine prevents steatohepatitis-associated heoatocarcinogenesis in hepatocyte-specific PTEN knockout mice through of lipid pofiles; citation_author=K Kon, K Arai, A Uchiyama, H Fukada, S Yamashina, K Ikejima; citation_publication_date=2024; citation_doi=10.1016/S0016-5085(24)04221-5; citation_id=CR60"/>
    <meta name="citation_reference" content="citation_journal_title=J Endocr; citation_title=Association of GLP-1 receptor agonists and SGLT-2 inhibitors with major adverse cardiovascular events and serious liver events among patients with type 2; citation_author=A Kutz, DJ Wexler, J Liu, JM Paik, E Patorno; citation_publication_date=2024; citation_doi=10.1210/jendso/bvae163.555; citation_id=CR61"/>
    <meta name="citation_reference" content="citation_journal_title=Am J Gastroenterol; citation_title=Do weight loss medications reduce the risk of cirrhosis and HCC?; citation_author=S Trujillo, S Kamionkowski, E Walsh, J Davila, I Asaad; citation_volume=116; citation_issue=SUPPL; citation_publication_date=2021; citation_pages=S547-S548; citation_doi=10.14309/01.ajg.0000778232.15515.30; citation_id=CR62"/>
    <meta name="citation_reference" content="citation_journal_title=World J Gastroenterol; citation_title=Liver decompensation after rapid weight loss from semaglutide in a patient with non-alcoholic steatohepatitis -associated cirrhosis; citation_author=M Peverelle, J Ng, J Peverelle, RD Hirsch, A Testro; citation_volume=29; citation_issue=47; citation_publication_date=2023; citation_pages=6165-6167; citation_doi=10.3748/wjg.v29.i47.6165; citation_id=CR63"/>
    <meta name="citation_reference" content="citation_journal_title=Med U S; citation_title=Advances in the treatment of hepatogenous diabetes: a review; citation_author=Y Deng, K Li, A Li, W Hu, W Hu; citation_volume=102; citation_issue=46; citation_publication_date=2023; citation_pages=E36068; citation_doi=10.1097/MD.0000000000036068; citation_id=CR64"/>
    <meta name="citation_reference" content="A. Yelam and PC Bollu. 2018. Delayed Hypoxic Reversible Leukoencephalopathy Syndrome. Cureus Inc. 
                  https://doi.org/10.7759/cureus.2702
                  
                ."/>
    <meta name="citation_reference" content="citation_journal_title=Oxford Univ Press; citation_title=Hypothermia for newborns with hypoxic-ischemic encephalopathy; citation_author=B Lemyre, V Chau; citation_volume=23; citation_issue=4; citation_publication_date=2018; citation_pages=285-291; citation_doi=10.1093/pch/pxy028; citation_id=CR66"/>
    <meta name="citation_reference" content="citation_journal_title=Elsevier BV; citation_title=Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer&#8217;s and Parkinson&#8217;s disease models; citation_author=C H&#246;lscher; citation_volume=136; citation_publication_date=2018; citation_pages=251-259; citation_doi=10.1016/j.neuropharm.2018.01.040; citation_id=CR67"/>
    <meta name="citation_reference" content="citation_journal_title=Elsevier BV; citation_title=Protective effect of rhGLP-1 (7&#8211;36) on brain ischemia/reperfusion damage in diabetic rats; citation_author=L Zhao; citation_volume=1602; citation_publication_date=2015; citation_pages=153-159; citation_doi=10.1016/j.brainres.2015.01.014; citation_id=CR68"/>
    <meta name="citation_reference" content="citation_journal_title=Brain J Neurol; citation_title=Neuroprotective exendin-4 enhances hypothermia therapy in a model of hypoxic-ischaemic encephalopathy; citation_author=E Rocha-Ferreira; citation_volume=141; citation_issue=10; citation_publication_date=2018; citation_pages=2925-2942; citation_doi=10.1093/brain/awy220; citation_id=CR69"/>
    <meta name="citation_reference" content="citation_journal_title=Neuropharmacology; citation_title=Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats; citation_author=Z Xie; citation_volume=128; citation_publication_date=2018; citation_pages=142-151; citation_doi=10.1016/j.neuropharm.2017.09.040; citation_id=CR70"/>
    <meta name="citation_reference" content="S. Kim et al. Anti-inflammatory Effect of Glucagon Like Peptide-1 Receptor Agonist, Exendin-4, through Modulation of IB1/JIP1 Expression and JNK Signaling in Stroke,&#8221; vol. 26, no. 4, pp. 227&#8211;239, Aug. 2017, 
                  https://doi.org/10.5607/en.2017.26.4.227
                  
                ."/>
    <meta name="citation_reference" content="citation_journal_title=Sage Publ; citation_title=Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral Ischemia; citation_author=S Teramoto; citation_volume=31; citation_issue=8; citation_publication_date=2011; citation_pages=1696-1705; citation_doi=10.1038/jcbfm.2011.51; citation_id=CR72"/>
    <meta name="citation_reference" content="citation_title=Analysis of the neuroprotective effect of GLP-1 receptor agonist peptide on cerebral ischemia-reperfusion injury by quantitative proteomics mass spectrometry; citation_publication_date=2021; citation_id=CR73; citation_author=Y Li; citation_author=M Gong; citation_publisher=Wiley"/>
    <meta name="citation_reference" content="citation_journal_title=Eur J Pediatr; citation_title=New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy; citation_author=S Victor, E Rocha-Ferreira, A Rahim, H Hagberg, D Edwards; citation_volume=181; citation_issue=3; citation_publication_date=2022; citation_pages=875-887; citation_doi=10.1007/s00431-021-04320-8; citation_id=CR74"/>
    <meta name="citation_reference" content="citation_journal_title=Front Neurol; citation_title=Neuroprotective treatment of post-anoxic encephalopathy: a review of clinical evidence; citation_author=S Nutma, J Feber, J Hofmeijer; citation_volume=12; citation_publication_date=2021; citation_doi=10.3389/fneur.2021.614698; citation_id=CR75"/>
    <meta name="citation_reference" content="citation_journal_title=Trials; citation_title=GLP-1 analogues for neuroprotection after out-of-hospital cardiac arrest: study protocol for a randomized controlled trial; citation_author=S Wiberg; citation_volume=17; citation_issue=1; citation_publication_date=2016; citation_pages=304; citation_doi=10.1186/s13063-016-1421-2; citation_id=CR76"/>
    <meta name="citation_reference" content="citation_journal_title=Acta Diabetol; citation_title=Encephalopathies: the emerging diabetic complications; citation_author=AAF Sima; citation_volume=47; citation_issue=4; citation_publication_date=2010; citation_pages=279-293; citation_doi=10.1007/s00592-010-0218-0; citation_id=CR77"/>
    <meta name="citation_reference" content="citation_journal_title=Neuroscience; citation_title=Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway; citation_author=R Kimura; citation_volume=162; citation_issue=4; citation_publication_date=2009; citation_pages=1212-1219; citation_doi=10.1016/j.neuroscience.2009.05.025; citation_id=CR78"/>
    <meta name="citation_reference" content="citation_journal_title=Int J Mol Sci; citation_title=Chemokine CX3CL1 (fractalkine) signaling and diabetic encephalopathy; citation_author=M W&#261;troba, AD Grabowska, D Szukiewicz; citation_volume=25; citation_issue=14; citation_publication_date=2024; citation_pages=7527; citation_doi=10.3390/ijms25147527; citation_id=CR79"/>
    <meta name="citation_reference" content="citation_journal_title=World J Diabetes; citation_title=Antidiabetic treatment on memory and spatial learning: from the pancreas to the neuron; citation_author=E Xourgia, A Papazafiropoulou, A Melidonis; citation_volume=10; citation_issue=3; citation_publication_date=2019; citation_pages=169-180; citation_doi=10.4239/wjd.v10.i3.169; citation_id=CR80"/>
    <meta name="citation_reference" content="citation_journal_title=Int J Interferon Cytokine Mediat Res; citation_title=Diabetic encephalopathy: the role of oxidative stress and inflammation in type 2 diabetes; citation_author=E Soares, S Nunes, F Reis, FC Pereira; citation_volume=4; citation_issue=1; citation_publication_date=2012; citation_pages=75-85; citation_doi=10.2147/IJICMR.S29322; citation_id=CR81"/>
    <meta name="citation_reference" content="citation_journal_title=Elsevier; citation_title=Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: a pilot, open-label study; citation_author=RB Mansur; citation_volume=207; citation_publication_date=2016; citation_pages=114-120; citation_doi=10.1016/j.jad.2016.09.056; citation_id=CR82"/>
    <meta name="citation_reference" content="citation_journal_title=Informa; citation_title=Alcohol withdrawal syndrome; citation_author=M Bayard, J McIntyre, KR Hill, JR Woodside; citation_publication_date=2000; citation_doi=10.1201/9781420036961-14; citation_id=CR83"/>
    <meta name="citation_reference" content="citation_journal_title=Wiley; citation_title=Alcohol withdrawal syndrome: mechanisms, manifestations, and management; citation_author=S Jesse; citation_volume=135; citation_issue=1; citation_publication_date=2016; citation_pages=4-16; citation_doi=10.1111/ane.12671; citation_id=CR84"/>
    <meta name="citation_reference" content="citation_title=The management of alcohol withdrawal; citation_publication_date=2006; citation_id=CR85; citation_author=A Vale; citation_publisher=Elsevier Ltd"/>
    <meta name="citation_reference" content="citation_journal_title=Camb Univ Press; citation_title=Seizures and alcohol withdrawal: a literature review; citation_author=MCB Gon&#231;alves, F F&#233;lix, J Rom&#227;o, R Andr&#233;, C Sereijo, F Ismail; citation_publication_date=2022; citation_doi=10.1192/j.eurpsy.2022.2143; citation_id=CR86"/>
    <meta name="citation_reference" content="citation_journal_title=Cureus; citation_title=The role of glucagon-like peptide-1 agonists in the treatment of multiple sclerosis: a narrative review; citation_author=AD Kaye; citation_publication_date=2024; citation_doi=10.7759/cureus.67232; citation_id=CR87"/>
    <meta name="citation_reference" content="citation_journal_title=Adis Springer Healthcare; citation_title=Identification and management of alcohol withdrawal syndrome; citation_author=A Mirijello; citation_volume=75; citation_issue=4; citation_publication_date=2015; citation_pages=353-365; citation_doi=10.1007/s40265-015-0358-1; citation_id=CR88"/>
    <meta name="citation_reference" content="citation_journal_title=Medknow; citation_title=Use of propofol as adjuvant therapy in refractory delirium tremens; citation_author=R Mahajan, R Singh, P Bansal, R Bala; citation_volume=19; citation_issue=1; citation_publication_date=2010; citation_pages=58-58; citation_doi=10.4103/0972-6748.77641; citation_id=CR89"/>
    <meta name="citation_reference" content="citation_journal_title=Natl Inst Health; citation_title=Complications of alcohol withdrawal: pathophysiological insights; citation_author=L Trevisan, NN Boutros, IL Petrakis, JH Krystal; citation_volume=22; citation_issue=1; citation_publication_date=1998; citation_pages=61-66; citation_id=CR90"/>
    <meta name="citation_reference" content="citation_journal_title=Springer Nat; citation_title=Attenuation of ethanol withdrawal by ceftriaxone-induced upregulation of glutamate transporter EAAT2; citation_author=OA Abulseoud, UM &#199;amsar&#305;, CL Ruby, A Kasasbeh, S Choi, D-S Choi; citation_volume=39; citation_issue=7; citation_publication_date=2014; citation_pages=1674-1684; citation_doi=10.1038/npp.2014.14; citation_id=CR91"/>
    <meta name="citation_reference" content="citation_journal_title=Springer Nat; citation_title=Craving in alcohol-dependent patients after detoxification is related to glutamatergic dysfunction in the nucleus accumbens and the anterior cingulate cortex; citation_author=J Bauer; citation_volume=38; citation_issue=8; citation_publication_date=2013; citation_pages=1401-1408; citation_doi=10.1038/npp.2013.45; citation_id=CR92"/>
    <meta name="citation_reference" content="citation_journal_title=Wiley; citation_title=Management of acute alcohol withdrawal syndrome in critically Ill patients; citation_author=D Dixit; citation_volume=36; citation_issue=7; citation_publication_date=2016; citation_pages=797-822; citation_doi=10.1002/phar.1770; citation_id=CR93"/>
    <meta name="citation_reference" content="citation_journal_title=Lippincott Williams Wilkins; citation_title=Caring for hospitalized patients with alcohol withdrawal syndrome; citation_author=DY Elliott; citation_volume=14; citation_issue=5; citation_publication_date=2019; citation_pages=18-30; citation_doi=10.1097/01.ccn.0000578828.37034.c2; citation_id=CR94"/>
    <meta name="citation_reference" content="citation_journal_title=Elsevier BV; citation_title=Novel algorithms for the prophylaxis and management of alcohol withdrawal syndromes-beyond benzodiazepines; citation_author=JR Maldonado; citation_volume=33; citation_issue=3; citation_publication_date=2017; citation_pages=559-599; citation_doi=10.1016/j.ccc.2017.03.012; citation_id=CR95"/>
    <meta name="citation_reference" content="citation_journal_title=Wiley; citation_title=Naltrexone, acamprosate show strongest results in review of alcohol use disorder treatments; citation_author=M McPheeters, EA O&#8217;Connor, S Riley; citation_volume=35; citation_issue=3; citation_publication_date=2024; citation_pages=4-4; citation_doi=10.1002/pu.31133; citation_id=CR96"/>
    <meta name="citation_reference" content="citation_journal_title=Public Libr Sci; citation_title=County-level factors associated with a mismatch between opioid overdose mortality and availability of opioid treatment facilities; citation_author=JG Rizk, J Saini, K Kim, U Pathan, DM Qato; citation_publication_date=2024; citation_doi=10.1371/journal.pone.0301863; citation_id=CR97"/>
    <meta name="citation_reference" content="citation_title=Emerging approaches to managing alcohol dependence; citation_publication_date=2007; citation_id=CR98; citation_author=RM Swift; citation_publisher=Oxford University Press"/>
    <meta name="citation_reference" content="citation_journal_title=Frontiers Media; citation_title=Glucagon-like peptide-1: a focus on neurodegenerative diseases; citation_author=M Grieco; citation_publication_date=2019; citation_doi=10.3389/fnins.2019.01112; citation_id=CR99"/>
    <meta name="citation_reference" content="citation_journal_title=Elsevier BV; citation_title=GLP-1 signaling and alcohol-mediated behaviors; preclinical and clinical evidence; citation_author=E Jerlhag; citation_volume=136; citation_publication_date=2018; citation_pages=343-349; citation_doi=10.1016/j.neuropharm.2018.01.013; citation_id=CR100"/>
    <meta name="citation_reference" content="citation_journal_title=Metab Brain Dis; citation_title=Glucagon-like peptide-1 (GLP-1) receptor agonist prevents development of tolerance to anti-anxiety effect of ethanol and withdrawal-induced anxiety in rats; citation_author=AN Sharma, A Pise, JN Sharma, P Shukla; citation_volume=30; citation_issue=3; citation_publication_date=2015; citation_pages=719-730; citation_doi=10.1007/s11011-014-9627-z; citation_id=CR101"/>
    <meta name="citation_reference" content="citation_journal_title=Springer Nat; citation_title=Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist; citation_author=GR Breese, DH Overstreet, DJ Knapp, M Navarro; citation_volume=30; citation_issue=9; citation_publication_date=2005; citation_pages=1662-1669; citation_doi=10.1038/sj.npp.1300706; citation_id=CR102"/>
    <meta name="citation_reference" content="citation_journal_title=Front Pharmacol; citation_title=The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies; citation_author=E Jerlhag; citation_publication_date=2023; citation_doi=10.3389/fphar.2023.1063033; citation_id=CR103"/>
    <meta name="citation_reference" content="citation_journal_title=Brain Sci; citation_title=A narrative review of current and emerging trends in the treatment of alcohol use disorder; citation_author=M Celik, MS Gold, B Fuehrlein; citation_volume=14; citation_issue=3; citation_publication_date=2024; citation_pages=294; citation_doi=10.3390/brainsci14030294; citation_id=CR104"/>
    <meta name="citation_reference" content="citation_journal_title=Elsevier BV; citation_title=Alcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1; citation_author=E Jerlhag; citation_volume=1727; citation_publication_date=2019; citation_pages=146562-146562; citation_doi=10.1016/j.brainres.2019.146562; citation_id=CR105"/>
    <meta name="citation_reference" content="citation_journal_title=Springer Sci Media; citation_title=Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys; citation_author=M Thomsen, JJ Holst, A Molander, K L&#237;nnet, M Ptito, A Fink-Jensen; citation_volume=236; citation_issue=2; citation_publication_date=2018; citation_pages=603-611; citation_doi=10.1007/s00213-018-5089-z; citation_id=CR106"/>
    <meta name="citation_reference" content="M. R. Shen, K. Owusu-Boaitey, L. M. Holsen, and J. Suzuki, &#8220;The Efficacy of GLP-1 Agonists in Treating Substance Use Disorder in Patients: A Scoping Review.&#8221; Jan. 2024."/>
    <meta name="citation_reference" content="citation_journal_title=Elsevier BV; citation_title=Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment; citation_author=KO Kopp, EJ Glotfelty, Y Li, NH Greig; citation_volume=186; citation_publication_date=2022; citation_pages=106550-106550; citation_doi=10.1016/j.phrs.2022.106550; citation_id=CR108"/>
    <meta name="citation_reference" content="citation_journal_title=Aging Dis; citation_title=Autophagy and diabetic encephalopathy: mechanistic insights and potential therapeutic implications; citation_author=L-Z Cheng, W Li, Y-X Chen, Y-J Lin, Y Miao; citation_volume=13; citation_issue=2; citation_publication_date=2022; citation_pages=447-457; citation_doi=10.14336/AD.2021.0823; citation_id=CR109"/>
    <meta name="citation_reference" content="citation_journal_title=Oxf Univ Press; citation_title=Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5&#8242;-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway; citation_author=H Hui, A Nourparvar, X Zhao, R Perfetti; citation_volume=144; citation_issue=4; citation_publication_date=2003; citation_pages=1444-1455; citation_doi=10.1210/en.2002-220897; citation_id=CR110"/>
    <meta name="citation_reference" content="citation_journal_title=J Cardiovasc Pharmacol; citation_title=A glucagon-like peptide 1 analog protects mitochondria and attenuates hypoxia-reoxygenation injury in cultured cardiomyocytes; citation_author=M Kobara, H Toba, T Nakata; citation_volume=79; citation_issue=4; citation_publication_date=2022; citation_pages=568-576; citation_doi=10.1097/FJC.0000000000001218; citation_id=CR111"/>
    <meta name="citation_reference" content="I. S. D. T. Y. L. N. H. G. Salcedo, &#8220;Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders,&#8221; vol. undefined, no. undefined. Apr. 2012. 
                  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419902/
                  
                "/>
    <meta name="citation_author" content="Mercado, Francisco"/>
    <meta name="citation_author_email" content="fsmerc425@hotmail.com"/>
    <meta name="citation_author_institution" content="University of Hawaii John A. Burns School of Medicine Honolulu, Hawaii, USA"/>
    <meta name="citation_author_institution" content="Tripler Army Medical Center, Honolulu, USA"/>
    <meta name="citation_author" content="Kop, Michaela"/>
    <meta name="citation_author_email" content="Mkop@hawaii.edu"/>
    <meta name="citation_author_institution" content="University of Hawaii John A. Burns School of Medicine Honolulu, Hawaii, USA"/>
    <meta name="citation_author" content="Trinh, Michelle"/>
    <meta name="citation_author_email" content="trinhm@hawaii.edu"/>
    <meta name="citation_author_institution" content="University of Hawaii John A. Burns School of Medicine Honolulu, Hawaii, USA"/>
    <meta name="format-detection" content="telephone=no"/>
    <meta name="citation_cover_date" content="2025/12/01"/>
    

            
    
    <meta property="og:url" content="https://link.springer.com/article/10.1007/s44337-025-00428-0"/>
    <meta property="og:type" content="article"/>
    <meta property="og:site_name" content="SpringerLink"/>
    <meta property="og:title" content="GLP-1 receptor agonists in delirium and encephalopathies: a neuroprotective scoping review - Discover Medicine"/>
    <meta property="og:description" content="Background and Purpose Delirium and encephalopathy are frequent causes of hospitalization leading to functional disability and cognitive impairment. Recent studies have suggested that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may protect against neurodegeneration in conditions such as Alzheimer&#39;s dementia and Parkinson&#8217;s disease. However, there is limited literature on their benefits in delirium and encephalopathy. This scoping review explores the mechanisms of GLP-1 RAs in relation to delirium and encephalopathy based on animal studies, and presents current clinical evidence on their potential benefits for managing these neurological disorders. Methodology A literature search was conducted on PubMed, Embase, Google Scholar,Web of Science, and APA PsycInfo using search terms related to GLP-1 RAs, delirium, and encephalopathy, in which GLP-1 RAs may have potential benefits. In accordance with the Prisma-Scr guidelines, a total of 38 articles were included in the scoping review. Results This review focuses on several key brain dysfunctions in which GLP-1 RAs may offer potential benefits. These include postoperative delirium, sepsis-associated encephalopathy, hepatic encephalopathy, hypoxia-induced encephalopathy, diabetic encephalopathy, and alcohol withdrawal syndrome. Both preclinical and clinical studies suggest that GLP-1 RAs may provide neuroprotective benefits, including anti-apoptotic, anti-inflammatory, and cognitive-enhancing properties. These neuroprotective effects are supported by the molecular and pathophysiological pathways that could serve as potential targets for GLP-1 RAs. Conclusion GLP-1 RAs may offer neuroprotective benefits in patients with postoperative delirium and encephalopathies.. Cellular benefits involve pathophysiological or molecular pathways that are shared with other biological systems. While the current evidence is based on preclinical and clinical studies, more research involving human subjects is needed to clarify the role of GLP-1 RAs in various brain dysfunctions."/>
    <meta property="og:image" content="https://static-content.springer.com/image/art%3A10.1007%2Fs44337-025-00428-0/MediaObjects/44337_2025_428_Figa_HTML.png"/>
    

        

        <meta name="format-detection" content="telephone=no">

        
    
        
    
    
    

    


        <link rel="apple-touch-icon" sizes="180x180" href=/oscar-static/img/favicons/darwin/apple-touch-icon-6ef0829b9c.png>
<link rel="icon" type="image/png" sizes="192x192" href=/oscar-static/img/favicons/darwin/android-chrome-192x192.png>
<link rel="icon" type="image/png" sizes="32x32" href=/oscar-static/img/favicons/darwin/favicon-32x32.png>
<link rel="icon" type="image/png" sizes="16x16" href=/oscar-static/img/favicons/darwin/favicon-16x16.png>
<link rel="shortcut icon" data-test="shortcut-icon" href=/oscar-static/img/favicons/darwin/favicon-de0c289efe.ico>

<meta name="theme-color" content="#e6e6e6">


        



<link rel="stylesheet" media="print" href=/oscar-static/app-springerlink/css/print-b8af42253b.css>



    
        
            
    <style> html{line-height:1.15;text-size-adjust:100%}body{font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif;line-height:1.8;margin:0}details,main{display:block}h1{font-size:2em;margin:.67em 0}a{background-color:transparent;color:#025e8d}b{font-weight:bolder}sub{bottom:-.25em;font-size:75%;line-height:0;position:relative;vertical-align:baseline}img{border:0;height:auto;max-width:100%;vertical-align:middle}button,input{font-family:inherit;font-size:100%;line-height:1.15;margin:0;overflow:visible}button{text-transform:none}[type=button],[type=submit],button{-webkit-appearance:button}[type=search]{-webkit-appearance:textfield;outline-offset:-2px}summary{display:list-item}[hidden]{display:none}button{cursor:pointer}svg{height:1rem;width:1rem}.eds-c-header__brand img{max-width:100%}@media only screen and (min-width:768px){.eds-c-header__brand img{max-width:340px}} </style>
    <style>@media only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark) {  body{background:#fff;color:#222;font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif;line-height:1.8;min-height:100%}a{color:#025e8d;padding:initial;text-decoration:underline;text-decoration-skip-ink:auto}button{cursor:pointer}img{border:0;height:auto;max-width:100%;vertical-align:middle}html{box-sizing:border-box;font-size:100%;height:100%;overflow-y:scroll}h1{font-size:2.25rem}h2{font-size:1.75rem}h1,h2,h3{font-weight:700;line-height:1.2}h3{font-size:1.5rem}body{font-size:1.125rem}*{box-sizing:inherit}p{margin-bottom:2rem;margin-top:0}p:last-of-type{margin-bottom:0}.c-ad{text-align:center}@media only screen and (min-width:480px){.c-ad{padding:8px}}.c-ad--728x90{display:none}.c-ad--728x90 .c-ad__inner{min-height:calc(1.5em + 94px)}@media only screen and (min-width:876px){.js .c-ad--728x90{display:none}}.c-ad__label,.c-status-message{font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif}.c-ad__label{color:#333;font-size:.875rem;font-weight:400;line-height:1.5;margin-bottom:4px}.c-status-message{align-items:center;box-sizing:border-box;display:flex;position:relative;width:100%}.c-status-message--boxed{background-color:#fff;border:1px solid #ccc;line-height:1.4;padding:16px}.c-status-message__heading{font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif;font-size:1rem;font-weight:700}.c-status-message__icon{fill:currentcolor;display:inline-block;flex:0 0 auto;height:1.5em;margin-right:8px;transform:translate(0);vertical-align:text-top;width:1.5em}.c-status-message__icon--top{align-self:flex-start}.c-status-message--info .c-status-message__icon{color:#003f8d}.c-status-message--boxed.c-status-message--info{border-bottom:4px solid #003f8d}.c-status-message--error .c-status-message__icon{color:#c40606}.c-status-message--boxed.c-status-message--error{border-bottom:4px solid #c40606}.c-status-message--success .c-status-message__icon{color:#00b8b0}.c-status-message--boxed.c-status-message--success{border-bottom:4px solid #00b8b0}.c-status-message--warning .c-status-message__icon{color:#edbc53}.c-status-message--boxed.c-status-message--warning{border-bottom:4px solid #edbc53}.c-status-message :last-child{margin-bottom:0}.eds-c-button{border-radius:32px;cursor:pointer;display:inline-block;font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif;font-size:1rem;font-weight:700;line-height:1.5;margin:0;padding:.5rem 1.5rem;position:relative;text-align:center;text-decoration:none;transition:all .2s ease 0s;width:100%}.eds-c-button span,.eds-c-button svg{vertical-align:middle}.eds-c-button svg{height:1.5rem;width:1.5rem}.eds-c-button svg:first-child{margin-right:8px}@media only screen and (min-width:480px){.eds-c-button{width:auto}}.eds-c-button--primary{background-color:#025e8d;background-image:none;border:2px solid transparent;box-shadow:none;color:#fff;text-decoration:none}.eds-c-button--primary svg{fill:currentcolor}.eds-c-header{background-color:#fff;border-bottom:2px solid #01324b;font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif;font-size:1rem;line-height:1.5;padding:8px 0 0}.eds-c-header__container{align-items:center;display:flex;flex-wrap:nowrap;gap:8px 16px;justify-content:space-between;margin:0 auto 8px;max-width:1280px;padding:0 8px;position:relative}.eds-c-header__nav{border-top:2px solid #c5e0f4;padding-top:4px;position:relative}.eds-c-header__nav-container{align-items:center;display:flex;flex-wrap:wrap;margin:0 auto 4px;max-width:1280px;padding:0 8px;position:relative}.eds-c-header__nav-container>:not(:last-child){margin-right:32px}.eds-c-header__link-container{align-items:center;display:flex;flex:1 0 auto;gap:8px 16px;justify-content:space-between}.eds-c-header__list{list-style:none;margin:0;padding:0}.eds-c-header__list-item{font-weight:700;margin:0 auto;max-width:1280px;padding:8px}.eds-c-header__list-item:not(:last-child){border-bottom:2px solid #c5e0f4}.eds-c-header__item{color:inherit}@media only screen and (min-width:768px){.eds-c-header__item--menu{display:none;visibility:hidden}.eds-c-header__item--menu:first-child+*{margin-block-start:0}}.eds-c-header__item--inline-links{display:none;visibility:hidden}@media only screen and (min-width:768px){.eds-c-header__item--inline-links{display:flex;gap:16px 16px;visibility:visible}}.eds-c-header__item--divider:before{border-left:2px solid #c5e0f4;content:"";height:calc(100% - 16px);margin-left:-15px;position:absolute;top:8px}.eds-c-header__brand{padding:16px 8px}.eds-c-header__brand a{display:block;line-height:1;text-decoration:none}.eds-c-header__brand img{height:1.5rem;width:auto}.eds-c-header__link{color:inherit;display:inline-block;font-weight:700;padding:16px 8px;position:relative;text-decoration-color:transparent;white-space:nowrap;word-break:normal}.eds-c-header__icon{fill:currentcolor;display:inline-block;font-size:1.5rem;height:1em;transform:translate(0);vertical-align:bottom;width:1em}.eds-c-header__icon+*{margin-left:8px}.eds-c-header__expander{background-color:#f0f7fc}.eds-c-header__search{display:block;padding:24px 0}@media only screen and (min-width:768px){.eds-c-header__search{max-width:70%}}.eds-c-header__search-container{position:relative}.eds-c-header__search-label{color:inherit;display:inline-block;font-weight:700;margin-bottom:8px}.eds-c-header__search-input{background-color:#fff;border:1px solid #000;padding:8px 48px 8px 8px;width:100%}.eds-c-header__search-button{background-color:transparent;border:0;color:inherit;height:100%;padding:0 8px;position:absolute;right:0}.has-tethered.eds-c-header__expander{border-bottom:2px solid #01324b;left:0;margin-top:-2px;top:100%;width:100%;z-index:10}@media only screen and (min-width:768px){.has-tethered.eds-c-header__expander--menu{display:none;visibility:hidden}}.has-tethered .eds-c-header__heading{display:none;visibility:hidden}.has-tethered .eds-c-header__heading:first-child+*{margin-block-start:0}.has-tethered .eds-c-header__search{margin:auto}.eds-c-header__heading{margin:0 auto;max-width:1280px;padding:16px 16px 0}.eds-c-pagination{align-items:center;display:flex;flex-wrap:wrap;font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif;font-size:.875rem;gap:16px 0;justify-content:center;line-height:1.4;list-style:none;margin:0;padding:32px 0}@media only screen and (min-width:480px){.eds-c-pagination{padding:32px 16px}}.eds-c-pagination__item{margin-right:8px}.eds-c-pagination__item--prev{margin-right:16px}.eds-c-pagination__item--next .eds-c-pagination__link,.eds-c-pagination__item--prev .eds-c-pagination__link{padding:16px 8px}.eds-c-pagination__item--next{margin-left:8px}.eds-c-pagination__item:last-child{margin-right:0}.eds-c-pagination__link{align-items:center;color:#222;cursor:pointer;display:inline-block;font-size:1rem;margin:0;padding:16px 24px;position:relative;text-align:center;transition:all .2s ease 0s}.eds-c-pagination__link:visited{color:#222}.eds-c-pagination__link--disabled{border-color:#555;color:#555;cursor:default}.eds-c-pagination__link--active{background-color:#01324b;background-image:none;border-radius:8px;color:#fff}.eds-c-pagination__link--active:focus,.eds-c-pagination__link--active:hover,.eds-c-pagination__link--active:visited{color:#fff}.eds-c-pagination__link-container{align-items:center;display:flex}.eds-c-pagination__icon{fill:#222;height:1.5rem;width:1.5rem}.eds-c-pagination__icon--disabled{fill:#555}.eds-c-pagination__visually-hidden{border:0;clip:rect(0,0,0,0);clip-path:inset(50%);height:1px;overflow:hidden;padding:0;position:absolute!important;white-space:nowrap;width:1px}.c-breadcrumbs{color:#333;font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif;font-size:1rem;list-style:none;margin:0;padding:0}.c-breadcrumbs>li{display:inline}svg.c-breadcrumbs__chevron{margin:0 .25rem;fill:#333;height:10px;width:10px}.c-breadcrumbs--contrast,.c-breadcrumbs--contrast .c-breadcrumbs__link{color:#fff}.c-breadcrumbs--contrast svg.c-breadcrumbs__chevron{fill:#fff}@media only screen and (max-width:479px){.c-breadcrumbs .c-breadcrumbs__item{display:none}.c-breadcrumbs .c-breadcrumbs__item:last-child,.c-breadcrumbs .c-breadcrumbs__item:nth-last-child(2){display:inline}}.c-skip-link{background:#01324b;bottom:auto;color:#fff;font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif;font-size:1rem;padding:8px;position:absolute;text-align:center;transform:translateY(-100%);width:100%;z-index:9999}@media (prefers-reduced-motion:reduce){.c-skip-link{transition:top .3s ease-in-out 0s}}@media print{.c-skip-link{display:none}}.c-skip-link:active,.c-skip-link:hover,.c-skip-link:link,.c-skip-link:visited{color:#fff}.c-skip-link:focus{transform:translateY(0)}.l-with-sidebar{display:flex;flex-wrap:wrap}.l-with-sidebar>*{margin:0}.l-with-sidebar__sidebar{flex-basis:var(--with-sidebar--basis,400px);flex-grow:1}.l-with-sidebar>:not(.l-with-sidebar__sidebar){flex-basis:0px;flex-grow:999;min-width:var(--with-sidebar--min,53%)}.l-with-sidebar>:first-child{padding-right:4rem}@supports (gap:1em){.l-with-sidebar>:first-child{padding-right:0}.l-with-sidebar{gap:var(--with-sidebar--gap,4rem)}}.c-header__link{color:inherit;display:inline-block;font-weight:700;padding:16px 8px;position:relative;text-decoration-color:transparent;white-space:nowrap;word-break:normal}.app-masthead__colour-4{--background-color:#ff9500;--gradient-light:rgba(0,0,0,.5);--gradient-dark:rgba(0,0,0,.8)}.app-masthead{background:var(--background-color,#0070a8);position:relative}.app-masthead:after{background:radial-gradient(circle at top right,var(--gradient-light,rgba(0,0,0,.4)),var(--gradient-dark,rgba(0,0,0,.7)));bottom:0;content:"";left:0;position:absolute;right:0;top:0}@media only screen and (max-width:479px){.app-masthead:after{background:linear-gradient(225deg,var(--gradient-light,rgba(0,0,0,.4)),var(--gradient-dark,rgba(0,0,0,.7)))}}.app-masthead__container{color:var(--masthead-color,#fff);margin:0 auto;max-width:1280px;padding:0 16px;position:relative;z-index:1}.u-clear-both{clear:both}.u-container{margin:0 auto;max-width:1280px;padding:0 16px}.u-justify-content-space-between{justify-content:space-between}.u-display-none{display:none}.js .u-js-hide,.u-hide{display:none;visibility:hidden}.u-visually-hidden{border:0;clip:rect(0,0,0,0);clip-path:inset(50%);height:1px;overflow:hidden;padding:0;position:absolute!important;white-space:nowrap;width:1px}.u-icon{fill:currentcolor;display:inline-block;height:1em;transform:translate(0);vertical-align:text-top;width:1em}.u-list-reset{list-style:none;margin:0;padding:0}.u-ma-16{margin:16px}.u-mt-0{margin-top:0}.u-mt-24{margin-top:24px}.u-mt-32{margin-top:32px}.u-mb-8{margin-bottom:8px}.u-mb-32{margin-bottom:32px}.u-sans-serif{font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif}.u-serif{font-family:Merriweather,serif}h1,h2,h3{-webkit-font-smoothing:antialiased}p{overflow-wrap:break-word;word-break:break-word}.u-h4{font-size:1.25rem;font-weight:700;line-height:1.2}.u-mbs-0{margin-block-start:0!important}.c-article-header{font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif}.c-article-identifiers{color:#6f6f6f;display:flex;flex-wrap:wrap;font-size:1rem;line-height:1.3;list-style:none;padding:0}.c-article-identifiers__item{list-style:none;margin-right:8px;padding-right:8px}.c-article-identifiers__item:last-child{margin-right:0;padding-right:0}@media only screen and (min-width:876px){.c-article-title{font-size:1.875rem;line-height:1.2}}.c-article-author-list{display:inline;font-size:1rem;list-style:none;margin:0 8px 0 0;padding:0;width:100%}.c-article-author-list__item{display:inline;padding-right:0}.c-article-author-list__show-more{display:none;margin-right:4px}.c-article-author-list__button,.js .c-article-author-list__item--hide,.js .c-article-author-list__show-more{display:none}.js .c-article-author-list--long .c-article-author-list__show-more,.js .c-article-author-list--long+.c-article-author-list__button{display:inline}@media only screen and (max-width:767px){.js .c-article-author-list__item--hide-small-screen{display:none}.js .c-article-author-list--short .c-article-author-list__show-more,.js .c-article-author-list--short+.c-article-author-list__button{display:inline}}#uptodate-client,.js .c-article-author-list--expanded .c-article-author-list__show-more{display:none!important}.js .c-article-author-list--expanded .c-article-author-list__item--hide-small-screen{display:inline!important}.c-article-author-list__button,.c-button-author-list{background:#ebf1f5;border:4px solid #ebf1f5;border-radius:20px;color:#666;font-size:.875rem;line-height:1.4;padding:2px 11px 2px 8px;text-decoration:none}.c-article-author-list__button svg,.c-button-author-list svg{margin:1px 4px 0 0}.c-article-author-list__button:hover,.c-button-author-list:hover{background:#025e8d;border-color:transparent;color:#fff}.c-article-body .c-article-access-provider{padding:8px 16px}.c-article-body .c-article-access-provider,.c-notes{border:1px solid #d5d5d5;border-image:initial;border-left:none;border-right:none;margin:24px 0}.c-article-body .c-article-access-provider__text{color:#555}.c-article-body .c-article-access-provider__text,.c-notes__text{font-size:1rem;margin-bottom:0;padding-bottom:2px;padding-top:2px;text-align:center}.c-article-body .c-article-author-affiliation__address{color:inherit;font-weight:700;margin:0}.c-article-body .c-article-author-affiliation__authors-list{list-style:none;margin:0;padding:0}.c-article-body .c-article-author-affiliation__authors-item{display:inline;margin-left:0}.c-article-authors-search{margin-bottom:24px;margin-top:0}.c-article-authors-search__item,.c-article-authors-search__title{font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif}.c-article-authors-search__title{color:#626262;font-size:1.05rem;font-weight:700;margin:0;padding:0}.c-article-authors-search__item{font-size:1rem}.c-article-authors-search__text{margin:0}.c-article-body .c-article-subject-list--no-mb{margin-bottom:0}.c-code-block{border:1px solid #fff;font-family:monospace;margin:0 0 24px;padding:20px}.c-code-block__heading{font-weight:400;margin-bottom:16px}.c-code-block__line{display:block;overflow-wrap:break-word;white-space:pre-wrap}.c-article-share-box{font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif;margin-bottom:24px}.c-article-share-box__description{font-size:1rem;margin-bottom:8px}.c-article-share-box__no-sharelink-info{font-size:.813rem;font-weight:700;margin-bottom:24px;padding-top:4px}.c-article-share-box__only-read-input{border:1px solid #d5d5d5;box-sizing:content-box;display:inline-block;font-size:.875rem;font-weight:700;height:24px;margin-bottom:8px;padding:8px 10px}.c-article-share-box__additional-info{color:#626262;font-size:.813rem}.c-article-share-box__button{background:#fff;box-sizing:content-box;text-align:center}.c-article-share-box__button--link-like{background-color:transparent;border:0;color:#025e8d;cursor:pointer;font-size:.875rem;margin-bottom:8px;margin-left:10px}.c-article-associated-content__container .c-article-associated-content__collection-label{font-size:.875rem;line-height:1.4}.c-article-associated-content__container .c-article-associated-content__collection-title{line-height:1.3}.c-reading-companion{clear:both;min-height:389px}.c-reading-companion__figures-list,.c-reading-companion__references-list{list-style:none;min-height:389px;padding:0}.c-reading-companion__references-list--numeric{list-style:decimal inside}.c-reading-companion__figure-item{border-top:1px solid #d5d5d5;font-size:1rem;padding:16px 8px 16px 0}.c-reading-companion__figure-item:first-child{border-top:none;padding-top:8px}.c-reading-companion__reference-item{font-size:1rem}.c-reading-companion__reference-item:first-child{border-top:none}.c-reading-companion__reference-item a{word-break:break-word}.c-reading-companion__reference-citation{display:inline}.c-reading-companion__reference-links{font-size:.813rem;font-weight:700;list-style:none;margin:8px 0 0;padding:0;text-align:right}.c-reading-companion__reference-links>a{display:inline-block;padding-left:8px}.c-reading-companion__reference-links>a:first-child{display:inline-block;padding-left:0}.c-reading-companion__figure-title{display:block;font-size:1.25rem;font-weight:700;line-height:1.2;margin:0 0 8px}.c-reading-companion__figure-links{display:flex;justify-content:space-between;margin:8px 0 0}.c-reading-companion__figure-links>a{align-items:center;display:flex}.c-article-section__figure-caption{display:block;margin-bottom:8px;word-break:break-word}.c-article-section__figure .video,p.app-article-masthead__access--above-download{margin:0 0 16px}.c-cod{display:block;font-size:1rem;width:100%}.c-cod__form{background:#ebf0f3}.c-cod__prompt{font-size:1.125rem;line-height:1.3;margin:0 0 24px}.c-cod__label{display:block;margin:0 0 4px}.c-cod__row{display:flex;margin:0 0 16px}.c-cod__row:last-child{margin:0}.c-cod__input{border:1px solid #d5d5d5;border-radius:2px;flex-shrink:0;margin:0;padding:13px}.c-cod__input--submit{background-color:#025e8d;border:1px solid #025e8d;color:#fff;flex-shrink:1;margin-left:8px;transition:background-color .2s ease-out 0s,color .2s ease-out 0s}.c-cod__input--submit-single{flex-basis:100%;flex-shrink:0;margin:0}.c-cod__input--submit:focus,.c-cod__input--submit:hover{background-color:#fff;color:#025e8d}.save-data .c-article-author-institutional-author__sub-division,.save-data .c-article-equation__number,.save-data .c-article-figure-description,.save-data .c-article-fullwidth-content,.save-data .c-article-main-column,.save-data .c-article-satellite-article-link,.save-data .c-article-satellite-subtitle,.save-data .c-article-table-container,.save-data .c-blockquote__body,.save-data .c-code-block__heading,.save-data .c-reading-companion__figure-title,.save-data .c-reading-companion__reference-citation,.save-data .c-site-messages--nature-briefing-email-variant .serif,.save-data .c-site-messages--nature-briefing-email-variant.serif,.save-data .serif,.save-data .u-serif,.save-data h1,.save-data h2,.save-data h3{font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif}.c-pdf-download__link{display:flex;flex:1 1 0%;padding:13px 24px}.c-pdf-download__link:hover{text-decoration:none}@media only screen and (min-width:768px){.c-context-bar--sticky .c-pdf-download__link{align-items:center;flex:1 1 183px}}@media only screen and (max-width:320px){.c-context-bar--sticky .c-pdf-download__link{padding:16px}}.c-article-body .c-article-recommendations-list,.c-book-body .c-article-recommendations-list{display:flex;flex-direction:row;gap:16px 16px;margin:0;max-width:100%;padding:16px 0 0}.c-article-body .c-article-recommendations-list__item,.c-book-body .c-article-recommendations-list__item{flex:1 1 0%}@media only screen and (max-width:767px){.c-article-body .c-article-recommendations-list,.c-book-body .c-article-recommendations-list{flex-direction:column}}.c-article-body .c-article-recommendations-card__authors{display:none;font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif;font-size:.875rem;line-height:1.5;margin:0 0 8px}@media only screen and (max-width:767px){.c-article-body .c-article-recommendations-card__authors{display:block;margin:0}}.c-article-body .c-article-history{margin-top:24px}.app-article-metrics-bar p{margin:0}.app-article-masthead{display:flex;flex-direction:column;gap:16px 16px;padding:16px 0 24px}.app-article-masthead__info{display:flex;flex-direction:column;flex-grow:1}.app-article-masthead__brand{border-top:1px solid hsla(0,0%,100%,.8);display:flex;flex-direction:column;flex-shrink:0;gap:8px 8px;min-height:96px;padding:16px 0 0}.app-article-masthead__brand img{border:1px solid #fff;border-radius:8px;box-shadow:0 4px 15px 0 hsla(0,0%,50%,.25);height:auto;left:0;position:absolute;width:72px}.app-article-masthead__journal-link{display:block;font-size:1.125rem;font-weight:700;margin:0 0 8px;max-width:400px;padding:0 0 0 88px;position:relative}.app-article-masthead__journal-title{display:-webkit-box;overflow:hidden;-webkit-box-orient:vertical;-webkit-line-clamp:3}.app-article-masthead__submission-link{align-items:center;display:flex;font-size:1rem;gap:4px 4px;margin:0 0 0 88px}.app-article-masthead__access{align-items:center;display:flex;flex-wrap:wrap;font-size:.875rem;font-weight:300;gap:4px 4px;margin:0}.app-article-masthead__buttons{display:flex;flex-flow:column wrap;gap:16px 16px}.app-article-masthead__access svg{fill:currentcolor}.app-article-masthead a{color:#fff}.app-article-masthead a.c-pdf-download__link,.app-article-masthead__syndicated-card a,.app-article-masthead__syndicated-card a:visited,.app-masthead--pastel .app-article-masthead a,.app-masthead--pastel .app-article-masthead a:visited{color:#000}.app-masthead--pastel .c-pdf-download a.u-button--primary,.c-context-bar--sticky .c-context-bar__container .c-pdf-download a.u-button--primary{background-color:#025e8d;border:2px solid transparent;box-shadow:none;color:#fff;font-weight:700}.app-masthead--pastel .c-pdf-download a.u-button--primary:focus,.app-masthead--pastel .c-pdf-download a.u-button--primary:hover,.c-context-bar--sticky .c-context-bar__container .c-pdf-download a.u-button--primary:focus,.c-context-bar--sticky .c-context-bar__container .c-pdf-download a.u-button--primary:hover{background:0 0;border:2px solid #025e8d;box-shadow:none;color:#025e8d}.app-masthead--pastel .c-pdf-download a.u-button--secondary,.c-context-bar--sticky .c-context-bar__container .c-pdf-download a.u-button--secondary{background:0 0;border:2px solid #025e8d;color:#025e8d}.app-masthead--pastel .c-pdf-download a.u-button--secondary:focus,.app-masthead--pastel .c-pdf-download a.u-button--secondary:hover,.c-context-bar--sticky .c-context-bar__container .c-pdf-download a.u-button--secondary:focus,.c-context-bar--sticky .c-context-bar__container .c-pdf-download a.u-button--secondary:hover{background-color:#025e8d;border:2px solid transparent;color:#fff}@media only screen and (min-width:768px){.app-article-masthead{flex-direction:row;gap:64px 64px;padding:24px 0}.app-article-masthead__brand{border:0;padding:0}.app-article-masthead__brand img{height:auto;position:static;width:auto}.app-article-masthead__buttons{align-items:center;flex-direction:row;margin-top:auto}.app-article-masthead__journal-link{display:flex;flex-direction:column;gap:24px 24px;margin:0 0 8px;padding:0}.app-article-masthead__submission-link{margin:0}}@media only screen and (min-width:1024px){.app-article-masthead__brand{flex-basis:400px}}.app-article-masthead .c-article-identifiers{font-size:.875rem;font-weight:300;line-height:1;margin:0 0 8px;overflow:hidden;padding:0}.app-article-masthead .c-article-identifiers--cite-list{margin:0 0 16px}.app-article-masthead .c-article-identifiers *{color:#fff}.app-article-masthead .c-cod{display:none}.app-article-masthead .c-article-identifiers__item{border-left:1px solid #fff;border-right:0;margin:0 17px 8px -9px;padding:0 0 0 8px}.app-article-masthead .c-article-identifiers__item--cite{border-left:0}.app-article-metrics-bar{display:flex;flex-wrap:wrap;font-size:1rem;padding:16px 0 0;row-gap:24px}.app-article-metrics-bar__item{padding:0 16px 0 0}.app-article-metrics-bar__count{font-weight:700}.app-article-metrics-bar__label{font-weight:400;padding-left:4px}.app-article-metrics-bar__icon{height:auto;margin-right:4px;margin-top:-4px;width:auto}.app-article-metrics-bar__arrow-icon{margin:4px 0 0 4px}.app-article-metrics-bar a{color:#000}.app-article-metrics-bar .app-article-metrics-bar__item--metrics{padding-right:0}.app-overview-section .c-article-author-list,.app-overview-section__authors{line-height:2}.app-article-metrics-bar{margin-top:8px}.c-book-toc-pagination+.c-book-section__back-to-top{margin-top:0}.c-article-body .c-article-access-provider__text--chapter{color:#222;font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif;padding:20px 0}.c-article-body .c-article-access-provider__text--chapter svg.c-status-message__icon{fill:#003f8d;vertical-align:middle}.c-article-body-section__content--separator{padding-top:40px}.c-pdf-download__link{max-height:44px}.app-article-access .u-button--primary,.app-article-access .u-button--primary:visited{color:#fff}.c-article-authors-search__list{align-items:center;display:flex;flex-wrap:wrap;gap:16px 16px;justify-content:center}@media only screen and (min-width:480px){.c-article-authors-search__list{justify-content:normal}}.c-article-authors-search__text{align-items:center;display:flex;flex-flow:column wrap;font-size:14px;justify-content:center}@media only screen and (min-width:480px){.c-article-authors-search__text{flex-direction:row;font-size:16px}}.c-article-authors-search__links-text{font-weight:700;margin-right:8px;text-align:center}@media only screen and (min-width:480px){.c-article-authors-search__links-text{text-align:left}}.c-article-authors-search__list-item--left{flex:1 1 100%}@media only screen and (min-width:480px){.c-article-authors-search__list-item--left{flex-basis:auto}}.c-article-authors-search__list-item--right{flex:1 1 auto}.c-article-identifiers{margin:0}.c-article-identifiers__item{border-right:2px solid #cedbe0;color:#222;font-size:14px}@media only screen and (min-width:480px){.c-article-identifiers__item{font-size:16px}}.c-article-identifiers__item:last-child{border-right:none}.c-article-authors-search__cta-link{font-size:14px}@media only screen and (min-width:480px){.c-article-authors-search__cta-link{font-size:16px}}.c-article-sidebar{display:none}@media only screen and (min-width:1024px){.c-article-sidebar{display:block}}.c-cod__form{border-radius:12px}.c-cod__label{font-size:.875rem}.c-cod .c-status-message{align-items:center;justify-content:center;margin-bottom:16px;padding-bottom:16px}@media only screen and (min-width:1024px){.c-cod .c-status-message{align-items:inherit}}.c-cod .c-status-message__icon{margin-top:4px}.c-cod .c-cod__prompt{font-size:1rem;margin-bottom:16px}.c-spp-access-message .c-status-message__icon{color:#00a69d;margin-top:8px}.c-article-body .app-article-access,.c-book-body .app-article-access{display:block}@media only screen and (min-width:1024px){.c-article-body .app-article-access,.c-book-body .app-article-access{display:none}}.c-article-body .app-card-service{margin-bottom:32px}@media only screen and (min-width:1024px){.c-article-body .app-card-service{display:none}}.app-article-access .buybox__buy .u-button--secondary,.app-article-access .u-button--primary,.c-cod__row .u-button--primary{background-color:#025e8d;border:2px solid #025e8d;box-shadow:none;font-size:1rem;font-weight:700;gap:8px 8px;justify-content:center;line-height:1.4;padding:8px 24px}.app-article-access .buybox__buy .u-button--secondary,.app-article-access .u-button--primary:hover,.c-cod__row .u-button--primary:hover{background-color:#fff;color:#025e8d}.app-article-access .buybox__buy .u-button--secondary:hover{background-color:#025e8d;color:#fff}.buybox__buy .c-notes__text{color:#666;font-size:.875rem;padding:0 16px 8px}.c-cod__input{flex-basis:auto;width:100%}.c-article-title{font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif;font-size:2.25rem;font-weight:700;line-height:1.2;margin:12px 0}.c-reading-companion__figure-item figure{margin:0}@media only screen and (min-width:768px){.c-article-title{margin:16px 0}}.app-article-access{border:1px solid #cedbe0;border-radius:12px;margin:0 0 32px}.app-article-access__heading{border-bottom:1px solid #cedbe0;font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif;font-size:1.125rem;font-weight:700;margin:0;padding:16px;text-align:center}.c-article-body .app-article-access p{margin-bottom:0}@media only screen and (min-width:1024px){.app-article-access{margin:0 0 24px}}.c-status-message{font-size:1rem}.c-article-body{font-size:1.125rem}.c-article-body dl,.c-article-body ol,.c-article-body p,.c-article-body ul{margin-bottom:32px;margin-top:0}.c-article-access-provider__text:last-of-type,.c-article-body .c-notes__text:last-of-type{margin-bottom:0}.c-article-body ol p,.c-article-body ul p{margin-bottom:16px}.c-article-section__figure-caption{font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif}.c-reading-companion__figure-item{border-top-color:#cedbe0}.c-reading-companion__sticky{max-width:400px}.c-reading-companion__reference-item{border-top:1px solid #d5d5d5;padding:16px 0}.c-reading-companion__reference-item:first-child{padding-top:0}.c-article-share-box__button,.js .c-article-authors-search__item .c-article-button{background:0 0;border:2px solid #025e8d;border-radius:32px;box-shadow:none;color:#025e8d;font-size:1rem;font-weight:700;line-height:1.4;margin:0;padding:8px 24px;transition:all .2s ease 0s}.c-article-authors-search__item .c-article-button{width:100%}.c-pdf-download .c-pdf-download__link{align-items:center;background-color:#fff;border:2px solid #fff;border-radius:32px;box-shadow:none;color:#01324b;cursor:pointer;font-family:Merriweather Sans,Helvetica Neue,Helvetica,Arial,sans-serif;font-size:1rem;font-weight:700;justify-content:center;line-height:1.4;padding:8px 24px;text-decoration:none}.c-context-bar__container .c-pdf-download .c-pdf-download__link{background-color:#025e8d;background-image:none;border:2px solid #025e8d;box-shadow:none;color:#fff;font-size:1rem;font-weight:700;line-height:1.4;padding:8px 24px}.c-pdf-download .c-pdf-download__link:hover{background:0 0;border:2px solid #fff;box-shadow:none;color:#fff}.c-pdf-download .c-pdf-download__link:focus{background:0 0;box-shadow:none;color:#fff}.c-context-bar__container .c-pdf-download .c-pdf-download__link:hover{border:2px solid #025e8d;box-shadow:none;color:#025e8d}.c-context-bar__container .c-pdf-download .c-pdf-download__link:focus,.c-pdf-download .c-pdf-download__link:focus{border:2px solid #025e8d}.c-article-share-box__button:focus:focus,.c-article__pill-button:focus:focus,.c-context-bar__container .c-pdf-download .c-pdf-download__link:focus:focus,.c-pdf-download .c-pdf-download__link:focus:focus{outline:3px solid #08c;will-change:transform}.c-pdf-download__link .u-icon{padding-top:0}.c-bibliographic-information__column button{margin-bottom:16px}.c-article-body .c-article-author-affiliation__list p,.c-article-body .c-article-author-information__list p,figure{margin:0}.c-article-share-box__button{margin-right:16px}.c-status-message--boxed{border-radius:12px}.c-article-associated-content__collection-title{font-size:1rem}.app-card-service__description,.c-article-body .app-card-service__description{color:#222;margin-bottom:0;margin-top:8px}.app-article-access__subscriptions a,.app-article-access__subscriptions a:visited,.app-book-series-listing__item a,.app-book-series-listing__item a:hover,.app-book-series-listing__item a:visited,.c-article-author-list a,.c-article-author-list a:visited,.c-article-buy-box a,.c-article-buy-box a:visited,.c-article-peer-review a,.c-article-peer-review a:visited,.c-article-satellite-subtitle a,.c-article-satellite-subtitle a:visited,.c-breadcrumbs__link,.c-breadcrumbs__link:hover,.c-breadcrumbs__link:visited{color:#000}.c-article-author-list svg{height:24px;margin:0 0 0 6px;width:24px}.c-article-header{margin-bottom:32px}@media only screen and (min-width:876px){.js .c-ad--conditional{display:block}}.u-lazy-ad-wrapper{background-color:#fff;display:none;min-height:149px}@media only screen and (min-width:876px){.u-lazy-ad-wrapper{display:block}}p.c-ad__label{margin-bottom:4px}.c-ad--728x90{background-color:#fff;border-bottom:2px solid #cedbe0} } </style>
    <style>@media only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark) {  .eds-c-header__brand img{height:24px;width:203px}.app-article-masthead__journal-link img{height:93px;width:72px}@media only screen and (min-width:769px){.app-article-masthead__journal-link img{height:161px;width:122px}} } </style>

        
        <link rel="stylesheet" data-test="critical-css-handler" data-inline-css-source="critical-css" href=/oscar-static/app-springerlink/css/core-darwin-9fe647df8f.css media="print" onload="this.media='all';this.onload=null">
        <link rel="stylesheet" data-test="critical-css-handler" data-inline-css-source="critical-css" href="/oscar-static/app-springerlink/css/enhanced-darwin-article-1bb0e1f642.css" media="print" onload="this.media='only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)';this.onload=null">
    

        
        
    <script type="text/javascript">
        config = {
            env: 'live',
            site: '44337.springer.com',
            siteWithPath: '44337.springer.com' + window.location.pathname,
            twitterHashtag: '44337',
            cmsPrefix: 'https://studio-cms.springernature.com/studio/',
            
            
            
            
            publisherBrand: 'Springer',
            mustardcut: false
        };
    </script>

        




    <script>
        window.dataLayer = [{"GA Key":"UA-26408784-1","DOI":"10.1007/s44337-025-00428-0","Page":"article","springerJournal":true,"Publishing Model":"Open Access","Country":"US","japan":false,"doi":"10.1007-s44337-025-00428-0","Journal Id":44337,"Journal Title":"Discover Medicine","imprint":"Discover","Keywords":"Glucagon-like peptide-1 receptor agonists (GLP-1 RA or GLP-1 RAs), Delirium, Encephalopathy, Neuroprotection, Neurodegenerative diseases, Neuroinflammation, Cognitive impairment","kwrd":["Glucagon-like_peptide-1_receptor_agonists_(GLP-1_RA_or_GLP-1_RAs)","Delirium","Encephalopathy","Neuroprotection","Neurodegenerative_diseases","Neuroinflammation","Cognitive_impairment"],"Labs":"Y","ksg":"Krux.segments","kuid":"Krux.uid","Has Body":"Y","Features":[],"Open Access":"Y","hasAccess":"Y","bypassPaywall":"N","user":{"license":{"businessPartnerID":[],"businessPartnerIDString":""}},"Access Type":"open","Bpids":"","Bpnames":"","BPID":["1"],"VG Wort Identifier":"vgzm.415900-10.1007-s44337-025-00428-0","Full HTML":"Y","Subject Codes":["SCB","SCB0000X","SCH00007"],"pmc":["B","B0000X","H00007"],"session":{"authentication":{"loginStatus":"N"},"attributes":{"edition":"academic"}},"entitlement":{"accessDecision":"OpenAccess"},"content":{"serial":{"eissn":"3004-8885"},"type":"Article","category":{"pmc":{"primarySubject":"Biomedicine","primarySubjectCode":"B","secondarySubjects":{"1":"Biomedicine, general","2":"Medicine/Public Health, general"},"secondarySubjectCodes":{"1":"B0000X","2":"H00007"}},"sucode":"SC3","articleType":"Review","snt":["G protein-coupled receptors","Neuropharmacology","Geriatric Psychiatry","Neuroendocrinology","Alzheimer\u0027s disease","Insulin Signalling"]},"attributes":{"deliveryPlatform":"oscar"}},"page":{"attributes":{"environment":"live"},"category":{"pageType":"article"}},"Event Category":"Article"}];
    </script>











    <script data-test="springer-link-article-datalayer">
        window.dataLayer = window.dataLayer || [];
        window.dataLayer.push({
            ga4MeasurementId: 'G-B3E4QL2TPR',
            ga360TrackingId: 'UA-26408784-1',
            twitterId: 'o47a7',
            baiduId: 'aef3043f025ccf2305af8a194652d70b',
            ga4ServerUrl: 'https://collect.springer.com',
            imprint: 'springerlink',
                page: {
                    attributes:{
                        featureFlags: [
                            
                                { name: 'darwin-orion', active: true },
                            
                                { name: 'show-profile-page-links', active: true },
                            
                                { name: 'article-summaries', active: false },
                            
                        ],
                        darwinAvailable: true
                    }
                }
            
        });
    </script>



        <script>
    (function(w, d) {
        w.config = w.config || {};
        w.config.mustardcut = false;

        
        if (w.matchMedia && w.matchMedia('only print, only all and (prefers-color-scheme: no-preference), only all and (prefers-color-scheme: light), only all and (prefers-color-scheme: dark)').matches) {
            w.config.mustardcut = true;
            d.classList.add('js');
            d.classList.remove('grade-c');
            d.classList.remove('no-js');
        }
    })(window, document.documentElement);
</script>


        <script class="js-entry">
    if (window.config.mustardcut) {
        (function(w, d) {
            
            
            
                window.Component = {};
                window.suppressShareButton = false;
                window.onArticlePage = true;
            

            var currentScript = d.currentScript || d.head.querySelector('script.js-entry');

            
            function catchNoModuleSupport() {
                var scriptEl = d.createElement('script');
                return (!('noModule' in scriptEl) && 'onbeforeload' in scriptEl)
            }

            var headScripts = [
                {'src': '/oscar-static/js/polyfill-es5-bundle-b4356fa7f5.js', 'async': false}
            ];

            var bodyScripts = [
                
                    {'src': '/oscar-static/js/global-article-es5-bundle-c7bdbee6e7.js', 'async': false, 'module': false},
                    {'src': '/oscar-static/js/global-article-es6-bundle-8cfe1d6fdf.js', 'async': false, 'module': true}
                
                
                    
                
                
                
            ];

            function createScript(script) {
                var scriptEl = d.createElement('script');
                scriptEl.src = script.src;
                scriptEl.async = script.async;
                if (script.module === true) {
                    scriptEl.type = "module";
                    if (catchNoModuleSupport()) {
                        scriptEl.src = '';
                    }
                } else if (script.module === false) {
                    scriptEl.setAttribute('nomodule', true)
                }
                if (script.charset) {
                    scriptEl.setAttribute('charset', script.charset);
                }

                return scriptEl;
            }

            for (var i = 0; i < headScripts.length; ++i) {
                var scriptEl = createScript(headScripts[i]);
                currentScript.parentNode.insertBefore(scriptEl, currentScript.nextSibling);
            }

            d.addEventListener('DOMContentLoaded', function() {
                for (var i = 0; i < bodyScripts.length; ++i) {
                    var scriptEl = createScript(bodyScripts[i]);
                    d.body.appendChild(scriptEl);
                }
            });

            // Webfont repeat view
            var config = w.config;
            if (config && config.publisherBrand && sessionStorage.fontsLoaded === 'true') {
                d.documentElement.className += ' webfonts-loaded';
            }
        })(window, document);
    }
</script>



        
            
            
                
<script data-test="gtm-head">
    window.initGTM = function() {
        if (window.config.mustardcut) {
            (function (w, d, s, l, i) {
                w[l] = w[l] || [];
                w[l].push({'gtm.start': new Date().getTime(), event: 'gtm.js'});
                var f = d.getElementsByTagName(s)[0],
                    j = d.createElement(s),
                    dl = l != 'dataLayer' ? '&l=' + l : '';
                j.async = true;
                j.src = 'https://sgtm.springer.com/gtm.js?id=' + i + dl;
                f.parentNode.insertBefore(j, f);
            })(window, document, 'script', 'dataLayer', 'GTM-MRVXSHQ');
        }
    }
</script>

            
            
            
        

        <script>
(function (w, d, t) {
    function cc() {
        var h = w.location.hostname;
        var e = d.createElement(t),
        s = d.getElementsByTagName(t)[0];

        
        if (h.indexOf('springer.com') > -1 && h.indexOf('biomedcentral.com') === -1 && h.indexOf('springeropen.com') === -1) {
            e.src = 'https://cmp.springer.com/production_live/en/consent-bundle-17-68.js';
            e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
        } else if (h.indexOf('biomedcentral.com') > -1) {
            e.src = 'https://cmp.biomedcentral.com/production_live/en/consent-bundle-15-45.js';
            e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
        } else if (h.indexOf('springeropen.com') > -1) {
            e.src = 'https://cmp.springernature.com/production_live/en/consent-bundle-16-40.js';
            e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-MRVXSHQ')");
        } else if (h.indexOf('springernature.com') > -1) {
            e.src = 'https://cmp.springernature.com/production_live/en/consent-bundle-49-43.js';
            e.setAttribute('onload', "initGTM(window,document,'script','dataLayer','GTM-NK22KLS')");
        } else {
            e.src = '/oscar-static/js/cookie-consent-es5-bundle-8d962b73c2.js';
            e.setAttribute('data-consent', h);
        }
        s.insertAdjacentElement('afterend', e);
    }

    cc();
})(window, document, 'script');
</script>


        
        
        
    
        
    

        
    
    <link rel="canonical" href="https://link.springer.com/article/10.1007/s44337-025-00428-0"/>
    

        
        
        
        
        
    <script type="application/ld+json">{"mainEntity":{"headline":"GLP-1 receptor agonists in delirium and encephalopathies: a neuroprotective scoping review","description":"Delirium and encephalopathy are frequent causes of hospitalization leading to functional disability and cognitive impairment. Recent studies have suggested that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may protect against neurodegeneration in conditions such as Alzheimer's dementia and Parkinson’s disease. However, there is limited literature on their benefits in delirium and encephalopathy. This scoping review explores the mechanisms of GLP-1 RAs in relation to delirium and encephalopathy based on animal studies, and presents current clinical evidence on their potential benefits for managing these neurological disorders. A literature search was conducted on PubMed, Embase, Google Scholar,Web of Science, and APA PsycInfo using search terms related to GLP-1 RAs, delirium, and encephalopathy, in which GLP-1 RAs may have potential benefits. In accordance with the Prisma-Scr guidelines, a total of 38 articles were included in the scoping review. This review focuses on several key brain dysfunctions in which GLP-1 RAs may offer potential benefits. These include postoperative delirium, sepsis-associated encephalopathy, hepatic encephalopathy, hypoxia-induced encephalopathy, diabetic encephalopathy, and alcohol withdrawal syndrome. Both preclinical and clinical studies suggest that GLP-1 RAs may provide neuroprotective benefits, including anti-apoptotic, anti-inflammatory, and cognitive-enhancing properties. These neuroprotective effects are supported by the molecular and pathophysiological pathways that could serve as potential targets for GLP-1 RAs. GLP-1 RAs may offer neuroprotective benefits in patients with postoperative delirium and encephalopathies.. Cellular benefits involve pathophysiological or molecular pathways that are shared with other biological systems. While the current evidence is based on preclinical and clinical studies, more research involving human subjects is needed to clarify the role of GLP-1 RAs in various brain dysfunctions.","datePublished":"2025-07-31T00:00:00Z","dateModified":"2025-07-31T00:00:00Z","pageStart":"1","pageEnd":"18","license":"http://creativecommons.org/licenses/by/4.0/","sameAs":"https://doi.org/10.1007/s44337-025-00428-0","keywords":["Glucagon-like peptide-1 receptor agonists (GLP-1 RA or GLP-1 RAs)","Delirium","Encephalopathy","Neuroprotection","Neurodegenerative diseases","Neuroinflammation","Cognitive impairment","Biomedicine","general","Medicine/Public Health"],"image":["https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs44337-025-00428-0/MediaObjects/44337_2025_428_Figa_HTML.png","https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs44337-025-00428-0/MediaObjects/44337_2025_428_Fig1_HTML.png"],"isPartOf":{"name":"Discover Medicine","issn":["3004-8885"],"volumeNumber":"2","@type":["Periodical","PublicationVolume"]},"publisher":{"name":"Springer Nature Singapore","logo":{"url":"https://www.springernature.com/app-sn/public/images/logo-springernature.png","@type":"ImageObject"},"@type":"Organization"},"author":[{"name":"Francisco Mercado","url":"http://orcid.org/0000-0003-0091-0082","affiliation":[{"name":"University of Hawaii John A. Burns School of Medicine Honolulu","address":{"name":"University of Hawaii John A. Burns School of Medicine Honolulu, Hawaii, USA","@type":"PostalAddress"},"@type":"Organization"},{"name":"Tripler Army Medical Center","address":{"name":"Tripler Army Medical Center, Honolulu, USA","@type":"PostalAddress"},"@type":"Organization"}],"email":"fsmerc425@hotmail.com","@type":"Person"},{"name":"Michaela Kop","url":"http://orcid.org/0000-0001-6964-0573","affiliation":[{"name":"University of Hawaii John A. Burns School of Medicine Honolulu","address":{"name":"University of Hawaii John A. Burns School of Medicine Honolulu, Hawaii, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"},{"name":"Michelle Trinh","url":"http://orcid.org/0009-0000-1148-1493","affiliation":[{"name":"University of Hawaii John A. Burns School of Medicine Honolulu","address":{"name":"University of Hawaii John A. Burns School of Medicine Honolulu, Hawaii, USA","@type":"PostalAddress"},"@type":"Organization"}],"@type":"Person"}],"isAccessibleForFree":true,"@type":"ScholarlyArticle"},"@context":"https://schema.org","@type":"WebPage"}</script>

        
        
    </head>

    <body class=""
    
          >
        <div class="u-visually-hidden" aria-hidden="true" data-test="darwin-icons">
    <svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink"><symbol id="icon-eds-i-accesses-medium" viewBox="0 0 24 24"><path d="M15.59 1a1 1 0 0 1 .706.291l5.41 5.385a1 1 0 0 1 .294.709v13.077c0 .674-.269 1.32-.747 1.796a2.549 2.549 0 0 1-1.798.742H15a1 1 0 0 1 0-2h4.455a.549.549 0 0 0 .387-.16.535.535 0 0 0 .158-.378V7.8L15.178 3H5.545a.543.543 0 0 0-.538.451L5 3.538v8.607a1 1 0 0 1-2 0V3.538A2.542 2.542 0 0 1 5.545 1h10.046ZM8 13c2.052 0 4.66 1.61 6.36 3.4l.124.141c.333.41.516.925.516 1.459 0 .6-.232 1.178-.64 1.599C12.666 21.388 10.054 23 8 23c-2.052 0-4.66-1.61-6.353-3.393A2.31 2.31 0 0 1 1 18c0-.6.232-1.178.64-1.6C3.34 14.61 5.948 13 8 13Zm0 2c-1.369 0-3.552 1.348-4.917 2.785A.31.31 0 0 0 3 18c0 .083.031.161.09.222C4.447 19.652 6.631 21 8 21c1.37 0 3.556-1.35 4.917-2.785A.31.31 0 0 0 13 18a.32.32 0 0 0-.048-.17l-.042-.052C11.553 16.348 9.369 15 8 15Zm0 1a2 2 0 1 1 0 4 2 2 0 0 1 0-4Z"/></symbol><symbol id="icon-eds-i-altmetric-medium" viewBox="0 0 24 24"><path d="M12 1c5.978 0 10.843 4.77 10.996 10.712l.004.306-.002.022-.002.248C22.843 18.23 17.978 23 12 23 5.925 23 1 18.075 1 12S5.925 1 12 1Zm-1.726 9.246L8.848 12.53a1 1 0 0 1-.718.461L8.003 13l-4.947.014a9.001 9.001 0 0 0 17.887-.001L16.553 13l-2.205 3.53a1 1 0 0 1-1.735-.068l-.05-.11-2.289-6.106ZM12 3a9.001 9.001 0 0 0-8.947 8.013l4.391-.012L9.652 7.47a1 1 0 0 1 1.784.179l2.288 6.104 1.428-2.283a1 1 0 0 1 .722-.462l.129-.008 4.943.012A9.001 9.001 0 0 0 12 3Z"/></symbol><symbol id="icon-eds-i-arrow-bend-down-medium" viewBox="0 0 24 24"><path d="m11.852 20.989.058.007L12 21l.075-.003.126-.017.111-.03.111-.044.098-.052.104-.074.082-.073 6-6a1 1 0 0 0-1.414-1.414L13 17.585v-12.2C13 4.075 11.964 3 10.667 3H4a1 1 0 1 0 0 2h6.667c.175 0 .333.164.333.385v12.2l-4.293-4.292a1 1 0 0 0-1.32-.083l-.094.083a1 1 0 0 0 0 1.414l6 6c.035.036.073.068.112.097l.11.071.114.054.105.035.118.025Z"/></symbol><symbol id="icon-eds-i-arrow-bend-down-small" viewBox="0 0 16 16"><path d="M1 2a1 1 0 0 0 1 1h5v8.585L3.707 8.293a1 1 0 0 0-1.32-.083l-.094.083a1 1 0 0 0 0 1.414l5 5 .063.059.093.069.081.048.105.048.104.035.105.022.096.01h.136l.122-.018.113-.03.103-.04.1-.053.102-.07.052-.043 5.04-5.037a1 1 0 1 0-1.415-1.414L9 11.583V3a2 2 0 0 0-2-2H2a1 1 0 0 0-1 1Z"/></symbol><symbol id="icon-eds-i-arrow-bend-up-medium" viewBox="0 0 24 24"><path d="m11.852 3.011.058-.007L12 3l.075.003.126.017.111.03.111.044.098.052.104.074.082.073 6 6a1 1 0 1 1-1.414 1.414L13 6.415v12.2C13 19.925 11.964 21 10.667 21H4a1 1 0 0 1 0-2h6.667c.175 0 .333-.164.333-.385v-12.2l-4.293 4.292a1 1 0 0 1-1.32.083l-.094-.083a1 1 0 0 1 0-1.414l6-6c.035-.036.073-.068.112-.097l.11-.071.114-.054.105-.035.118-.025Z"/></symbol><symbol id="icon-eds-i-arrow-bend-up-small" viewBox="0 0 16 16"><path d="M1 13.998a1 1 0 0 1 1-1h5V4.413L3.707 7.705a1 1 0 0 1-1.32.084l-.094-.084a1 1 0 0 1 0-1.414l5-5 .063-.059.093-.068.081-.05.105-.047.104-.035.105-.022L7.94 1l.136.001.122.017.113.03.103.04.1.053.102.07.052.043 5.04 5.037a1 1 0 1 1-1.415 1.414L9 4.415v8.583a2 2 0 0 1-2 2H2a1 1 0 0 1-1-1Z"/></symbol><symbol id="icon-eds-i-arrow-diagonal-medium" viewBox="0 0 24 24"><path d="M14 3h6l.075.003.126.017.111.03.111.044.098.052.096.067.09.08c.036.035.068.073.097.112l.071.11.054.114.035.105.03.148L21 4v6a1 1 0 0 1-2 0V6.414l-4.293 4.293a1 1 0 0 1-1.414-1.414L17.584 5H14a1 1 0 0 1-.993-.883L13 4a1 1 0 0 1 1-1ZM4 13a1 1 0 0 1 1 1v3.584l4.293-4.291a1 1 0 1 1 1.414 1.414L6.414 19H10a1 1 0 0 1 .993.883L11 20a1 1 0 0 1-1 1l-6.075-.003-.126-.017-.111-.03-.111-.044-.098-.052-.096-.067-.09-.08a1.01 1.01 0 0 1-.097-.112l-.071-.11-.054-.114-.035-.105-.025-.118-.007-.058L3 20v-6a1 1 0 0 1 1-1Z"/></symbol><symbol id="icon-eds-i-arrow-diagonal-small" viewBox="0 0 16 16"><path d="m2 15-.082-.004-.119-.016-.111-.03-.111-.044-.098-.052-.096-.067-.09-.08a1.008 1.008 0 0 1-.097-.112l-.071-.11-.031-.062-.034-.081-.024-.076-.025-.118-.007-.058L1 14.02V9a1 1 0 1 1 2 0v2.584l2.793-2.791a1 1 0 1 1 1.414 1.414L4.414 13H7a1 1 0 0 1 .993.883L8 14a1 1 0 0 1-1 1H2ZM14 1l.081.003.12.017.111.03.111.044.098.052.096.067.09.08c.036.035.068.073.097.112l.071.11.031.062.034.081.024.076.03.148L15 2v5a1 1 0 0 1-2 0V4.414l-2.96 2.96A1 1 0 1 1 8.626 5.96L11.584 3H9a1 1 0 0 1-.993-.883L8 2a1 1 0 0 1 1-1h5Z"/></symbol><symbol id="icon-eds-i-arrow-down-medium" viewBox="0 0 24 24"><path d="m20.707 12.728-7.99 7.98a.996.996 0 0 1-.561.281l-.157.011a.998.998 0 0 1-.788-.384l-7.918-7.908a1 1 0 0 1 1.414-1.416L11 17.576V4a1 1 0 0 1 2 0v13.598l6.293-6.285a1 1 0 0 1 1.32-.082l.095.083a1 1 0 0 1-.001 1.414Z"/></symbol><symbol id="icon-eds-i-arrow-down-small" viewBox="0 0 16 16"><path d="m1.293 8.707 6 6 .063.059.093.069.081.048.105.049.104.034.056.013.118.017L8 15l.076-.003.122-.017.113-.03.085-.032.063-.03.098-.058.06-.043.05-.043 6.04-6.037a1 1 0 0 0-1.414-1.414L9 11.583V2a1 1 0 1 0-2 0v9.585L2.707 7.293a1 1 0 0 0-1.32-.083l-.094.083a1 1 0 0 0 0 1.414Z"/></symbol><symbol id="icon-eds-i-arrow-left-medium" viewBox="0 0 24 24"><path d="m11.272 3.293-7.98 7.99a.996.996 0 0 0-.281.561L3 12.001c0 .32.15.605.384.788l7.908 7.918a1 1 0 0 0 1.416-1.414L6.424 13H20a1 1 0 0 0 0-2H6.402l6.285-6.293a1 1 0 0 0 .082-1.32l-.083-.095a1 1 0 0 0-1.414.001Z"/></symbol><symbol id="icon-eds-i-arrow-left-small" viewBox="0 0 16 16"><path d="m7.293 1.293-6 6-.059.063-.069.093-.048.081-.049.105-.034.104-.013.056-.017.118L1 8l.003.076.017.122.03.113.032.085.03.063.058.098.043.06.043.05 6.037 6.04a1 1 0 0 0 1.414-1.414L4.417 9H14a1 1 0 0 0 0-2H4.415l4.292-4.293a1 1 0 0 0 .083-1.32l-.083-.094a1 1 0 0 0-1.414 0Z"/></symbol><symbol id="icon-eds-i-arrow-right-medium" viewBox="0 0 24 24"><path d="m12.728 3.293 7.98 7.99a.996.996 0 0 1 .281.561l.011.157c0 .32-.15.605-.384.788l-7.908 7.918a1 1 0 0 1-1.416-1.414L17.576 13H4a1 1 0 0 1 0-2h13.598l-6.285-6.293a1 1 0 0 1-.082-1.32l.083-.095a1 1 0 0 1 1.414.001Z"/></symbol><symbol id="icon-eds-i-arrow-right-small" viewBox="0 0 16 16"><path d="m8.707 1.293 6 6 .059.063.069.093.048.081.049.105.034.104.013.056.017.118L15 8l-.003.076-.017.122-.03.113-.032.085-.03.063-.058.098-.043.06-.043.05-6.037 6.04a1 1 0 0 1-1.414-1.414L11.583 9H2a1 1 0 1 1 0-2h9.585L7.293 2.707a1 1 0 0 1-.083-1.32l.083-.094a1 1 0 0 1 1.414 0Z"/></symbol><symbol id="icon-eds-i-arrow-up-medium" viewBox="0 0 24 24"><path d="m3.293 11.272 7.99-7.98a.996.996 0 0 1 .561-.281L12.001 3c.32 0 .605.15.788.384l7.918 7.908a1 1 0 0 1-1.414 1.416L13 6.424V20a1 1 0 0 1-2 0V6.402l-6.293 6.285a1 1 0 0 1-1.32.082l-.095-.083a1 1 0 0 1 .001-1.414Z"/></symbol><symbol id="icon-eds-i-arrow-up-small" viewBox="0 0 16 16"><path d="m1.293 7.293 6-6 .063-.059.093-.069.081-.048.105-.049.104-.034.056-.013.118-.017L8 1l.076.003.122.017.113.03.085.032.063.03.098.058.06.043.05.043 6.04 6.037a1 1 0 0 1-1.414 1.414L9 4.417V14a1 1 0 0 1-2 0V4.415L2.707 8.707a1 1 0 0 1-1.32.083l-.094-.083a1 1 0 0 1 0-1.414Z"/></symbol><symbol id="icon-eds-i-article-medium" viewBox="0 0 24 24"><path d="M8 7a1 1 0 0 0 0 2h4a1 1 0 1 0 0-2H8ZM8 11a1 1 0 1 0 0 2h8a1 1 0 1 0 0-2H8ZM7 16a1 1 0 0 1 1-1h8a1 1 0 1 1 0 2H8a1 1 0 0 1-1-1Z"/><path d="M5.545 1A2.542 2.542 0 0 0 3 3.538v16.924A2.542 2.542 0 0 0 5.545 23h12.91A2.542 2.542 0 0 0 21 20.462V3.5A2.5 2.5 0 0 0 18.5 1H5.545ZM5 3.538C5 3.245 5.24 3 5.545 3H18.5a.5.5 0 0 1 .5.5v16.962c0 .293-.24.538-.546.538H5.545A.542.542 0 0 1 5 20.462V3.538Z" clip-rule="evenodd"/></symbol><symbol id="icon-eds-i-book-medium" viewBox="0 0 24 24"><path d="M18.5 1A2.5 2.5 0 0 1 21 3.5v12c0 1.16-.79 2.135-1.86 2.418l-.14.031V21h1a1 1 0 0 1 .993.883L21 22a1 1 0 0 1-1 1H6.5A3.5 3.5 0 0 1 3 19.5v-15A3.5 3.5 0 0 1 6.5 1h12ZM17 18H6.5a1.5 1.5 0 0 0-1.493 1.356L5 19.5A1.5 1.5 0 0 0 6.5 21H17v-3Zm1.5-15h-12A1.5 1.5 0 0 0 5 4.5v11.837l.054-.025a3.481 3.481 0 0 1 1.254-.307L6.5 16h12a.5.5 0 0 0 .492-.41L19 15.5v-12a.5.5 0 0 0-.5-.5ZM15 6a1 1 0 0 1 0 2H9a1 1 0 1 1 0-2h6Z"/></symbol><symbol id="icon-eds-i-book-series-medium" viewBox="0 0 24 24"><path fill-rule="evenodd" d="M1 3.786C1 2.759 1.857 2 2.82 2H6.18c.964 0 1.82.759 1.82 1.786V4h3.168c.668 0 1.298.364 1.616.938.158-.109.333-.195.523-.252l3.216-.965c.923-.277 1.962.204 2.257 1.187l4.146 13.82c.296.984-.307 1.957-1.23 2.234l-3.217.965c-.923.277-1.962-.203-2.257-1.187L13 10.005v10.21c0 1.04-.878 1.785-1.834 1.785H7.833c-.291 0-.575-.07-.83-.195A1.849 1.849 0 0 1 6.18 22H2.821C1.857 22 1 21.241 1 20.214V3.786ZM3 4v11h3V4H3Zm0 16v-3h3v3H3Zm15.075-.04-.814-2.712 2.874-.862.813 2.712-2.873.862Zm1.485-5.49-2.874.862-2.634-8.782 2.873-.862 2.635 8.782ZM8 20V6h3v14H8Z" clip-rule="evenodd"/></symbol><symbol id="icon-eds-i-calendar-acceptance-medium" viewBox="0 0 24 24"><path d="M17 2a1 1 0 0 1 1 1v1h1.5C20.817 4 22 5.183 22 6.5v13c0 1.317-1.183 2.5-2.5 2.5h-15C3.183 22 2 20.817 2 19.5v-13C2 5.183 3.183 4 4.5 4a1 1 0 1 1 0 2c-.212 0-.5.288-.5.5v13c0 .212.288.5.5.5h15c.212 0 .5-.288.5-.5v-13c0-.212-.288-.5-.5-.5H18v1a1 1 0 0 1-2 0V3a1 1 0 0 1 1-1Zm-.534 7.747a1 1 0 0 1 .094 1.412l-4.846 5.538a1 1 0 0 1-1.352.141l-2.77-2.076a1 1 0 0 1 1.2-1.6l2.027 1.519 4.236-4.84a1 1 0 0 1 1.411-.094ZM7.5 2a1 1 0 0 1 1 1v1H14a1 1 0 0 1 0 2H8.5v1a1 1 0 1 1-2 0V3a1 1 0 0 1 1-1Z"/></symbol><symbol id="icon-eds-i-calendar-date-medium" viewBox="0 0 24 24"><path d="M17 2a1 1 0 0 1 1 1v1h1.5C20.817 4 22 5.183 22 6.5v13c0 1.317-1.183 2.5-2.5 2.5h-15C3.183 22 2 20.817 2 19.5v-13C2 5.183 3.183 4 4.5 4a1 1 0 1 1 0 2c-.212 0-.5.288-.5.5v13c0 .212.288.5.5.5h15c.212 0 .5-.288.5-.5v-13c0-.212-.288-.5-.5-.5H18v1a1 1 0 0 1-2 0V3a1 1 0 0 1 1-1ZM8 15a1 1 0 1 1 0 2 1 1 0 0 1 0-2Zm4 0a1 1 0 1 1 0 2 1 1 0 0 1 0-2Zm-4-4a1 1 0 1 1 0 2 1 1 0 0 1 0-2Zm4 0a1 1 0 1 1 0 2 1 1 0 0 1 0-2Zm4 0a1 1 0 1 1 0 2 1 1 0 0 1 0-2ZM7.5 2a1 1 0 0 1 1 1v1H14a1 1 0 0 1 0 2H8.5v1a1 1 0 1 1-2 0V3a1 1 0 0 1 1-1Z"/></symbol><symbol id="icon-eds-i-calendar-decision-medium" viewBox="0 0 24 24"><path d="M17 2a1 1 0 0 1 1 1v1h1.5C20.817 4 22 5.183 22 6.5v13c0 1.317-1.183 2.5-2.5 2.5h-15C3.183 22 2 20.817 2 19.5v-13C2 5.183 3.183 4 4.5 4a1 1 0 1 1 0 2c-.212 0-.5.288-.5.5v13c0 .212.288.5.5.5h15c.212 0 .5-.288.5-.5v-13c0-.212-.288-.5-.5-.5H18v1a1 1 0 0 1-2 0V3a1 1 0 0 1 1-1Zm-2.935 8.246 2.686 2.645c.34.335.34.883 0 1.218l-2.686 2.645a.858.858 0 0 1-1.213-.009.854.854 0 0 1 .009-1.21l1.05-1.035H7.984a.992.992 0 0 1-.984-1c0-.552.44-1 .984-1h5.928l-1.051-1.036a.854.854 0 0 1-.085-1.121l.076-.088a.858.858 0 0 1 1.213-.009ZM7.5 2a1 1 0 0 1 1 1v1H14a1 1 0 0 1 0 2H8.5v1a1 1 0 1 1-2 0V3a1 1 0 0 1 1-1Z"/></symbol><symbol id="icon-eds-i-calendar-impact-factor-medium" viewBox="0 0 24 24"><path d="M17 2a1 1 0 0 1 1 1v1h1.5C20.817 4 22 5.183 22 6.5v13c0 1.317-1.183 2.5-2.5 2.5h-15C3.183 22 2 20.817 2 19.5v-13C2 5.183 3.183 4 4.5 4a1 1 0 1 1 0 2c-.212 0-.5.288-.5.5v13c0 .212.288.5.5.5h15c.212 0 .5-.288.5-.5v-13c0-.212-.288-.5-.5-.5H18v1a1 1 0 0 1-2 0V3a1 1 0 0 1 1-1Zm-3.2 6.924a.48.48 0 0 1 .125.544l-1.52 3.283h2.304c.27 0 .491.215.491.483a.477.477 0 0 1-.13.327l-4.18 4.484a.498.498 0 0 1-.69.031.48.48 0 0 1-.125-.544l1.52-3.284H9.291a.487.487 0 0 1-.491-.482c0-.121.047-.238.13-.327l4.18-4.484a.498.498 0 0 1 .69-.031ZM7.5 2a1 1 0 0 1 1 1v1H14a1 1 0 0 1 0 2H8.5v1a1 1 0 1 1-2 0V3a1 1 0 0 1 1-1Z"/></symbol><symbol id="icon-eds-i-call-papers-medium" viewBox="0 0 24 24"><g><path d="m20.707 2.883-1.414 1.414a1 1 0 0 0 1.414 1.414l1.414-1.414a1 1 0 0 0-1.414-1.414Z"/><path d="M6 16.054c0 2.026 1.052 2.943 3 2.943a1 1 0 1 1 0 2c-2.996 0-5-1.746-5-4.943v-1.227a4.068 4.068 0 0 1-1.83-1.189 4.553 4.553 0 0 1-.87-1.455 4.868 4.868 0 0 1-.3-1.686c0-1.17.417-2.298 1.17-3.14.38-.426.834-.767 1.338-1 .51-.237 1.06-.36 1.617-.36L6.632 6H7l7.932-2.895A2.363 2.363 0 0 1 18 5.36v9.28a2.36 2.36 0 0 1-3.069 2.25l.084.03L7 14.997H6v1.057Zm9.637-11.057a.415.415 0 0 0-.083.008L8 7.638v5.536l7.424 1.786.104.02c.035.01.072.02.109.02.2 0 .363-.16.363-.36V5.36c0-.2-.163-.363-.363-.363Zm-9.638 3h-.874a1.82 1.82 0 0 0-.625.111l-.15.063a2.128 2.128 0 0 0-.689.517c-.42.47-.661 1.123-.661 1.81 0 .34.06.678.176.992.114.308.28.585.485.816.4.447.925.691 1.464.691h.874v-5Z" clip-rule="evenodd"/><path d="M20 8.997h2a1 1 0 1 1 0 2h-2a1 1 0 1 1 0-2ZM20.707 14.293l1.414 1.414a1 1 0 0 1-1.414 1.414l-1.414-1.414a1 1 0 0 1 1.414-1.414Z"/></g></symbol><symbol id="icon-eds-i-card-medium" viewBox="0 0 24 24"><path d="M19.615 2c.315 0 .716.067 1.14.279.76.38 1.245 1.107 1.245 2.106v15.23c0 .315-.067.716-.279 1.14-.38.76-1.107 1.245-2.106 1.245H4.385a2.56 2.56 0 0 1-1.14-.279C2.485 21.341 2 20.614 2 19.615V4.385c0-.315.067-.716.279-1.14C2.659 2.485 3.386 2 4.385 2h15.23Zm0 2H4.385c-.213 0-.265.034-.317.14A.71.71 0 0 0 4 4.385v15.23c0 .213.034.265.14.317a.71.71 0 0 0 .245.068h15.23c.213 0 .265-.034.317-.14a.71.71 0 0 0 .068-.245V4.385c0-.213-.034-.265-.14-.317A.71.71 0 0 0 19.615 4ZM17 16a1 1 0 0 1 0 2H7a1 1 0 0 1 0-2h10Zm0-3a1 1 0 0 1 0 2H7a1 1 0 0 1 0-2h10Zm-.5-7A1.5 1.5 0 0 1 18 7.5v3a1.5 1.5 0 0 1-1.5 1.5h-9A1.5 1.5 0 0 1 6 10.5v-3A1.5 1.5 0 0 1 7.5 6h9ZM16 8H8v2h8V8Z"/></symbol><symbol id="icon-eds-i-cart-medium" viewBox="0 0 24 24"><path d="M5.76 1a1 1 0 0 1 .994.902L7.155 6h13.34c.18 0 .358.02.532.057l.174.045a2.5 2.5 0 0 1 1.693 3.103l-2.069 7.03c-.36 1.099-1.398 1.823-2.49 1.763H8.65c-1.272.015-2.352-.927-2.546-2.244L4.852 3H2a1 1 0 0 1-.993-.883L1 2a1 1 0 0 1 1-1h3.76Zm2.328 14.51a.555.555 0 0 0 .55.488l9.751.001a.533.533 0 0 0 .527-.357l2.059-7a.5.5 0 0 0-.48-.642H7.351l.737 7.51ZM18 19a2 2 0 1 1 0 4 2 2 0 0 1 0-4ZM8 19a2 2 0 1 1 0 4 2 2 0 0 1 0-4Z"/></symbol><symbol id="icon-eds-i-check-circle-medium" viewBox="0 0 24 24"><path d="M12 1c6.075 0 11 4.925 11 11s-4.925 11-11 11S1 18.075 1 12 5.925 1 12 1Zm0 2a9 9 0 1 0 0 18 9 9 0 0 0 0-18Zm5.125 4.72a1 1 0 0 1 .156 1.405l-6 7.5a1 1 0 0 1-1.421.143l-3-2.5a1 1 0 0 1 1.28-1.536l2.217 1.846 5.362-6.703a1 1 0 0 1 1.406-.156Z"/></symbol><symbol id="icon-eds-i-check-filled-medium" viewBox="0 0 24 24"><path d="M12 1c6.075 0 11 4.925 11 11s-4.925 11-11 11S1 18.075 1 12 5.925 1 12 1Zm5.125 6.72a1 1 0 0 0-1.406.155l-5.362 6.703-2.217-1.846a1 1 0 1 0-1.28 1.536l3 2.5a1 1 0 0 0 1.42-.143l6-7.5a1 1 0 0 0-.155-1.406Z"/></symbol><symbol id="icon-eds-i-chevron-down-medium" viewBox="0 0 24 24"><path d="M3.305 8.28a1 1 0 0 0-.024 1.415l7.495 7.762c.314.345.757.543 1.224.543.467 0 .91-.198 1.204-.522l7.515-7.783a1 1 0 1 0-1.438-1.39L12 15.845l-7.28-7.54A1 1 0 0 0 3.4 8.2l-.096.082Z"/></symbol><symbol id="icon-eds-i-chevron-down-small" viewBox="0 0 16 16"><path d="M13.692 5.278a1 1 0 0 1 .03 1.414L9.103 11.51a1.491 1.491 0 0 1-2.188.019L2.278 6.692a1 1 0 0 1 1.444-1.384L8 9.771l4.278-4.463a1 1 0 0 1 1.318-.111l.096.081Z"/></symbol><symbol id="icon-eds-i-chevron-left-medium" viewBox="0 0 24 24"><path d="M15.72 3.305a1 1 0 0 0-1.415-.024l-7.762 7.495A1.655 1.655 0 0 0 6 12c0 .467.198.91.522 1.204l7.783 7.515a1 1 0 1 0 1.39-1.438L8.155 12l7.54-7.28A1 1 0 0 0 15.8 3.4l-.082-.096Z"/></symbol><symbol id="icon-eds-i-chevron-left-small" viewBox="0 0 16 16"><path d="M10.722 2.308a1 1 0 0 0-1.414-.03L4.49 6.897a1.491 1.491 0 0 0-.019 2.188l4.838 4.637a1 1 0 1 0 1.384-1.444L6.229 8l4.463-4.278a1 1 0 0 0 .111-1.318l-.081-.096Z"/></symbol><symbol id="icon-eds-i-chevron-right-medium" viewBox="0 0 24 24"><path d="M8.28 3.305a1 1 0 0 1 1.415-.024l7.762 7.495c.345.314.543.757.543 1.224 0 .467-.198.91-.522 1.204l-7.783 7.515a1 1 0 1 1-1.39-1.438L15.845 12l-7.54-7.28A1 1 0 0 1 8.2 3.4l.082-.096Z"/></symbol><symbol id="icon-eds-i-chevron-right-small" viewBox="0 0 16 16"><path d="M5.278 2.308a1 1 0 0 1 1.414-.03l4.819 4.619a1.491 1.491 0 0 1 .019 2.188l-4.838 4.637a1 1 0 1 1-1.384-1.444L9.771 8 5.308 3.722a1 1 0 0 1-.111-1.318l.081-.096Z"/></symbol><symbol id="icon-eds-i-chevron-up-medium" viewBox="0 0 24 24"><path d="M20.695 15.72a1 1 0 0 0 .024-1.415l-7.495-7.762A1.655 1.655 0 0 0 12 6c-.467 0-.91.198-1.204.522l-7.515 7.783a1 1 0 1 0 1.438 1.39L12 8.155l7.28 7.54a1 1 0 0 0 1.319.106l.096-.082Z"/></symbol><symbol id="icon-eds-i-chevron-up-small" viewBox="0 0 16 16"><path d="M13.692 10.722a1 1 0 0 0 .03-1.414L9.103 4.49a1.491 1.491 0 0 0-2.188-.019L2.278 9.308a1 1 0 0 0 1.444 1.384L8 6.229l4.278 4.463a1 1 0 0 0 1.318.111l.096-.081Z"/></symbol><symbol id="icon-eds-i-citations-medium" viewBox="0 0 24 24"><path d="M15.59 1a1 1 0 0 1 .706.291l5.41 5.385a1 1 0 0 1 .294.709v13.077c0 .674-.269 1.32-.747 1.796a2.549 2.549 0 0 1-1.798.742h-5.843a1 1 0 1 1 0-2h5.843a.549.549 0 0 0 .387-.16.535.535 0 0 0 .158-.378V7.8L15.178 3H5.545a.543.543 0 0 0-.538.451L5 3.538v8.607a1 1 0 0 1-2 0V3.538A2.542 2.542 0 0 1 5.545 1h10.046ZM5.483 14.35c.197.26.17.62-.049.848l-.095.083-.016.011c-.36.24-.628.45-.804.634-.393.409-.59.93-.59 1.562.077-.019.192-.028.345-.028.442 0 .84.158 1.195.474.355.316.532.716.532 1.2 0 .501-.173.9-.518 1.198-.345.298-.767.446-1.266.446-.672 0-1.209-.195-1.612-.585-.403-.39-.604-.976-.604-1.757 0-.744.11-1.39.33-1.938.222-.549.49-1.009.807-1.38a4.28 4.28 0 0 1 .992-.88c.07-.043.148-.087.232-.133a.881.881 0 0 1 1.121.245Zm5 0c.197.26.17.62-.049.848l-.095.083-.016.011c-.36.24-.628.45-.804.634-.393.409-.59.93-.59 1.562.077-.019.192-.028.345-.028.442 0 .84.158 1.195.474.355.316.532.716.532 1.2 0 .501-.173.9-.518 1.198-.345.298-.767.446-1.266.446-.672 0-1.209-.195-1.612-.585-.403-.39-.604-.976-.604-1.757 0-.744.11-1.39.33-1.938.222-.549.49-1.009.807-1.38a4.28 4.28 0 0 1 .992-.88c.07-.043.148-.087.232-.133a.881.881 0 0 1 1.121.245Z"/></symbol><symbol id="icon-eds-i-clipboard-check-medium" viewBox="0 0 24 24"><path d="M14.4 1c1.238 0 2.274.865 2.536 2.024L18.5 3C19.886 3 21 4.14 21 5.535v14.93C21 21.86 19.886 23 18.5 23h-13C4.114 23 3 21.86 3 20.465V5.535C3 4.14 4.114 3 5.5 3h1.57c.27-1.147 1.3-2 2.53-2h4.8Zm4.115 4-1.59.024A2.601 2.601 0 0 1 14.4 7H9.6c-1.23 0-2.26-.853-2.53-2H5.5c-.27 0-.5.234-.5.535v14.93c0 .3.23.535.5.535h13c.27 0 .5-.234.5-.535V5.535c0-.3-.23-.535-.485-.535Zm-1.909 4.205a1 1 0 0 1 .19 1.401l-5.334 7a1 1 0 0 1-1.344.23l-2.667-1.75a1 1 0 1 1 1.098-1.672l1.887 1.238 4.769-6.258a1 1 0 0 1 1.401-.19ZM14.4 3H9.6a.6.6 0 0 0-.6.6v.8a.6.6 0 0 0 .6.6h4.8a.6.6 0 0 0 .6-.6v-.8a.6.6 0 0 0-.6-.6Z"/></symbol><symbol id="icon-eds-i-clipboard-report-medium" viewBox="0 0 24 24"><path d="M14.4 1c1.238 0 2.274.865 2.536 2.024L18.5 3C19.886 3 21 4.14 21 5.535v14.93C21 21.86 19.886 23 18.5 23h-13C4.114 23 3 21.86 3 20.465V5.535C3 4.14 4.114 3 5.5 3h1.57c.27-1.147 1.3-2 2.53-2h4.8Zm4.115 4-1.59.024A2.601 2.601 0 0 1 14.4 7H9.6c-1.23 0-2.26-.853-2.53-2H5.5c-.27 0-.5.234-.5.535v14.93c0 .3.23.535.5.535h13c.27 0 .5-.234.5-.535V5.535c0-.3-.23-.535-.485-.535Zm-2.658 10.929a1 1 0 0 1 0 2H8a1 1 0 0 1 0-2h7.857Zm0-3.929a1 1 0 0 1 0 2H8a1 1 0 0 1 0-2h7.857ZM14.4 3H9.6a.6.6 0 0 0-.6.6v.8a.6.6 0 0 0 .6.6h4.8a.6.6 0 0 0 .6-.6v-.8a.6.6 0 0 0-.6-.6Z"/></symbol><symbol id="icon-eds-i-close-medium" viewBox="0 0 24 24"><path d="M12 1c6.075 0 11 4.925 11 11s-4.925 11-11 11S1 18.075 1 12 5.925 1 12 1Zm0 2a9 9 0 1 0 0 18 9 9 0 0 0 0-18ZM8.707 7.293 12 10.585l3.293-3.292a1 1 0 0 1 1.414 1.414L13.415 12l3.292 3.293a1 1 0 0 1-1.414 1.414L12 13.415l-3.293 3.292a1 1 0 1 1-1.414-1.414L10.585 12 7.293 8.707a1 1 0 0 1 1.414-1.414Z"/></symbol><symbol id="icon-eds-i-cloud-upload-medium" viewBox="0 0 24 24"><path d="m12.852 10.011.028-.004L13 10l.075.003.126.017.086.022.136.052.098.052.104.074.082.073 3 3a1 1 0 0 1 0 1.414l-.094.083a1 1 0 0 1-1.32-.083L14 13.416V20a1 1 0 0 1-2 0v-6.586l-1.293 1.293a1 1 0 0 1-1.32.083l-.094-.083a1 1 0 0 1 0-1.414l3-3 .112-.097.11-.071.114-.054.105-.035.118-.025Zm.587-7.962c3.065.362 5.497 2.662 5.992 5.562l.013.085.207.073c2.117.782 3.496 2.845 3.337 5.097l-.022.226c-.297 2.561-2.503 4.491-5.124 4.502a1 1 0 1 1-.009-2c1.619-.007 2.967-1.186 3.147-2.733.179-1.542-.86-2.979-2.487-3.353-.512-.149-.894-.579-.981-1.165-.21-2.237-2-4.035-4.308-4.308-2.31-.273-4.497 1.06-5.25 3.19l-.049.113c-.234.468-.718.756-1.176.743-1.418.057-2.689.857-3.32 2.084a3.668 3.668 0 0 0 .262 3.798c.796 1.136 2.169 1.764 3.583 1.635a1 1 0 1 1 .182 1.992c-2.125.194-4.193-.753-5.403-2.48a5.668 5.668 0 0 1-.403-5.86c.85-1.652 2.449-2.79 4.323-3.092l.287-.039.013-.028c1.207-2.741 4.125-4.404 7.186-4.042Z"/></symbol><symbol id="icon-eds-i-collection-medium" viewBox="0 0 24 24"><path d="M21 7a1 1 0 0 1 1 1v12.5a2.5 2.5 0 0 1-2.5 2.5H8a1 1 0 0 1 0-2h11.5a.5.5 0 0 0 .5-.5V8a1 1 0 0 1 1-1Zm-5.5-5A2.5 2.5 0 0 1 18 4.5v12a2.5 2.5 0 0 1-2.5 2.5h-11A2.5 2.5 0 0 1 2 16.5v-12A2.5 2.5 0 0 1 4.5 2h11Zm0 2h-11a.5.5 0 0 0-.5.5v12a.5.5 0 0 0 .5.5h11a.5.5 0 0 0 .5-.5v-12a.5.5 0 0 0-.5-.5ZM13 13a1 1 0 0 1 0 2H7a1 1 0 0 1 0-2h6Zm0-3.5a1 1 0 0 1 0 2H7a1 1 0 0 1 0-2h6ZM13 6a1 1 0 0 1 0 2H7a1 1 0 1 1 0-2h6Z"/></symbol><symbol id="icon-eds-i-conference-series-medium" viewBox="0 0 24 24"><path fill-rule="evenodd" d="M4.5 2A2.5 2.5 0 0 0 2 4.5v11A2.5 2.5 0 0 0 4.5 18h2.37l-2.534 2.253a1 1 0 0 0 1.328 1.494L9.88 18H11v3a1 1 0 1 0 2 0v-3h1.12l4.216 3.747a1 1 0 0 0 1.328-1.494L17.13 18h2.37a2.5 2.5 0 0 0 2.5-2.5v-11A2.5 2.5 0 0 0 19.5 2h-15ZM20 6V4.5a.5.5 0 0 0-.5-.5h-15a.5.5 0 0 0-.5.5V6h16ZM4 8v7.5a.5.5 0 0 0 .5.5h15a.5.5 0 0 0 .5-.5V8H4Z" clip-rule="evenodd"/></symbol><symbol id="icon-eds-i-delivery-medium" viewBox="0 0 24 24"><path d="M8.51 20.598a3.037 3.037 0 0 1-3.02 0A2.968 2.968 0 0 1 4.161 19L3.5 19A2.5 2.5 0 0 1 1 16.5v-11A2.5 2.5 0 0 1 3.5 3h10a2.5 2.5 0 0 1 2.45 2.004L16 5h2.527c.976 0 1.855.585 2.27 1.49l2.112 4.62a1 1 0 0 1 .091.416v4.856C23 17.814 21.889 19 20.484 19h-.523a1.01 1.01 0 0 1-.121-.007 2.96 2.96 0 0 1-1.33 1.605 3.037 3.037 0 0 1-3.02 0A2.968 2.968 0 0 1 14.161 19H9.838a2.968 2.968 0 0 1-1.327 1.597Zm-2.024-3.462a.955.955 0 0 0-.481.73L5.999 18l.001.022a.944.944 0 0 0 .388.777l.098.065c.316.181.712.181 1.028 0A.97.97 0 0 0 8 17.978a.95.95 0 0 0-.486-.842 1.037 1.037 0 0 0-1.028 0Zm10 0a.955.955 0 0 0-.481.73l-.005.156a.944.944 0 0 0 .388.777l.098.065c.316.181.712.181 1.028 0a.97.97 0 0 0 .486-.886.95.95 0 0 0-.486-.842 1.037 1.037 0 0 0-1.028 0ZM21 12h-5v3.17a3.038 3.038 0 0 1 2.51.232 2.993 2.993 0 0 1 1.277 1.45l.058.155.058-.005.581-.002c.27 0 .516-.263.516-.618V12Zm-7.5-7h-10a.5.5 0 0 0-.5.5v11a.5.5 0 0 0 .5.5h.662a2.964 2.964 0 0 1 1.155-1.491l.172-.107a3.037 3.037 0 0 1 3.022 0A2.987 2.987 0 0 1 9.843 17H13.5a.5.5 0 0 0 .5-.5v-11a.5.5 0 0 0-.5-.5Zm5.027 2H16v3h4.203l-1.224-2.677a.532.532 0 0 0-.375-.316L18.527 7Z"/></symbol><symbol id="icon-eds-i-download-medium" viewBox="0 0 24 24"><path d="M22 18.5a3.5 3.5 0 0 1-3.5 3.5h-13A3.5 3.5 0 0 1 2 18.5V18a1 1 0 0 1 2 0v.5A1.5 1.5 0 0 0 5.5 20h13a1.5 1.5 0 0 0 1.5-1.5V18a1 1 0 0 1 2 0v.5Zm-3.293-7.793-6 6-.063.059-.093.069-.081.048-.105.049-.104.034-.056.013-.118.017L12 17l-.076-.003-.122-.017-.113-.03-.085-.032-.063-.03-.098-.058-.06-.043-.05-.043-6.04-6.037a1 1 0 0 1 1.414-1.414l4.294 4.29L11 3a1 1 0 0 1 2 0l.001 10.585 4.292-4.292a1 1 0 0 1 1.32-.083l.094.083a1 1 0 0 1 0 1.414Z"/></symbol><symbol id="icon-eds-i-edit-medium" viewBox="0 0 24 24"><path d="M17.149 2a2.38 2.38 0 0 1 1.699.711l2.446 2.46a2.384 2.384 0 0 1 .005 3.38L10.01 19.906a1 1 0 0 1-.434.257l-6.3 1.8a1 1 0 0 1-1.237-1.237l1.8-6.3a1 1 0 0 1 .257-.434L15.443 2.718A2.385 2.385 0 0 1 17.15 2Zm-3.874 5.689-7.586 7.536-1.234 4.319 4.318-1.234 7.54-7.582-3.038-3.039ZM17.149 4a.395.395 0 0 0-.286.126L14.695 6.28l3.029 3.029 2.162-2.173a.384.384 0 0 0 .106-.197L20 6.864c0-.103-.04-.2-.119-.278l-2.457-2.47A.385.385 0 0 0 17.149 4Z"/></symbol><symbol id="icon-eds-i-education-medium" viewBox="0 0 24 24"><path fill-rule="evenodd" d="M12.41 2.088a1 1 0 0 0-.82 0l-10 4.5a1 1 0 0 0 0 1.824L3 9.047v7.124A3.001 3.001 0 0 0 4 22a3 3 0 0 0 1-5.83V9.948l1 .45V14.5a1 1 0 0 0 .087.408L7 14.5c-.913.408-.912.41-.912.41l.001.003.003.006.007.015a1.988 1.988 0 0 0 .083.16c.054.097.131.225.236.373.21.297.53.68.993 1.057C8.351 17.292 9.824 18 12 18c2.176 0 3.65-.707 4.589-1.476.463-.378.783-.76.993-1.057a4.162 4.162 0 0 0 .319-.533l.007-.015.003-.006v-.003h.002s0-.002-.913-.41l.913.408A1 1 0 0 0 18 14.5v-4.103l4.41-1.985a1 1 0 0 0 0-1.824l-10-4.5ZM16 11.297l-3.59 1.615a1 1 0 0 1-.82 0L8 11.297v2.94a3.388 3.388 0 0 0 .677.739C9.267 15.457 10.294 16 12 16s2.734-.543 3.323-1.024a3.388 3.388 0 0 0 .677-.739v-2.94ZM4.437 7.5 12 4.097 19.563 7.5 12 10.903 4.437 7.5ZM3 19a1 1 0 1 1 2 0 1 1 0 0 1-2 0Z" clip-rule="evenodd"/></symbol><symbol id="icon-eds-i-error-diamond-medium" viewBox="0 0 24 24"><path d="M12.002 1c.702 0 1.375.279 1.871.775l8.35 8.353a2.646 2.646 0 0 1 .001 3.744l-8.353 8.353a2.646 2.646 0 0 1-3.742 0l-8.353-8.353a2.646 2.646 0 0 1 0-3.744l8.353-8.353.156-.142c.424-.362.952-.58 1.507-.625l.21-.008Zm0 2a.646.646 0 0 0-.38.123l-.093.08-8.34 8.34a.646.646 0 0 0-.18.355L3 12c0 .171.068.336.19.457l8.353 8.354a.646.646 0 0 0 .914 0l8.354-8.354a.646.646 0 0 0-.001-.914l-8.351-8.354A.646.646 0 0 0 12.002 3ZM12 14.5a1.5 1.5 0 0 1 .144 2.993L12 17.5a1.5 1.5 0 0 1 0-3ZM12 6a1 1 0 0 1 1 1v5a1 1 0 0 1-2 0V7a1 1 0 0 1 1-1Z"/></symbol><symbol id="icon-eds-i-error-filled-medium" viewBox="0 0 24 24"><path d="M12.002 1c.702 0 1.375.279 1.871.775l8.35 8.353a2.646 2.646 0 0 1 .001 3.744l-8.353 8.353a2.646 2.646 0 0 1-3.742 0l-8.353-8.353a2.646 2.646 0 0 1 0-3.744l8.353-8.353.156-.142c.424-.362.952-.58 1.507-.625l.21-.008ZM12 14.5a1.5 1.5 0 0 0 0 3l.144-.007A1.5 1.5 0 0 0 12 14.5ZM12 6a1 1 0 0 0-1 1v5a1 1 0 0 0 2 0V7a1 1 0 0 0-1-1Z"/></symbol><symbol id="icon-eds-i-external-link-medium" viewBox="0 0 24 24"><path d="M9 2a1 1 0 1 1 0 2H4.6c-.371 0-.6.209-.6.5v15c0 .291.229.5.6.5h14.8c.371 0 .6-.209.6-.5V15a1 1 0 0 1 2 0v4.5c0 1.438-1.162 2.5-2.6 2.5H4.6C3.162 22 2 20.938 2 19.5v-15C2 3.062 3.162 2 4.6 2H9Zm6 0h6l.075.003.126.017.111.03.111.044.098.052.096.067.09.08c.036.035.068.073.097.112l.071.11.054.114.035.105.03.148L22 3v6a1 1 0 0 1-2 0V5.414l-6.693 6.693a1 1 0 0 1-1.414-1.414L18.584 4H15a1 1 0 0 1-.993-.883L14 3a1 1 0 0 1 1-1Z"/></symbol><symbol id="icon-eds-i-external-link-small" viewBox="0 0 16 16"><path d="M5 1a1 1 0 1 1 0 2l-2-.001V13L13 13v-2a1 1 0 0 1 2 0v2c0 1.15-.93 2-2.067 2H3.067C1.93 15 1 14.15 1 13V3c0-1.15.93-2 2.067-2H5Zm4 0h5l.075.003.126.017.111.03.111.044.098.052.096.067.09.08.044.047.073.093.051.083.054.113.035.105.03.148L15 2v5a1 1 0 0 1-2 0V4.414L9.107 8.307a1 1 0 0 1-1.414-1.414L11.584 3H9a1 1 0 0 1-.993-.883L8 2a1 1 0 0 1 1-1Z"/></symbol><symbol id="icon-eds-i-file-download-medium" viewBox="0 0 24 24"><path d="M14.5 1a1 1 0 0 1 .707.293l5.5 5.5A1 1 0 0 1 21 7.5v12.962A2.542 2.542 0 0 1 18.455 23H5.545A2.542 2.542 0 0 1 3 20.462V3.538A2.542 2.542 0 0 1 5.545 1H14.5Zm-.415 2h-8.54A.542.542 0 0 0 5 3.538v16.924c0 .296.243.538.545.538h12.91a.542.542 0 0 0 .545-.538V7.915L14.085 3ZM12 7a1 1 0 0 1 1 1v6.585l2.293-2.292a1 1 0 0 1 1.32-.083l.094.083a1 1 0 0 1 0 1.414l-4 4a1.008 1.008 0 0 1-.112.097l-.11.071-.114.054-.105.035-.149.03L12 18l-.075-.003-.126-.017-.111-.03-.111-.044-.098-.052-.096-.067-.09-.08-4-4a1 1 0 0 1 1.414-1.414L11 14.585V8a1 1 0 0 1 1-1Z"/></symbol><symbol id="icon-eds-i-file-report-medium" viewBox="0 0 24 24"><path d="M14.5 1a1 1 0 0 1 .707.293l5.5 5.5A1 1 0 0 1 21 7.5v12.962c0 .674-.269 1.32-.747 1.796a2.549 2.549 0 0 1-1.798.742H5.545c-.674 0-1.32-.267-1.798-.742A2.535 2.535 0 0 1 3 20.462V3.538A2.542 2.542 0 0 1 5.545 1H14.5Zm-.415 2h-8.54A.542.542 0 0 0 5 3.538v16.924c0 .142.057.278.158.379.102.102.242.159.387.159h12.91a.549.549 0 0 0 .387-.16.535.535 0 0 0 .158-.378V7.915L14.085 3ZM16 17a1 1 0 0 1 0 2H8a1 1 0 0 1 0-2h8Zm0-3a1 1 0 0 1 0 2H8a1 1 0 0 1 0-2h8Zm-4.793-6.207L13 9.585l1.793-1.792a1 1 0 0 1 1.32-.083l.094.083a1 1 0 0 1 0 1.414l-2.5 2.5a1 1 0 0 1-1.414 0L10.5 9.915l-1.793 1.792a1 1 0 0 1-1.32.083l-.094-.083a1 1 0 0 1 0-1.414l2.5-2.5a1 1 0 0 1 1.414 0Z"/></symbol><symbol id="icon-eds-i-file-text-medium" viewBox="0 0 24 24"><path d="M14.5 1a1 1 0 0 1 .707.293l5.5 5.5A1 1 0 0 1 21 7.5v12.962A2.542 2.542 0 0 1 18.455 23H5.545A2.542 2.542 0 0 1 3 20.462V3.538A2.542 2.542 0 0 1 5.545 1H14.5Zm-.415 2h-8.54A.542.542 0 0 0 5 3.538v16.924c0 .296.243.538.545.538h12.91a.542.542 0 0 0 .545-.538V7.915L14.085 3ZM16 15a1 1 0 0 1 0 2H8a1 1 0 0 1 0-2h8Zm0-4a1 1 0 0 1 0 2H8a1 1 0 0 1 0-2h8Zm-5-4a1 1 0 0 1 0 2H8a1 1 0 1 1 0-2h3Z"/></symbol><symbol id="icon-eds-i-file-upload-medium" viewBox="0 0 24 24"><path d="M14.5 1a1 1 0 0 1 .707.293l5.5 5.5A1 1 0 0 1 21 7.5v12.962A2.542 2.542 0 0 1 18.455 23H5.545A2.542 2.542 0 0 1 3 20.462V3.538A2.542 2.542 0 0 1 5.545 1H14.5Zm-.415 2h-8.54A.542.542 0 0 0 5 3.538v16.924c0 .296.243.538.545.538h12.91a.542.542 0 0 0 .545-.538V7.915L14.085 3Zm-2.233 4.011.058-.007L12 7l.075.003.126.017.111.03.111.044.098.052.104.074.082.073 4 4a1 1 0 0 1 0 1.414l-.094.083a1 1 0 0 1-1.32-.083L13 10.415V17a1 1 0 0 1-2 0v-6.585l-2.293 2.292a1 1 0 0 1-1.32.083l-.094-.083a1 1 0 0 1 0-1.414l4-4 .112-.097.11-.071.114-.054.105-.035.118-.025Z"/></symbol><symbol id="icon-eds-i-filter-medium" viewBox="0 0 24 24"><path d="M21 2a1 1 0 0 1 .82 1.573L15 13.314V18a1 1 0 0 1-.31.724l-.09.076-4 3A1 1 0 0 1 9 21v-7.684L2.18 3.573a1 1 0 0 1 .707-1.567L3 2h18Zm-1.921 2H4.92l5.9 8.427a1 1 0 0 1 .172.45L11 13v6l2-1.5V13a1 1 0 0 1 .117-.469l.064-.104L19.079 4Z"/></symbol><symbol id="icon-eds-i-funding-medium" viewBox="0 0 24 24"><path fill-rule="evenodd" d="M23 8A7 7 0 1 0 9 8a7 7 0 0 0 14 0ZM9.006 12.225A4.07 4.07 0 0 0 6.12 11.02H2a.979.979 0 1 0 0 1.958h4.12c.558 0 1.094.222 1.489.617l2.207 2.288c.27.27.27.687.012.944a.656.656 0 0 1-.928 0L7.744 15.67a.98.98 0 0 0-1.386 1.384l1.157 1.158c.535.536 1.244.791 1.946.765l.041.002h6.922c.874 0 1.597.748 1.597 1.688 0 .203-.146.354-.309.354H7.755c-.487 0-.96-.178-1.339-.504L2.64 17.259a.979.979 0 0 0-1.28 1.482L5.137 22c.733.631 1.66.979 2.618.979h9.957c1.26 0 2.267-1.043 2.267-2.312 0-2.006-1.584-3.646-3.555-3.646h-4.529a2.617 2.617 0 0 0-.681-2.509l-2.208-2.287ZM16 3a5 5 0 1 0 0 10 5 5 0 0 0 0-10Zm.979 3.5a.979.979 0 1 0-1.958 0v3a.979.979 0 1 0 1.958 0v-3Z" clip-rule="evenodd"/></symbol><symbol id="icon-eds-i-hashtag-medium" viewBox="0 0 24 24"><path d="M12 1c6.075 0 11 4.925 11 11s-4.925 11-11 11S1 18.075 1 12 5.925 1 12 1Zm0 2a9 9 0 1 0 0 18 9 9 0 0 0 0-18ZM9.52 18.189a1 1 0 1 1-1.964-.378l.437-2.274H6a1 1 0 1 1 0-2h2.378l.592-3.076H6a1 1 0 0 1 0-2h3.354l.51-2.65a1 1 0 1 1 1.964.378l-.437 2.272h3.04l.51-2.65a1 1 0 1 1 1.964.378l-.438 2.272H18a1 1 0 0 1 0 2h-1.917l-.592 3.076H18a1 1 0 0 1 0 2h-2.893l-.51 2.652a1 1 0 1 1-1.964-.378l.437-2.274h-3.04l-.51 2.652Zm.895-4.652h3.04l.591-3.076h-3.04l-.591 3.076Z"/></symbol><symbol id="icon-eds-i-home-medium" viewBox="0 0 24 24"><path d="M5 22a1 1 0 0 1-1-1v-8.586l-1.293 1.293a1 1 0 0 1-1.32.083l-.094-.083a1 1 0 0 1 0-1.414l10-10a1 1 0 0 1 1.414 0l10 10a1 1 0 0 1-1.414 1.414L20 12.415V21a1 1 0 0 1-1 1H5Zm7-17.585-6 5.999V20h5v-4a1 1 0 0 1 2 0v4h5v-9.585l-6-6Z"/></symbol><symbol id="icon-eds-i-image-medium" viewBox="0 0 24 24"><path d="M19.615 2A2.385 2.385 0 0 1 22 4.385v15.23A2.385 2.385 0 0 1 19.615 22H4.385A2.385 2.385 0 0 1 2 19.615V4.385A2.385 2.385 0 0 1 4.385 2h15.23Zm0 2H4.385A.385.385 0 0 0 4 4.385v15.23c0 .213.172.385.385.385h1.244l10.228-8.76a1 1 0 0 1 1.254-.037L20 13.392V4.385A.385.385 0 0 0 19.615 4Zm-3.07 9.283L8.703 20h10.912a.385.385 0 0 0 .385-.385v-3.713l-3.455-2.619ZM9.5 6a3.5 3.5 0 1 1 0 7 3.5 3.5 0 0 1 0-7Zm0 2a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3Z"/></symbol><symbol id="icon-eds-i-impact-factor-medium" viewBox="0 0 24 24"><path d="M16.49 2.672c.74.694.986 1.765.632 2.712l-.04.1-1.549 3.54h1.477a2.496 2.496 0 0 1 2.485 2.34l.005.163c0 .618-.23 1.21-.642 1.675l-7.147 7.961a2.48 2.48 0 0 1-3.554.165 2.512 2.512 0 0 1-.633-2.712l.042-.103L9.108 15H7.46c-1.393 0-2.379-1.11-2.455-2.369L5 12.473c0-.593.142-1.145.628-1.692l7.307-7.944a2.48 2.48 0 0 1 3.555-.165ZM14.43 4.164l-7.33 7.97c-.083.093-.101.214-.101.34 0 .277.19.526.46.526h4.163l.097-.009c.015 0 .03.003.046.009.181.078.264.32.186.5l-2.554 5.817a.512.512 0 0 0 .127.552.48.48 0 0 0 .69-.033l7.155-7.97a.513.513 0 0 0 .13-.34.497.497 0 0 0-.49-.502h-3.988a.355.355 0 0 1-.328-.497l2.555-5.844a.512.512 0 0 0-.127-.552.48.48 0 0 0-.69.033Z"/></symbol><symbol id="icon-eds-i-info-circle-medium" viewBox="0 0 24 24"><path d="M12 1c6.075 0 11 4.925 11 11s-4.925 11-11 11S1 18.075 1 12 5.925 1 12 1Zm0 2a9 9 0 1 0 0 18 9 9 0 0 0 0-18Zm0 7a1 1 0 0 1 1 1v5h1.5a1 1 0 0 1 0 2h-5a1 1 0 0 1 0-2H11v-4h-.5a1 1 0 0 1-.993-.883L9.5 11a1 1 0 0 1 1-1H12Zm0-4.5a1.5 1.5 0 0 1 .144 2.993L12 8.5a1.5 1.5 0 0 1 0-3Z"/></symbol><symbol id="icon-eds-i-info-filled-medium" viewBox="0 0 24 24"><path d="M12 1c6.075 0 11 4.925 11 11s-4.925 11-11 11S1 18.075 1 12 5.925 1 12 1Zm0 9h-1.5a1 1 0 0 0-1 1l.007.117A1 1 0 0 0 10.5 12h.5v4H9.5a1 1 0 0 0 0 2h5a1 1 0 0 0 0-2H13v-5a1 1 0 0 0-1-1Zm0-4.5a1.5 1.5 0 0 0 0 3l.144-.007A1.5 1.5 0 0 0 12 5.5Z"/></symbol><symbol id="icon-eds-i-journal-medium" viewBox="0 0 24 24"><path d="M18.5 1A2.5 2.5 0 0 1 21 3.5v14a2.5 2.5 0 0 1-2.5 2.5h-13a.5.5 0 1 0 0 1H20a1 1 0 0 1 0 2H5.5A2.5 2.5 0 0 1 3 20.5v-17A2.5 2.5 0 0 1 5.5 1h13ZM7 3H5.5a.5.5 0 0 0-.5.5v14.549l.016-.002c.104-.02.211-.035.32-.042L5.5 18H7V3Zm11.5 0H9v15h9.5a.5.5 0 0 0 .5-.5v-14a.5.5 0 0 0-.5-.5ZM16 5a1 1 0 0 1 1 1v4a1 1 0 0 1-1 1h-5a1 1 0 0 1-1-1V6a1 1 0 0 1 1-1h5Zm-1 2h-3v2h3V7Z"/></symbol><symbol id="icon-eds-i-mail-medium" viewBox="0 0 24 24"><path d="M20.462 3C21.875 3 23 4.184 23 5.619v12.762C23 19.816 21.875 21 20.462 21H3.538C2.125 21 1 19.816 1 18.381V5.619C1 4.184 2.125 3 3.538 3h16.924ZM21 8.158l-7.378 6.258a2.549 2.549 0 0 1-3.253-.008L3 8.16v10.222c0 .353.253.619.538.619h16.924c.285 0 .538-.266.538-.619V8.158ZM20.462 5H3.538c-.264 0-.5.228-.534.542l8.65 7.334c.2.165.492.165.684.007l8.656-7.342-.001-.025c-.044-.3-.274-.516-.531-.516Z"/></symbol><symbol id="icon-eds-i-mail-send-medium" viewBox="0 0 24 24"><path d="M20.444 5a2.562 2.562 0 0 1 2.548 2.37l.007.078.001.123v7.858A2.564 2.564 0 0 1 20.444 18H9.556A2.564 2.564 0 0 1 7 15.429l.001-7.977.007-.082A2.561 2.561 0 0 1 9.556 5h10.888ZM21 9.331l-5.46 3.51a1 1 0 0 1-1.08 0L9 9.332v6.097c0 .317.251.571.556.571h10.888a.564.564 0 0 0 .556-.571V9.33ZM20.444 7H9.556a.543.543 0 0 0-.32.105l5.763 3.706 5.766-3.706a.543.543 0 0 0-.32-.105ZM4.308 5a1 1 0 1 1 0 2H2a1 1 0 1 1 0-2h2.308Zm0 5.5a1 1 0 0 1 0 2H2a1 1 0 0 1 0-2h2.308Zm0 5.5a1 1 0 0 1 0 2H2a1 1 0 0 1 0-2h2.308Z"/></symbol><symbol id="icon-eds-i-mentions-medium" viewBox="0 0 24 24"><path d="m9.452 1.293 5.92 5.92 2.92-2.92a1 1 0 0 1 1.415 1.414l-2.92 2.92 5.92 5.92a1 1 0 0 1 0 1.415 10.371 10.371 0 0 1-10.378 2.584l.652 3.258A1 1 0 0 1 12 23H2a1 1 0 0 1-.874-1.486l4.789-8.62C4.194 9.074 4.9 4.43 8.038 1.292a1 1 0 0 1 1.414 0Zm-2.355 13.59L3.699 21h7.081l-.689-3.442a10.392 10.392 0 0 1-2.775-2.396l-.22-.28Zm1.69-11.427-.07.09a8.374 8.374 0 0 0 11.737 11.737l.089-.071L8.787 3.456Z"/></symbol><symbol id="icon-eds-i-menu-medium" viewBox="0 0 24 24"><path d="M21 4a1 1 0 0 1 0 2H3a1 1 0 1 1 0-2h18Zm-4 7a1 1 0 0 1 0 2H3a1 1 0 0 1 0-2h14Zm4 7a1 1 0 0 1 0 2H3a1 1 0 0 1 0-2h18Z"/></symbol><symbol id="icon-eds-i-metrics-medium" viewBox="0 0 24 24"><path d="M3 22a1 1 0 0 1-1-1V3a1 1 0 0 1 1-1h6a1 1 0 0 1 1 1v7h4V8a1 1 0 0 1 1-1h6a1 1 0 0 1 1 1v13a1 1 0 0 1-.883.993L21 22H3Zm17-2V9h-4v11h4Zm-6-8h-4v8h4v-8ZM8 4H4v16h4V4Z"/></symbol><symbol id="icon-eds-i-news-medium" viewBox="0 0 24 24"><path d="M17.384 3c.975 0 1.77.787 1.77 1.762v13.333c0 .462.354.846.815.899l.107.006.109-.006a.915.915 0 0 0 .809-.794l.006-.105V8.19a1 1 0 0 1 2 0v9.905A2.914 2.914 0 0 1 20.077 21H3.538a2.547 2.547 0 0 1-1.644-.601l-.147-.135A2.516 2.516 0 0 1 1 18.476V4.762C1 3.787 1.794 3 2.77 3h14.614Zm-.231 2H3v13.476c0 .11.035.216.1.304l.054.063c.101.1.24.157.384.157l13.761-.001-.026-.078a2.88 2.88 0 0 1-.115-.655l-.004-.17L17.153 5ZM14 15.021a.979.979 0 1 1 0 1.958H6a.979.979 0 1 1 0-1.958h8Zm0-8c.54 0 .979.438.979.979v4c0 .54-.438.979-.979.979H6A.979.979 0 0 1 5.021 12V8c0-.54.438-.979.979-.979h8Zm-.98 1.958H6.979v2.041h6.041V8.979Z"/></symbol><symbol id="icon-eds-i-newsletter-medium" viewBox="0 0 24 24"><path d="M21 10a1 1 0 0 1 1 1v9.5a2.5 2.5 0 0 1-2.5 2.5h-15A2.5 2.5 0 0 1 2 20.5V11a1 1 0 0 1 2 0v.439l8 4.888 8-4.889V11a1 1 0 0 1 1-1Zm-1 3.783-7.479 4.57a1 1 0 0 1-1.042 0l-7.48-4.57V20.5a.5.5 0 0 0 .501.5h15a.5.5 0 0 0 .5-.5v-6.717ZM15 9a1 1 0 0 1 0 2H9a1 1 0 0 1 0-2h6Zm2.5-8A2.5 2.5 0 0 1 20 3.5V9a1 1 0 0 1-2 0V3.5a.5.5 0 0 0-.5-.5h-11a.5.5 0 0 0-.5.5V9a1 1 0 1 1-2 0V3.5A2.5 2.5 0 0 1 6.5 1h11ZM15 5a1 1 0 0 1 0 2H9a1 1 0 1 1 0-2h6Z"/></symbol><symbol id="icon-eds-i-notifcation-medium" viewBox="0 0 24 24"><path d="M14 20a1 1 0 0 1 0 2h-4a1 1 0 0 1 0-2h4ZM3 18l-.133-.007c-1.156-.124-1.156-1.862 0-1.986l.3-.012C4.32 15.923 5 15.107 5 14V9.5C5 5.368 8.014 2 12 2s7 3.368 7 7.5V14c0 1.107.68 1.923 1.832 1.995l.301.012c1.156.124 1.156 1.862 0 1.986L21 18H3Zm9-14C9.17 4 7 6.426 7 9.5V14c0 .671-.146 1.303-.416 1.858L6.51 16h10.979l-.073-.142a4.192 4.192 0 0 1-.412-1.658L17 14V9.5C17 6.426 14.83 4 12 4Z"/></symbol><symbol id="icon-eds-i-publish-medium" viewBox="0 0 24 24"><g><path d="M16.296 1.291A1 1 0 0 0 15.591 1H5.545A2.542 2.542 0 0 0 3 3.538V13a1 1 0 1 0 2 0V3.538l.007-.087A.543.543 0 0 1 5.545 3h9.633L20 7.8v12.662a.534.534 0 0 1-.158.379.548.548 0 0 1-.387.159H11a1 1 0 1 0 0 2h8.455c.674 0 1.32-.267 1.798-.742A2.534 2.534 0 0 0 22 20.462V7.385a1 1 0 0 0-.294-.709l-5.41-5.385Z"/><path d="M10.762 16.647a1 1 0 0 0-1.525-1.294l-4.472 5.271-2.153-1.665a1 1 0 1 0-1.224 1.582l2.91 2.25a1 1 0 0 0 1.374-.144l5.09-6ZM16 10a1 1 0 1 1 0 2H8a1 1 0 1 1 0-2h8ZM12 7a1 1 0 0 0-1-1H8a1 1 0 1 0 0 2h3a1 1 0 0 0 1-1Z"/></g></symbol><symbol id="icon-eds-i-refresh-medium" viewBox="0 0 24 24"><g><path d="M7.831 5.636H6.032A8.76 8.76 0 0 1 9 3.631 8.549 8.549 0 0 1 12.232 3c.603 0 1.192.063 1.76.182C17.979 4.017 21 7.632 21 12a1 1 0 1 0 2 0c0-5.296-3.674-9.746-8.591-10.776A10.61 10.61 0 0 0 5 3.851V2.805a1 1 0 0 0-.987-1H4a1 1 0 0 0-1 1v3.831a1 1 0 0 0 1 1h3.831a1 1 0 0 0 .013-2h-.013ZM17.968 18.364c-1.59 1.632-3.784 2.636-6.2 2.636C6.948 21 3 16.993 3 12a1 1 0 1 0-2 0c0 6.053 4.799 11 10.768 11 2.788 0 5.324-1.082 7.232-2.85v1.045a1 1 0 1 0 2 0v-3.831a1 1 0 0 0-1-1h-3.831a1 1 0 0 0 0 2h1.799Z"/></g></symbol><symbol id="icon-eds-i-search-medium" viewBox="0 0 24 24"><path d="M11 1c5.523 0 10 4.477 10 10 0 2.4-.846 4.604-2.256 6.328l3.963 3.965a1 1 0 0 1-1.414 1.414l-3.965-3.963A9.959 9.959 0 0 1 11 21C5.477 21 1 16.523 1 11S5.477 1 11 1Zm0 2a8 8 0 1 0 0 16 8 8 0 0 0 0-16Z"/></symbol><symbol id="icon-eds-i-settings-medium" viewBox="0 0 24 24"><path d="M11.382 1h1.24a2.508 2.508 0 0 1 2.334 1.63l.523 1.378 1.59.933 1.444-.224c.954-.132 1.89.3 2.422 1.101l.095.155.598 1.066a2.56 2.56 0 0 1-.195 2.848l-.894 1.161v1.896l.92 1.163c.6.768.707 1.812.295 2.674l-.09.17-.606 1.08a2.504 2.504 0 0 1-2.531 1.25l-1.428-.223-1.589.932-.523 1.378a2.512 2.512 0 0 1-2.155 1.625L12.65 23h-1.27a2.508 2.508 0 0 1-2.334-1.63l-.524-1.379-1.59-.933-1.443.225c-.954.132-1.89-.3-2.422-1.101l-.095-.155-.598-1.066a2.56 2.56 0 0 1 .195-2.847l.891-1.161v-1.898l-.919-1.162a2.562 2.562 0 0 1-.295-2.674l.09-.17.606-1.08a2.504 2.504 0 0 1 2.531-1.25l1.43.223 1.618-.938.524-1.375.07-.167A2.507 2.507 0 0 1 11.382 1Zm.003 2a.509.509 0 0 0-.47.338l-.65 1.71a1 1 0 0 1-.434.51L7.6 6.85a1 1 0 0 1-.655.123l-1.762-.275a.497.497 0 0 0-.498.252l-.61 1.088a.562.562 0 0 0 .04.619l1.13 1.43a1 1 0 0 1 .216.62v2.585a1 1 0 0 1-.207.61L4.15 15.339a.568.568 0 0 0-.036.634l.601 1.072a.494.494 0 0 0 .484.26l1.78-.278a1 1 0 0 1 .66.126l2.2 1.292a1 1 0 0 1 .43.507l.648 1.71a.508.508 0 0 0 .467.338h1.263a.51.51 0 0 0 .47-.34l.65-1.708a1 1 0 0 1 .428-.507l2.201-1.292a1 1 0 0 1 .66-.126l1.763.275a.497.497 0 0 0 .498-.252l.61-1.088a.562.562 0 0 0-.04-.619l-1.13-1.43a1 1 0 0 1-.216-.62v-2.585a1 1 0 0 1 .207-.61l1.105-1.437a.568.568 0 0 0 .037-.634l-.601-1.072a.494.494 0 0 0-.484-.26l-1.78.278a1 1 0 0 1-.66-.126l-2.2-1.292a1 1 0 0 1-.43-.507l-.649-1.71A.508.508 0 0 0 12.62 3h-1.234ZM12 8a4 4 0 1 1 0 8 4 4 0 0 1 0-8Zm0 2a2 2 0 1 0 0 4 2 2 0 0 0 0-4Z"/></symbol><symbol id="icon-eds-i-shipping-medium" viewBox="0 0 24 24"><path d="M16.515 2c1.406 0 2.706.728 3.352 1.902l2.02 3.635.02.042.036.089.031.105.012.058.01.073.004.075v11.577c0 .64-.244 1.255-.683 1.713a2.356 2.356 0 0 1-1.701.731H4.386a2.356 2.356 0 0 1-1.702-.731 2.476 2.476 0 0 1-.683-1.713V7.948c.01-.217.083-.43.22-.6L4.2 3.905C4.833 2.755 6.089 2.032 7.486 2h9.029ZM20 9H4v10.556a.49.49 0 0 0 .075.26l.053.07a.356.356 0 0 0 .257.114h15.23c.094 0 .186-.04.258-.115a.477.477 0 0 0 .127-.33V9Zm-2 7.5a1 1 0 0 1 0 2h-4a1 1 0 0 1 0-2h4ZM16.514 4H13v3h6.3l-1.183-2.13c-.288-.522-.908-.87-1.603-.87ZM11 3.999H7.51c-.679.017-1.277.36-1.566.887L4.728 7H11V3.999Z"/></symbol><symbol id="icon-eds-i-step-guide-medium" viewBox="0 0 24 24"><path d="M11.394 9.447a1 1 0 1 0-1.788-.894l-.88 1.759-.019-.02a1 1 0 1 0-1.414 1.415l1 1a1 1 0 0 0 1.601-.26l1.5-3ZM12 11a1 1 0 0 1 1-1h3a1 1 0 1 1 0 2h-3a1 1 0 0 1-1-1ZM12 17a1 1 0 0 1 1-1h3a1 1 0 1 1 0 2h-3a1 1 0 0 1-1-1ZM10.947 14.105a1 1 0 0 1 .447 1.342l-1.5 3a1 1 0 0 1-1.601.26l-1-1a1 1 0 1 1 1.414-1.414l.02.019.879-1.76a1 1 0 0 1 1.341-.447Z"/><path d="M5.545 1A2.542 2.542 0 0 0 3 3.538v16.924A2.542 2.542 0 0 0 5.545 23h12.91A2.542 2.542 0 0 0 21 20.462V7.5a1 1 0 0 0-.293-.707l-5.5-5.5A1 1 0 0 0 14.5 1H5.545ZM5 3.538C5 3.245 5.24 3 5.545 3h8.54L19 7.914v12.547c0 .294-.24.539-.546.539H5.545A.542.542 0 0 1 5 20.462V3.538Z" clip-rule="evenodd"/></symbol><symbol id="icon-eds-i-submission-medium" viewBox="0 0 24 24"><g><path d="M5 3.538C5 3.245 5.24 3 5.545 3h9.633L20 7.8v12.662a.535.535 0 0 1-.158.379.549.549 0 0 1-.387.159H6a1 1 0 0 1-1-1v-2.5a1 1 0 1 0-2 0V20a3 3 0 0 0 3 3h13.455c.673 0 1.32-.266 1.798-.742A2.535 2.535 0 0 0 22 20.462V7.385a1 1 0 0 0-.294-.709l-5.41-5.385A1 1 0 0 0 15.591 1H5.545A2.542 2.542 0 0 0 3 3.538V7a1 1 0 0 0 2 0V3.538Z"/><path d="m13.707 13.707-4 4a1 1 0 0 1-1.414 0l-.083-.094a1 1 0 0 1 .083-1.32L10.585 14 2 14a1 1 0 1 1 0-2l8.583.001-2.29-2.294a1 1 0 0 1 1.414-1.414l4.037 4.04.043.05.043.06.059.098.03.063.031.085.03.113.017.122L14 13l-.004.087-.017.118-.013.056-.034.104-.049.105-.048.081-.07.093-.058.063Z"/></g></symbol><symbol id="icon-eds-i-table-1-medium" viewBox="0 0 24 24"><path d="M4.385 22a2.56 2.56 0 0 1-1.14-.279C2.485 21.341 2 20.614 2 19.615V4.385c0-.315.067-.716.279-1.14C2.659 2.485 3.386 2 4.385 2h15.23c.315 0 .716.067 1.14.279.76.38 1.245 1.107 1.245 2.106v15.23c0 .315-.067.716-.279 1.14-.38.76-1.107 1.245-2.106 1.245H4.385ZM4 19.615c0 .213.034.265.14.317a.71.71 0 0 0 .245.068H8v-4H4v3.615ZM20 16H10v4h9.615c.213 0 .265-.034.317-.14a.71.71 0 0 0 .068-.245V16Zm0-2v-4H10v4h10ZM4 14h4v-4H4v4ZM19.615 4H10v4h10V4.385c0-.213-.034-.265-.14-.317A.71.71 0 0 0 19.615 4ZM8 4H4.385l-.082.002c-.146.01-.19.047-.235.138A.71.71 0 0 0 4 4.385V8h4V4Z"/></symbol><symbol id="icon-eds-i-table-2-medium" viewBox="0 0 24 24"><path d="M4.384 22A2.384 2.384 0 0 1 2 19.616V4.384A2.384 2.384 0 0 1 4.384 2h15.232A2.384 2.384 0 0 1 22 4.384v15.232A2.384 2.384 0 0 1 19.616 22H4.384ZM10 15H4v4.616c0 .212.172.384.384.384H10v-5Zm5 0h-3v5h3v-5Zm5 0h-3v5h2.616a.384.384 0 0 0 .384-.384V15ZM10 9H4v4h6V9Zm5 0h-3v4h3V9Zm5 0h-3v4h3V9Zm-.384-5H4.384A.384.384 0 0 0 4 4.384V7h16V4.384A.384.384 0 0 0 19.616 4Z"/></symbol><symbol id="icon-eds-i-tag-medium" viewBox="0 0 24 24"><path d="m12.621 1.998.127.004L20.496 2a1.5 1.5 0 0 1 1.497 1.355L22 3.5l-.005 7.669c.038.456-.133.905-.447 1.206l-9.02 9.018a2.075 2.075 0 0 1-2.932 0l-6.99-6.99a2.075 2.075 0 0 1 .001-2.933L11.61 2.47c.246-.258.573-.418.881-.46l.131-.011Zm.286 2-8.885 8.886a.075.075 0 0 0 0 .106l6.987 6.988c.03.03.077.03.106 0l8.883-8.883L19.999 4l-7.092-.002ZM16 6.5a1.5 1.5 0 0 1 .144 2.993L16 9.5a1.5 1.5 0 0 1 0-3Z"/></symbol><symbol id="icon-eds-i-trash-medium" viewBox="0 0 24 24"><path d="M12 1c2.717 0 4.913 2.232 4.997 5H21a1 1 0 0 1 0 2h-1v12.5c0 1.389-1.152 2.5-2.556 2.5H6.556C5.152 23 4 21.889 4 20.5V8H3a1 1 0 1 1 0-2h4.003l.001-.051C7.114 3.205 9.3 1 12 1Zm6 7H6v12.5c0 .238.19.448.454.492l.102.008h10.888c.315 0 .556-.232.556-.5V8Zm-4 3a1 1 0 0 1 1 1v6.005a1 1 0 0 1-2 0V12a1 1 0 0 1 1-1Zm-4 0a1 1 0 0 1 1 1v6a1 1 0 0 1-2 0v-6a1 1 0 0 1 1-1Zm2-8c-1.595 0-2.914 1.32-2.996 3h5.991v-.02C14.903 4.31 13.589 3 12 3Z"/></symbol><symbol id="icon-eds-i-user-account-medium" viewBox="0 0 24 24"><path d="M12 1c6.075 0 11 4.925 11 11s-4.925 11-11 11S1 18.075 1 12 5.925 1 12 1Zm0 16c-1.806 0-3.52.994-4.664 2.698A8.947 8.947 0 0 0 12 21a8.958 8.958 0 0 0 4.664-1.301C15.52 17.994 13.806 17 12 17Zm0-14a9 9 0 0 0-6.25 15.476C7.253 16.304 9.54 15 12 15s4.747 1.304 6.25 3.475A9 9 0 0 0 12 3Zm0 3a4 4 0 1 1 0 8 4 4 0 0 1 0-8Zm0 2a2 2 0 1 0 0 4 2 2 0 0 0 0-4Z"/></symbol><symbol id="icon-eds-i-user-add-medium" viewBox="0 0 24 24"><path d="M9 1a5 5 0 1 1 0 10A5 5 0 0 1 9 1Zm0 2a3 3 0 1 0 0 6 3 3 0 0 0 0-6Zm9 10a1 1 0 0 1 1 1v3h3a1 1 0 0 1 0 2h-3v3a1 1 0 0 1-2 0v-3h-3a1 1 0 0 1 0-2h3v-3a1 1 0 0 1 1-1Zm-5.545-.15a1 1 0 1 1-.91 1.78 5.713 5.713 0 0 0-5.705.282c-1.67 1.068-2.728 2.927-2.832 4.956L3.004 20 11.5 20a1 1 0 0 1 .993.883L12.5 21a1 1 0 0 1-1 1H2a1 1 0 0 1-1-1v-.876c.028-2.812 1.446-5.416 3.763-6.897a7.713 7.713 0 0 1 7.692-.378Z"/></symbol><symbol id="icon-eds-i-user-assign-medium" viewBox="0 0 24 24"><path d="M16.226 13.298a1 1 0 0 1 1.414-.01l.084.093a1 1 0 0 1-.073 1.32L15.39 17H22a1 1 0 0 1 0 2h-6.611l2.262 2.298a1 1 0 0 1-1.425 1.404l-3.939-4a1 1 0 0 1 0-1.404l3.94-4Zm-3.771-.449a1 1 0 1 1-.91 1.781 5.713 5.713 0 0 0-5.705.282c-1.67 1.068-2.728 2.927-2.832 4.956L3.004 20 10.5 20a1 1 0 0 1 .993.883L11.5 21a1 1 0 0 1-1 1H2a1 1 0 0 1-1-1v-.876c.028-2.812 1.446-5.416 3.763-6.897a7.713 7.713 0 0 1 7.692-.378ZM9 1a5 5 0 1 1 0 10A5 5 0 0 1 9 1Zm0 2a3 3 0 1 0 0 6 3 3 0 0 0 0-6Z"/></symbol><symbol id="icon-eds-i-user-block-medium" viewBox="0 0 24 24"><path d="M9 1a5 5 0 1 1 0 10A5 5 0 0 1 9 1Zm0 2a3 3 0 1 0 0 6 3 3 0 0 0 0-6Zm9 10a5 5 0 1 1 0 10 5 5 0 0 1 0-10Zm-5.545-.15a1 1 0 1 1-.91 1.78 5.713 5.713 0 0 0-5.705.282c-1.67 1.068-2.728 2.927-2.832 4.956L3.004 20 11.5 20a1 1 0 0 1 .993.883L12.5 21a1 1 0 0 1-1 1H2a1 1 0 0 1-1-1v-.876c.028-2.812 1.446-5.416 3.763-6.897a7.713 7.713 0 0 1 7.692-.378ZM15 18a3 3 0 0 0 4.294 2.707l-4.001-4c-.188.391-.293.83-.293 1.293Zm3-3c-.463 0-.902.105-1.294.293l4.001 4A3 3 0 0 0 18 15Z"/></symbol><symbol id="icon-eds-i-user-check-medium" viewBox="0 0 24 24"><path d="M9 1a5 5 0 1 1 0 10A5 5 0 0 1 9 1Zm0 2a3 3 0 1 0 0 6 3 3 0 0 0 0-6Zm13.647 12.237a1 1 0 0 1 .116 1.41l-5.091 6a1 1 0 0 1-1.375.144l-2.909-2.25a1 1 0 1 1 1.224-1.582l2.153 1.665 4.472-5.271a1 1 0 0 1 1.41-.116Zm-8.139-.977c.22.214.428.44.622.678a1 1 0 1 1-1.548 1.266 6.025 6.025 0 0 0-1.795-1.49.86.86 0 0 1-.163-.048l-.079-.036a5.721 5.721 0 0 0-2.62-.63l-.194.006c-2.76.134-5.022 2.177-5.592 4.864l-.035.175-.035.213c-.03.201-.05.405-.06.61L3.003 20 10 20a1 1 0 0 1 .993.883L11 21a1 1 0 0 1-1 1H2a1 1 0 0 1-1-1v-.876l.005-.223.02-.356.02-.222.03-.248.022-.15c.02-.133.044-.265.071-.397.44-2.178 1.725-4.105 3.595-5.301a7.75 7.75 0 0 1 3.755-1.215l.12-.004a7.908 7.908 0 0 1 5.87 2.252Z"/></symbol><symbol id="icon-eds-i-user-delete-medium" viewBox="0 0 24 24"><path d="M9 1a5 5 0 1 1 0 10A5 5 0 0 1 9 1Zm0 2a3 3 0 1 0 0 6 3 3 0 0 0 0-6ZM4.763 13.227a7.713 7.713 0 0 1 7.692-.378 1 1 0 1 1-.91 1.781 5.713 5.713 0 0 0-5.705.282c-1.67 1.068-2.728 2.927-2.832 4.956L3.004 20H11.5a1 1 0 0 1 .993.883L12.5 21a1 1 0 0 1-1 1H2a1 1 0 0 1-1-1v-.876c.028-2.812 1.446-5.416 3.763-6.897Zm11.421 1.543 2.554 2.553 2.555-2.553a1 1 0 0 1 1.414 1.414l-2.554 2.554 2.554 2.555a1 1 0 0 1-1.414 1.414l-2.555-2.554-2.554 2.554a1 1 0 0 1-1.414-1.414l2.553-2.555-2.553-2.554a1 1 0 0 1 1.414-1.414Z"/></symbol><symbol id="icon-eds-i-user-edit-medium" viewBox="0 0 24 24"><path d="m19.876 10.77 2.831 2.83a1 1 0 0 1 0 1.415l-7.246 7.246a1 1 0 0 1-.572.284l-3.277.446a1 1 0 0 1-1.125-1.13l.461-3.277a1 1 0 0 1 .283-.567l7.23-7.246a1 1 0 0 1 1.415-.001Zm-7.421 2.08a1 1 0 1 1-.91 1.78 5.713 5.713 0 0 0-5.705.282c-1.67 1.068-2.728 2.927-2.832 4.956L3.004 20 7.5 20a1 1 0 0 1 .993.883L8.5 21a1 1 0 0 1-1 1H2a1 1 0 0 1-1-1v-.876c.028-2.812 1.446-5.416 3.763-6.897a7.713 7.713 0 0 1 7.692-.378Zm6.715.042-6.29 6.3-.23 1.639 1.633-.222 6.302-6.302-1.415-1.415ZM9 1a5 5 0 1 1 0 10A5 5 0 0 1 9 1Zm0 2a3 3 0 1 0 0 6 3 3 0 0 0 0-6Z"/></symbol><symbol id="icon-eds-i-user-linked-medium" viewBox="0 0 24 24"><path d="M15.65 6c.31 0 .706.066 1.122.274C17.522 6.65 18 7.366 18 8.35v12.3c0 .31-.066.706-.274 1.122-.375.75-1.092 1.228-2.076 1.228H3.35a2.52 2.52 0 0 1-1.122-.274C1.478 22.35 1 21.634 1 20.65V8.35c0-.31.066-.706.274-1.122C1.65 6.478 2.366 6 3.35 6h12.3Zm0 2-12.376.002c-.134.007-.17.04-.21.12A.672.672 0 0 0 3 8.35v12.3c0 .198.028.24.122.287.09.044.2.063.228.063h.887c.788-2.269 2.814-3.5 5.263-3.5 2.45 0 4.475 1.231 5.263 3.5h.887c.198 0 .24-.028.287-.122.044-.09.063-.2.063-.228V8.35c0-.198-.028-.24-.122-.287A.672.672 0 0 0 15.65 8ZM9.5 19.5c-1.36 0-2.447.51-3.06 1.5h6.12c-.613-.99-1.7-1.5-3.06-1.5ZM20.65 1A2.35 2.35 0 0 1 23 3.348V15.65A2.35 2.35 0 0 1 20.65 18H20a1 1 0 0 1 0-2h.65a.35.35 0 0 0 .35-.35V3.348A.35.35 0 0 0 20.65 3H8.35a.35.35 0 0 0-.35.348V4a1 1 0 1 1-2 0v-.652A2.35 2.35 0 0 1 8.35 1h12.3ZM9.5 10a3.5 3.5 0 1 1 0 7 3.5 3.5 0 0 1 0-7Zm0 2a1.5 1.5 0 1 0 0 3 1.5 1.5 0 0 0 0-3Z"/></symbol><symbol id="icon-eds-i-user-multiple-medium" viewBox="0 0 24 24"><path d="M9 1a5 5 0 1 1 0 10A5 5 0 0 1 9 1Zm6 0a5 5 0 0 1 0 10 1 1 0 0 1-.117-1.993L15 9a3 3 0 0 0 0-6 1 1 0 0 1 0-2ZM9 3a3 3 0 1 0 0 6 3 3 0 0 0 0-6Zm8.857 9.545a7.99 7.99 0 0 1 2.651 1.715A8.31 8.31 0 0 1 23 20.134V21a1 1 0 0 1-1 1h-3a1 1 0 0 1 0-2h1.995l-.005-.153a6.307 6.307 0 0 0-1.673-3.945l-.204-.209a5.99 5.99 0 0 0-1.988-1.287 1 1 0 1 1 .732-1.861Zm-3.349 1.715A8.31 8.31 0 0 1 17 20.134V21a1 1 0 0 1-1 1H2a1 1 0 0 1-1-1v-.877c.044-4.343 3.387-7.908 7.638-8.115a7.908 7.908 0 0 1 5.87 2.252ZM9.016 14l-.285.006c-3.104.15-5.58 2.718-5.725 5.9L3.004 20h11.991l-.005-.153a6.307 6.307 0 0 0-1.673-3.945l-.204-.209A5.924 5.924 0 0 0 9.3 14.008L9.016 14Z"/></symbol><symbol id="icon-eds-i-user-notify-medium" viewBox="0 0 24 24"><path d="M9 1a5 5 0 1 1 0 10A5 5 0 0 1 9 1Zm0 2a3 3 0 1 0 0 6 3 3 0 0 0 0-6Zm10 18v1a1 1 0 0 1-2 0v-1h-3a1 1 0 0 1 0-2v-2.818C14 13.885 15.777 12 18 12s4 1.885 4 4.182V19a1 1 0 0 1 0 2h-3Zm-6.545-8.15a1 1 0 1 1-.91 1.78 5.713 5.713 0 0 0-5.705.282c-1.67 1.068-2.728 2.927-2.832 4.956L3.004 20 11.5 20a1 1 0 0 1 .993.883L12.5 21a1 1 0 0 1-1 1H2a1 1 0 0 1-1-1v-.876c.028-2.812 1.446-5.416 3.763-6.897a7.713 7.713 0 0 1 7.692-.378ZM18 14c-1.091 0-2 .964-2 2.182V19h4v-2.818c0-1.165-.832-2.098-1.859-2.177L18 14Z"/></symbol><symbol id="icon-eds-i-user-remove-medium" viewBox="0 0 24 24"><path d="M9 1a5 5 0 1 1 0 10A5 5 0 0 1 9 1Zm0 2a3 3 0 1 0 0 6 3 3 0 0 0 0-6Zm3.455 9.85a1 1 0 1 1-.91 1.78 5.713 5.713 0 0 0-5.705.282c-1.67 1.068-2.728 2.927-2.832 4.956L3.004 20 11.5 20a1 1 0 0 1 .993.883L12.5 21a1 1 0 0 1-1 1H2a1 1 0 0 1-1-1v-.876c.028-2.812 1.446-5.416 3.763-6.897a7.713 7.713 0 0 1 7.692-.378ZM22 17a1 1 0 0 1 0 2h-8a1 1 0 0 1 0-2h8Z"/></symbol><symbol id="icon-eds-i-user-single-medium" viewBox="0 0 24 24"><path d="M12 1a5 5 0 1 1 0 10 5 5 0 0 1 0-10Zm0 2a3 3 0 1 0 0 6 3 3 0 0 0 0-6Zm-.406 9.008a8.965 8.965 0 0 1 6.596 2.494A9.161 9.161 0 0 1 21 21.025V22a1 1 0 0 1-1 1H4a1 1 0 0 1-1-1v-.985c.05-4.825 3.815-8.777 8.594-9.007Zm.39 1.992-.299.006c-3.63.175-6.518 3.127-6.678 6.775L5 21h13.998l-.009-.268a7.157 7.157 0 0 0-1.97-4.573l-.214-.213A6.967 6.967 0 0 0 11.984 14Z"/></symbol><symbol id="icon-eds-i-warning-circle-medium" viewBox="0 0 24 24"><path d="M12 1c6.075 0 11 4.925 11 11s-4.925 11-11 11S1 18.075 1 12 5.925 1 12 1Zm0 2a9 9 0 1 0 0 18 9 9 0 0 0 0-18Zm0 11.5a1.5 1.5 0 0 1 .144 2.993L12 17.5a1.5 1.5 0 0 1 0-3ZM12 6a1 1 0 0 1 1 1v5a1 1 0 0 1-2 0V7a1 1 0 0 1 1-1Z"/></symbol><symbol id="icon-eds-i-warning-filled-medium" viewBox="0 0 24 24"><path d="M12 1c6.075 0 11 4.925 11 11s-4.925 11-11 11S1 18.075 1 12 5.925 1 12 1Zm0 13.5a1.5 1.5 0 0 0 0 3l.144-.007A1.5 1.5 0 0 0 12 14.5ZM12 6a1 1 0 0 0-1 1v5a1 1 0 0 0 2 0V7a1 1 0 0 0-1-1Z"/></symbol><symbol id="icon-eds-i-work-medium" viewBox="0 0 24 24"><path d="M4 3.53808C4 3.24519 4.23975 3 4.5451 3H14.1778L19 7.80031V8C19 8.55228 19.4477 9 20 9C20.5523 9 21 8.55228 21 8V7.38477C21 7.11876 20.894 6.86372 20.7055 6.67605L15.2962 1.29129C15.1088 1.10473 14.8551 1 14.5907 1H4.5451C3.14377 1 2 2.13206 2 3.53808V20.5007C2 21.882 3.11988 23 4.5 23H8C8.55228 23 9 22.5523 9 22C9 21.4477 8.55228 21 8 21H4.5C4.22327 21 4 20.7762 4 20.5007V3.53808Z"/><path fill-rule="evenodd" clip-rule="evenodd" d="M19.8764 10.7698C19.6887 10.5822 19.4341 10.4768 19.1687 10.4769C18.9033 10.4771 18.6489 10.5827 18.4614 10.7706L11.2306 18.0167C11.0776 18.1701 10.9785 18.3691 10.9483 18.5836L10.4867 21.8605C10.443 22.1707 10.5472 22.4835 10.7682 22.7055C10.9892 22.9275 11.3015 23.0331 11.6118 22.9909L14.8888 22.5447C15.1054 22.5152 15.3064 22.4155 15.461 22.261L22.7071 15.0148C22.8947 14.8273 23 14.5729 23 14.3077C23 14.0425 22.8947 13.7881 22.7071 13.6006L19.8764 10.7698ZM12.8821 19.1931L19.17 12.8919L20.5858 14.3077L14.285 20.6085L12.6515 20.8309L12.8821 19.1931Z"/><path d="M11.0812 4.68628C11.5307 5.00729 11.6347 5.63184 11.3137 6.08125L8.81373 9.58125C8.64288 9.82045 8.37543 9.97236 8.08248 9.99661C7.78953 10.0209 7.50075 9.91498 7.29289 9.70712L5.79289 8.20712C5.40237 7.8166 5.40237 7.18343 5.79289 6.79291C6.18342 6.40239 6.81658 6.40239 7.20711 6.79291L7.8724 7.4582L9.68627 4.91878C10.0073 4.46937 10.6318 4.36527 11.0812 4.68628Z"/><path d="M11.3137 12.0813C11.6347 11.6318 11.5307 11.0073 11.0812 10.6863C10.6318 10.3653 10.0073 10.4694 9.68627 10.9188L7.8724 13.4582L7.20711 12.7929C6.81658 12.4024 6.18342 12.4024 5.79289 12.7929C5.40237 13.1834 5.40237 13.8166 5.79289 14.2071L7.29289 15.7071C7.50075 15.915 7.78953 16.0209 8.08248 15.9966C8.37543 15.9724 8.64288 15.8205 8.81373 15.5813L11.3137 12.0813Z"/></symbol><symbol id="icon-ai-stars"><path d="M22.294 13.39c.941.536.941 1.945 0 2.482l-3.613 2.061c-.228.13-.415.325-.54.563l-1.976 3.768a1.33 1.33 0 0 1-2.38 0l-1.977-3.768a1.4 1.4 0 0 0-.539-.563l-3.614-2.061c-.94-.537-.94-1.946 0-2.482l3.614-2.061c.228-.13.415-.325.54-.563l1.976-3.768a1.33 1.33 0 0 1 2.38 0l1.977 3.768c.124.238.311.433.539.563zM10.08 4.861c1.044.508 1.044 2.056 0 2.564l-1.543.751c-.29.14-.521.383-.656.684l-.72 1.61a1.334 1.334 0 0 1-2.459 0l-.72-1.61a1.4 1.4 0 0 0-.656-.684l-1.543-.751c-1.044-.508-1.044-2.056 0-2.564l1.543-.751c.29-.14.521-.383.656-.684l.72-1.61a1.334 1.334 0 0 1 2.459 0l.72 1.61c.135.301.367.543.656.684z"/></symbol><symbol id="icon-chevron-left-medium" viewBox="0 0 24 24"><path d="M15.7194 3.3054C15.3358 2.90809 14.7027 2.89699 14.3054 3.28061L6.54342 10.7757C6.19804 11.09 6 11.5335 6 12C6 12.4665 6.19804 12.91 6.5218 13.204L14.3054 20.7194C14.7027 21.103 15.3358 21.0919 15.7194 20.6946C16.103 20.2973 16.0919 19.6642 15.6946 19.2806L8.155 12L15.6946 4.71939C16.0614 4.36528 16.099 3.79863 15.8009 3.40105L15.7194 3.3054Z"/></symbol><symbol id="icon-chevron-right-medium" viewBox="0 0 24 24"><path d="M8.28061 3.3054C8.66423 2.90809 9.29729 2.89699 9.6946 3.28061L17.4566 10.7757C17.802 11.09 18 11.5335 18 12C18 12.4665 17.802 12.91 17.4782 13.204L9.6946 20.7194C9.29729 21.103 8.66423 21.0919 8.28061 20.6946C7.89699 20.2973 7.90809 19.6642 8.3054 19.2806L15.845 12L8.3054 4.71939C7.93865 4.36528 7.90098 3.79863 8.19908 3.40105L8.28061 3.3054Z"/></symbol><symbol id="icon-eds-alerts" viewBox="0 0 32 32"><path d="M28 12.667c.736 0 1.333.597 1.333 1.333v13.333A3.333 3.333 0 0 1 26 30.667H6a3.333 3.333 0 0 1-3.333-3.334V14a1.333 1.333 0 1 1 2.666 0v1.252L16 21.769l10.667-6.518V14c0-.736.597-1.333 1.333-1.333Zm-1.333 5.71-9.972 6.094c-.427.26-.963.26-1.39 0l-9.972-6.094v8.956c0 .368.299.667.667.667h20a.667.667 0 0 0 .667-.667v-8.956ZM19.333 12a1.333 1.333 0 1 1 0 2.667h-6.666a1.333 1.333 0 1 1 0-2.667h6.666Zm4-10.667a3.333 3.333 0 0 1 3.334 3.334v6.666a1.333 1.333 0 1 1-2.667 0V4.667A.667.667 0 0 0 23.333 4H8.667A.667.667 0 0 0 8 4.667v6.666a1.333 1.333 0 1 1-2.667 0V4.667a3.333 3.333 0 0 1 3.334-3.334h14.666Zm-4 5.334a1.333 1.333 0 0 1 0 2.666h-6.666a1.333 1.333 0 1 1 0-2.666h6.666Z"/></symbol><symbol id="icon-eds-arrow-up" viewBox="0 0 24 24"><path fill-rule="evenodd" d="m13.002 7.408 4.88 4.88a.99.99 0 0 0 1.32.08l.09-.08c.39-.39.39-1.03 0-1.42l-6.58-6.58a1.01 1.01 0 0 0-1.42 0l-6.58 6.58a1 1 0 0 0-.09 1.32l.08.1a1 1 0 0 0 1.42-.01l4.88-4.87v11.59a.99.99 0 0 0 .88.99l.12.01c.55 0 1-.45 1-1V7.408z" class="layer"/></symbol><symbol id="icon-eds-checklist" viewBox="0 0 32 32"><path d="M19.2 1.333a3.468 3.468 0 0 1 3.381 2.699L24.667 4C26.515 4 28 5.52 28 7.38v19.906c0 1.86-1.485 3.38-3.333 3.38H7.333c-1.848 0-3.333-1.52-3.333-3.38V7.38C4 5.52 5.485 4 7.333 4h2.093A3.468 3.468 0 0 1 12.8 1.333h6.4ZM9.426 6.667H7.333c-.36 0-.666.312-.666.713v19.906c0 .401.305.714.666.714h17.334c.36 0 .666-.313.666-.714V7.38c0-.4-.305-.713-.646-.714l-2.121.033A3.468 3.468 0 0 1 19.2 9.333h-6.4a3.468 3.468 0 0 1-3.374-2.666Zm12.715 5.606c.586.446.7 1.283.253 1.868l-7.111 9.334a1.333 1.333 0 0 1-1.792.306l-3.556-2.333a1.333 1.333 0 1 1 1.463-2.23l2.517 1.651 6.358-8.344a1.333 1.333 0 0 1 1.868-.252ZM19.2 4h-6.4a.8.8 0 0 0-.8.8v1.067a.8.8 0 0 0 .8.8h6.4a.8.8 0 0 0 .8-.8V4.8a.8.8 0 0 0-.8-.8Z"/></symbol><symbol id="icon-eds-citation" viewBox="0 0 36 36"><path d="M23.25 1.5a1.5 1.5 0 0 1 1.06.44l8.25 8.25a1.5 1.5 0 0 1 .44 1.06v19.5c0 2.105-1.645 3.75-3.75 3.75H18a1.5 1.5 0 0 1 0-3h11.25c.448 0 .75-.302.75-.75V11.873L22.628 4.5H8.31a.811.811 0 0 0-.8.68l-.011.13V16.5a1.5 1.5 0 0 1-3 0V5.31A3.81 3.81 0 0 1 8.31 1.5h14.94ZM8.223 20.358a.984.984 0 0 1-.192 1.378l-.048.034c-.54.36-.942.676-1.206.951-.59.614-.885 1.395-.885 2.343.115-.028.288-.042.518-.042.662 0 1.26.237 1.791.711.533.474.799 1.074.799 1.799 0 .753-.259 1.352-.777 1.799-.518.446-1.151.669-1.9.669-1.006 0-1.812-.293-2.417-.878C3.302 28.536 3 27.657 3 26.486c0-1.115.165-2.085.496-2.907.331-.823.734-1.513 1.209-2.071.475-.558.971-.997 1.49-1.318a6.01 6.01 0 0 1 .347-.2 1.321 1.321 0 0 1 1.681.368Zm7.5 0a.984.984 0 0 1-.192 1.378l-.048.034c-.54.36-.942.676-1.206.951-.59.614-.885 1.395-.885 2.343.115-.028.288-.042.518-.042.662 0 1.26.237 1.791.711.533.474.799 1.074.799 1.799 0 .753-.259 1.352-.777 1.799-.518.446-1.151.669-1.9.669-1.006 0-1.812-.293-2.417-.878-.604-.586-.906-1.465-.906-2.636 0-1.115.165-2.085.496-2.907.331-.823.734-1.513 1.209-2.071.475-.558.971-.997 1.49-1.318a6.01 6.01 0 0 1 .347-.2 1.321 1.321 0 0 1 1.681.368Z"/></symbol><symbol id="icon-eds-i-access-indicator" viewBox="0 0 16 16"><circle cx="4.5" cy="11.5" r="3.5" style="fill:currentColor"/><path fill-rule="evenodd" d="M4 3v3a1 1 0 0 1-2 0V2.923C2 1.875 2.84 1 3.909 1h5.909a1 1 0 0 1 .713.298l3.181 3.231a1 1 0 0 1 .288.702v7.846c0 .505-.197.993-.554 1.354a1.902 1.902 0 0 1-1.355.569H10a1 1 0 1 1 0-2h2V5.64L9.4 3H4Z" clip-rule="evenodd" style="fill:#222"/></symbol><symbol id="icon-eds-i-accessibility-medium" viewBox="0 0 24 24"><path d="M17 10.5C17.5523 10.5 18 10.9477 18 11.5C18 12.0523 17.5523 12.5 17 12.5H13V13C13 13.4952 13.2735 14.3106 13.7695 15.3027C14.1249 16.0135 14.551 16.7321 14.9483 17.3564L15.332 17.9453L15.3848 18.0332C15.6218 18.4812 15.4855 19.0448 15.0547 19.332C14.6238 19.6193 14.0508 19.5282 13.7285 19.1367L13.668 19.0547L13.2627 18.4326C12.8412 17.7703 12.3781 16.9924 11.9844 16.2061C11.4619 17.2978 10.8292 18.309 10.332 19.0547C10.0257 19.5142 9.40486 19.6384 8.94533 19.332C8.4858 19.0257 8.36163 18.4048 8.66798 17.9453C9.15666 17.2123 9.75032 16.2592 10.2197 15.2617C10.6385 14.372 10.9221 13.5218 10.9863 12.8008L11 12.5H7.00002C6.44774 12.5 6.00002 12.0523 6.00002 11.5C6.00002 10.9477 6.44774 10.5 7.00002 10.5H17Z"/><path fill-rule="evenodd" clip-rule="evenodd" d="M12 4C12.7957 4 13.5585 4.3163 14.1211 4.87891C14.6837 5.44152 15 6.20435 15 7C15 7.79565 14.6837 8.55848 14.1211 9.12109C13.5585 9.6837 12.7957 10 12 10C11.2044 10 10.4415 9.6837 9.87892 9.12109C9.31631 8.55848 9.00002 7.79565 9.00002 7C9.00002 6.20435 9.31631 5.44152 9.87892 4.87891C10.4415 4.3163 11.2044 4 12 4ZM12 6C11.7348 6 11.4805 6.10543 11.293 6.29297C11.1054 6.4805 11 6.73478 11 7C11 7.26522 11.1054 7.5195 11.293 7.70703C11.4805 7.89457 11.7348 8 12 8C12.2652 8 12.5195 7.89457 12.707 7.70703C12.8946 7.5195 13 7.26522 13 7C13 6.73478 12.8946 6.48051 12.707 6.29297C12.5195 6.10543 12.2652 6 12 6Z"/><path fill-rule="evenodd" clip-rule="evenodd" d="M12 1C18.0751 1 23 5.92487 23 12C23 18.0751 18.0751 23 12 23C5.92488 23 1.00002 18.0751 1.00002 12C1.00002 5.92487 5.92488 1 12 1ZM12 3C7.02945 3 3.00002 7.02944 3.00002 12C3.00002 16.9706 7.02945 21 12 21C16.9706 21 21 16.9706 21 12C21 7.02944 16.9706 3 12 3Z"/></symbol><symbol id="icon-eds-i-book-research-medium"><path fill-rule="evenodd" d="M9.99.952c.922 0 1.822.273 2.589.784l2.42 1.614 2.421-1.614a4.667 4.667 0 0 1 2.283-.774l.306-.01h6.324a3.333 3.333 0 0 1 3.333 3.334v8.666a1.333 1.333 0 0 1-2.666 0V4.286a.667.667 0 0 0-.667-.667h-6.324a2 2 0 0 0-1.11.336l-2.566 1.71v5.954a1.333 1.333 0 1 1-2.667 0V5.666L11.1 3.955a2 2 0 0 0-1.11-.336H3.666A.667.667 0 0 0 3 4.286v17.333c0 .368.298.667.666.667h10a1.333 1.333 0 1 1 0 2.666h-10A3.333 3.333 0 0 1 .333 21.62V4.286A3.333 3.333 0 0 1 3.666.952H9.99Zm12.343 13.334a6 6 0 0 1 5.08 9.193l1.863 1.864a1.333 1.333 0 1 1-1.886 1.886l-1.864-1.863a6 6 0 1 1-3.193-11.08Zm-3.333 6a3.333 3.333 0 1 1 6.666 0 3.333 3.333 0 0 1-6.666 0Z" clip-rule="evenodd"/></symbol><symbol id="icon-eds-i-copy-link" viewBox="0 0 24 24"><path fill-rule="evenodd" clip-rule="evenodd" d="M19.4594 8.57015C19.0689 8.17963 19.0689 7.54646 19.4594 7.15594L20.2927 6.32261C20.2927 6.32261 20.2927 6.32261 20.2927 6.32261C21.0528 5.56252 21.0528 4.33019 20.2928 3.57014C19.5327 2.81007 18.3004 2.81007 17.5404 3.57014L16.7071 4.40347C16.3165 4.794 15.6834 4.794 15.2928 4.40348C14.9023 4.01296 14.9023 3.3798 15.2928 2.98927L16.1262 2.15594C17.6673 0.614803 20.1659 0.614803 21.707 2.15593C23.2481 3.69705 23.248 6.19569 21.707 7.7368L20.8737 8.57014C20.4831 8.96067 19.85 8.96067 19.4594 8.57015Z"/><path fill-rule="evenodd" clip-rule="evenodd" d="M18.0944 5.90592C18.4849 6.29643 18.4849 6.9296 18.0944 7.32013L16.4278 8.9868C16.0373 9.37733 15.4041 9.37734 15.0136 8.98682C14.6231 8.59631 14.6231 7.96314 15.0136 7.57261L16.6802 5.90594C17.0707 5.51541 17.7039 5.5154 18.0944 5.90592Z"/><path fill-rule="evenodd" clip-rule="evenodd" d="M13.5113 6.32243C13.9018 6.71295 13.9018 7.34611 13.5113 7.73664L12.678 8.56997C12.678 8.56997 12.678 8.56997 12.678 8.56997C11.9179 9.33006 11.9179 10.5624 12.6779 11.3224C13.438 12.0825 14.6703 12.0825 15.4303 11.3224L16.2636 10.4891C16.6542 10.0986 17.2873 10.0986 17.6779 10.4891C18.0684 10.8796 18.0684 11.5128 17.6779 11.9033L16.8445 12.7366C15.3034 14.2778 12.8048 14.2778 11.2637 12.7366C9.72262 11.1955 9.72266 8.69689 11.2637 7.15578L12.097 6.32244C12.4876 5.93191 13.1207 5.93191 13.5113 6.32243Z"/><path d="M8 20V22H19.4619C20.136 22 20.7822 21.7311 21.2582 21.2529C21.7333 20.7757 22 20.1289 22 19.4549V15C22 14.4477 21.5523 14 21 14C20.4477 14 20 14.4477 20 15V19.4549C20 19.6004 19.9426 19.7397 19.8408 19.842C19.7399 19.9433 19.6037 20 19.4619 20H8Z"/><path d="M4 13H2V19.4619C2 20.136 2.26889 20.7822 2.74705 21.2582C3.22434 21.7333 3.87105 22 4.5451 22H9C9.55228 22 10 21.5523 10 21C10 20.4477 9.55228 20 9 20H4.5451C4.39957 20 4.26028 19.9426 4.15804 19.8408C4.05668 19.7399 4 19.6037 4 19.4619V13Z"/><path d="M4 13H2V4.53808C2 3.86398 2.26889 3.21777 2.74705 2.74178C3.22434 2.26666 3.87105 2 4.5451 2H9C9.55228 2 10 2.44772 10 3C10 3.55228 9.55228 4 9 4H4.5451C4.39957 4 4.26028 4.05743 4.15804 4.15921C4.05668 4.26011 4 4.39633 4 4.53808V13Z"/></symbol><symbol id="icon-eds-i-funding-dollar" viewBox="0 0 32 32"><path d="M17.333 7.79549V9.21808C18.3681 9.32469 19.2889 9.82002 19.9444 10.5523C20.2938 10.9427 20.5697 11.4022 20.7488 11.9089C20.9942 12.6031 20.6303 13.3649 19.936 13.6103C19.2418 13.8558 18.48 13.4919 18.2346 12.7976C18.1735 12.6249 18.0788 12.4665 17.9574 12.3308C17.6988 12.0419 17.3272 11.8632 16.9122 11.8632H16.042C16.028 11.8636 16.0139 11.8639 15.9997 11.8639C15.9907 11.8639 15.9817 11.8638 15.9727 11.8636C15.9676 11.8635 15.9624 11.8634 15.9573 11.8632H14.7952C14.1833 11.8632 13.6872 12.3593 13.6872 12.9713C13.6872 13.492 14.0498 13.9424 14.5584 14.0537L17.7816 14.7588C19.6498 15.1675 20.9806 16.8226 20.9806 18.734C20.9806 20.8383 19.3827 22.5712 17.333 22.7819V24.2051C17.333 24.9415 16.7361 25.5384 15.9997 25.5384C15.2633 25.5384 14.6663 24.9415 14.6663 24.2051V22.7817C13.0793 22.618 11.7653 21.5424 11.2524 20.091C11.007 19.3967 11.3709 18.635 12.0651 18.3896C12.7594 18.1442 13.5212 18.5081 13.7666 19.2024C13.9597 19.7486 14.4807 20.1367 15.0889 20.1367H15.9849C15.9898 20.1367 15.9947 20.1366 15.9997 20.1366C16.0046 20.1366 16.0095 20.1367 16.0144 20.1367H16.9122C17.6857 20.1367 18.3139 19.5088 18.3139 18.734C18.3139 18.0748 17.8548 17.5045 17.2118 17.3639L13.9886 16.6588C12.2557 16.2797 11.0205 14.7451 11.0205 12.9713C11.0205 10.9297 12.6413 9.26664 14.6663 9.19869V7.79549C14.6663 7.05911 15.2633 6.46216 15.9997 6.46216C16.7361 6.46216 17.333 7.05911 17.333 7.79549Z"/><path fill-rule="evenodd" clip-rule="evenodd" d="M15.9997 1.33325C7.8995 1.33325 1.33301 7.89974 1.33301 15.9999C1.33301 24.1002 7.89951 30.6666 15.9997 30.6666C24.1 30.6666 30.6663 24.1002 30.6663 15.9999C30.6663 7.89975 24.1 1.33325 15.9997 1.33325ZM3.99967 15.9999C3.99967 9.3725 9.37226 3.99992 15.9997 3.99992C22.6272 3.99992 27.9997 9.3725 27.9997 15.9999C27.9997 22.6274 22.6272 27.9999 15.9997 27.9999C9.37225 27.9999 3.99967 22.6274 3.99967 15.9999Z"/></symbol><symbol id="icon-eds-i-github-medium" viewBox="0 0 24 24"><path d="M 11.964844 0 C 5.347656 0 0 5.269531 0 11.792969 C 0 17.003906 3.425781 21.417969 8.179688 22.976562 C 8.773438 23.09375 8.992188 22.722656 8.992188 22.410156 C 8.992188 22.136719 8.972656 21.203125 8.972656 20.226562 C 5.644531 20.929688 4.953125 18.820312 4.953125 18.820312 C 4.417969 17.453125 3.625 17.101562 3.625 17.101562 C 2.535156 16.378906 3.703125 16.378906 3.703125 16.378906 C 4.914062 16.457031 5.546875 17.589844 5.546875 17.589844 C 6.617188 19.386719 8.339844 18.878906 9.03125 18.566406 C 9.132812 17.804688 9.449219 17.277344 9.785156 16.984375 C 7.132812 16.710938 4.339844 15.695312 4.339844 11.167969 C 4.339844 9.878906 4.8125 8.824219 5.566406 8.003906 C 5.445312 7.710938 5.03125 6.5 5.683594 4.878906 C 5.683594 4.878906 6.695312 4.566406 8.972656 6.089844 C 9.949219 5.832031 10.953125 5.703125 11.964844 5.699219 C 12.972656 5.699219 14.003906 5.835938 14.957031 6.089844 C 17.234375 4.566406 18.242188 4.878906 18.242188 4.878906 C 18.898438 6.5 18.480469 7.710938 18.363281 8.003906 C 19.136719 8.824219 19.589844 9.878906 19.589844 11.167969 C 19.589844 15.695312 16.796875 16.691406 14.125 16.984375 C 14.558594 17.355469 14.933594 18.058594 14.933594 19.171875 C 14.933594 20.753906 14.914062 22.019531 14.914062 22.410156 C 14.914062 22.722656 15.132812 23.09375 15.726562 22.976562 C 20.480469 21.414062 23.910156 17.003906 23.910156 11.792969 C 23.929688 5.269531 18.558594 0 11.964844 0 Z M 11.964844 0 "/></symbol><symbol id="icon-eds-i-institution-medium" viewBox="0 0 24 24"><g><path fill-rule="evenodd" clip-rule="evenodd" d="M11.9967 1C11.6364 1 11.279 1.0898 10.961 1.2646C10.9318 1.28061 10.9035 1.29806 10.8761 1.31689L2.79765 6.87C2.46776 7.08001 2.20618 7.38466 2.07836 7.76668C1.94823 8.15561 1.98027 8.55648 2.12665 8.90067C2.42086 9.59246 3.12798 10 3.90107 10H4.99994V16H4.49994C3.11923 16 1.99994 17.1193 1.99994 18.5V19.5C1.99994 20.8807 3.11923 22 4.49994 22H19.4999C20.8807 22 21.9999 20.8807 21.9999 19.5V18.5C21.9999 17.1193 20.8807 16 19.4999 16H18.9999V10H20.0922C20.8653 10 21.5725 9.59252 21.8667 8.90065C22.0131 8.55642 22.0451 8.15553 21.9149 7.7666C21.7871 7.38459 21.5255 7.07997 21.1956 6.86998L13.1172 1.31689C13.0898 1.29806 13.0615 1.28061 13.0324 1.2646C12.7143 1.0898 12.357 1 11.9967 1ZM4.6844 8L11.9472 3.00755C11.9616 3.00295 11.9783 3 11.9967 3C12.015 3 12.0318 3.00295 12.0461 3.00755L19.3089 8H4.6844ZM16.9999 16V10H14.9999V16H16.9999ZM12.9999 16V10H10.9999V16H12.9999ZM8.99994 16V10H6.99994V16H8.99994ZM3.99994 18.5C3.99994 18.2239 4.2238 18 4.49994 18H19.4999C19.7761 18 19.9999 18.2239 19.9999 18.5V19.5C19.9999 19.7761 19.7761 20 19.4999 20H4.49994C4.2238 20 3.99994 19.7761 3.99994 19.5V18.5Z"/></g></symbol><symbol id="icon-eds-i-limited-access" viewBox="0 0 16 16"><path fill-rule="evenodd" d="M4 3v3a1 1 0 0 1-2 0V2.923C2 1.875 2.84 1 3.909 1h5.909a1 1 0 0 1 .713.298l3.181 3.231a1 1 0 0 1 .288.702V6a1 1 0 1 1-2 0v-.36L9.4 3H4ZM3 8a1 1 0 0 1 1 1v1a1 1 0 1 1-2 0V9a1 1 0 0 1 1-1Zm10 0a1 1 0 0 1 1 1v1a1 1 0 1 1-2 0V9a1 1 0 0 1 1-1Zm-3.5 6a1 1 0 0 1-1 1h-1a1 1 0 1 1 0-2h1a1 1 0 0 1 1 1Zm2.441-1a1 1 0 0 1 2 0c0 .73-.246 1.306-.706 1.664a1.61 1.61 0 0 1-.876.334l-.032.002H11.5a1 1 0 1 1 0-2h.441ZM4 13a1 1 0 0 0-2 0c0 .73.247 1.306.706 1.664a1.609 1.609 0 0 0 .876.334l.032.002H4.5a1 1 0 1 0 0-2H4Z" clip-rule="evenodd"/></symbol><symbol id="icon-eds-i-rss" viewBox="0 0 22 22"><path d="M1.96094 1C1.96094 0.447715 2.40865 0 2.96094 0C5.46109 0 7.93678 0.492038 10.2467 1.44806C12.5565 2.40407 14.6554 3.80534 16.4234 5.57189C18.1913 7.33843 19.5939 9.4357 20.5508 11.744C21.5077 14.0522 22.0001 16.5263 22.0001 19.0247C22.0001 19.577 21.5524 20.0247 21.0001 20.0247C20.4478 20.0247 20.0001 19.577 20.0001 19.0247C20.0001 16.7891 19.5595 14.5753 18.7033 12.5098C17.8471 10.4444 16.5919 8.56762 15.0097 6.98666C13.4275 5.40575 11.5492 4.15167 9.48182 3.29604C7.41447 2.4404 5.19868 2 2.96094 2C2.40865 2 1.96094 1.55228 1.96094 1Z"/><path fill-rule="evenodd" clip-rule="evenodd" d="M0 18.649C0 16.7974 1.50196 15.298 3.35294 15.298C5.20392 15.298 6.70588 16.7974 6.70588 18.649C6.70588 20.5003 5.20397 22 3.35294 22C1.50191 22 0 20.5003 0 18.649ZM3.35294 17.298C2.60493 17.298 2 17.9036 2 18.649C2 19.3943 2.60498 20 3.35294 20C4.1009 20 4.70588 19.3943 4.70588 18.649C4.70588 17.9036 4.10095 17.298 3.35294 17.298Z"/><path d="M3.3374 7.46115C2.78512 7.46115 2.3374 7.90887 2.3374 8.46115C2.3374 9.01344 2.78512 9.46115 3.3374 9.46115C4.54515 9.46115 5.74107 9.69885 6.85684 10.1606C7.97262 10.6224 8.98639 11.2993 9.84028 12.1525C10.6942 13.0057 11.3715 14.0185 11.8336 15.1332C12.2956 16.2478 12.5335 17.4424 12.5335 18.649C12.5335 19.2013 12.9812 19.649 13.5335 19.649C14.0858 19.649 14.5335 19.2013 14.5335 18.649C14.5335 17.1796 14.2438 15.7247 13.6811 14.3673C13.1184 13.0099 12.2936 11.7765 11.2539 10.7377C10.2142 9.69885 8.97999 8.87484 7.62168 8.31266C6.26337 7.75049 4.80757 7.46115 3.3374 7.46115Z"/></symbol><symbol id="icon-eds-i-search-category-medium" viewBox="0 0 32 32"><path fill-rule="evenodd" d="M2 5.306A3.306 3.306 0 0 1 5.306 2h5.833a3.306 3.306 0 0 1 3.306 3.306v5.833a3.306 3.306 0 0 1-3.306 3.305H5.306A3.306 3.306 0 0 1 2 11.14V5.306Zm3.306-.584a.583.583 0 0 0-.584.584v5.833c0 .322.261.583.584.583h5.833a.583.583 0 0 0 .583-.583V5.306a.583.583 0 0 0-.583-.584H5.306Zm15.555 8.945a7.194 7.194 0 1 0 4.034 13.153l2.781 2.781a1.361 1.361 0 1 0 1.925-1.925l-2.781-2.781a7.194 7.194 0 0 0-5.958-11.228Zm3.173 10.346a4.472 4.472 0 1 0-.021.021l.01-.01.011-.011Zm-5.117-19.29a.583.583 0 0 0-.584.583v5.833a1.361 1.361 0 0 1-2.722 0V5.306A3.306 3.306 0 0 1 18.917 2h5.833a3.306 3.306 0 0 1 3.306 3.306v5.833c0 .6-.161 1.166-.443 1.654a1.361 1.361 0 1 1-2.357-1.363.575.575 0 0 0 .078-.291V5.306a.583.583 0 0 0-.584-.584h-5.833ZM2 18.916a3.306 3.306 0 0 1 3.306-3.306h5.833a1.361 1.361 0 1 1 0 2.722H5.306a.583.583 0 0 0-.584.584v5.833c0 .322.261.583.584.583h5.833a.574.574 0 0 0 .29-.077 1.361 1.361 0 1 1 1.364 2.356 3.296 3.296 0 0 1-1.654.444H5.306A3.306 3.306 0 0 1 2 24.75v-5.833Z" clip-rule="evenodd"/></symbol><symbol id="icon-eds-i-search-magic" viewBox="0 0 20 20"><path d="M8.695 1.667a9.1 9.1 0 0 1 1.756.17A3.098 3.098 0 0 0 9.436 3.37a7.333 7.333 0 0 0-.738-.038c-3.841 0-6.956 2.986-6.956 6.668 0 3.681 3.115 6.665 6.956 6.665 3.642 0 6.627-2.681 6.928-6.096a3.19 3.19 0 0 0 1.763-.548 8.091 8.091 0 0 1-1.961 5.25l3.446 3.306a.81.81 0 0 1 0 1.178.897.897 0 0 1-1.23 0l-3.447-3.303a8.892 8.892 0 0 1-5.502 1.88C3.893 18.334 0 14.603 0 10c0-4.603 3.893-8.333 8.695-8.334Z"/><path d="M20 4.166a.663.663 0 0 1-.128.395.709.709 0 0 1-.342.251l-2.341.827-.863 2.244a.693.693 0 0 1-.263.326.74.74 0 0 1-.821 0 .693.693 0 0 1-.264-.326l-.862-2.244-2.341-.827a.715.715 0 0 1-.341-.252.669.669 0 0 1 0-.787.715.715 0 0 1 .34-.252l2.342-.827.862-2.244a.693.693 0 0 1 .264-.327.74.74 0 0 1 .821 0 .7.7 0 0 1 .263.327l.863 2.244 2.34.827a.709.709 0 0 1 .343.251.663.663 0 0 1 .128.394Z"/></symbol><symbol id="icon-eds-i-subjects-medium" viewBox="0 0 24 24"><g id="icon-subjects-copy" stroke="none" stroke-width="1" fill-rule="evenodd"><path d="M13.3846154,2 C14.7015971,2 15.7692308,3.06762994 15.7692308,4.38461538 L15.7692308,7.15384615 C15.7692308,8.47082629 14.7015955,9.53846154 13.3846154,9.53846154 L13.1038388,9.53925278 C13.2061091,9.85347965 13.3815528,10.1423885 13.6195822,10.3804178 C13.9722182,10.7330539 14.436524,10.9483278 14.9293854,10.9918129 L15.1153846,11 C16.2068332,11 17.2535347,11.433562 18.0254647,12.2054189 C18.6411944,12.8212361 19.0416785,13.6120766 19.1784166,14.4609738 L19.6153846,14.4615385 C20.932386,14.4615385 22,15.5291672 22,16.8461538 L22,19.6153846 C22,20.9323924 20.9323924,22 19.6153846,22 L16.8461538,22 C15.5291672,22 14.4615385,20.932386 14.4615385,19.6153846 L14.4615385,16.8461538 C14.4615385,15.5291737 15.5291737,14.4615385 16.8461538,14.4615385 L17.126925,14.460779 C17.0246537,14.1465537 16.8492179,13.857633 16.6112344,13.6196157 C16.2144418,13.2228606 15.6764136,13 15.1153846,13 C14.0239122,13 12.9771569,12.5664197 12.2053686,11.7946314 C12.1335167,11.7227795 12.0645962,11.6485444 11.9986839,11.5721119 C11.9354038,11.6485444 11.8664833,11.7227795 11.7946314,11.7946314 C11.0228431,12.5664197 9.97608778,13 8.88461538,13 C8.323576,13 7.78552852,13.2228666 7.38881294,13.6195822 C7.15078359,13.8576115 6.97533988,14.1465203 6.8730696,14.4607472 L7.15384615,14.4615385 C8.47082629,14.4615385 9.53846154,15.5291737 9.53846154,16.8461538 L9.53846154,19.6153846 C9.53846154,20.932386 8.47083276,22 7.15384615,22 L4.38461538,22 C3.06762347,22 2,20.9323876 2,19.6153846 L2,16.8461538 C2,15.5291721 3.06762994,14.4615385 4.38461538,14.4615385 L4.8215823,14.4609378 C4.95831893,13.6120029 5.3588057,12.8211623 5.97459937,12.2053686 C6.69125996,11.488708 7.64500941,11.0636656 8.6514968,11.0066017 L8.88461538,11 C9.44565477,11 9.98370225,10.7771334 10.3804178,10.3804178 C10.6184472,10.1423885 10.7938909,9.85347965 10.8961612,9.53925278 L10.6153846,9.53846154 C9.29840448,9.53846154 8.23076923,8.47082629 8.23076923,7.15384615 L8.23076923,4.38461538 C8.23076923,3.06762994 9.29840286,2 10.6153846,2 L13.3846154,2 Z M7.15384615,16.4615385 L4.38461538,16.4615385 C4.17220099,16.4615385 4,16.63374 4,16.8461538 L4,19.6153846 C4,19.8278134 4.17218833,20 4.38461538,20 L7.15384615,20 C7.36626945,20 7.53846154,19.8278103 7.53846154,19.6153846 L7.53846154,16.8461538 C7.53846154,16.6337432 7.36625679,16.4615385 7.15384615,16.4615385 Z M19.6153846,16.4615385 L16.8461538,16.4615385 C16.6337432,16.4615385 16.4615385,16.6337432 16.4615385,16.8461538 L16.4615385,19.6153846 C16.4615385,19.8278103 16.6337306,20 16.8461538,20 L19.6153846,20 C19.8278229,20 20,19.8278229 20,19.6153846 L20,16.8461538 C20,16.6337306 19.8278103,16.4615385 19.6153846,16.4615385 Z M13.3846154,4 L10.6153846,4 C10.4029708,4 10.2307692,4.17220099 10.2307692,4.38461538 L10.2307692,7.15384615 C10.2307692,7.36625679 10.402974,7.53846154 10.6153846,7.53846154 L13.3846154,7.53846154 C13.597026,7.53846154 13.7692308,7.36625679 13.7692308,7.15384615 L13.7692308,4.38461538 C13.7692308,4.17220099 13.5970292,4 13.3846154,4 Z" id="Shape" fill-rule="nonzero"/></g></symbol><symbol id="icon-eds-small-arrow-left" viewBox="0 0 16 17"><path stroke="currentColor" stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M14 8.092H2m0 0L8 2M2 8.092l6 6.035"/></symbol><symbol id="icon-eds-small-arrow-right" viewBox="0 0 16 16"><g fill-rule="evenodd" stroke="currentColor" stroke-linecap="round" stroke-linejoin="round" stroke-width="2"><path d="M2 8.092h12M8 2l6 6.092M8 14.127l6-6.035"/></g></symbol><symbol id="icon-globe-with-star" viewBox="0 0 32 32"><path style="fill:none;stroke:#fff" stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M27.282 17.026c0 6.797-5.51 12.307-12.307 12.307-6.798 0-12.308-5.51-12.308-12.307 0-6.798 5.51-12.308 12.308-12.308M2.667 17.026h14.201"/><path style="fill:none;stroke:#fff" stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M14.975 4.718a21.244 21.244 0 0 0-4.734 12.308c.233 4.5 1.89 8.81 4.734 12.307a21.245 21.245 0 0 0 4.394-9.467M17.045 9.72c-.709-.126-.709-1.16 0-1.286 2.568-.454 4.61-2.443 5.168-5.032l.043-.199c.153-.712 1.15-.716 1.31-.006l.052.232c.578 2.577 2.621 4.549 5.182 5.002.712.126.712 1.166 0 1.292-2.561.453-4.604 2.425-5.182 5.002l-.052.231c-.16.711-1.157.707-1.31-.005l-.043-.199c-.557-2.59-2.6-4.578-5.168-5.032Z"/></symbol><symbol id="icon-orcid-logo" viewBox="0 0 40 40"><path fill-rule="evenodd" d="M12.281 10.453c.875 0 1.578-.719 1.578-1.578 0-.86-.703-1.578-1.578-1.578-.875 0-1.578.703-1.578 1.578 0 .86.703 1.578 1.578 1.578Zm-1.203 18.641h2.406V12.359h-2.406v16.735Z"/><path fill-rule="evenodd" d="M17.016 12.36h6.5c6.187 0 8.906 4.421 8.906 8.374 0 4.297-3.36 8.375-8.875 8.375h-6.531V12.36Zm6.234 14.578h-3.828V14.53h3.703c4.688 0 6.828 2.844 6.828 6.203 0 2.063-1.25 6.203-6.703 6.203Z" clip-rule="evenodd"/></symbol><symbol id="icon-thumbs-down" viewBox="41 0 33 33"><path stroke="currentcolor" stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M61 17.611h-1l-2.085 4.436a1 1 0 0 1-.366.332 1.04 1.04 0 0 1-1.197-.159.95.95 0 0 1-.298-.678v-3.32h-3.93c-.61 0-.674-1.066-.599-1.55l.726-4.301a.98.98 0 0 1 .341-.622 1.06 1.06 0 0 1 .685-.249H61M63.5 11.5v6"/></symbol><symbol id="icon-thumbs-up-medium" viewBox="0 0 24 24"><path d="M6.75 9.33333H8.25L11.3778 2.67913C11.5138 2.47128 11.7025 2.29994 11.9263 2.18116C12.1502 2.06239 12.4018 2.00005 12.6576 2C13.056 1.99999 13.4384 2.15092 13.7214 2.41998C14.0044 2.68903 14.1652 3.05442 14.1688 3.43663V8.41667C16.1342 8.41667 18.1116 8.41667 20.0648 8.41667C20.9795 8.41667 21.0744 10.0164 20.9625 10.7422L19.8733 17.194C19.8269 17.5542 19.6449 17.8856 19.3616 18.1261C19.0783 18.3667 18.7132 18.4996 18.3349 18.5H6.75" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"/><path d="M3 18.5V9.5" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"/></symbol><symbol id="icon-thumbs-up"><path stroke="currentcolor" stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 15.389h1l2.085-4.436a1 1 0 0 1 .366-.332 1.04 1.04 0 0 1 1.197.159.95.95 0 0 1 .298.678v3.32h3.93c.61 0 .674 1.066.599 1.55l-.726 4.301a.98.98 0 0 1-.341.622 1.06 1.06 0 0 1-.685.249H13m-2.5 0v-6"/></symbol><symbol id="icon-tick-with-curly-circle" viewBox="0 0 40 40"><path d="M17.923.757a3.227 3.227 0 0 1 4.401.231l2.168 2.25 3.001-.866.33-.076a3.23 3.23 0 0 1 3.598 2.076l.099.325.75 3.03 3.033.753a3.229 3.229 0 0 1 2.4 3.697l-.075.33-.865 3.001 2.249 2.168.231.247a3.227 3.227 0 0 1-.231 4.401l-2.25 2.166.866 3.003.076.33a3.228 3.228 0 0 1-2.401 3.697l-3.033.75-.75 3.033a3.229 3.229 0 0 1-4.027 2.325l-3.001-.867-2.168 2.25a3.227 3.227 0 0 1-4.648 0l-2.17-2.25-2.999.867a3.229 3.229 0 0 1-4.027-2.325l-.752-3.033-3.03-.75a3.229 3.229 0 0 1-2.326-4.027l.865-3.001-2.249-2.168a3.227 3.227 0 0 1 0-4.648l2.25-2.17-.866-2.999A3.229 3.229 0 0 1 4.697 8.48l3.031-.752.752-3.03a3.229 3.229 0 0 1 4.027-2.326l3 .865L17.675.988l.247-.231Zm.027 5.156a3.23 3.23 0 0 1-3.219.864l-2.838-.82-.712 2.87a3.227 3.227 0 0 1-2.355 2.354l-2.868.712.819 2.838a3.23 3.23 0 0 1-.864 3.219L3.786 20l2.127 2.05a3.23 3.23 0 0 1 .864 3.219l-.82 2.837 2.87.713.215.062a3.228 3.228 0 0 1 2.14 2.293l.71 2.867 2.84-.818a3.229 3.229 0 0 1 3.218.864L20 36.214l2.05-2.127.16-.156a3.228 3.228 0 0 1 2.841-.76l.218.052 2.837.818.713-2.867.062-.214a3.227 3.227 0 0 1 2.293-2.141l2.867-.713-.816-2.837c-.331-1.15 0-2.389.861-3.219L36.212 20l-2.126-2.05a3.229 3.229 0 0 1-.861-3.219l.816-2.838-2.867-.712a3.228 3.228 0 0 1-2.355-2.355l-.713-2.868-2.837.819a3.23 3.23 0 0 1-3.219-.864L20 3.786l-2.05 2.127Z" stroke="transparent" stroke-width=".9"/><path d="M25.723 13.406a1.807 1.807 0 0 1 2.699 2.397l-9.658 12.074a1.808 1.808 0 0 1-2.497.316L11.44 24.57a1.806 1.806 0 1 1 2.168-2.892l3.427 2.57 8.565-10.704.124-.138Z" stroke="transparent" stroke-width=".9"/></symbol></svg>
</div>


        

        
        
    <a class="c-skip-link" href="#main">Skip to main content</a>

    
        
    <aside class="u-lazy-ad-wrapper u-mbs-0" aria-label="Advertisement">
        <div class="c-ad c-ad--728x90 c-ad--conditional" data-test="springer-doubleclick-ad">
            <div class="c-ad c-ad__inner" >
                <p class="c-ad__label">Advertisement</p>
                <div id="div-gpt-ad-LB1"
                     class="div-gpt-ad grade-c-hide"
                     data-gpt
                     data-gpt-unitpath="/270604982/springerlink/44337/article"
                     data-gpt-sizes="728x90"
                     data-gpt-targeting="pos=top;articleid=s44337-025-00428-0;"
                     data-ad-type="top"
                     style="min-width:728px;min-height:90px">
                    
                    <script>
                        window.SN = window.SN || {};
                        window.SN.libs = window.SN.libs || {};
                        window.SN.libs.ads = window.SN.libs.ads || {};
                        window.SN.libs.ads.slotConfig = window.SN.libs.ads.slotConfig || {};
                        window.SN.libs.ads.slotConfig['LB1'] = {
                            'pos': 'top',
                            'type': 'top',
                        };
                        window.SN.libs.ads.slotConfig['unitPath'] = '/270604982/springerlink/44337/article';
                    </script>
                    <noscript>
                        <a href="//pubads.g.doubleclick.net/gampad/jump?iu=/270604982/springerlink/44337/article&amp;sz=728x90&amp;pos=top&amp;articleid=s44337-025-00428-0">
                            <img data-test="gpt-advert-fallback-img"
                                 src="//pubads.g.doubleclick.net/gampad/ad?iu=/270604982/springerlink/44337/article&amp;sz=728x90&amp;pos=top&amp;articleid=s44337-025-00428-0"
                                 alt="Advertisement"
                                 width="728"
                                 height="90">
                        </a>
                    </noscript>
                </div>
            </div>
        </div>
    </aside>

    

    <header class="eds-c-header" data-eds-c-header>
    <div class="eds-c-header__container" data-eds-c-header-expander-anchor>
        <div class="eds-c-header__brand">
            
                
                    <a href="https://link.springer.com"
                    	 data-test=springerlink-logo
                        
                            data-track="click_imprint_logo"
                        
                            data-track-context="unified header"
                        
                            data-track-action="click logo link"
                        
                            data-track-category="unified header"
                        
                            data-track-label="link"
                        
					>
                        <img src="/oscar-static/images/darwin/header/img/logo-springer-nature-link-3149409f62.svg" alt="Springer Nature Link">
                    </a>
                
            
        </div>

        
            
                
    
        <a class="c-header__link eds-c-header__link" id="identity-account-widget" data-track="click_login" data-track-context="header" href='https://idp.springer.com/auth/personal/springernature?redirect_uri=https://link.springer.com/article/10.1007/s44337-025-00428-0'><span class="eds-c-header__widget-fragment-title">Log in</span></a>
    


            
        
    </div>

    
        <nav class="eds-c-header__nav" aria-label="header navigation">
            <div class="eds-c-header__nav-container">
                <div class="eds-c-header__item eds-c-header__item--menu">
                   <a href="#eds-c-header-nav" class="eds-c-header__link" data-eds-c-header-expander>
                        <svg class="eds-c-header__icon" width="24" height="24" aria-hidden="true" focusable="false">
                            <use xlink:href="#icon-eds-i-menu-medium"></use>
                        </svg><span>Menu</span>
                    </a>
                </div>

                <div class="eds-c-header__item eds-c-header__item--inline-links">
                    
                        <a class="eds-c-header__link" href="https://link.springer.com/journals/"
                            
                                data-track="nav_find_a_journal"
                            
                                data-track-context="unified header"
                            
                                data-track-action="click find a journal"
                            
                                data-track-category="unified header"
                            
                                data-track-label="link"
                            
						>
                            Find a journal
                        </a>
                    
                        <a class="eds-c-header__link" href="https://www.springernature.com/gp/authors"
                            
                                data-track="nav_how_to_publish"
                            
                                data-track-context="unified header"
                            
                                data-track-action="click publish with us link"
                            
                                data-track-category="unified header"
                            
                                data-track-label="link"
                            
						>
                            Publish with us
                        </a>
                    
                        <a class="eds-c-header__link" href="https://link.springernature.com/home/"
                            
                                data-track="nav_track_your_research"
                            
                                data-track-context="unified header"
                            
                                data-track-action="click track your research"
                            
                                data-track-category="unified header"
                            
                                data-track-label="link"
                            
						>
                            Track your research
                        </a>
                    
                </div>

                <div class="eds-c-header__link-container">
                    
                        <div class="eds-c-header__item eds-c-header__item--divider">
                            <a href="#eds-c-header-popup-search" class="eds-c-header__link" data-eds-c-header-expander data-eds-c-header-test-search-btn>
                                <svg class="eds-c-header__icon" width="24" height="24" aria-hidden="true" focusable="false">
                                    <use xlink:href="#icon-eds-i-search-medium"></use>
                                </svg><span>Search</span>
                            </a>
                        </div>
                    
                    
                        <div id="ecommerce-header-cart-icon-link" class="eds-c-header__item ecommerce-cart" style="display:inline-block">
 <a class="eds-c-header__link" href="https://order.springer.com/public/cart" style="appearance:none;border:none;background:none;color:inherit;position:relative">
  <svg id="eds-i-cart" class="eds-c-header__icon" xmlns="http://www.w3.org/2000/svg" height="24" width="24" viewBox="0 0 24 24" aria-hidden="true" focusable="false">
   <path fill="currentColor" fill-rule="nonzero" d="M2 1a1 1 0 0 0 0 2l1.659.001 2.257 12.808a2.599 2.599 0 0 0 2.435 2.185l.167.004 9.976-.001a2.613 2.613 0 0 0 2.61-1.748l.03-.106 1.755-7.82.032-.107a2.546 2.546 0 0 0-.311-1.986l-.108-.157a2.604 2.604 0 0 0-2.197-1.076L6.042 5l-.56-3.17a1 1 0 0 0-.864-.82l-.12-.007L2.001 1ZM20.35 6.996a.63.63 0 0 1 .54.26.55.55 0 0 1 .082.505l-.028.1L19.2 15.63l-.022.05c-.094.177-.282.299-.526.317l-10.145.002a.61.61 0 0 1-.618-.515L6.394 6.999l13.955-.003ZM18 19a2 2 0 1 0 0 4 2 2 0 0 0 0-4ZM8 19a2 2 0 1 0 0 4 2 2 0 0 0 0-4Z"></path>
  </svg>
  <span>Cart</span><span class="cart-info" style="display:none;position:absolute;top:10px;right:45px;background-color:#C65301;color:#fff;width:18px;height:18px;font-size:11px;border-radius:50%;line-height:17.5px;text-align:center"></span>
 </a>
 <script>(function () { var exports = {}; if (window.fetch) {
            
            "use strict";
Object.defineProperty(exports, "__esModule", { value: true });
exports.headerWidgetClientInit = void 0;
var headerWidgetClientInit = function (getCartInfo) {
    document.body.addEventListener("updatedCart", function () {
        updateCartIcon();
    }, false);
    return updateCartIcon();
    function updateCartIcon() {
        return getCartInfo()
            .then(function (res) { return res.json(); })
            .then(refreshCartState)
            .catch(function (_) { });
    }
    function refreshCartState(json) {
        var indicator = document.querySelector("#ecommerce-header-cart-icon-link .cart-info");
        /* istanbul ignore else */
        if (indicator && json.itemCount) {
            indicator.style.display = 'block';
            indicator.textContent = json.itemCount > 9 ? '9+' : json.itemCount.toString();
            var moreThanOneItem = json.itemCount > 1;
            indicator.setAttribute('title', "there ".concat(moreThanOneItem ? "are" : "is", " ").concat(json.itemCount, " item").concat(moreThanOneItem ? "s" : "", " in your cart"));
        }
        return json;
    }
};
exports.headerWidgetClientInit = headerWidgetClientInit;

            
            headerWidgetClientInit(
              function () {
                return window.fetch("https://cart.springer.com/cart-info", {
                  credentials: "include",
                  headers: { Accept: "application/json" }
                })
              }
            )
        }})()</script>
</div>
                    
                </div>
            </div>
        </nav>
    
</header>



    <article lang="en" id="main" class="app-masthead__colour-31">
        <section class="app-masthead " aria-label="article masthead">
    <div class="app-masthead__container">
        
            <div class="app-article-masthead u-sans-serif js-context-bar-sticky-point-masthead" data-track-component="article" data-test="masthead-component">
                <div class="app-article-masthead__info">
                    
    
        <nav aria-label="breadcrumbs" data-test="breadcrumbs">
            <ol class="c-breadcrumbs c-breadcrumbs--contrast" itemscope itemtype="https://schema.org/BreadcrumbList">
                
                    <li class="c-breadcrumbs__item" id="breadcrumb0" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem">
                        <a href="/" class="c-breadcrumbs__link" itemprop="item" data-track="click_breadcrumb" data-track-context="article page"  data-track-category="article" data-track-action="breadcrumbs" data-track-label="breadcrumb1"><span itemprop="name">Home</span></a><meta itemprop="position" content="1">
                            <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" width="10" height="10" viewBox="0 0 10 10">
                                <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"/>
                            </svg>
                    </li>
                
                    <li class="c-breadcrumbs__item" id="breadcrumb1" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem">
                        <a href="/journal/44337" class="c-breadcrumbs__link" itemprop="item" data-track="click_breadcrumb" data-track-context="article page"  data-track-category="article" data-track-action="breadcrumbs" data-track-label="breadcrumb2"><span itemprop="name">Discover Medicine</span></a><meta itemprop="position" content="2">
                            <svg class="c-breadcrumbs__chevron" role="img" aria-hidden="true" focusable="false" width="10" height="10" viewBox="0 0 10 10">
                                <path d="m5.96738168 4.70639573 2.39518594-2.41447274c.37913917-.38219212.98637524-.38972225 1.35419292-.01894278.37750606.38054586.37784436.99719163-.00013556 1.37821513l-4.03074001 4.06319683c-.37758093.38062133-.98937525.38100976-1.367372-.00003075l-4.03091981-4.06337806c-.37759778-.38063832-.38381821-.99150444-.01600053-1.3622839.37750607-.38054587.98772445-.38240057 1.37006824.00302197l2.39538588 2.4146743.96295325.98624457z" fill-rule="evenodd" transform="matrix(0 -1 1 0 0 10)"/>
                            </svg>
                    </li>
                
                    <li class="c-breadcrumbs__item" id="breadcrumb2" itemprop="itemListElement" itemscope="" itemtype="https://schema.org/ListItem">
                        <span itemprop="name">Article</span><meta itemprop="position" content="3">
                    </li>
                
            </ol>
        </nav>
    

                    <h1 class="c-article-title" data-test="article-title" data-article-title="">GLP-1 receptor agonists in delirium and encephalopathies: a neuroprotective scoping review</h1>

                    <ul class="c-article-identifiers">
                        
        <li class="c-article-identifiers__item" data-test="article-category">Review</li>
    
        <li class="c-article-identifiers__item">
            <a href="https://www.springernature.com/gp/open-science/about/the-fundamentals-of-open-access-and-open-research" data-track="click" data-track-action="open access" data-track-label="link" class="u-color-open-access" data-test="open-access">Open access</a>
        </li>
    
    

                        <li class="c-article-identifiers__item">
                            Published: <time datetime="2025-07-31">31 July 2025</time>
                        </li>
                    </ul>
                    <ul class="c-article-identifiers c-article-identifiers--cite-list">
                        <li class="c-article-identifiers__item">
                            <span data-test="journal-volume">Volume 2</span>, article number <span data-test="article-number">207</span>, (<span data-test="article-publication-year">2025</span>)
            
                        </li>
                        <li class="c-article-identifiers__item c-article-identifiers__item--cite">
                            <a href="#citeas" data-track="click" data-track-action="cite this article" data-track-category="article body" data-track-label="link">Cite this article</a>
                        </li>
                    </ul>

                    <div class="app-article-masthead__buttons" data-test="download-article-link-wrapper" data-track-context="masthead">
                        
        <div class="c-pdf-container">
            <div class="c-pdf-download u-clear-both u-mb-16">
                <a href="/content/pdf/10.1007/s44337-025-00428-0.pdf" class="c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="pdf-link" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="button" data-track-external download>
                    
                        <span class="c-pdf-download__text">Download PDF</span>
                        <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-eds-i-download-medium"/></svg>
                    
                </a>
            </div>
        </div>
    

                        <p class="app-article-masthead__access">
                            <svg width="16" height="16" focusable="false" role="img" aria-hidden="true"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-check-filled-medium"></use></svg>
                            You have full access to this <a href="https://www.springernature.com/gp/open-science/about/the-fundamentals-of-open-access-and-open-research" data-track="click" data-track-action="open access" data-track-label="link">open access</a> article</p>
                        
                    </div>
                </div>
                <div class="app-article-masthead__brand">
                    
                        
                            <a href="/journal/44337"
                        
                           class="app-article-masthead__journal-link"
                           data-track="click_journal_home"
                           data-track-action="journal homepage"
                           data-track-context="article page"
                           data-track-label="link">
                            <picture>
                                <source type="image/webp" media="(min-width: 768px)" width="120" height="159"
                                        srcset="https://media.springernature.com/w120/springer-static/cover-hires/journal/44337?as=webp,
                                                    https://media.springernature.com/w316/springer-static/cover-hires/journal/44337?as=webp 2x">
                                <img width="72" height="95"
                                     src="https://media.springernature.com/w72/springer-static/cover-hires/journal/44337?as=webp"
                                     srcset="https://media.springernature.com/w144/springer-static/cover-hires/journal/44337?as=webp 2x" alt="">
                            </picture>
                            <span class="app-article-masthead__journal-title">Discover Medicine</span>
                        </a>
                        
                            <a href="/journal/44337/aims-and-scope" class="app-article-masthead__submission-link"
                               data-track="click_aims_and_scope"
                               data-track-action="aims and scope"
                               data-track-context="article page"
                               data-track-label="link">
                                Aims and scope
                                <svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-arrow-right-medium"></use></svg>
                            </a>
                        
                        
                            <a href="https://submission.nature.com/new-submission/44337/3" class="app-article-masthead__submission-link"
                               data-track="click_submit_manuscript"
                               data-track-context="article masthead on springerlink article page"
                               data-track-action="submit manuscript"
                               data-track-label="link">
                                Submit manuscript
                                <svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-arrow-right-medium"></use></svg>
                            </a>
                        
                    
                </div>
            </div>
        
    </div>
</section>

        <div class="c-article-main u-container u-mt-24 u-mb-32 l-with-sidebar" id="main-content"
             data-component="article-container">
            <main class="u-serif js-main-column" data-track-component="article body">
                
                
                    <div class="c-context-bar u-hide"
                         data-test="context-bar"
                         data-context-bar
                         aria-hidden="true">
                        <div class="c-context-bar__container u-container">
                            <div class="c-context-bar__title">
                                GLP-1 receptor agonists in delirium and encephalopathies: a neuroprotective scoping review
                            </div>
                            
                                <div data-test="inCoD" data-track-context="sticky banner">
                                    
        <div class="c-pdf-container">
            <div class="c-pdf-download u-clear-both u-mb-16">
                <a href="/content/pdf/10.1007/s44337-025-00428-0.pdf" class="c-pdf-download__link" data-article-pdf="true" data-readcube-pdf-url="true" data-test="pdf-link" data-draft-ignore="true" data-track="content_download" data-track-type="article pdf download" data-track-action="download pdf" data-track-label="button" data-track-external download>
                    
                        <span class="c-pdf-download__text">Download PDF</span>
                        <svg aria-hidden="true" focusable="false" width="16" height="16" class="u-icon"><use xlink:href="#icon-eds-i-download-medium"/></svg>
                    
                </a>
            </div>
        </div>
    

                                </div>
                            
                        </div>
                    </div>
                

                <div class="c-article-header">
                    <header>
                        <ul class="c-article-author-list c-article-author-list--short" data-test="authors-list" data-component-authors-activator="authors-list"><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-track-index="1_3" data-track-context="researcher popup with no profile" href="#auth-Francisco-Mercado-Aff1-Aff2" data-author-popup="auth-Francisco-Mercado-Aff1-Aff2" data-author-search="Mercado, Francisco" data-corresp-id="c1">Francisco Mercado<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-mail-medium"></use></svg></a><span class="u-js-hide"> 
            <a class="js-orcid" href="https://orcid.org/0000-0003-0091-0082"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0003-0091-0082</a></span><sup class="u-js-hide"><a href="#Aff1">1</a>,<a href="#Aff2">2</a></sup>, </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-track-index="2_3" data-track-context="researcher popup with no profile" href="#auth-Michaela-Kop-Aff1" data-author-popup="auth-Michaela-Kop-Aff1" data-author-search="Kop, Michaela">Michaela Kop</a><span class="u-js-hide"> 
            <a class="js-orcid" href="https://orcid.org/0000-0001-6964-0573"><span class="u-visually-hidden">ORCID: </span>orcid.org/0000-0001-6964-0573</a></span><sup class="u-js-hide"><a href="#Aff1">1</a></sup> &amp; </li><li class="c-article-author-list__item"><a data-test="author-name" data-track="click" data-track-action="open author" data-track-label="link" data-track-index="3_3" data-track-context="researcher popup with no profile" href="#auth-Michelle-Trinh-Aff1" data-author-popup="auth-Michelle-Trinh-Aff1" data-author-search="Trinh, Michelle">Michelle Trinh</a><span class="u-js-hide"> 
            <a class="js-orcid" href="https://orcid.org/0009-0000-1148-1493"><span class="u-visually-hidden">ORCID: </span>orcid.org/0009-0000-1148-1493</a></span><sup class="u-js-hide"><a href="#Aff1">1</a></sup> </li></ul>
                        
    


                        <div data-test="article-metrics">
                            
        <ul class="app-article-metrics-bar u-list-reset">
            
                <li class="app-article-metrics-bar__item" data-test="access-count">
                    <p class="app-article-metrics-bar__count"><svg class="u-icon app-article-metrics-bar__icon" width="24" height="24" aria-hidden="true" focusable="false">
                        <use xlink:href="#icon-eds-i-accesses-medium"></use>
                    </svg>502 <span class="app-article-metrics-bar__label">Accesses</span></p>
                </li>
            
            
            
            
            
                
                    <li class="app-article-metrics-bar__item app-article-metrics-bar__item--metrics">
                        <p class="app-article-metrics-bar__details"><a href="/article/10.1007/s44337-025-00428-0/metrics" data-track="click" data-track-action="view metrics" data-track-label="link" rel="nofollow">Explore all metrics <svg class="u-icon app-article-metrics-bar__arrow-icon" width="24" height="24" aria-hidden="true" focusable="false">
                            <use xlink:href="#icon-eds-i-arrow-right-medium"></use>
                        </svg></a></p>
                    </li>
                
            
        </ul>
    
                        </div>
                        
                        
    <div class="u-mt-32">
    

    
    </div>

                        
                    </header>
                </div>

                <div data-article-body="true" data-track-component="article body" class="c-article-body">

                    
                    <section aria-labelledby="Abs1" data-title="Abstract" lang="en"><div class="c-article-section" id="Abs1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Abs1">Abstract</h2><div class="c-article-section__content" id="Abs1-content"><h3 class="c-article__sub-heading" data-test="abstract-sub-heading">Background and Purpose</h3><p>Delirium and encephalopathy are frequent causes of hospitalization leading to functional disability and cognitive impairment. Recent studies have suggested that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may protect against neurodegeneration in conditions such as Alzheimer's dementia and Parkinson’s disease. However, there is limited literature on their benefits in delirium and encephalopathy. This scoping review explores the mechanisms of GLP-1 RAs in relation to delirium and encephalopathy based on animal studies, and presents current clinical evidence on their potential benefits for managing these neurological disorders.</p><h3 class="c-article__sub-heading" data-test="abstract-sub-heading">Methodology</h3><p>A literature search was conducted on PubMed, Embase, Google Scholar,Web of Science, and APA PsycInfo using search terms related to GLP-1 RAs, delirium, and encephalopathy, in which GLP-1 RAs may have potential benefits. In accordance with the Prisma-Scr guidelines, a total of 38 articles were included in the scoping review.</p><h3 class="c-article__sub-heading" data-test="abstract-sub-heading">Results</h3><p>This review focuses on several key brain dysfunctions in which GLP-1 RAs may offer potential benefits. These include postoperative delirium, sepsis-associated encephalopathy, hepatic encephalopathy, hypoxia-induced encephalopathy, diabetic encephalopathy, and alcohol withdrawal syndrome. Both preclinical and clinical studies suggest that GLP-1 RAs may provide neuroprotective benefits, including anti-apoptotic, anti-inflammatory, and cognitive-enhancing properties. These neuroprotective effects are supported by the molecular and pathophysiological pathways that could serve as potential targets for GLP-1 RAs.</p><h3 class="c-article__sub-heading" data-test="abstract-sub-heading">Conclusion</h3><p>GLP-1 RAs may offer neuroprotective benefits in patients with postoperative delirium and encephalopathies.. Cellular benefits involve pathophysiological or molecular pathways that are shared with other biological systems. While the current evidence is based on preclinical and clinical studies, more research involving human subjects is needed to clarify the role of GLP-1 RAs in various brain dysfunctions.</p></div></div></section>

                    

                    
    


                    

                    <div data-test="cobranding-download">
                        
                    </div>

                    
                        
        
            <section aria-labelledby="inline-recommendations" data-title="Inline Recommendations" class="c-article-recommendations" data-track-component="inline-recommendations">
                <h3 class="c-article-recommendations-title" id="inline-recommendations">Similar content being viewed by others</h3>
                <div class="c-article-recommendations-list">
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1007%2Fs40501-024-00331-y/MediaObjects/40501_2024_331_Figa_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link"
                                           itemprop="url"
                                           href="https://link.springer.com/10.1007/s40501-024-00331-y?fromPaywallRec=false"
                                           data-track="select_recommendations_1"
                                           data-track-context="inline recommendations"
                                           data-track-action="click recommendations inline - 1"
                                           data-track-label="10.1007/s40501-024-00331-y">The Impact of GLP-1 Receptor Agonists (GLP-1 RAs) on Mental Health: A Systematic Review
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                        
                                         <span class="c-article-meta-recommendations__date">18 September 2024</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3Aplaceholder%2Fimages/placeholder-figure-springernature.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link"
                                           itemprop="url"
                                           href="https://link.springer.com/10.1007/s40120-025-00724-y?fromPaywallRec=false"
                                           data-track="select_recommendations_2"
                                           data-track-context="inline recommendations"
                                           data-track-action="click recommendations inline - 2"
                                           data-track-label="10.1007/s40120-025-00724-y">Are Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Central Nervous System (CNS) Penetrant: A Narrative Review
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                         <span class="c-article-meta-recommendations__access-type">Open access</span>
                                         <span class="c-article-meta-recommendations__date">02 April 2025</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                        <div class="c-article-recommendations-list__item">
                            <article class="c-article-recommendations-card" itemscope itemtype="http://schema.org/ScholarlyArticle">
                                
                                    <div class="c-article-recommendations-card__img"><img src="https://media.springernature.com/w215h120/springer-static/image/art%3A10.1007%2Fs11154-023-09807-3/MediaObjects/11154_2023_9807_Fig1_HTML.png" loading="lazy" alt=""></div>
                                
                                <div class="c-article-recommendations-card__main">
                                    <h3 class="c-article-recommendations-card__heading" itemprop="name headline">
                                        <a class="c-article-recommendations-card__link"
                                           itemprop="url"
                                           href="https://link.springer.com/10.1007/s11154-023-09807-3?fromPaywallRec=false"
                                           data-track="select_recommendations_3"
                                           data-track-context="inline recommendations"
                                           data-track-action="click recommendations inline - 3"
                                           data-track-label="10.1007/s11154-023-09807-3">Effects of GLP-1 receptor agonists on neurological complications of diabetes
                                        </a>
                                    </h3>
                                    <div class="c-article-meta-recommendations" data-test="recommendation-info">
                                        <span class="c-article-meta-recommendations__item-type">Article</span>
                                         <span class="c-article-meta-recommendations__access-type">Open access</span>
                                         <span class="c-article-meta-recommendations__date">26 May 2023</span>
                                    </div>
                                </div>
                            </article>
                        </div>
                    
                </div>
            </section>
        
            <script>
                window.dataLayer = window.dataLayer || [];
                window.dataLayer.push({
                    recommendations: {
                        recommender: 'semantic',
                        model: 'specter',
                        policy_id: 'NA',
                        timestamp: 1760257880,
                        embedded_user: 'null'
                    }
                });
            </script>
        
    
                    

                    
                        
    <section class="app-explore-related-subjects" aria-labelledby="content-related-subjects" data-test="subject-content">
        <h3 id="content-related-subjects" class="app-explore-related-subjects__title">Explore related subjects</h3>
        <span class="u-sans-serif u-text-xs u-display-block u-mb-16">Discover the latest articles, books and news in related subjects, suggested using machine learning.</span>
        <ul class="app-explore-related-subjects__list app-explore-related-subjects__list--no-mb" role="list">
        
            <li class="app-explore-related-subjects__items" data-test="related-subject-item">
                <a href="/subjects/alzheimers-disease"  data-track="select_related_subject_1" data-track-context="related subjects from content page" data-track-label="Alzheimer&#x27;s disease">Alzheimer&#x27;s disease</a>
            </li>
        
            <li class="app-explore-related-subjects__items" data-test="related-subject-item">
                <a href="/subjects/g-protein-coupled-receptors"  data-track="select_related_subject_2" data-track-context="related subjects from content page" data-track-label="G protein-coupled receptors">G protein-coupled receptors</a>
            </li>
        
            <li class="app-explore-related-subjects__items" data-test="related-subject-item">
                <a href="/subjects/geriatric-psychiatry"  data-track="select_related_subject_3" data-track-context="related subjects from content page" data-track-label="Geriatric Psychiatry">Geriatric Psychiatry</a>
            </li>
        
            <li class="app-explore-related-subjects__items" data-test="related-subject-item">
                <a href="/subjects/insulin-signalling"  data-track="select_related_subject_4" data-track-context="related subjects from content page" data-track-label="Insulin Signalling">Insulin Signalling</a>
            </li>
        
            <li class="app-explore-related-subjects__items" data-test="related-subject-item">
                <a href="/subjects/neuroendocrinology"  data-track="select_related_subject_5" data-track-context="related subjects from content page" data-track-label="Neuroendocrinology">Neuroendocrinology</a>
            </li>
        
            <li class="app-explore-related-subjects__items" data-test="related-subject-item">
                <a href="/subjects/neuropharmacology"  data-track="select_related_subject_6" data-track-context="related subjects from content page" data-track-label="Neuropharmacology">Neuropharmacology</a>
            </li>
        
        </ul>
    </section>

                    

                    
                        
    <div class="app-card-service" data-test="article-checklist-banner">
        <div>
            <a class="app-card-service__link" data-track="click_presubmission_checklist" data-track-context="article page top of reading companion" data-track-category="pre-submission-checklist" data-track-action="clicked article page checklist banner test 2 old version" data-track-label="link" href="https://beta.springernature.com/pre-submission?journalId=44337"
            data-test="article-checklist-banner-link">
            <span class="app-card-service__link-text">Use our pre-submission checklist</span>
            <svg class="app-card-service__link-icon" aria-hidden="true" focusable="false"><use xlink:href="#icon-eds-i-arrow-right-small"></use></svg>
            </a>
            <p class="app-card-service__description">Avoid common mistakes on your manuscript.</p>
        </div>
        <div class="app-card-service__icon-container">
            <svg class="app-card-service__icon" aria-hidden="true" focusable="false">
                <use xlink:href="#icon-eds-i-clipboard-check-medium"></use>
            </svg>
        </div>
    </div>

                    

                    
                        
                                <div class="main-content">
                                    <section data-title="Introduction"><div class="c-article-section" id="Sec1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec1"><span class="c-article-section__title-number">1 </span>Introduction</h2><div class="c-article-section__content" id="Sec1-content"><p>Delirium and encephalopathy are brain dysfunctions characterized by altered mental status, confusion, and cognitive impairment [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 1" title="Tsuruta R, Oda Y. A clinical perspective of sepsis-associated delirium. BioMed Cent. 2016. &#xA;                  https://doi.org/10.1186/s40560-016-0145-4&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR1" id="ref-link-section-d297950435e424">1</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 2" title="Young GB. Encephalopathy of infection and systemic inflammation. Lippincott Williams Wilkins. 2013;30(5):454–61. &#xA;                  https://doi.org/10.1097/wnp.0b013e3182a73d83&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR2" id="ref-link-section-d297950435e427">2</a>]. Delirium is a neurological syndrome characterized by an acute change in mental status with a fluctuating course, inattention, and disorganized thinking [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 3" title="Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Elsevier. 2013;383(9920):911–22. &#xA;                  https://doi.org/10.1016/s0140-6736(13)60688-1&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR3" id="ref-link-section-d297950435e430">3</a>]. On the other hand, encephalopathy is a broad term representing a global brain disorder that can manifest as delirium, subsyndromal delirium, or even coma, depending on the severity of the underlying brain dysfunction [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 4" title="Gupta R, Shrinuvasan S. Encephalopathy: a comprehensive case series of five patients with MRI. Insights. 2024. &#xA;                  https://doi.org/10.36106/ijsr/8114421&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR4" id="ref-link-section-d297950435e433">4</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 5" title="Slooter AJC, Stevens RD. Updated nomenclature of delirium and acute encephalopathy. Springer Sci Media. 2020;33(3):864–864. &#xA;                  https://doi.org/10.1007/s12028-020-01074-3&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR5" id="ref-link-section-d297950435e436">5</a>].</p><p>Encephalopathy and delirium are frequently observed in critically ill and elderly patients. These neurological conditions lead to poorer outcomes, including increased mortality rates, long-term cognitive impairment, and dementia [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Denk A, et al. Liver diseases as a novel risk factor for delirium in the ICU–delirium and hepatic encephalopathy are two distinct entities. Publ Libr Sci. 2022. &#xA;                  https://doi.org/10.1371/journal.pone.0276914&#xA;                  &#xA;                ." href="#ref-CR6" id="ref-link-section-d297950435e442">6</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Dunne C, Dunne SS. Casting light on the links between delirium, infection, and dementia risk. Amsterdam: Elsevier; 2024." href="#ref-CR7" id="ref-link-section-d297950435e442_1">7</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 8" title="Sfera A, Osorio C, Price A, Gradini R, Cummings MA. Delirium from the gliocentric perspective. Front Media. 2015;9:171–171. &#xA;                  https://doi.org/10.3389/fncel.2015.00171&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR8" id="ref-link-section-d297950435e445">8</a>]. These conditions often result in hospitalization, and because of their association with an increased risk of cognitive impairment, patients may require extra care or transition to long-term care facilities [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 9" title="Neufeld KJ, et al. Outcomes of early delirium diagnosis after general anesthesia in the elderly. Lippincott Williams Wilkins. 2013;117(2):471–8. &#xA;                  https://doi.org/10.1213/ane.0b013e3182973650&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR9" id="ref-link-section-d297950435e448">9</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 10" title="M. E. Wilcox, N. E. Brummel, K. Archer, E. W. Ely, J. C. Jackson, and R. O. Hopkins, “Cognitive Dysfunction in ICU Patients: Risk Factors, Predictors, and Rehabilitation Interventions.” United States: by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins, Sep. 2013. &#xA;                  https://journals.lww.com/ccmjournal/abstract/2013/09001/cognitive_dysfunction_in_icu_patients__risk.8.aspx&#xA;                  &#xA;                " href="/article/10.1007/s44337-025-00428-0#ref-CR10" id="ref-link-section-d297950435e451">10</a>]. Given this background, prompt diagnosis and management are critical for improving patient outcomes [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 11" title="Israni J, Lesser A, Kent T, Ko KJ. Delirium as a predictor of mortality in US medicare beneficiaries discharged from the emergency department: a national claims-level analysis up to 12 months. BMJ. 2018. &#xA;                  https://doi.org/10.1136/bmjopen-2017-021258&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR11" id="ref-link-section-d297950435e454">11</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 12" title="Kosar CM, Thomas KS, Inouye SK, Mor V. Delirium during postacute nursing home admission and risk for adverse outcomes. Wiley. 2017;65(7):1470–5. &#xA;                  https://doi.org/10.1111/jgs.14823&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR12" id="ref-link-section-d297950435e458">12</a>].</p><p>The management of encephalopathy and delirium share similar principles. These include identifying and treating the underlying cause, such as infections, correcting metabolic issues, emphasizing supportive care, and promoting cerebral perfusion [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Frontera J. Metabolic encephalopathies in the critical care unit. Lippincott Williams &amp; Wilkins. 2012;18:611–39. &#xA;                  https://doi.org/10.1212/01.con.0000415431.07019.c2&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR13" id="ref-link-section-d297950435e464">13</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 14" title="Nicholson TR, Henderson M. Management of delirium. MA Healthc. 2009;70(4):217–21. &#xA;                  https://doi.org/10.12968/hmed.2009.70.4.41625&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR14" id="ref-link-section-d297950435e467">14</a>]. In delirium, pharmacological management, including the use of antipsychotics or dexmedetomidine, focuses on controlling agitation but may overlook the complex neurochemical pathways involved [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 15" title="M. Cascella, M. Fiore, S. Leone, D. Carbone, and R. D. Napoli. Current controversies and future perspectives on treatment of intensive care unit delirium in adults,” vol. 8, no. 3. pp. 18–27, Jun. 2019. &#xA;                  https://doi.org/10.5492/wjccm.v8.i3.18&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR15" id="ref-link-section-d297950435e470">15</a>]. Similarly, in encephalopathy, no direct therapies targeting the neurochemical and neurotransmitter pathways are currently available [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 13" title="Frontera J. Metabolic encephalopathies in the critical care unit. Lippincott Williams &amp; Wilkins. 2012;18:611–39. &#xA;                  https://doi.org/10.1212/01.con.0000415431.07019.c2&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR13" id="ref-link-section-d297950435e473">13</a>]. Emerging research suggests that glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may offer neuroprotective benefits, particularly in neurodegenerative diseases [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Romano AD, Villani R, Sangineto M, Cassano T, Serviddio G. The GLP-1 receptor agonist exendin-4 modulates hippocampal NMDA-receptor signaling in aged rats and improves cognitive impairment in diabetic elderly patients. J Gerontol Geriatr. 2022;70(2):1–7. &#xA;                  https://doi.org/10.36150/2499-6564-N474&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR16" id="ref-link-section-d297950435e476">16</a>].</p><p>GLP-1 receptors are present in the central nervous system and potentially mediate additional neuroprotective effects [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Mehan S, Bhalla S, Siddiqui EM, Sharma N, Shandilya A, Khan A. Potential roles of glucagon-like peptide-1 and its analogues in dementia targeting impaired insulin secretion and neurodegeneration. Dove Med Press. 2022;12:31–59. &#xA;                  https://doi.org/10.2147/dnnd.s247153&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR17" id="ref-link-section-d297950435e482">17</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Salcedo I, Tweedie D, Li Y, Greig NH. Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders. Wiley. 2012;166(5):1586–99. &#xA;                  https://doi.org/10.1111/j.1476-5381.2012.01971.x&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR18" id="ref-link-section-d297950435e485">18</a>]. Activation of GLP-1 receptors in the brain regions essential for cognition and memory, such as the hippocampus, cortex, and amygdala, offers neuroprotection in animal models of neurodegenerative diseases (e.g., reducing neuroinflammation, oxidative stress, and apoptosis) [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Zaky DA, Abdallah DM, El-Abhar HS. Intranasal exendin-4 modifies necroptosis-mediated innate immune response to combat septic encephalopathy in rats: role of mTORC1 in immunogenic and tolerogenic cell demise. Eur J Pharmacol. 2023;961: 176191. &#xA;                  https://doi.org/10.1016/j.ejphar.2023.176191&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR19" id="ref-link-section-d297950435e488">19</a>]. Furthermore, GLP-1 RAs have become a promising therapy for managing type 2 diabetes mellitus (T2DM) and obesity [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 20" title="j. p. h. wilding@liverpool. ac. uk B. Emily Brown Daniel J. Cuthbertson, John P. Wilding, “Newer GLP-1 receptor agonists and obesity-diabetes,” vol. undefined, no. undefined. Feb. 2018. &#xA;                  https://www.sciencedirect.com/science/article/pii/S0196978117303789&#xA;                  &#xA;                " href="/article/10.1007/s44337-025-00428-0#ref-CR20" id="ref-link-section-d297950435e491">20</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 21" title="K. Tran et al. Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes. s10, no. 4, pp. 178–188, Jun. 2017." href="/article/10.1007/s44337-025-00428-0#ref-CR21" id="ref-link-section-d297950435e494">21</a>]. At the molecular level, it emulates the function of the natural incretin hormone GLP-1, which is essential for regulating glucose metabolism and energy balance [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 22" title="S. L. D. Y. L. Lee. Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes. Korea (South): The Korean Society of Pediatric Endocrinology. &#xA;                  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401818/&#xA;                  &#xA;                " href="/article/10.1007/s44337-025-00428-0#ref-CR22" id="ref-link-section-d297950435e498">22</a>]. Moreover, GLP-1 RAs offer weight loss, reduced blood pressure, and potential cardiovascular benefits beyond glycemic control [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 23" title="Ryan DH, Acosta A. GLP-1 receptor agonists: nonglycemic clinical effects in weight loss and beyond. Wiley. 2015;23(6):1119–29. &#xA;                  https://doi.org/10.1002/oby.21107&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR23" id="ref-link-section-d297950435e501">23</a>]. Indeed, the first GLP-1 RA (i.e., Exenatide or Ex-4) was approved by the FDA in 2005 for T2DM treatment [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 24" title="Buse JB, Henry RR, Han J, Kim DDH, Fineman M, Baron A. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. Am Diabetes Assoc. 2004;27(11):2628–35. &#xA;                  https://doi.org/10.2337/diacare.27.11.2628&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR24" id="ref-link-section-d297950435e504">24</a>]. Since then, several GLP-1 RAs drugs have become available, including Liraglutide, Semaglutide, and Dulaglutide [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 25" title="H. W. Rodbard. 2018. The Clinical Impact of GLP 1 Receptor Agonists in Type 2 Diabetes Focus on the Long Acting Analogs. Mary Ann Liebert Inc. &#xA;                  https://doi.org/10.1089/dia.2018.0103&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR25" id="ref-link-section-d297950435e507">25</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 26" title="Trujillo JM, Nuffer W, Ellis SL. GLP-1 receptor agonists: a review of head-to-head clinical studies. SAGE Publ. 2014;6(1):19–28. &#xA;                  https://doi.org/10.1177/2042018814559725&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR26" id="ref-link-section-d297950435e510">26</a>].</p><p>While recent studies have demonstrated the possible neuroprotective effects of GLP-1 RAs in neurodegenerative conditions, such as Alzheimer’s dementia, there is a lack of literature reviews on their benefits in the highly neurodegenerative-related condition of delirium [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 17" title="Mehan S, Bhalla S, Siddiqui EM, Sharma N, Shandilya A, Khan A. Potential roles of glucagon-like peptide-1 and its analogues in dementia targeting impaired insulin secretion and neurodegeneration. Dove Med Press. 2022;12:31–59. &#xA;                  https://doi.org/10.2147/dnnd.s247153&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR17" id="ref-link-section-d297950435e517">17</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Salcedo I, Tweedie D, Li Y, Greig NH. Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders. Wiley. 2012;166(5):1586–99. &#xA;                  https://doi.org/10.1111/j.1476-5381.2012.01971.x&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR18" id="ref-link-section-d297950435e520">18</a>]. Additionally, the role and mechanism of GLP-1 RAs in certain acute global brain dysfunction conditions that manifest as delirium, such as postoperative delirium, hepatic encephalopathy, hypoxia-induced encephalopathy, alcohol withdrawal syndrome, diabetic encephalopathy, and sepsis-associated encephalopathy, remain poorly understood.</p><p>Against this background, this scoping review aims to clarify the pathophysiological mechanisms of GLP-1 RAs in relation to delirium and encephalopathy based on experimental animal and human models, and to provide current clinical evidence regarding their potential benefits in preventing and managing these brain dysfunctions.</p></div></div></section><section data-title="Methodology"><div class="c-article-section" id="Sec2-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec2"><span class="c-article-section__title-number">2 </span>Methodology</h2><div class="c-article-section__content" id="Sec2-content"><p>The search strategy was conducted in accordance with the PRISMA-ScR guidelines (Diagram 1) using PubMed, Embase, Web of Science, EBSCOhost (APA PsycInfo), and Google Scholar databases from the time of inception to January 23,2025. The search terms utilized, including delirium, "acute delirium,’’ ‘‘GLP-1 RA,’’ ‘‘GLP-1 receptor agonist,’’ and GLP-1 receptor agonist*,’’ were carefully selected to ensure a focused and productive search. Truncation was used where appropriate in those databases that support wildcard searching, and in those that did not support truncation, separate search terms were used. Given the topic’s novelty and the potential link between delirium and encephalopathy, search terms related to encephalopathy, such as ‘‘encephalopathy’’ and ‘‘acute encephalopathy,’’ were also included [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 27" title="Oldham MA, Holloway RG. Delirium disorder: integrating delirium and acute encephalopathy. Neurology. 2020;95(4):173–8. &#xA;                  https://doi.org/10.1212/WNL.0000000000009949&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR27" id="ref-link-section-d297950435e534">27</a>]. We also considered the names of the GLP-1 RA available on the market: Exenatide, Liraglutide, Semaglutide, Dulaglutide, Lixisenatide, and Tirzepatide. </p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-a" data-title="Diagram 1"><figure><figcaption><b id="Figa" class="c-article-section__figure-caption" data-test="figure-caption-text">Diagram 1</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/article/10.1007/s44337-025-00428-0/figures/a" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs44337-025-00428-0/MediaObjects/44337_2025_428_Figa_HTML.png?as=webp"><img aria-describedby="Figa" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs44337-025-00428-0/MediaObjects/44337_2025_428_Figa_HTML.png" alt="figure a" loading="lazy" width="685" height="802"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-a-desc"><p>PRISMA Flow Diagram for GLP-1 Receptor Agonists in Delirium and Encephalopathies: A Neuroprotective Scoping Review</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/article/10.1007/s44337-025-00428-0/figures/a" data-track-dest="link:Figurea Full size image" aria-label="Full size image figure a" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><p>The inclusion criteria were as follows: (1) animal studies, (2) human studies, (3) observational studies (cohort or case–control, cross-sectional), (4) randomized controlled trials (RCTs), (5) case reports, and (6) scoping/systemic/meta-analyses. Articles were excluded if they (1) were published before 2015, (2) were written in a non-English language, (3) had unavailable abstracts and manuscripts, (4) were poster presentations only, (5) were editorials, (6) included subjects under the age of 18 years, or (7) were guidelines or consensus reports.</p><p>FM and MK independently screened the titles and abstracts. To eliminate duplicate entries, Zotero was employed. The remaining articles were then screened independently by FM and MK based on the established inclusion and exclusion criteria. After applying these criteria, FM and MK independently extracted the data from the final set of articles included in the scoping review. MT resolved any discrepancies between the two authors.</p><p>Based on available evidence, the following topics were identified in relation to GLP-1 RAs: postoperative delirium, sepsis-associated encephalopathy, hepatic encephalopathy, alcohol withdrawal syndrome, hypoxia-induced encephalopathy, and diabetic encephalopathy. To strengthen the study, due diligence was conducted to search for additional articles by combining the terms from each theme with GLP-1 RAs.</p></div></div></section><section data-title="Results"><div class="c-article-section" id="Sec3-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec3"><span class="c-article-section__title-number">3 </span>Results</h2><div class="c-article-section__content" id="Sec3-content"><p>The initial search yielded 152 studies. After removing 21 duplicates using Zotero, 131 articles were eligible for the title and abstract screening. After applying predefined selection criteria, a total of 38 articles (Supplementary Tables 1 and 2) were selected for further full-text review and data extraction.</p><p>In this section, six main neurologic dysfunctions or conditions identified through the literature search will each be presented as topics: postoperative delirium, sepsis-associated encephalopathy, hepatic encephalopathy, hypoxia-induced encephalopathy, diabetic encephalopathy, and alcohol withdrawal syndrome. The role of GLP-1 RA, based on preclinical (animal) and clinical (human) studies, is presented for each topic to address our first research aim. Additionally, the pathophysiological or molecular mechanism, if it exists, will be discussed to fulfill our second research aim. A simplified diagram (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/article/10.1007/s44337-025-00428-0#Fig1">1</a>) illustrates the possible pathophysiological mechanisms or pathways linking GLP-1 RA and brain dysfunction.</p><div class="c-article-section__figure js-c-reading-companion-figures-item" data-test="figure" data-container-section="figure" id="figure-1" data-title="Fig. 1"><figure><figcaption><b id="Fig1" class="c-article-section__figure-caption" data-test="figure-caption-text">Fig. 1</b></figcaption><div class="c-article-section__figure-content"><div class="c-article-section__figure-item"><a class="c-article-section__figure-link" data-test="img-link" data-track="click" data-track-label="image" data-track-action="view figure" href="/article/10.1007/s44337-025-00428-0/figures/1" rel="nofollow"><picture><source type="image/webp" srcset="//media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs44337-025-00428-0/MediaObjects/44337_2025_428_Fig1_HTML.png?as=webp"><img aria-describedby="Fig1" src="//media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs44337-025-00428-0/MediaObjects/44337_2025_428_Fig1_HTML.png" alt="figure 1" loading="lazy" width="685" height="803"></picture></a></div><div class="c-article-section__figure-description" data-test="bottom-caption" id="figure-1-desc"><p>Possible pathophysiological pathways linking GLP-1RA and brain dysfunctions</p></div></div><div class="u-text-right u-hide-print"><a class="c-article__pill-button" data-test="article-link" data-track="click" data-track-label="button" data-track-action="view figure" href="/article/10.1007/s44337-025-00428-0/figures/1" data-track-dest="link:Figure1 Full size image" aria-label="Full size image figure 1" rel="nofollow"><span>Full size image</span><svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-chevron-right-small"></use></svg></a></div></figure></div><h3 class="c-article__sub-heading" id="Sec4"><span class="c-article-section__title-number">3.1 </span>Postoperative delirium</h3><p>Postoperative delirium is a common complication of surgeries, with an estimated.</p><p>incidence of 15% in the post-anesthesia care unit and 70% upon Intensive Care Unit (ICU) admission [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Theuerkauf N, Guenther U, Putensen C. Postoperative delirium in the PACU and intensive care unit. Elsevier BV. 2012;2(4):148–55. &#xA;                  https://doi.org/10.1016/j.tacc.2012.03.002&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR28" id="ref-link-section-d297950435e604">28</a>]. Among elderly patients admitted for surgery, the incidence of postoperative delirium can reach 15–53% [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Theuerkauf N, Guenther U, Putensen C. Postoperative delirium in the PACU and intensive care unit. Elsevier BV. 2012;2(4):148–55. &#xA;                  https://doi.org/10.1016/j.tacc.2012.03.002&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR28" id="ref-link-section-d297950435e607">28</a>]. Unfortunately, postoperative delirium poses a significant risk of adverse consequences, including increased morbidity, mortality, extended length of hospital stay, and cognitive decline [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 28" title="Theuerkauf N, Guenther U, Putensen C. Postoperative delirium in the PACU and intensive care unit. Elsevier BV. 2012;2(4):148–55. &#xA;                  https://doi.org/10.1016/j.tacc.2012.03.002&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR28" id="ref-link-section-d297950435e610">28</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 29" title="T. Fong, S. Tulebaev, and S. Inouye. Delirium in elderly adults: diagnosis, prevention and treatment. 2009. &#xA;                  https://doi.org/10.1038/nrneurol.2009.24&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR29" id="ref-link-section-d297950435e613">29</a>]. GLP-1 RAs, owing to their potential neuroprotective effects in neurodegenerative disorders, may benefit the treatment and prevention of postoperative delirium[<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 30" title="Laurindo LF, Barbalho SM, Guiguer EL. GLP-1a: going beyond traditional use. Switzerland AGInter J Mol Sci. 2022. &#xA;                  https://doi.org/10.3390/ijms23020739&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR30" id="ref-link-section-d297950435e616">30</a>].</p><p>The potential role of GLP-1 RAs in treating postoperative delirium has been reported in some animal studies. In aged mice undergoing cardiac surgery, delirium-like behaviors, such as anxiety and memory deficits, have been linked to A1 astrocyte activation in the hippocampus. This leads to microglial activation and glutamate accumulation, which can be mitigated by Liraglutide and Ex-4 [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="Jia M, Lv X, Zhu T, Shen J-C, Liu W-X, Yang J-J. Liraglutide ameliorates delirium-like behaviors of aged mice undergoing cardiac surgery by mitigating microglia activation via promoting mitophagy. Psychopharmacology. 2024;241(4):687–98. &#xA;                  https://doi.org/10.1007/s00213-023-06492-7&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR31" id="ref-link-section-d297950435e622">31</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="Liu W, Wang Z, Wang W, Wang Z, Xing Y, Hölscher C. Liraglutide reduces alcohol consumption, anxiety, memory impairment, and synapse loss in alcohol dependent mice. Neurochem Res. 2024;49(4):1061–75. &#xA;                  https://doi.org/10.1007/s11064-023-04093-6&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR32" id="ref-link-section-d297950435e625">32</a>]. Furthermore, Liraglutide reduced the heightened neuroinflammation and impaired neuronal health observed during surgery in aged mice. Neuroinflammation is eased by reduced microglial and NLRP3 inflammasome activation through the PINK1/Parkin pathway, whereas neuronal health is enhanced by increased mitophagy and synaptic plasticity[<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="Jia M, Lv X, Zhu T, Shen J-C, Liu W-X, Yang J-J. Liraglutide ameliorates delirium-like behaviors of aged mice undergoing cardiac surgery by mitigating microglia activation via promoting mitophagy. Psychopharmacology. 2024;241(4):687–98. &#xA;                  https://doi.org/10.1007/s00213-023-06492-7&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR31" id="ref-link-section-d297950435e628">31</a>]. In addition, Liraglutide prevents apoptosis by reducing oxidative stress and phosphorylation of tau proteins and neurofilaments in brain cells, supporting its potential neuroprotective effects [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 33" title="Xiong H, et al. The neuroprotection of liraglutide on Alzheimer-like learning and memory impairment by modulating the hyperphosphorylation of tau and neurofilament proteins and insulin signaling pathways in mice. IOS Press. 2013;37(3):623–35. &#xA;                  https://doi.org/10.3233/jad-130584&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR33" id="ref-link-section-d297950435e631">33</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 34" title="Zhang J, et al. Liraglutide nano-preparation on perioperative neurocognitive dysfunction in aged mice. Cell Mol Biol. 2022;68(3):356–64. &#xA;                  https://doi.org/10.14715/cmb/2022.68.3.39&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR34" id="ref-link-section-d297950435e634">34</a>]. Although these animal studies suggest a promising treatment for postoperative delirium using GLP-1 RAs, these animal models do not capture the complexity of human perioperative care, and the underlying molecular pathways remain unclear; thus, further investigation is needed for validation.</p><p>Research on the use of GLP-1 RAs to manage delirium in humans is limited. Glucose metabolism is essential for preventing hypoglycemia and hyperglycemia, particularly with GLP-1 RA, which can mitigate the risk of postoperative delirium [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Androsova G, Krause R, Winterer G, Schneider R. Biomarkers of postoperative delirium and cognitive dysfunction. Front Aging Neurosci. 2015. &#xA;                  https://doi.org/10.3389/fnagi.2015.00112&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR35" id="ref-link-section-d297950435e640">35</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 36" title="Lagonigro E, Pansini A, Mone P, Guerra G, Komici K, Fantini C. The role of stress hyperglycemia on delirium onset. J Clin Med. 2025;14(2):407. &#xA;                  https://doi.org/10.3390/jcm14020407&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR36" id="ref-link-section-d297950435e643">36</a>]. However, it is important to weigh this benefit against the potential aspiration risk associated with administering GLP-1 RA during surgery [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 37" title="Wolfe RC. Perioperative implications of glucagon-like peptide-1 receptor agonists. J Perianesth Nurs. 2024;39(6):1108–10. &#xA;                  https://doi.org/10.1016/j.jopan.2024.09.022&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR37" id="ref-link-section-d297950435e646">37</a>]. In a triple-blind randomized controlled trial involving 261 patients with diabetes undergoing cardiac surgery, the mean blood sugar level was significantly lower in the Liraglutide group (6.3 mmol/L) than in the placebo group (7.0 mmol/L), with a 95% confidence interval of 0.39–0.93 (p &lt; 0.0001). There was no significant difference in hypoglycemic events between the groups. Interestingly, patients who received Liraglutide showed no difference in delirium outcomes compared to those who received placebo, both in the ICU and ward settings (p &lt; 0.17) [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 38" title="A. H. Hulst. Glucose control therapies in the perioperative period. &#xA;                  https://hdl.handle.net/11245.1/9f8b3eed-fbd4-4d84-96aa-593b390f447c&#xA;                  &#xA;                " href="/article/10.1007/s44337-025-00428-0#ref-CR38" id="ref-link-section-d297950435e649">38</a>]. This demonstrates the complex relationship between glucose metabolism and delirium, where excessive glucose control may not necessarily translate into improved delirium outcomes [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 39" title="Olmo-García MID, et al. Glycemic variability in type 2 diabetes mellitus and acute coronary syndrome: liraglutide compared with insulin glargine: a pilot study. SAGE Publ. 2020. &#xA;                  https://doi.org/10.1177/0300060520926063&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR39" id="ref-link-section-d297950435e652">39</a>]. In addition, postoperative delirium is an inflammatory condition characterized by elevated levels of pro-inflammatory markers (e.g., NF-KB, TNF-α, and IL-1β), that GLP-1RAs may modulate [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 31" title="Jia M, Lv X, Zhu T, Shen J-C, Liu W-X, Yang J-J. Liraglutide ameliorates delirium-like behaviors of aged mice undergoing cardiac surgery by mitigating microglia activation via promoting mitophagy. Psychopharmacology. 2024;241(4):687–98. &#xA;                  https://doi.org/10.1007/s00213-023-06492-7&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR31" id="ref-link-section-d297950435e656">31</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 35" title="Androsova G, Krause R, Winterer G, Schneider R. Biomarkers of postoperative delirium and cognitive dysfunction. Front Aging Neurosci. 2015. &#xA;                  https://doi.org/10.3389/fnagi.2015.00112&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR35" id="ref-link-section-d297950435e659">35</a>].</p><h3 class="c-article__sub-heading" id="Sec5"><span class="c-article-section__title-number">3.2 </span>Sepsis-associated encephalopathy</h3><p>Sepsis is characterized by a dysregulated host response to infection that can result in multiorgan dysfunction, including the brain [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 40" title="Pinsky MR. Dysregulation of the immune response in severe sepsis. Elsevier BV. 2004;328(4):220–9. &#xA;                  https://doi.org/10.1097/00000441-200410000-00005&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR40" id="ref-link-section-d297950435e670">40</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 41" title="Pool R, Gómez H, Kellum JA. Mechanisms of organ dysfunction in sepsis. Elsevier BV. 2017;34(1):63–80. &#xA;                  https://doi.org/10.1016/j.ccc.2017.08.003&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR41" id="ref-link-section-d297950435e673">41</a>]. During sepsis, the inflammatory response can lead to blood–brain barrier disruption, cellular exhaustion, neuroinflammation, and metabolic disturbances, all of which contribute to the development of sepsis-associated encephalopathy [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 42" title="Sonneville R, et al. The spectrum of sepsis-associated encephalopathy: a clinical perspective. BioMed Central. 2013. &#xA;                  https://doi.org/10.1186/s13054-023-04655-8&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR42" id="ref-link-section-d297950435e676">42</a>]. Sepsis-associated encephalopathy represents an acute change in the patient’s cognitive state compared to the baseline and can manifest as delirium or, in severe cases, coma [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 43" title="Piva S, Bertoni M, Gitti N, Rasulo F, Latronico N. Neurological complications of sepsis. Lippincott Williams Wilkins. 2023;29(2):75–84. &#xA;                  https://doi.org/10.1097/mcc.0000000000001022&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR43" id="ref-link-section-d297950435e679">43</a>]. Longitudinal studies have indicated that sepsis survivors experience cognitive impairment, neuropsychiatric disorders, and functional disabilities [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 44" title="Barichello T, et al. Long-term cognitive outcomes after sepsis: a translational systematic review. Mol Neurobiol. 2019;56:186–251." href="/article/10.1007/s44337-025-00428-0#ref-CR44" id="ref-link-section-d297950435e682">44</a>]. Previous studies have suggested that GLP-1RAs may serve as a novel target for treating sepsis. In addition to optimizing glucose control during acute illness, GLP-1RAs may offer anti-inflammatory and neuroprotective benefits that can help prevent sepsis-associated encephalopathy [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 45" title="Yang F, et al. GLP-1 receptor: a new target for sepsis. Front Pharmacol. 2021;12: 706908. &#xA;                  https://doi.org/10.3389/fphar.2021.706908&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR45" id="ref-link-section-d297950435e686">45</a>]. However, human studies investigating the role of GLP-1RAs in sepsis-associated encephalopathy are limited, as most are preclinical and based on animal studies.</p><p>In animal models of sepsis, treatment with GLP-1RAs has been shown to reduce neuroinflammation and neuronal degeneration, thereby improving cognitive impairment. Specifically, Liraglutide administration in septic mouse models decreased neuroinflammation by enhancing the hippocampal brain insulin pathway, lowering pro-inflammatory markers (e.g., TNF-α), and reducing glycogen synthase kinase 3 beta activity (GSK3B) levels. Subsequently, decreased neuroinflammation leads to enhanced synaptic plasticity [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="Neves FS, et al. Brain-defective insulin signaling is associated to late cognitive impairment in post-septic mice. Mol Neurobiol. 2018;55(1):435–44. &#xA;                  https://doi.org/10.1007/s12035-016-0307-3&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR46" id="ref-link-section-d297950435e692">46</a>]. The enhancement of insulin signaling and the reduction of GSK3β activity contribute to improved cognitive function, as indicated by lower tau phosphorylation levels, a marker of neurodegeneration. In addition, Liraglutide treatment affects proteins crucial for synaptic plasticity, such as cAMP response element-binding protein (CREB) and AMPA receptors (types of glutamate receptors). In post-septic mice, reduced phosphorylated CREB and GluA1 levels (a subunit of AMPA receptors) impair memory and learning, and Liraglutide may restore these levels and improve cognitive function [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 46" title="Neves FS, et al. Brain-defective insulin signaling is associated to late cognitive impairment in post-septic mice. Mol Neurobiol. 2018;55(1):435–44. &#xA;                  https://doi.org/10.1007/s12035-016-0307-3&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR46" id="ref-link-section-d297950435e695">46</a>]. Conversely, neuronal degeneration is associated with microglial activation, which leads to programmed cell death, known as apoptosis, and immunologically mediated cell death, known as necroptosis [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Zaky DA, Abdallah DM, El-Abhar HS. Intranasal exendin-4 modifies necroptosis-mediated innate immune response to combat septic encephalopathy in rats: role of mTORC1 in immunogenic and tolerogenic cell demise. Eur J Pharmacol. 2023;961: 176191. &#xA;                  https://doi.org/10.1016/j.ejphar.2023.176191&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR19" id="ref-link-section-d297950435e698">19</a>]. In mouse models, treatment with Liraglutide decreased both necroptosis and apoptosis in hippocampal neurons, further supporting the neuroprotective effects of GLP-1 RAs [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Zaky DA, Abdallah DM, El-Abhar HS. Intranasal exendin-4 modifies necroptosis-mediated innate immune response to combat septic encephalopathy in rats: role of mTORC1 in immunogenic and tolerogenic cell demise. Eur J Pharmacol. 2023;961: 176191. &#xA;                  https://doi.org/10.1016/j.ejphar.2023.176191&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR19" id="ref-link-section-d297950435e701">19</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 47" title="Yi H, et al. Activation of glucagon-like peptide-1 receptor in microglia exerts protective effects against sepsis-induced encephalopathy via attenuating endoplasmic reticulum stress-associated inflammation and apoptosis in a mouse model of sepsis. Exp Neurol. 2023;363: 114348. &#xA;                  https://doi.org/10.1016/j.expneurol.2023.114348&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR47" id="ref-link-section-d297950435e704">47</a>]. A critical pathway involved in necroptosis during sepsis is the reduced activity of mammalian target of rapamycin (mTOR) [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="Park SW, et al. Liraglutide activates mTORC1 signaling and AMPA receptors in rat hippocampal neurons under toxic conditions. Front Media. 2018. &#xA;                  https://doi.org/10.3389/fnins.2018.00756&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR48" id="ref-link-section-d297950435e708">48</a>]. The mTOR-dependent pathway is a crucial molecular mechanism for cellular life and energy metabolism [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 49" title="Garcı́a Arencibia M, Hochfeld WE, Toh PC, Rubinsztein DC. Autophagy, a guardian against neurodegeneration. Amsterdam: Elsevier; 2010." href="/article/10.1007/s44337-025-00428-0#ref-CR49" id="ref-link-section-d297950435e711">49</a>]. When this pathway is activated, autophagy diminishes. Intriguingly, GLP-1 RAs, such as Ex-4, enhance mTOR activity by reducing caspases-3 and -8 levels, which are key components of apoptosis. This modulation protects neurons from necroptotic cell death in models of neurodegenerative disorders [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Zaky DA, Abdallah DM, El-Abhar HS. Intranasal exendin-4 modifies necroptosis-mediated innate immune response to combat septic encephalopathy in rats: role of mTORC1 in immunogenic and tolerogenic cell demise. Eur J Pharmacol. 2023;961: 176191. &#xA;                  https://doi.org/10.1016/j.ejphar.2023.176191&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR19" id="ref-link-section-d297950435e714">19</a>]. However, the intricate relationship between neuroinflammation, apoptosis, necroptosis, and mTOR activity in sepsis-induced encephalopathy is not entirely understood [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 19" title="Zaky DA, Abdallah DM, El-Abhar HS. Intranasal exendin-4 modifies necroptosis-mediated innate immune response to combat septic encephalopathy in rats: role of mTORC1 in immunogenic and tolerogenic cell demise. Eur J Pharmacol. 2023;961: 176191. &#xA;                  https://doi.org/10.1016/j.ejphar.2023.176191&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR19" id="ref-link-section-d297950435e717">19</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 48" title="Park SW, et al. Liraglutide activates mTORC1 signaling and AMPA receptors in rat hippocampal neurons under toxic conditions. Front Media. 2018. &#xA;                  https://doi.org/10.3389/fnins.2018.00756&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR48" id="ref-link-section-d297950435e720">48</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 49" title="Garcı́a Arencibia M, Hochfeld WE, Toh PC, Rubinsztein DC. Autophagy, a guardian against neurodegeneration. Amsterdam: Elsevier; 2010." href="/article/10.1007/s44337-025-00428-0#ref-CR49" id="ref-link-section-d297950435e723">49</a>]. Furthermore, the efficacy of GLP-1 RA in treating sepsis and enhancing patient outcomes has not yet been established. Caution is warranted when translating preclinical findings to clinical practice, as further research is essential to understand their mechanisms and optimal use in sepsis-associated encephalopathy.</p><h3 class="c-article__sub-heading" id="Sec6"><span class="c-article-section__title-number">3.3 </span>Hepatic encephalopathy</h3><p>Hepatic encephalopathy is a complex neuropsychiatric syndrome that is a significant complication of liver cirrhosis and, less frequently, of other forms of liver dysfunction [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 50" title="Pérez-Monter C, Torre-Delgadillo A. Astrocyte pathophysiology in liver disease. IntechOpen. 2018. &#xA;                  https://doi.org/10.5772/intechopen.72506&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR50" id="ref-link-section-d297950435e735">50</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 51" title="Swaminathan M, Ellul M, Cross T. Hepatic encephalopathy: current challenges and future prospects. Dove Med Press. 2018. &#xA;                  https://doi.org/10.2147/hmer.s118964&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR51" id="ref-link-section-d297950435e738">51</a>]. This condition leads to cognitive issues, personality changes, and motor function difficulties [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 52" title="S. Elwir and R. S. Rahimi. Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options. pp. 1–10, May 2017. &#xA;                  https://doi.org/10.14218/jcth.2016.00069&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR52" id="ref-link-section-d297950435e741">52</a>]. Delirium is one of the manifestations of hepatic encephalopathy and, when present, is associated with higher mortality and functional decline [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 53" title="Amodio P. Hepatic encephalopathy: diagnosis and management. Wiley. 2018;38(6):966–75. &#xA;                  https://doi.org/10.1111/liv.13752&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR53" id="ref-link-section-d297950435e744">53</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 54" title="Montagnese S, Bajaj JS. Impact of hepatic encephalopathy in cirrhosis on quality-of-life issues. Adis Springer Healthcare. 2019;79:11–6. &#xA;                  https://doi.org/10.1007/s40265-018-1019-y&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR54" id="ref-link-section-d297950435e747">54</a>]. Currently, options for treating hepatic encephalopathy are focused on addressing precipitating factors and using ammonia-reducing regimens [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 53" title="Amodio P. Hepatic encephalopathy: diagnosis and management. Wiley. 2018;38(6):966–75. &#xA;                  https://doi.org/10.1111/liv.13752&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR53" id="ref-link-section-d297950435e751">53</a>]. However, these approaches lack long-lasting benefits; thus, exploring alternative therapies is essential in this context. GLP-1 RAs may help manage hepatic encephalopathy and reduce the risk of decompensated cirrhosis.</p><p>A limited number of animal studies are available regarding the role of GLP-1 RAs in hepatic encephalopathy. Kjærgaard et al. (2023) explored the effects of Semaglutide, a GLP-1 RA, on cognitive dysfunction in a mouse model of non-alcoholic steatohepatitis (NASH). They found that a 10-week treatment with Semaglutide prevented cognitive decline and depression-like behaviors, primarily by reducing systemic inflammation and protecting the synaptic density in the prefrontal cortex. However, acute treatment does not have the same benefits. The study also noted that Semaglutide reduced hyperammonemia, a factor that contributes to cognitive dysfunction and hepatic encephalopathy in NASH. These results indicate that Semaglutide may have therapeutic potential for cognitive impairment in NASH; however, further clinical studies are needed to verify these effects in humans[<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 55" title="Kjærgaard K, et al. Semaglutide reduces cognitive dysfunction in experimental non-alcoholic steatohepatitis through anti-inflammatory and neuroprotective effects. Am J Gastroenterol. 2023;118(9):S28–9. &#xA;                  https://doi.org/10.14309/01.ajg.0000948452.01988.0c&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR55" id="ref-link-section-d297950435e757">55</a>].</p><p>Current human studies indicate that GLP-1 RAs are associated with a decreased risk of hepatic encephalopathy. Several observational studies have found that patients with cirrhosis and T2DM treated with GLP-1 RAs have a significantly lower risk of hepatic encephalopathy[<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Elsaid MI, et al. Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease cirrhosis and type 2 diabetes. Aliment Pharmacol Ther. 2024;59(9):1096–110. &#xA;                  https://doi.org/10.1111/apt.17925&#xA;                  &#xA;                ." href="#ref-CR56" id="ref-link-section-d297950435e763">56</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Passos PRC, Filho VOC, Noronha MM, Hyppolito EB, Saldanha EF, Motta RV. Influence of glucagon-like peptide-1 receptor agonists on hepatic events in type 2 diabetes: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2024. &#xA;                  https://doi.org/10.1111/jgh.16752&#xA;                  &#xA;                ." href="#ref-CR57" id="ref-link-section-d297950435e763_1">57</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 58" title="Yen F-S, et al. Glucagon-like peptide-1 receptor agonist use in patients with liver cirrhosis and type 2 diabetes. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2024;22(6):1255-1264.e18. &#xA;                  https://doi.org/10.1016/j.cgh.2023.06.004&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR58" id="ref-link-section-d297950435e766">58</a>]. However, the population study involved patients with a stable liver and may not be applicable to patients with decompensated cirrhosis [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 58" title="Yen F-S, et al. Glucagon-like peptide-1 receptor agonist use in patients with liver cirrhosis and type 2 diabetes. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2024;22(6):1255-1264.e18. &#xA;                  https://doi.org/10.1016/j.cgh.2023.06.004&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR58" id="ref-link-section-d297950435e769">58</a>]. In contrast, Simon et al. (2021) showed that the hepatoprotective benefits of GLP-1 RA persist in both compensated and decompensated cirrhosis [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 59" title="Simon TG, Patorno E, Schneeweiss S. Glucagon-like peptide-1 receptor agonists and hepatic decompensation events in patients with cirrhosis and diabetes. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2022;20(6):1382-1393.e19. &#xA;                  https://doi.org/10.1016/j.cgh.2021.07.010&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR59" id="ref-link-section-d297950435e772">59</a>].This inconsistency indicates that GLP-1 RA therapy may be protective in a range of patients with cirrhosis, reinforcing the idea that these medications can be beneficial regardless of the cirrhosis stage. In addition, this study suggests that GLP-1 RAs may provide a hepatoprotective effect that is not solely dependent on the severity of cirrhosis but also on its pharmacological properties that benefit liver function overall. In addition to their cardiovascular and metabolic benefits [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Kon K, Arai K, Uchiyama A, Fukada H, Yamashina S, Ikejima K. Glycine prevents steatohepatitis-associated heoatocarcinogenesis in hepatocyte-specific PTEN knockout mice through of lipid pofiles. Gastroenterology. 2024. &#xA;                  https://doi.org/10.1016/S0016-5085(24)04221-5&#xA;                  &#xA;                ." href="#ref-CR60" id="ref-link-section-d297950435e775">60</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Kutz A, Wexler DJ, Liu J, Paik JM, Patorno E. Association of GLP-1 receptor agonists and SGLT-2 inhibitors with major adverse cardiovascular events and serious liver events among patients with type 2. J Endocr. 2024. &#xA;                  https://doi.org/10.1210/jendso/bvae163.555&#xA;                  &#xA;                ." href="#ref-CR61" id="ref-link-section-d297950435e775_1">61</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 62" title="Trujillo S, Kamionkowski S, Walsh E, Davila J, Asaad I. Do weight loss medications reduce the risk of cirrhosis and HCC? Am J Gastroenterol. 2021;116(SUPPL):S547–8. &#xA;                  https://doi.org/10.14309/01.ajg.0000778232.15515.30&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR62" id="ref-link-section-d297950435e779">62</a>], GLP-1 RAs are associated with a lower risk of cirrhotic complications, including hepatic encephalopathy. More importantly, the safety profile of GLP-1 RA is acceptable, with non-inferior adverse events compared with sodium glucose transporter-2 inhibitor (SGLT-2i) and dipeptidyl peptidase-4 inhibitor (DPP-4i) [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 61" title="Kutz A, Wexler DJ, Liu J, Paik JM, Patorno E. Association of GLP-1 receptor agonists and SGLT-2 inhibitors with major adverse cardiovascular events and serious liver events among patients with type 2. J Endocr. 2024. &#xA;                  https://doi.org/10.1210/jendso/bvae163.555&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR61" id="ref-link-section-d297950435e782">61</a>]. However, liver decompensation, including ascites and hepatic encephalopathy, have been reported following significant weight loss while using Semaglutide. Discontinuing Semaglutide leads to reversal of liver decompensation [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 63" title="Peverelle M, Ng J, Peverelle J, Hirsch RD, Testro A. Liver decompensation after rapid weight loss from semaglutide in a patient with non-alcoholic steatohepatitis -associated cirrhosis. World J Gastroenterol. 2023;29(47):6165–7. &#xA;                  https://doi.org/10.3748/wjg.v29.i47.6165&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR63" id="ref-link-section-d297950435e785">63</a>]. Thus, a potential link between the rapid weight loss induced by GLP1 RA and liver decompensation in vulnerable individuals is possible.</p><p>Since human studies are observational and challenged by confounding factors, the results should be interpreted with caution. Although GLP-1 RA, particularly Liraglutide, offer hepatoprotective benefits through their antioxidant effects by regulating superoxide dismutase and glycated serum protein levels [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 64" title="Deng Y, Li K, Li A, Hu W, Hu W. Advances in the treatment of hepatogenous diabetes: a review. Med U S. 2023;102(46):E36068. &#xA;                  https://doi.org/10.1097/MD.0000000000036068&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR64" id="ref-link-section-d297950435e791">64</a>], the precise mechanisms by which GLP-1 RAs protect the liver remain unclear. More randomized controlled trials are needed to further clarify the causal benefit of GLP1 RA in association with hepatic encephalopathy.</p><h3 class="c-article__sub-heading" id="Sec7"><span class="c-article-section__title-number">3.4 </span>Hypoxia-induced encephalopathy</h3><p>Hypoxia-induced encephalopathy (HIE), caused by severely restricted or completely lost oxygen supply to the brain, results in neuronal damage and long-term neurological deficits [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 65" title="A. Yelam and PC Bollu. 2018. Delayed Hypoxic Reversible Leukoencephalopathy Syndrome. Cureus Inc. &#xA;                  https://doi.org/10.7759/cureus.2702&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR65" id="ref-link-section-d297950435e802">65</a>]. Therapeutic hypothermia is the standard treatment for HIE [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 66" title="Lemyre B, Chau V. Hypothermia for newborns with hypoxic-ischemic encephalopathy. Oxford Univ Press. 2018;23(4):285–91. &#xA;                  https://doi.org/10.1093/pch/pxy028&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR66" id="ref-link-section-d297950435e805">66</a>]. However, a significant number of patients, specifically infants, still experience adverse outcomes (e.g., neurodevelopmental delay and mortality), highlighting the need for adjunctive therapies [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 66" title="Lemyre B, Chau V. Hypothermia for newborns with hypoxic-ischemic encephalopathy. Oxford Univ Press. 2018;23(4):285–91. &#xA;                  https://doi.org/10.1093/pch/pxy028&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR66" id="ref-link-section-d297950435e808">66</a>]. GLP-1 RAs have demonstrated potential as neuroprotective agents in various neurodegenerative disorders and brain ischemia models, possibly offering a treatment option for HIE and its long-term neurological effects[<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 67" title="Hölscher C. Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer’s and Parkinson’s disease models. Elsevier BV. 2018;136:251–9. &#xA;                  https://doi.org/10.1016/j.neuropharm.2018.01.040&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR67" id="ref-link-section-d297950435e811">67</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 68" title="Zhao L, et al. Protective effect of rhGLP-1 (7–36) on brain ischemia/reperfusion damage in diabetic rats. Elsevier BV. 2015;1602:153–9. &#xA;                  https://doi.org/10.1016/j.brainres.2015.01.014&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR68" id="ref-link-section-d297950435e814">68</a>].</p><p>Several animal studies have highlighted the neuroprotective benefits of GLP-1 RAs via their anti-inflammatory and anti-apoptotic effects in HIE models. For instance, the administering of Exendin-4, even six hours post-hypoxia, resulted in significant neuroprotective and anti-inflammatory effects, as evidenced by improved injury scores and reduced infarct volume [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 69" title="Rocha-Ferreira E, et al. Neuroprotective exendin-4 enhances hypothermia therapy in a model of hypoxic-ischaemic encephalopathy. Brain J Neurol. 2018;141(10):2925–42. &#xA;                  https://doi.org/10.1093/brain/awy220&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR69" id="ref-link-section-d297950435e820">69</a>]. This anti-inflammatory effect is linked to reduced pro-inflammatory cytokine production and microglial activation in the brain, which are key features of HIE. This study also highlights the role of GLP-1 RAs in maintaining the blood–brain barrier, lowering vascular permeability, and preventing inflammatory cell infiltration. In addition, GLP-1 RAs, such as Exendin-4, reduce neuronal death or apoptosis by activating the GLP-1R/PI3K/Akt pathway [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 70" title="Xie Z, et al. Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats. Neuropharmacology. 2018;128:142–51. &#xA;                  https://doi.org/10.1016/j.neuropharm.2017.09.040&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR70" id="ref-link-section-d297950435e823">70</a>]. Activation of this pathway increases the expression of key proteins involved in cell survival, including PI3K, phosphorylated Akt (p-Akt), Bcl-xl, and Bcl-2, while decreasing pro-apoptotic factors, such as BAX. Exendin-4 also enhances neuroprotection following transient middle cerebral artery occlusion by increasing islet-brain 1, increasing intracellular cAMP levels through elevated GLP1R expression, and attenuating c-Jun NH2 terminal kinase (JNK), COX-2, and prostaglandin E2 [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 71" title="S. Kim et al. Anti-inflammatory Effect of Glucagon Like Peptide-1 Receptor Agonist, Exendin-4, through Modulation of IB1/JIP1 Expression and JNK Signaling in Stroke,” vol. 26, no. 4, pp. 227–239, Aug. 2017, &#xA;                  https://doi.org/10.5607/en.2017.26.4.227&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR71" id="ref-link-section-d297950435e826">71</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 72" title="Teramoto S, et al. Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral Ischemia. Sage Publ. 2011;31(8):1696–705. &#xA;                  https://doi.org/10.1038/jcbfm.2011.51&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR72" id="ref-link-section-d297950435e829">72</a>]. Furthermore, in mouse models after middle cerebral artery occlusion (MCAO), Liraglutide inhibits neuronal apoptosis by reducing oxidative stress and improving mitochondrial function [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 73" title="Li Y, Gong M. Analysis of the neuroprotective effect of GLP-1 receptor agonist peptide on cerebral ischemia-reperfusion injury by quantitative proteomics mass spectrometry. Cambridge: Wiley; 2021." href="/article/10.1007/s44337-025-00428-0#ref-CR73" id="ref-link-section-d297950435e832">73</a>]. Lastly, animal studies suggest a synergistic benefit of GLP-1 RA administration with therapeutic hypothermia in HIE treatment. This could be due to the combined effects of reduced inflammation, promotion of neuronal survival, and improvement in cerebral blood flow [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 69" title="Rocha-Ferreira E, et al. Neuroprotective exendin-4 enhances hypothermia therapy in a model of hypoxic-ischaemic encephalopathy. Brain J Neurol. 2018;141(10):2925–42. &#xA;                  https://doi.org/10.1093/brain/awy220&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR69" id="ref-link-section-d297950435e836">69</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 70" title="Xie Z, et al. Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats. Neuropharmacology. 2018;128:142–51. &#xA;                  https://doi.org/10.1016/j.neuropharm.2017.09.040&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR70" id="ref-link-section-d297950435e839">70</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 74" title="Victor S, Rocha-Ferreira E, Rahim A, Hagberg H, Edwards D. New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy. Eur J Pediatr. 2022;181(3):875–87. &#xA;                  https://doi.org/10.1007/s00431-021-04320-8&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR74" id="ref-link-section-d297950435e842">74</a>].</p><p>Clinical data on GLP-1 RAs in HIE are limited. However, available preclinical data provide a strong rationale for clinical investigations. Exenatide is a potential neuroprotective treatment for post-anoxic encephalopathy, highlighting its role in mediating glutamate release and preventing toxic overexcitation [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 75" title="Nutma S, Le Feber J, Hofmeijer J. Neuroprotective treatment of post-anoxic encephalopathy: a review of clinical evidence. Front Neurol. 2021;12: 614698. &#xA;                  https://doi.org/10.3389/fneur.2021.614698&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR75" id="ref-link-section-d297950435e848">75</a>]. Although a clinical trial of Exenatide in patients with post-cardiac arrest did not show statistically significant effects on neuron-specific enolase levels or clinical outcomes [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 76" title="Wiberg S, et al. GLP-1 analogues for neuroprotection after out-of-hospital cardiac arrest: study protocol for a randomized controlled trial. Trials. 2016;17(1):304. &#xA;                  https://doi.org/10.1186/s13063-016-1421-2&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR76" id="ref-link-section-d297950435e851">76</a>], preclinical data support the need for further exploration of other GLP-1 RAs, particularly in the context of HIE.</p><h3 class="c-article__sub-heading" id="Sec8"><span class="c-article-section__title-number">3.5 </span>Diabetic encephalopathy</h3><p>Diabetic encephalopathy is a serious complication of diabetes mellitus that results in progressive cognitive decline. This decline is caused by structural and functional changes in brain neurons [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 77" title="Sima AAF. Encephalopathies: the emerging diabetic complications. Acta Diabetol. 2010;47(4):279–93. &#xA;                  https://doi.org/10.1007/s00592-010-0218-0&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR77" id="ref-link-section-d297950435e862">77</a>]. Several key factors contribute to the development of diabetic encephalopathy including insulin resistance, chronic hyperglycemia, oxidative stress, and inflammation. These factors can ultimately lead to neuronal dysfunction and loss. Encouragingly, GLP-1 RAs have demonstrated promising neuroprotective benefits in diabetic encephalopathy based on both preclinical and clinical evidence.</p><p>Preclinical studies have demonstrated the diverse neuroprotective potential of GLP-1 RAs. Research in animals indicates that GLP-1 RAs provide various neuroprotective benefits, including anti-inflammatory effects, reduced apoptosis and oxidative stress, improved synaptic plasticity, and enhanced cognitive function [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Kimura R, et al. Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway. Neuroscience. 2009;162(4):1212–9. &#xA;                  https://doi.org/10.1016/j.neuroscience.2009.05.025&#xA;                  &#xA;                ." href="#ref-CR78" id="ref-link-section-d297950435e868">78</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Wątroba M, Grabowska AD, Szukiewicz D. Chemokine CX3CL1 (fractalkine) signaling and diabetic encephalopathy. Int J Mol Sci. 2024;25(14):7527. &#xA;                  https://doi.org/10.3390/ijms25147527&#xA;                  &#xA;                ." href="#ref-CR79" id="ref-link-section-d297950435e868_1">79</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 80" title="Xourgia E, Papazafiropoulou A, Melidonis A. Antidiabetic treatment on memory and spatial learning: from the pancreas to the neuron. World J Diabetes. 2019;10(3):169–80. &#xA;                  https://doi.org/10.4239/wjd.v10.i3.169&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR80" id="ref-link-section-d297950435e871">80</a>]. Specifically, the anti-inflammatory effects of GLP-1 RAs are associated with activation of the CX3CL1-CX3CR1 pathway, which plays a crucial role in modulating microglial inflammation [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 79" title="Wątroba M, Grabowska AD, Szukiewicz D. Chemokine CX3CL1 (fractalkine) signaling and diabetic encephalopathy. Int J Mol Sci. 2024;25(14):7527. &#xA;                  https://doi.org/10.3390/ijms25147527&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR79" id="ref-link-section-d297950435e874">79</a>]. In animal models of diabetic encephalopathy, GLP-1 RAs amplify their anti-inflammatory actions by decreasing NF-κB levels, resulting in lower production of pro-inflammatory cytokines such as interleukin, C-reactive proteins, and TNF-alpha [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 77" title="Sima AAF. Encephalopathies: the emerging diabetic complications. Acta Diabetol. 2010;47(4):279–93. &#xA;                  https://doi.org/10.1007/s00592-010-0218-0&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR77" id="ref-link-section-d297950435e877">77</a>]. Notably, the ability of GLP-1 RAs to enhance insulin sensitivity is associated with their anti-inflammatory properties [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 79" title="Wątroba M, Grabowska AD, Szukiewicz D. Chemokine CX3CL1 (fractalkine) signaling and diabetic encephalopathy. Int J Mol Sci. 2024;25(14):7527. &#xA;                  https://doi.org/10.3390/ijms25147527&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR79" id="ref-link-section-d297950435e880">79</a>]. Another significant neuroprotective benefit of GLP-1 receptor agonists is their ability to inhibit apoptosis. For instance, GLP-1 RA Liraglutide has been shown to increase brain-derived neurotrophic factor (BDNF) levels, thereby reducing apoptosis [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 80" title="Xourgia E, Papazafiropoulou A, Melidonis A. Antidiabetic treatment on memory and spatial learning: from the pancreas to the neuron. World J Diabetes. 2019;10(3):169–80. &#xA;                  https://doi.org/10.4239/wjd.v10.i3.169&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR80" id="ref-link-section-d297950435e884">80</a>]. Additionally, GLP-1 RAs protect against methylglyoxal-induced apoptosis in PC12 cells (rat pheochromocytoma cells), a model relevant to the neuronal damage observed in diabetic encephalopathy [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 78" title="Kimura R, et al. Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway. Neuroscience. 2009;162(4):1212–9. &#xA;                  https://doi.org/10.1016/j.neuroscience.2009.05.025&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR78" id="ref-link-section-d297950435e887">78</a>]. Importantly, GLP-1 RAs can also reduce apoptosis by protecting neuronal cells from oxidative stress, achieved through the activation of the AMPK, mTOR, and phosphoinositide 3-kinase (PI3K/Akt/mTOR) signaling pathway, a vital pathway for cell survival and maintenance of redox balance [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 78" title="Kimura R, et al. Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway. Neuroscience. 2009;162(4):1212–9. &#xA;                  https://doi.org/10.1016/j.neuroscience.2009.05.025&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR78" id="ref-link-section-d297950435e890">78</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 80" title="Xourgia E, Papazafiropoulou A, Melidonis A. Antidiabetic treatment on memory and spatial learning: from the pancreas to the neuron. World J Diabetes. 2019;10(3):169–80. &#xA;                  https://doi.org/10.4239/wjd.v10.i3.169&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR80" id="ref-link-section-d297950435e893">80</a>].</p><p>The cognitive benefits of GLP-1 RA in diabetic encephalopathy have also been explored extensively. Exendin-4 improves cognitive function in aged rats by modulating hippocampal NMDA subunits, specifically NMDA-R2A and NMDA-R2B, while increasing NMDA-R2B phosphorylation [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Romano AD, Villani R, Sangineto M, Cassano T, Serviddio G. The GLP-1 receptor agonist exendin-4 modulates hippocampal NMDA-receptor signaling in aged rats and improves cognitive impairment in diabetic elderly patients. J Gerontol Geriatr. 2022;70(2):1–7. &#xA;                  https://doi.org/10.36150/2499-6564-N474&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR16" id="ref-link-section-d297950435e899">16</a>]. As a result, this modulation potentially enhances neuronal plasticity and mitigates glutamate excitotoxicity, a crucial factor in the pathophysiology of diabetic encephalopathy. Likewise, Liraglutide improves cognitive impairment in rodent models of T2DM by activating and modifying downstream signaling of the PI3K/Akt/mTOR signaling pathway for neuronal survival, growth, and plasticity[<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 80" title="Xourgia E, Papazafiropoulou A, Melidonis A. Antidiabetic treatment on memory and spatial learning: from the pancreas to the neuron. World J Diabetes. 2019;10(3):169–80. &#xA;                  https://doi.org/10.4239/wjd.v10.i3.169&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR80" id="ref-link-section-d297950435e902">80</a>]. The cognitive benefits of GLP-1 RAs were further expanded in the hippocampus of diabetic mice, showing a decrease in amyloid-β peptide and tau protein levels, consequently decreasing amyloid plaque formation, and protecting neurons from amyloid-β-induced death [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 77" title="Sima AAF. Encephalopathies: the emerging diabetic complications. Acta Diabetol. 2010;47(4):279–93. &#xA;                  https://doi.org/10.1007/s00592-010-0218-0&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR77" id="ref-link-section-d297950435e905">77</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 80" title="Xourgia E, Papazafiropoulou A, Melidonis A. Antidiabetic treatment on memory and spatial learning: from the pancreas to the neuron. World J Diabetes. 2019;10(3):169–80. &#xA;                  https://doi.org/10.4239/wjd.v10.i3.169&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR80" id="ref-link-section-d297950435e908">80</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 81" title="Soares E, Nunes S, Reis F, Pereira FC. Diabetic encephalopathy: the role of oxidative stress and inflammation in type 2 diabetes. Int J Interferon Cytokine Mediat Res. 2012;4(1):75–85. &#xA;                  https://doi.org/10.2147/IJICMR.S29322&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR81" id="ref-link-section-d297950435e911">81</a>]. These findings underscore the potential of GLP-1 RAs to boost synaptic plasticity and promote cognitive resilience in diabetic encephalopathy.</p><p>Clinical studies have substantiated the therapeutic effects of GLP-1 RAs in humans. For instance, the use of Exendin-4 resulted in significant cognitive improvement in elderly patients with diabetes, independent of glycemic control [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Romano AD, Villani R, Sangineto M, Cassano T, Serviddio G. The GLP-1 receptor agonist exendin-4 modulates hippocampal NMDA-receptor signaling in aged rats and improves cognitive impairment in diabetic elderly patients. J Gerontol Geriatr. 2022;70(2):1–7. &#xA;                  https://doi.org/10.36150/2499-6564-N474&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR16" id="ref-link-section-d297950435e917">16</a>]. In this study of 138 elderly diabetic patients, treating diabetes with Exendin-4 substantially improved their mini-mental status exam scores (MMSE) without correlating with Hemoglobin A1c (HgbA1c) levels. This finding supports a direct neuroprotective effect rather than simply improving glucose metabolism [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 16" title="Romano AD, Villani R, Sangineto M, Cassano T, Serviddio G. The GLP-1 receptor agonist exendin-4 modulates hippocampal NMDA-receptor signaling in aged rats and improves cognitive impairment in diabetic elderly patients. J Gerontol Geriatr. 2022;70(2):1–7. &#xA;                  https://doi.org/10.36150/2499-6564-N474&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR16" id="ref-link-section-d297950435e920">16</a>]. In addition, Liraglutide may enhance cognitive function in patients with T2DM in the context of mood disorders [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 80" title="Xourgia E, Papazafiropoulou A, Melidonis A. Antidiabetic treatment on memory and spatial learning: from the pancreas to the neuron. World J Diabetes. 2019;10(3):169–80. &#xA;                  https://doi.org/10.4239/wjd.v10.i3.169&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR80" id="ref-link-section-d297950435e923">80</a>]. After a 4-week treatment with Liraglutide, there was a significant improvement in the Trail Making Test-B and composite Z-scores of several neuropsychiatric scales in patients with depression and bipolar disorders [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 82" title="Mansur RB, et al. Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: a pilot, open-label study. Elsevier. 2016;207:114–20. &#xA;                  https://doi.org/10.1016/j.jad.2016.09.056&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR82" id="ref-link-section-d297950435e926">82</a>]. While further research is needed with more extensive and diverse populations, these findings suggest the potential clinical use of GLP-1 RAs in addressing cognitive decline associated with diabetic encephalopathy.</p><h3 class="c-article__sub-heading" id="Sec9"><span class="c-article-section__title-number">3.6 </span>Alcohol withdrawal syndrome</h3><p>Alcohol Withdrawal Syndrome (AWS) is a constellation of symptoms that arise from abrupt cessation or reduction of alcohol consumption in individuals with prolonged alcohol use [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Bayard M, McIntyre J, Hill KR, Woodside JR. Alcohol withdrawal syndrome. Informa. 2000. &#xA;                  https://doi.org/10.1201/9781420036961-14&#xA;                  &#xA;                ." href="#ref-CR83" id="ref-link-section-d297950435e937">83</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Jesse S, et al. Alcohol withdrawal syndrome: mechanisms, manifestations, and management. Wiley. 2016;135(1):4–16. &#xA;                  https://doi.org/10.1111/ane.12671&#xA;                  &#xA;                ." href="#ref-CR84" id="ref-link-section-d297950435e937_1">84</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 85" title="Vale A. The management of alcohol withdrawal. Amsterdam: Elsevier Ltd; 2006." href="/article/10.1007/s44337-025-00428-0#ref-CR85" id="ref-link-section-d297950435e940">85</a>]. This syndrome presents with a range of symptoms, including tremors, anxiety, sweating, headaches, hallucinations, and, in severe cases, seizures and delirium tremens (DT)[<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Gonçalves MCB, Félix F, Romão J, André R, Sereijo C, Ismail F. Seizures and alcohol withdrawal: a literature review. Camb Univ Press. 2022. &#xA;                  https://doi.org/10.1192/j.eurpsy.2022.2143&#xA;                  &#xA;                ." href="#ref-CR86" id="ref-link-section-d297950435e943">86</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Kaye AD, et al. The role of glucagon-like peptide-1 agonists in the treatment of multiple sclerosis: a narrative review. Cureus. 2024. &#xA;                  https://doi.org/10.7759/cureus.67232&#xA;                  &#xA;                ." href="#ref-CR87" id="ref-link-section-d297950435e943_1">87</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 88" title="Mirijello A, et al. Identification and management of alcohol withdrawal syndrome. Adis Springer Healthcare. 2015;75(4):353–65. &#xA;                  https://doi.org/10.1007/s40265-015-0358-1&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR88" id="ref-link-section-d297950435e946">88</a>]. AWS is a common cause of hospitalization, and without adequate monitoring and treatment, it may lead to significant morbidity and mortality [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 89" title="Mahajan R, Singh R, Bansal P, Bala R. Use of propofol as adjuvant therapy in refractory delirium tremens. Medknow. 2010;19(1):58–58. &#xA;                  https://doi.org/10.4103/0972-6748.77641&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR89" id="ref-link-section-d297950435e949">89</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 90" title="Trevisan L, Boutros NN, Petrakis IL, Krystal JH. Complications of alcohol withdrawal: pathophysiological insights. Natl Inst Health. 1998;22(1):61–6." href="/article/10.1007/s44337-025-00428-0#ref-CR90" id="ref-link-section-d297950435e953">90</a>]. The pathophysiological mechanism of AWS involves an imbalance between inhibitory GABAergic and excitatory glutamatergic systems [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 88" title="Mirijello A, et al. Identification and management of alcohol withdrawal syndrome. Adis Springer Healthcare. 2015;75(4):353–65. &#xA;                  https://doi.org/10.1007/s40265-015-0358-1&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR88" id="ref-link-section-d297950435e956">88</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 91" title="Abulseoud OA, Çamsarı UM, Ruby CL, Kasasbeh A, Choi S, Choi D-S. Attenuation of ethanol withdrawal by ceftriaxone-induced upregulation of glutamate transporter EAAT2. Springer Nat. 2014;39(7):1674–84. &#xA;                  https://doi.org/10.1038/npp.2014.14&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR91" id="ref-link-section-d297950435e959">91</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 92" title="Bauer J, et al. Craving in alcohol-dependent patients after detoxification is related to glutamatergic dysfunction in the nucleus accumbens and the anterior cingulate cortex. Springer Nat. 2013;38(8):1401–8. &#xA;                  https://doi.org/10.1038/npp.2013.45&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR92" id="ref-link-section-d297950435e962">92</a>]. Current treatment strategies for AWS focus on the early identification and close monitoring of symptoms, administering symptom-relieving medications such as benzodiazepines, gabapentin, and phenobarbital, and offering craving-reducing agents such as naltrexone and acamprosate [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Dixit D, et al. Management of acute alcohol withdrawal syndrome in critically Ill patients. Wiley. 2016;36(7):797–822. &#xA;                  https://doi.org/10.1002/phar.1770&#xA;                  &#xA;                ." href="#ref-CR93" id="ref-link-section-d297950435e965">93</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Elliott DY. Caring for hospitalized patients with alcohol withdrawal syndrome. Lippincott Williams Wilkins. 2019;14(5):18–30. &#xA;                  https://doi.org/10.1097/01.ccn.0000578828.37034.c2&#xA;                  &#xA;                ." href="#ref-CR94" id="ref-link-section-d297950435e965_1">94</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Maldonado JR. Novel algorithms for the prophylaxis and management of alcohol withdrawal syndromes-beyond benzodiazepines. Elsevier BV. 2017;33(3):559–99. &#xA;                  https://doi.org/10.1016/j.ccc.2017.03.012&#xA;                  &#xA;                ." href="#ref-CR95" id="ref-link-section-d297950435e965_2">95</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 96" title="McPheeters M, O’Connor EA, Riley S. Naltrexone, acamprosate show strongest results in review of alcohol use disorder treatments. Wiley. 2024;35(3):4–4. &#xA;                  https://doi.org/10.1002/pu.31133&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR96" id="ref-link-section-d297950435e968">96</a>]. Although psychosocial interventions and the management of co-occurring psychiatric disorders are valuable in promoting abstinence from alcohol use, these strategies have limitations and new treatments are needed [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 97" title="Rizk JG, Saini J, Kim K, Pathan U, Qato DM. County-level factors associated with a mismatch between opioid overdose mortality and availability of opioid treatment facilities. Public Libr Sci. 2024. &#xA;                  https://doi.org/10.1371/journal.pone.0301863&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR97" id="ref-link-section-d297950435e972">97</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 98" title="Swift RM. Emerging approaches to managing alcohol dependence. Oxford: Oxford University Press; 2007." href="/article/10.1007/s44337-025-00428-0#ref-CR98" id="ref-link-section-d297950435e975">98</a>]. In this context, GLP-1 RAs may help prevent and alleviate AWS owing to their neuroprotective benefits, offering new therapeutic approaches to improve patient outcomes and quality of life[<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 99" title="Grieco M, et al. Glucagon-like peptide-1: a focus on neurodegenerative diseases. Frontiers Media. 2019. &#xA;                  https://doi.org/10.3389/fnins.2019.01112&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR99" id="ref-link-section-d297950435e978">99</a>]. Indeed, preclinical and clinical evidence suggests that GLP-1 signaling may regulate alcohol-mediated behaviors [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 100" title="Jerlhag E. GLP-1 signaling and alcohol-mediated behaviors; preclinical and clinical evidence. Elsevier BV. 2018;136:343–9. &#xA;                  https://doi.org/10.1016/j.neuropharm.2018.01.013&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR100" id="ref-link-section-d297950435e981">100</a>].</p><p>Several animal studies have suggested that GLP-1 RAs can effectively mitigate various aspects of AWS. An essential finding was their ability to attenuate anxiety-like behaviors during the withdrawal phase [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="Liu W, Wang Z, Wang W, Wang Z, Xing Y, Hölscher C. Liraglutide reduces alcohol consumption, anxiety, memory impairment, and synapse loss in alcohol dependent mice. Neurochem Res. 2024;49(4):1061–75. &#xA;                  https://doi.org/10.1007/s11064-023-04093-6&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR32" id="ref-link-section-d297950435e987">32</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 101" title="Sharma AN, Pise A, Sharma JN, Shukla P. Glucagon-like peptide-1 (GLP-1) receptor agonist prevents development of tolerance to anti-anxiety effect of ethanol and withdrawal-induced anxiety in rats. Metab Brain Dis. 2015;30(3):719–30. &#xA;                  https://doi.org/10.1007/s11011-014-9627-z&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR101" id="ref-link-section-d297950435e990">101</a>]. This finding is critical because anxiety is a major factor driving relapse [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 102" title="Breese GR, Overstreet DH, Knapp DJ, Navarro M. Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist. Springer Nat. 2005;30(9):1662–9. &#xA;                  https://doi.org/10.1038/sj.npp.1300706&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR102" id="ref-link-section-d297950435e993">102</a>]. For instance, Sharma et al. (2015) indicated that reduced anxiety-like behaviors, which are crucial for the maintenance of alcohol abstinence, persisted in alcohol-tolerant mice following acute Liraglutide administration [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 101" title="Sharma AN, Pise A, Sharma JN, Shukla P. Glucagon-like peptide-1 (GLP-1) receptor agonist prevents development of tolerance to anti-anxiety effect of ethanol and withdrawal-induced anxiety in rats. Metab Brain Dis. 2015;30(3):719–30. &#xA;                  https://doi.org/10.1007/s11011-014-9627-z&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR101" id="ref-link-section-d297950435e996">101</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 103" title="Jerlhag E. The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies. Front Pharmacol. 2023. &#xA;                  https://doi.org/10.3389/fphar.2023.1063033&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR103" id="ref-link-section-d297950435e999">103</a>]. In addition to anxiety, GLP-1 RAs, such as Dulaglutide and Liraglutide, attenuate alcohol consumption and preference in mice [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="Liu W, Wang Z, Wang W, Wang Z, Xing Y, Hölscher C. Liraglutide reduces alcohol consumption, anxiety, memory impairment, and synapse loss in alcohol dependent mice. Neurochem Res. 2024;49(4):1061–75. &#xA;                  https://doi.org/10.1007/s11064-023-04093-6&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR32" id="ref-link-section-d297950435e1003">32</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 103" title="Jerlhag E. The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies. Front Pharmacol. 2023. &#xA;                  https://doi.org/10.3389/fphar.2023.1063033&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR103" id="ref-link-section-d297950435e1006">103</a>]. Similarly, a decrease in alcohol-bingeing behavior after using Exendin-4 and Semaglutide has been observed in some animal models [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 104" title="Celik M, Gold MS, Fuehrlein B. A narrative review of current and emerging trends in the treatment of alcohol use disorder. Brain Sci. 2024;14(3):294. &#xA;                  https://doi.org/10.3390/brainsci14030294&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR104" id="ref-link-section-d297950435e1009">104</a>]. These outcomes following alcohol consumption are long-lasting, which is crucial for the potential long-term effects of recovery[<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="Liu W, Wang Z, Wang W, Wang Z, Xing Y, Hölscher C. Liraglutide reduces alcohol consumption, anxiety, memory impairment, and synapse loss in alcohol dependent mice. Neurochem Res. 2024;49(4):1061–75. &#xA;                  https://doi.org/10.1007/s11064-023-04093-6&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR32" id="ref-link-section-d297950435e1012">32</a>]. Moreover, GLP-1 RAs, specifically Semaglutide, provide anti-inflammatory properties by reducing pro-inflammatory cytokines in the brain, mitigating inflammation during alcohol withdrawal, and reducing alcohol relapse [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 105" title="Jerlhag E. Alcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1. Elsevier BV. 2019;1727:146562–146562. &#xA;                  https://doi.org/10.1016/j.brainres.2019.146562&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR105" id="ref-link-section-d297950435e1015">105</a>]. This finding highlights the neuroprotective benefits of GLP-1 RA, such as Semaglutide, in the medial prefrontal cortex and hippocampus. Specifically, by preserving synaptic density, Semaglutide plays a crucial role in safeguarding neuronal networks[<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 105" title="Jerlhag E. Alcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1. Elsevier BV. 2019;1727:146562–146562. &#xA;                  https://doi.org/10.1016/j.brainres.2019.146562&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR105" id="ref-link-section-d297950435e1018">105</a>]. Another important pathway is the modulation of hyperammonemia by GLP-1 RA [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 105" title="Jerlhag E. Alcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1. Elsevier BV. 2019;1727:146562–146562. &#xA;                  https://doi.org/10.1016/j.brainres.2019.146562&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR105" id="ref-link-section-d297950435e1022">105</a>] in the prefrontal cortex, which diminishes cognitive impairments observed during withdrawal [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="Liu W, Wang Z, Wang W, Wang Z, Xing Y, Hölscher C. Liraglutide reduces alcohol consumption, anxiety, memory impairment, and synapse loss in alcohol dependent mice. Neurochem Res. 2024;49(4):1061–75. &#xA;                  https://doi.org/10.1007/s11064-023-04093-6&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR32" id="ref-link-section-d297950435e1025">32</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 92" title="Bauer J, et al. Craving in alcohol-dependent patients after detoxification is related to glutamatergic dysfunction in the nucleus accumbens and the anterior cingulate cortex. Springer Nat. 2013;38(8):1401–8. &#xA;                  https://doi.org/10.1038/npp.2013.45&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR92" id="ref-link-section-d297950435e1028">92</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 106" title="Thomsen M, Holst JJ, Molander A, Línnet K, Ptito M, Fink-Jensen A. Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys. Springer Sci Media. 2018;236(2):603–11. &#xA;                  https://doi.org/10.1007/s00213-018-5089-z&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR106" id="ref-link-section-d297950435e1031">106</a>]. Although the findings of these animal studies show promise, additional clinical studies are necessary to demonstrate the applicability of GLP-1 RAs for managing AWS in humans.</p><p>To the best of our knowledge, only indirect effects of GLP-1 RAs in attenuating AWS in humans have been reported. For instance, some clinical trials have investigated the effects of GLP-1 RAs on alcohol consumption in patients with alcohol use disorders, an outcome that is crucial in preventing AWS. Additionally, a reduction in alcohol intake with GLP-1 RA treatment, particularly in individuals with comorbid obesity (BMI &gt; 30 kg/m2), has been reported [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 32" title="Liu W, Wang Z, Wang W, Wang Z, Xing Y, Hölscher C. Liraglutide reduces alcohol consumption, anxiety, memory impairment, and synapse loss in alcohol dependent mice. Neurochem Res. 2024;49(4):1061–75. &#xA;                  https://doi.org/10.1007/s11064-023-04093-6&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR32" id="ref-link-section-d297950435e1037">32</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 100" title="Jerlhag E. GLP-1 signaling and alcohol-mediated behaviors; preclinical and clinical evidence. Elsevier BV. 2018;136:343–9. &#xA;                  https://doi.org/10.1016/j.neuropharm.2018.01.013&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR100" id="ref-link-section-d297950435e1040">100</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 107" title="M. R. Shen, K. Owusu-Boaitey, L. M. Holsen, and J. Suzuki, “The Efficacy of GLP-1 Agonists in Treating Substance Use Disorder in Patients: A Scoping Review.” Jan. 2024." href="/article/10.1007/s44337-025-00428-0#ref-CR107" id="ref-link-section-d297950435e1043">107</a>]. In contrast, patients with a lower BMI (less than 25 kg/m<sup>2</sup>) treated with GLP-1 RA, particularly Exenatide, reported an increase in the number of heavy drinking days [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 107" title="M. R. Shen, K. Owusu-Boaitey, L. M. Holsen, and J. Suzuki, “The Efficacy of GLP-1 Agonists in Treating Substance Use Disorder in Patients: A Scoping Review.” Jan. 2024." href="/article/10.1007/s44337-025-00428-0#ref-CR107" id="ref-link-section-d297950435e1048">107</a>]. This indicates that additional research is necessary to determine the optimal parameters and suitable patient populations that will benefit the most from GLP-1 RAs. Currently, no studies have directly evaluated the efficacy of GLP-1 RA in patients with AWS.</p></div></div></section><section data-title="Discussion"><div class="c-article-section" id="Sec10-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec10"><span class="c-article-section__title-number">4 </span>Discussion</h2><div class="c-article-section__content" id="Sec10-content"><p>To the best of our knowledge, this is the first scoping review to examine the role of GLP-1 RAs in delirium and encephalopathies. A thorough literature search revealed that preclinical and clinical studies indicate that GLP-1 RAs may offer neuroprotective benefits for both the prevention and management of delirium and encephalopathies, including sepsis-associated encephalopathy, hepatic encephalopathy, HIE, diabetic encephalopathy and AWS. In summary, these neuroprotective effects include anti-inflammatory, anti-apoptotic, and cognitive-enhancing properties of GLP-1 RAs (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/article/10.1007/s44337-025-00428-0#Fig1">1</a>).</p><p>The anti-inflammatory benefit of GLP-1 RAs is a common mechanistic theme among brain dysfunctions presented in this scoping review. This anti-inflammatory function is linked to reduced levels of pro-inflammatory markers (TNF-alpha, NF-KB, CRP, and IL-1β), possibly contributing to the maintenance of cellular health. This aligns with findings in neurodegenerative diseases such as Alzheimer's and Parkinson's diseases, where anti-inflammation plays a crucial role in treatment, suggesting a shared mechanistic target for GLP-1 RAs across different neurological conditions [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 108" title="Kopp KO, Glotfelty EJ, Li Y, Greig NH. Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment. Elsevier BV. 2022;186:106550–106550. &#xA;                  https://doi.org/10.1016/j.phrs.2022.106550&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR108" id="ref-link-section-d297950435e1066">108</a>]. In this review, anti-inflammatory effects represent a promising benefit observed in animal studies used as models for delirium and certain encephalopathies. However, human studies on postoperative delirium and AWS have shown mixed results or are only beneficial for obese patients.</p><p>The benefits of GLP-1 RAs in preventing cell death or apoptosis are evident in animal models of postoperative delirium and various encephalopathies discussed in this review. Several pathophysiological mechanisms have been identified for the prevention of apoptosis, including the reduction of oxidative stress in postoperative delirium, diabetic encephalopathy, and hepatic encephalopathy. Additionally, the involvement of the mTOR pathway has been noted in septic and diabetic encephalopathy and the phosphorylation of tau proteins in diabetic and sepsis-associated encephalopathy and postoperative delirium. These anti-apoptotic benefits of GLP-1 RAs are not unique to delirium and encephalopathies, but have also been established in various biological systems, such as neuronal cells, cardiomyocytes, pancreatic beta cells, and cardiac progenitor cells[<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Cheng L-Z, Li W, Chen Y-X, Lin Y-J, Miao Y. Autophagy and diabetic encephalopathy: mechanistic insights and potential therapeutic implications. Aging Dis. 2022;13(2):447–57. &#xA;                  https://doi.org/10.14336/AD.2021.0823&#xA;                  &#xA;                ." href="#ref-CR109" id="ref-link-section-d297950435e1072">109</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Hui H, Nourparvar A, Zhao X, Perfetti R. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5′-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway. Oxf Univ Press. 2003;144(4):1444–55. &#xA;                  https://doi.org/10.1210/en.2002-220897&#xA;                  &#xA;                ." href="#ref-CR110" id="ref-link-section-d297950435e1072_1">110</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" title="Kobara M, Toba H, Nakata T. A glucagon-like peptide 1 analog protects mitochondria and attenuates hypoxia-reoxygenation injury in cultured cardiomyocytes. J Cardiovasc Pharmacol. 2022;79(4):568–76. &#xA;                  https://doi.org/10.1097/FJC.0000000000001218&#xA;                  &#xA;                ." href="#ref-CR111" id="ref-link-section-d297950435e1072_2">111</a>,<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 112" title="I. S. D. T. Y. L. N. H. G. Salcedo, “Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders,” vol. undefined, no. undefined. Apr. 2012. &#xA;                  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419902/&#xA;                  &#xA;                " href="/article/10.1007/s44337-025-00428-0#ref-CR112" id="ref-link-section-d297950435e1075">112</a>]. This demonstrated the versatility of GLP-1 RAs in different biological systems, indicating a convergence of shared cellular protection mechanisms through the modulation of apoptotic pathways and other mechanisms that regulate cell death. While the review highlights promising preclinical evidence for GLP-1 RAs in preventing cell death in various encephalopathies, clinical evidence remains limited. Indeed, this review notes that evidence for apoptotic mechanisms is lacking in human studies on sepsis-associated encephalopathy, and most human studies on hepatic encephalopathy are observational in nature. Additionally, limited research on hypoxia-induced encephalopathy has primarily focused on post-cardiac patients, which may not be representative of the broader patient population.</p><p>The cognitive-enhancing potential of GLP-1 RAs has been demonstrated in animal models of diabetic encephalopathy. Several pathophysiological mechanisms contribute to cognitive improvement, including the activation of the PI3K/Akt/mTOR pathways. For instance, these mechanisms lead to a reduction in amyloid-beta plaques and modulation of NMDA receptors and glutamate toxicity, all of which promote neuronal health and enhance synaptic plasticity. Similarly, these findings have been translated into improved cognition in human studies. These cognitive-enhancing potentials, similarly implicated in animal models of Alzheimer’s disease, stroke, and traumatic brain injury, suggest a broader applicability for GLP-1 RAs in neurological conditions marked by cognitive deficits [<a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 18" title="Salcedo I, Tweedie D, Li Y, Greig NH. Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders. Wiley. 2012;166(5):1586–99. &#xA;                  https://doi.org/10.1111/j.1476-5381.2012.01971.x&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR18" id="ref-link-section-d297950435e1081">18</a>, <a data-track="click" data-track-action="reference anchor" data-track-label="link" data-test="citation-ref" aria-label="Reference 99" title="Grieco M, et al. Glucagon-like peptide-1: a focus on neurodegenerative diseases. Frontiers Media. 2019. &#xA;                  https://doi.org/10.3389/fnins.2019.01112&#xA;                  &#xA;                ." href="/article/10.1007/s44337-025-00428-0#ref-CR99" id="ref-link-section-d297950435e1084">99</a>].</p><p>This scoping review had several strengths. First, considering the prevalence and harmful cognitive and functional consequences of delirium and encephalopathy, this review offers a comprehensive overview, based on available preclinical and clinical evidence, of the promising role of GLP-1 RAs in brain functions. Second, it highlights potential molecular or pathophysiological mechanisms by illustrating a diagram (Fig. <a data-track="click" data-track-label="link" data-track-action="figure anchor" href="/article/10.1007/s44337-025-00428-0#Fig1">1</a>) that shows how GLP-1 RAs may exert therapeutic effects in patients with these conditions.</p><p>While this review offers new insights about the neuroprotective benefits of GLP-1 RAs, we acknowledge some limitations of this study. First, this review does not include other types of delirium and encephalopathies (e.g., delirium due to metabolic causes, encephalopathy from demyelinating diseases such as multiple sclerosis, and seizure-associated encephalopathy). However, it provides a foundational overview of the benefits of GLP-1 RAs in relation to delirium and encephalopathies, laying the groundwork for future research. Second, this review was not a systematic review or meta-analysis; therefore, critical appraisal of each data was not performed, and the quality of evidence was not graded. However, systematic review and meta-analysis may not be appropriate or timely at this point, given the scarcity of human observational and randomized trials; thus, providing a scoping review is the best attempt or opportunity to present the current state of evidence. Third, this review represents brain dysfunction that mainly affects older adults or the elderly; thus, it may not be applicable to pediatric patients. Nevertheless, the hypoxia-induced encephalopathy discussed in this review is common in infants but may have underlying mechanisms that can be translated to other disease states, such as cerebral ischemia or anoxia in adult populations.</p><p>Finally, this review provides a comprehensive understanding of the neuroprotective potential of GLP-1 RAs. First, additional research is necessary to understand the effects of GLP-1 RAs on other types of encephalopathies and delirium, which are not covered in this review. Second, additional observational or randomized clinical trials are required to further investigate the efficacy and safety of GLP-1 RAs in preventing and treating delirium and encephalopathies. Third, the optimal dose, duration, and timing of GLP-1 RA treatment for delirium and encephalopathies should be determined. Fourth, comparative studies with other diabetic agents (e.g., insulin, SGLT-2i, and DPP-4i) must be undertaken to further elucidate the pharmacological properties and adverse effect profiles of GLP-1 RAs. Fifth, a systematic or meta-analysis review must be conducted to evaluate the therapeutic effects of GLP-1 RAs in encephalopathies and delirium once more observational or randomized studies are published. Sixth, the mechanisms underlying the exact roles of GLP-1 RAs in delirium and encephalopathies are complex. Therefore, further mechanistic studies are necessary to fully elucidate the intricate pathways through which GLP-1 RAs exert their neuroprotective effects, ultimately optimizing their clinical applications. Lastly, the literature search was restricted to studies published between 2015 and 2025. This timeframe may have influenced the identification of all relevant evidence related to the research question. Therefore, future reviews are essential to comprehensively map the existing literature.</p></div></div></section><section data-title="Conclusion"><div class="c-article-section" id="Sec11-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec11"><span class="c-article-section__title-number">5 </span>Conclusion</h2><div class="c-article-section__content" id="Sec11-content"><p>This scoping review indicates that GLP-1 RAs may provide neuroprotective advantages for treating postoperative delirium and certain types of encephalopathies. Both preclinical and clinical studies have demonstrated anti-inflammatory, anti-apoptotic, and cognitive enhancement properties. Anti-inflammatory properties are linked to a reduction in inflammatory markers, while anti-apoptotic benefits promote cellular health and synaptic plasticity. This cognitive-enhancing potential may delay cognitive impairment and functional decline in delirium and encephalopathies. Nevertheless, it is still necessary to understand the role of GLP-1 RAs in other types of encephalopathies and different causes of delirium. Further clinical trials are essential to evaluate the efficacy and safety of GLP-1 RAs, establish optimal dosing guidelines, and compare their effects with those of alternative treatments. Future studies should also investigate the mechanisms by which GLP-1 RAs deliver neuroprotective benefits, ultimately leading to improved clinical outcomes.</p></div></div></section>
                                </div>
                        
                    

                    
                        
                    

                    
                        
                    

                    
                    <section data-title="Data availability"><div class="c-article-section" id="data-availability-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="data-availability">Data availability</h2><div class="c-article-section__content" id="data-availability-content">
              
              <p>No datasets were generated or analysed during the current study.</p>
            </div></div></section><div id="MagazineFulltextArticleBodySuffix"><section aria-labelledby="Bib1" data-title="VII. References"><div class="c-article-section" id="Bib1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Bib1">VII. References</h2><div class="c-article-section__content" id="Bib1-content"><div data-container-section="references"><ol class="c-article-references" data-track-component="outbound reference" data-track-context="references section"><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="1."><p class="c-article-references__text" id="ref-CR1">Tsuruta R, Oda Y. A clinical perspective of sepsis-associated delirium. BioMed Cent. 2016. <a href="https://doi.org/10.1186/s40560-016-0145-4" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1186/s40560-016-0145-4">https://doi.org/10.1186/s40560-016-0145-4</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1186/s40560-016-0145-4" data-track-item_id="10.1186/s40560-016-0145-4" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s40560-016-0145-4" aria-label="Article reference 1" data-doi="10.1186/s40560-016-0145-4">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 1" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20clinical%20perspective%20of%20sepsis-associated%20delirium&amp;journal=BioMed%20Cent&amp;doi=10.1186%2Fs40560-016-0145-4&amp;publication_year=2016&amp;author=Tsuruta%2CR&amp;author=Oda%2CY">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="2."><p class="c-article-references__text" id="ref-CR2">Young GB. Encephalopathy of infection and systemic inflammation. Lippincott Williams Wilkins. 2013;30(5):454–61. <a href="https://doi.org/10.1097/wnp.0b013e3182a73d83" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1097/wnp.0b013e3182a73d83">https://doi.org/10.1097/wnp.0b013e3182a73d83</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1097/wnp.0b013e3182a73d83" data-track-item_id="10.1097/wnp.0b013e3182a73d83" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1097%2Fwnp.0b013e3182a73d83" aria-label="Article reference 2" data-doi="10.1097/wnp.0b013e3182a73d83">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 2" href="http://scholar.google.com/scholar_lookup?&amp;title=Encephalopathy%20of%20infection%20and%20systemic%20inflammation&amp;journal=Lippincott%20Williams%20Wilkins&amp;doi=10.1097%2Fwnp.0b013e3182a73d83&amp;volume=30&amp;issue=5&amp;pages=454-461&amp;publication_year=2013&amp;author=Young%2CGB">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="3."><p class="c-article-references__text" id="ref-CR3">Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Elsevier. 2013;383(9920):911–22. <a href="https://doi.org/10.1016/s0140-6736(13)60688-1" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/s0140-6736(13)60688-1">https://doi.org/10.1016/s0140-6736(13)60688-1</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/s0140-6736(13)60688-1" data-track-item_id="10.1016/s0140-6736(13)60688-1" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fs0140-6736%2813%2960688-1" aria-label="Article reference 3" data-doi="10.1016/s0140-6736(13)60688-1">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 3" href="http://scholar.google.com/scholar_lookup?&amp;title=Delirium%20in%20elderly%20people&amp;journal=Elsevier&amp;doi=10.1016%2Fs0140-6736%2813%2960688-1&amp;volume=383&amp;issue=9920&amp;pages=911-922&amp;publication_year=2013&amp;author=Inouye%2CSK&amp;author=Westendorp%2CRG&amp;author=Saczynski%2CJS">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="4."><p class="c-article-references__text" id="ref-CR4">Gupta R, Shrinuvasan S. Encephalopathy: a comprehensive case series of five patients with MRI. Insights. 2024. <a href="https://doi.org/10.36106/ijsr/8114421" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.36106/ijsr/8114421">https://doi.org/10.36106/ijsr/8114421</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.36106/ijsr/8114421" data-track-item_id="10.36106/ijsr/8114421" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.36106%2Fijsr%2F8114421" aria-label="Article reference 4" data-doi="10.36106/ijsr/8114421">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 4" href="http://scholar.google.com/scholar_lookup?&amp;title=Encephalopathy%3A%20a%20comprehensive%20case%20series%20of%20five%20patients%20with%20MRI&amp;journal=Insights&amp;doi=10.36106%2Fijsr%2F8114421&amp;publication_year=2024&amp;author=Gupta%2CR&amp;author=Shrinuvasan%2CS">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="5."><p class="c-article-references__text" id="ref-CR5">Slooter AJC, Stevens RD. Updated nomenclature of delirium and acute encephalopathy. Springer Sci Media. 2020;33(3):864–864. <a href="https://doi.org/10.1007/s12028-020-01074-3" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1007/s12028-020-01074-3">https://doi.org/10.1007/s12028-020-01074-3</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1007/s12028-020-01074-3" data-track-item_id="10.1007/s12028-020-01074-3" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s12028-020-01074-3" aria-label="Article reference 5" data-doi="10.1007/s12028-020-01074-3">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 5" href="http://scholar.google.com/scholar_lookup?&amp;title=Updated%20nomenclature%20of%20delirium%20and%20acute%20encephalopathy&amp;journal=Springer%20Sci%20Media&amp;doi=10.1007%2Fs12028-020-01074-3&amp;volume=33&amp;issue=3&amp;pages=864-864&amp;publication_year=2020&amp;author=Slooter%2CAJC&amp;author=Stevens%2CRD">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="6."><p class="c-article-references__text" id="ref-CR6">Denk A, et al. Liver diseases as a novel risk factor for delirium in the ICU–delirium and hepatic encephalopathy are two distinct entities. Publ Libr Sci. 2022. <a href="https://doi.org/10.1371/journal.pone.0276914" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1371/journal.pone.0276914">https://doi.org/10.1371/journal.pone.0276914</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1371/journal.pone.0276914" data-track-item_id="10.1371/journal.pone.0276914" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1371%2Fjournal.pone.0276914" aria-label="Article reference 6" data-doi="10.1371/journal.pone.0276914">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 6" href="http://scholar.google.com/scholar_lookup?&amp;title=Liver%20diseases%20as%20a%20novel%20risk%20factor%20for%20delirium%20in%20the%20ICU%E2%80%93delirium%20and%20hepatic%20encephalopathy%20are%20two%20distinct%20entities&amp;journal=Publ%20Libr%20Sci&amp;doi=10.1371%2Fjournal.pone.0276914&amp;publication_year=2022&amp;author=Denk%2CA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="7."><p class="c-article-references__text" id="ref-CR7">Dunne C, Dunne SS. Casting light on the links between delirium, infection, and dementia risk. Amsterdam: Elsevier; 2024.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S2666-7568(24)00003-5" data-track-item_id="10.1016/S2666-7568(24)00003-5" data-track-value="book reference" data-track-action="book reference" href="https://doi.org/10.1016%2FS2666-7568%2824%2900003-5" aria-label="Book reference 7" data-doi="10.1016/S2666-7568(24)00003-5">Book</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 7" href="http://scholar.google.com/scholar_lookup?&amp;title=Casting%20light%20on%20the%20links%20between%20delirium%2C%20infection%2C%20and%20dementia%20risk&amp;doi=10.1016%2FS2666-7568%2824%2900003-5&amp;publication_year=2024&amp;author=Dunne%2CC&amp;author=Dunne%2CSS">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="8."><p class="c-article-references__text" id="ref-CR8">Sfera A, Osorio C, Price A, Gradini R, Cummings MA. Delirium from the gliocentric perspective. Front Media. 2015;9:171–171. <a href="https://doi.org/10.3389/fncel.2015.00171" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3389/fncel.2015.00171">https://doi.org/10.3389/fncel.2015.00171</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.3389/fncel.2015.00171" data-track-item_id="10.3389/fncel.2015.00171" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3389%2Ffncel.2015.00171" aria-label="Article reference 8" data-doi="10.3389/fncel.2015.00171">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXlsVOqsb0%3D" aria-label="CAS reference 8">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 8" href="http://scholar.google.com/scholar_lookup?&amp;title=Delirium%20from%20the%20gliocentric%20perspective&amp;journal=Front%20Media&amp;doi=10.3389%2Ffncel.2015.00171&amp;volume=9&amp;pages=171-171&amp;publication_year=2015&amp;author=Sfera%2CA&amp;author=Osorio%2CC&amp;author=Price%2CA&amp;author=Gradini%2CR&amp;author=Cummings%2CMA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="9."><p class="c-article-references__text" id="ref-CR9">Neufeld KJ, et al. Outcomes of early delirium diagnosis after general anesthesia in the elderly. Lippincott Williams Wilkins. 2013;117(2):471–8. <a href="https://doi.org/10.1213/ane.0b013e3182973650" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1213/ane.0b013e3182973650">https://doi.org/10.1213/ane.0b013e3182973650</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1213/ane.0b013e3182973650" data-track-item_id="10.1213/ane.0b013e3182973650" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1213%2Fane.0b013e3182973650" aria-label="Article reference 9" data-doi="10.1213/ane.0b013e3182973650">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXhtFyjs77L" aria-label="CAS reference 9">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 9" href="http://scholar.google.com/scholar_lookup?&amp;title=Outcomes%20of%20early%20delirium%20diagnosis%20after%20general%20anesthesia%20in%20the%20elderly&amp;journal=Lippincott%20Williams%20Wilkins&amp;doi=10.1213%2Fane.0b013e3182973650&amp;volume=117&amp;issue=2&amp;pages=471-478&amp;publication_year=2013&amp;author=Neufeld%2CKJ">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="10."><p class="c-article-references__text" id="ref-CR10">M. E. Wilcox, N. E. Brummel, K. Archer, E. W. Ely, J. C. Jackson, and R. O. Hopkins, “Cognitive Dysfunction in ICU Patients: Risk Factors, Predictors, and Rehabilitation Interventions.” United States: by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins, Sep. 2013. <a href="https://journals.lww.com/ccmjournal/abstract/2013/09001/cognitive_dysfunction_in_icu_patients__risk.8.aspx" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://journals.lww.com/ccmjournal/abstract/2013/09001/cognitive_dysfunction_in_icu_patients__risk.8.aspx">https://journals.lww.com/ccmjournal/abstract/2013/09001/cognitive_dysfunction_in_icu_patients__risk.8.aspx</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="11."><p class="c-article-references__text" id="ref-CR11">Israni J, Lesser A, Kent T, Ko KJ. Delirium as a predictor of mortality in US medicare beneficiaries discharged from the emergency department: a national claims-level analysis up to 12 months. BMJ. 2018. <a href="https://doi.org/10.1136/bmjopen-2017-021258" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1136/bmjopen-2017-021258">https://doi.org/10.1136/bmjopen-2017-021258</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1136/bmjopen-2017-021258" data-track-item_id="10.1136/bmjopen-2017-021258" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1136%2Fbmjopen-2017-021258" aria-label="Article reference 11" data-doi="10.1136/bmjopen-2017-021258">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 11" href="http://scholar.google.com/scholar_lookup?&amp;title=Delirium%20as%20a%20predictor%20of%20mortality%20in%20US%20medicare%20beneficiaries%20discharged%20from%20the%20emergency%20department%3A%20a%20national%20claims-level%20analysis%20up%20to%2012%20months&amp;journal=BMJ&amp;doi=10.1136%2Fbmjopen-2017-021258&amp;publication_year=2018&amp;author=Israni%2CJ&amp;author=Lesser%2CA&amp;author=Kent%2CT&amp;author=Ko%2CKJ">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="12."><p class="c-article-references__text" id="ref-CR12">Kosar CM, Thomas KS, Inouye SK, Mor V. Delirium during postacute nursing home admission and risk for adverse outcomes. Wiley. 2017;65(7):1470–5. <a href="https://doi.org/10.1111/jgs.14823" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1111/jgs.14823">https://doi.org/10.1111/jgs.14823</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/jgs.14823" data-track-item_id="10.1111/jgs.14823" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Fjgs.14823" aria-label="Article reference 12" data-doi="10.1111/jgs.14823">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 12" href="http://scholar.google.com/scholar_lookup?&amp;title=Delirium%20during%20postacute%20nursing%20home%20admission%20and%20risk%20for%20adverse%20outcomes&amp;journal=Wiley&amp;doi=10.1111%2Fjgs.14823&amp;volume=65&amp;issue=7&amp;pages=1470-1475&amp;publication_year=2017&amp;author=Kosar%2CCM&amp;author=Thomas%2CKS&amp;author=Inouye%2CSK&amp;author=Mor%2CV">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="13."><p class="c-article-references__text" id="ref-CR13">Frontera J. Metabolic encephalopathies in the critical care unit. Lippincott Williams &amp; Wilkins. 2012;18:611–39. <a href="https://doi.org/10.1212/01.con.0000415431.07019.c2" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1212/01.con.0000415431.07019.c2">https://doi.org/10.1212/01.con.0000415431.07019.c2</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1212/01.con.0000415431.07019.c2" data-track-item_id="10.1212/01.con.0000415431.07019.c2" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1212%2F01.con.0000415431.07019.c2" aria-label="Article reference 13" data-doi="10.1212/01.con.0000415431.07019.c2">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 13" href="http://scholar.google.com/scholar_lookup?&amp;title=Metabolic%20encephalopathies%20in%20the%20critical%20care%20unit&amp;journal=Lippincott%20Williams%20%26%20Wilkins&amp;doi=10.1212%2F01.con.0000415431.07019.c2&amp;volume=18&amp;pages=611-639&amp;publication_year=2012&amp;author=Frontera%2CJ">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="14."><p class="c-article-references__text" id="ref-CR14">Nicholson TR, Henderson M. Management of delirium. MA Healthc. 2009;70(4):217–21. <a href="https://doi.org/10.12968/hmed.2009.70.4.41625" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.12968/hmed.2009.70.4.41625">https://doi.org/10.12968/hmed.2009.70.4.41625</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.12968/hmed.2009.70.4.41625" data-track-item_id="10.12968/hmed.2009.70.4.41625" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.12968%2Fhmed.2009.70.4.41625" aria-label="Article reference 14" data-doi="10.12968/hmed.2009.70.4.41625">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 14" href="http://scholar.google.com/scholar_lookup?&amp;title=Management%20of%20delirium&amp;journal=MA%20Healthc&amp;doi=10.12968%2Fhmed.2009.70.4.41625&amp;volume=70&amp;issue=4&amp;pages=217-221&amp;publication_year=2009&amp;author=Nicholson%2CTR&amp;author=Henderson%2CM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="15."><p class="c-article-references__text" id="ref-CR15">M. Cascella, M. Fiore, S. Leone, D. Carbone, and R. D. Napoli. Current controversies and future perspectives on treatment of intensive care unit delirium in adults,” vol. 8, no. 3. pp. 18–27, Jun. 2019. <a href="https://doi.org/10.5492/wjccm.v8.i3.18" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.5492/wjccm.v8.i3.18">https://doi.org/10.5492/wjccm.v8.i3.18</a>.</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="16."><p class="c-article-references__text" id="ref-CR16">Romano AD, Villani R, Sangineto M, Cassano T, Serviddio G. The GLP-1 receptor agonist exendin-4 modulates hippocampal NMDA-receptor signaling in aged rats and improves cognitive impairment in diabetic elderly patients. J Gerontol Geriatr. 2022;70(2):1–7. <a href="https://doi.org/10.36150/2499-6564-N474" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.36150/2499-6564-N474">https://doi.org/10.36150/2499-6564-N474</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.36150/2499-6564-N474" data-track-item_id="10.36150/2499-6564-N474" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.36150%2F2499-6564-N474" aria-label="Article reference 16" data-doi="10.36150/2499-6564-N474">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 16" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20GLP-1%20receptor%20agonist%20exendin-4%20modulates%20hippocampal%20NMDA-receptor%20signaling%20in%20aged%20rats%20and%20improves%20cognitive%20impairment%20in%20diabetic%20elderly%20patients&amp;journal=J%20Gerontol%20Geriatr&amp;doi=10.36150%2F2499-6564-N474&amp;volume=70&amp;issue=2&amp;pages=1-7&amp;publication_year=2022&amp;author=Romano%2CAD&amp;author=Villani%2CR&amp;author=Sangineto%2CM&amp;author=Cassano%2CT&amp;author=Serviddio%2CG">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="17."><p class="c-article-references__text" id="ref-CR17">Mehan S, Bhalla S, Siddiqui EM, Sharma N, Shandilya A, Khan A. Potential roles of glucagon-like peptide-1 and its analogues in dementia targeting impaired insulin secretion and neurodegeneration. Dove Med Press. 2022;12:31–59. <a href="https://doi.org/10.2147/dnnd.s247153" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.2147/dnnd.s247153">https://doi.org/10.2147/dnnd.s247153</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.2147/dnnd.s247153" data-track-item_id="10.2147/dnnd.s247153" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.2147%2Fdnnd.s247153" aria-label="Article reference 17" data-doi="10.2147/dnnd.s247153">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38Xps1yqur0%3D" aria-label="CAS reference 17">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 17" href="http://scholar.google.com/scholar_lookup?&amp;title=Potential%20roles%20of%20glucagon-like%20peptide-1%20and%20its%20analogues%20in%20dementia%20targeting%20impaired%20insulin%20secretion%20and%20neurodegeneration&amp;journal=Dove%20Med%20Press&amp;doi=10.2147%2Fdnnd.s247153&amp;volume=12&amp;pages=31-59&amp;publication_year=2022&amp;author=Mehan%2CS&amp;author=Bhalla%2CS&amp;author=Siddiqui%2CEM&amp;author=Sharma%2CN&amp;author=Shandilya%2CA&amp;author=Khan%2CA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="18."><p class="c-article-references__text" id="ref-CR18">Salcedo I, Tweedie D, Li Y, Greig NH. Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders. Wiley. 2012;166(5):1586–99. <a href="https://doi.org/10.1111/j.1476-5381.2012.01971.x" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1111/j.1476-5381.2012.01971.x">https://doi.org/10.1111/j.1476-5381.2012.01971.x</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/j.1476-5381.2012.01971.x" data-track-item_id="10.1111/j.1476-5381.2012.01971.x" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Fj.1476-5381.2012.01971.x" aria-label="Article reference 18" data-doi="10.1111/j.1476-5381.2012.01971.x">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC38XhtVOku7rN" aria-label="CAS reference 18">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 18" href="http://scholar.google.com/scholar_lookup?&amp;title=Neuroprotective%20and%20neurotrophic%20actions%20of%20glucagon-like%20peptide-1%3A%20an%20emerging%20opportunity%20to%20treat%20neurodegenerative%20and%20cerebrovascular%20disorders&amp;journal=Wiley&amp;doi=10.1111%2Fj.1476-5381.2012.01971.x&amp;volume=166&amp;issue=5&amp;pages=1586-1599&amp;publication_year=2012&amp;author=Salcedo%2CI&amp;author=Tweedie%2CD&amp;author=Li%2CY&amp;author=Greig%2CNH">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="19."><p class="c-article-references__text" id="ref-CR19">Zaky DA, Abdallah DM, El-Abhar HS. Intranasal exendin-4 modifies necroptosis-mediated innate immune response to combat septic encephalopathy in rats: role of mTORC1 in immunogenic and tolerogenic cell demise. Eur J Pharmacol. 2023;961: 176191. <a href="https://doi.org/10.1016/j.ejphar.2023.176191" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/j.ejphar.2023.176191">https://doi.org/10.1016/j.ejphar.2023.176191</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.ejphar.2023.176191" data-track-item_id="10.1016/j.ejphar.2023.176191" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.ejphar.2023.176191" aria-label="Article reference 19" data-doi="10.1016/j.ejphar.2023.176191">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXitlyiurnK" aria-label="CAS reference 19">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=37967645" aria-label="PubMed reference 19">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 19" href="http://scholar.google.com/scholar_lookup?&amp;title=Intranasal%20exendin-4%20modifies%20necroptosis-mediated%20innate%20immune%20response%20to%20combat%20septic%20encephalopathy%20in%20rats%3A%20role%20of%20mTORC1%20in%20immunogenic%20and%20tolerogenic%20cell%20demise&amp;journal=Eur%20J%20Pharmacol&amp;doi=10.1016%2Fj.ejphar.2023.176191&amp;volume=961&amp;publication_year=2023&amp;author=Zaky%2CDA&amp;author=Abdallah%2CDM&amp;author=El-Abhar%2CHS">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="20."><p class="c-article-references__text" id="ref-CR20">j. p. h. wilding@liverpool. ac. uk B. Emily Brown Daniel J. Cuthbertson, John P. Wilding, “Newer GLP-1 receptor agonists and obesity-diabetes,” vol. undefined, no. undefined. Feb. 2018. <a href="https://www.sciencedirect.com/science/article/pii/S0196978117303789" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.sciencedirect.com/science/article/pii/S0196978117303789">https://www.sciencedirect.com/science/article/pii/S0196978117303789</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="21."><p class="c-article-references__text" id="ref-CR21">K. Tran et al. Overview of Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Patients with Type 2 Diabetes. s10, no. 4, pp. 178–188, Jun. 2017.</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="22."><p class="c-article-references__text" id="ref-CR22">S. L. D. Y. L. Lee. Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes. Korea (South): The Korean Society of Pediatric Endocrinology. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401818/" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401818/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401818/</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="23."><p class="c-article-references__text" id="ref-CR23">Ryan DH, Acosta A. GLP-1 receptor agonists: nonglycemic clinical effects in weight loss and beyond. Wiley. 2015;23(6):1119–29. <a href="https://doi.org/10.1002/oby.21107" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1002/oby.21107">https://doi.org/10.1002/oby.21107</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/oby.21107" data-track-item_id="10.1002/oby.21107" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Foby.21107" aria-label="Article reference 23" data-doi="10.1002/oby.21107">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXpt1WrsLg%3D" aria-label="CAS reference 23">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 23" href="http://scholar.google.com/scholar_lookup?&amp;title=GLP-1%20receptor%20agonists%3A%20nonglycemic%20clinical%20effects%20in%20weight%20loss%20and%20beyond&amp;journal=Wiley&amp;doi=10.1002%2Foby.21107&amp;volume=23&amp;issue=6&amp;pages=1119-1129&amp;publication_year=2015&amp;author=Ryan%2CDH&amp;author=Acosta%2CA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="24."><p class="c-article-references__text" id="ref-CR24">Buse JB, Henry RR, Han J, Kim DDH, Fineman M, Baron A. Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes. Am Diabetes Assoc. 2004;27(11):2628–35. <a href="https://doi.org/10.2337/diacare.27.11.2628" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.2337/diacare.27.11.2628">https://doi.org/10.2337/diacare.27.11.2628</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.2337/diacare.27.11.2628" data-track-item_id="10.2337/diacare.27.11.2628" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.2337%2Fdiacare.27.11.2628" aria-label="Article reference 24" data-doi="10.2337/diacare.27.11.2628">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2cXhtVKis7zO" aria-label="CAS reference 24">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 24" href="http://scholar.google.com/scholar_lookup?&amp;title=Effects%20of%20exenatide%20%28exendin-4%29%20on%20glycemic%20control%20over%2030%20weeks%20in%20sulfonylurea-treated%20patients%20with%20type%202%20diabetes&amp;journal=Am%20Diabetes%20Assoc&amp;doi=10.2337%2Fdiacare.27.11.2628&amp;volume=27&amp;issue=11&amp;pages=2628-2635&amp;publication_year=2004&amp;author=Buse%2CJB&amp;author=Henry%2CRR&amp;author=Han%2CJ&amp;author=Kim%2CDDH&amp;author=Fineman%2CM&amp;author=Baron%2CA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="25."><p class="c-article-references__text" id="ref-CR25">H. W. Rodbard. 2018. The Clinical Impact of GLP 1 Receptor Agonists in Type 2 Diabetes Focus on the Long Acting Analogs. Mary Ann Liebert Inc. <a href="https://doi.org/10.1089/dia.2018.0103" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1089/dia.2018.0103">https://doi.org/10.1089/dia.2018.0103</a>.</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="26."><p class="c-article-references__text" id="ref-CR26">Trujillo JM, Nuffer W, Ellis SL. GLP-1 receptor agonists: a review of head-to-head clinical studies. SAGE Publ. 2014;6(1):19–28. <a href="https://doi.org/10.1177/2042018814559725" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1177/2042018814559725">https://doi.org/10.1177/2042018814559725</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1177/2042018814559725" data-track-item_id="10.1177/2042018814559725" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1177%2F2042018814559725" aria-label="Article reference 26" data-doi="10.1177/2042018814559725">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXjt1Git7w%3D" aria-label="CAS reference 26">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 26" href="http://scholar.google.com/scholar_lookup?&amp;title=GLP-1%20receptor%20agonists%3A%20a%20review%20of%20head-to-head%20clinical%20studies&amp;journal=SAGE%20Publ&amp;doi=10.1177%2F2042018814559725&amp;volume=6&amp;issue=1&amp;pages=19-28&amp;publication_year=2014&amp;author=Trujillo%2CJM&amp;author=Nuffer%2CW&amp;author=Ellis%2CSL">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="27."><p class="c-article-references__text" id="ref-CR27">Oldham MA, Holloway RG. Delirium disorder: integrating delirium and acute encephalopathy. Neurology. 2020;95(4):173–8. <a href="https://doi.org/10.1212/WNL.0000000000009949" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1212/WNL.0000000000009949">https://doi.org/10.1212/WNL.0000000000009949</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1212/WNL.0000000000009949" data-track-item_id="10.1212/WNL.0000000000009949" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1212%2FWNL.0000000000009949" aria-label="Article reference 27" data-doi="10.1212/WNL.0000000000009949">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=32518149" aria-label="PubMed reference 27">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 27" href="http://scholar.google.com/scholar_lookup?&amp;title=Delirium%20disorder%3A%20integrating%20delirium%20and%20acute%20encephalopathy&amp;journal=Neurology&amp;doi=10.1212%2FWNL.0000000000009949&amp;volume=95&amp;issue=4&amp;pages=173-178&amp;publication_year=2020&amp;author=Oldham%2CMA&amp;author=Holloway%2CRG">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="28."><p class="c-article-references__text" id="ref-CR28">Theuerkauf N, Guenther U, Putensen C. Postoperative delirium in the PACU and intensive care unit. Elsevier BV. 2012;2(4):148–55. <a href="https://doi.org/10.1016/j.tacc.2012.03.002" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/j.tacc.2012.03.002">https://doi.org/10.1016/j.tacc.2012.03.002</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.tacc.2012.03.002" data-track-item_id="10.1016/j.tacc.2012.03.002" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.tacc.2012.03.002" aria-label="Article reference 28" data-doi="10.1016/j.tacc.2012.03.002">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 28" href="http://scholar.google.com/scholar_lookup?&amp;title=Postoperative%20delirium%20in%20the%20PACU%20and%20intensive%20care%20unit&amp;journal=Elsevier%20BV&amp;doi=10.1016%2Fj.tacc.2012.03.002&amp;volume=2&amp;issue=4&amp;pages=148-155&amp;publication_year=2012&amp;author=Theuerkauf%2CN&amp;author=Guenther%2CU&amp;author=Putensen%2CC">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="29."><p class="c-article-references__text" id="ref-CR29">T. Fong, S. Tulebaev, and S. Inouye. Delirium in elderly adults: diagnosis, prevention and treatment. 2009. <a href="https://doi.org/10.1038/nrneurol.2009.24" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1038/nrneurol.2009.24">https://doi.org/10.1038/nrneurol.2009.24</a>.</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="30."><p class="c-article-references__text" id="ref-CR30">Laurindo LF, Barbalho SM, Guiguer EL. GLP-1a: going beyond traditional use. Switzerland AGInter J Mol Sci. 2022. <a href="https://doi.org/10.3390/ijms23020739" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3390/ijms23020739">https://doi.org/10.3390/ijms23020739</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.3390/ijms23020739" data-track-item_id="10.3390/ijms23020739" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3390%2Fijms23020739" aria-label="Article reference 30" data-doi="10.3390/ijms23020739">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 30" href="http://scholar.google.com/scholar_lookup?&amp;title=GLP-1a%3A%20going%20beyond%20traditional%20use&amp;journal=Switzerland%20AGInter%20J%20Mol%20Sci&amp;doi=10.3390%2Fijms23020739&amp;publication_year=2022&amp;author=Laurindo%2CLF&amp;author=Barbalho%2CSM&amp;author=Guiguer%2CEL">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="31."><p class="c-article-references__text" id="ref-CR31">Jia M, Lv X, Zhu T, Shen J-C, Liu W-X, Yang J-J. Liraglutide ameliorates delirium-like behaviors of aged mice undergoing cardiac surgery by mitigating microglia activation via promoting mitophagy. Psychopharmacology. 2024;241(4):687–98. <a href="https://doi.org/10.1007/s00213-023-06492-7" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1007/s00213-023-06492-7">https://doi.org/10.1007/s00213-023-06492-7</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1007/s00213-023-06492-7" data-track-item_id="10.1007/s00213-023-06492-7" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s00213-023-06492-7" aria-label="Article reference 31" data-doi="10.1007/s00213-023-06492-7">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXisVCgsL%2FM" aria-label="CAS reference 31">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=37968531" aria-label="PubMed reference 31">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 31" href="http://scholar.google.com/scholar_lookup?&amp;title=Liraglutide%20ameliorates%20delirium-like%20behaviors%20of%20aged%20mice%20undergoing%20cardiac%20surgery%20by%20mitigating%20microglia%20activation%20via%20promoting%20mitophagy&amp;journal=Psychopharmacology&amp;doi=10.1007%2Fs00213-023-06492-7&amp;volume=241&amp;issue=4&amp;pages=687-698&amp;publication_year=2024&amp;author=Jia%2CM&amp;author=Lv%2CX&amp;author=Zhu%2CT&amp;author=Shen%2CJ-C&amp;author=Liu%2CW-X&amp;author=Yang%2CJ-J">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="32."><p class="c-article-references__text" id="ref-CR32">Liu W, Wang Z, Wang W, Wang Z, Xing Y, Hölscher C. Liraglutide reduces alcohol consumption, anxiety, memory impairment, and synapse loss in alcohol dependent mice. Neurochem Res. 2024;49(4):1061–75. <a href="https://doi.org/10.1007/s11064-023-04093-6" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1007/s11064-023-04093-6">https://doi.org/10.1007/s11064-023-04093-6</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1007/s11064-023-04093-6" data-track-item_id="10.1007/s11064-023-04093-6" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s11064-023-04093-6" aria-label="Article reference 32" data-doi="10.1007/s11064-023-04093-6">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXhvF2qtLk%3D" aria-label="CAS reference 32">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=38267691" aria-label="PubMed reference 32">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 32" href="http://scholar.google.com/scholar_lookup?&amp;title=Liraglutide%20reduces%20alcohol%20consumption%2C%20anxiety%2C%20memory%20impairment%2C%20and%20synapse%20loss%20in%20alcohol%20dependent%20mice&amp;journal=Neurochem%20Res&amp;doi=10.1007%2Fs11064-023-04093-6&amp;volume=49&amp;issue=4&amp;pages=1061-1075&amp;publication_year=2024&amp;author=Liu%2CW&amp;author=Wang%2CZ&amp;author=Wang%2CW&amp;author=Wang%2CZ&amp;author=Xing%2CY&amp;author=H%C3%B6lscher%2CC">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="33."><p class="c-article-references__text" id="ref-CR33">Xiong H, et al. The neuroprotection of liraglutide on Alzheimer-like learning and memory impairment by modulating the hyperphosphorylation of tau and neurofilament proteins and insulin signaling pathways in mice. IOS Press. 2013;37(3):623–35. <a href="https://doi.org/10.3233/jad-130584" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3233/jad-130584">https://doi.org/10.3233/jad-130584</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.3233/jad-130584" data-track-item_id="10.3233/jad-130584" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3233%2Fjad-130584" aria-label="Article reference 33" data-doi="10.3233/jad-130584">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 33" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20neuroprotection%20of%20liraglutide%20on%20Alzheimer-like%20learning%20and%20memory%20impairment%20by%20modulating%20the%20hyperphosphorylation%20of%20tau%20and%20neurofilament%20proteins%20and%20insulin%20signaling%20pathways%20in%20mice&amp;journal=IOS%20Press&amp;doi=10.3233%2Fjad-130584&amp;volume=37&amp;issue=3&amp;pages=623-635&amp;publication_year=2013&amp;author=Xiong%2CH">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="34."><p class="c-article-references__text" id="ref-CR34">Zhang J, et al. Liraglutide nano-preparation on perioperative neurocognitive dysfunction in aged mice. Cell Mol Biol. 2022;68(3):356–64. <a href="https://doi.org/10.14715/cmb/2022.68.3.39" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.14715/cmb/2022.68.3.39">https://doi.org/10.14715/cmb/2022.68.3.39</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.14715/cmb/2022.68.3.39" data-track-item_id="10.14715/cmb/2022.68.3.39" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.14715%2Fcmb%2F2022.68.3.39" aria-label="Article reference 34" data-doi="10.14715/cmb/2022.68.3.39">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35988182" aria-label="PubMed reference 34">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 34" href="http://scholar.google.com/scholar_lookup?&amp;title=Liraglutide%20nano-preparation%20on%20perioperative%20neurocognitive%20dysfunction%20in%20aged%20mice&amp;journal=Cell%20Mol%20Biol&amp;doi=10.14715%2Fcmb%2F2022.68.3.39&amp;volume=68&amp;issue=3&amp;pages=356-364&amp;publication_year=2022&amp;author=Zhang%2CJ">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="35."><p class="c-article-references__text" id="ref-CR35">Androsova G, Krause R, Winterer G, Schneider R. Biomarkers of postoperative delirium and cognitive dysfunction. Front Aging Neurosci. 2015. <a href="https://doi.org/10.3389/fnagi.2015.00112" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3389/fnagi.2015.00112">https://doi.org/10.3389/fnagi.2015.00112</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.3389/fnagi.2015.00112" data-track-item_id="10.3389/fnagi.2015.00112" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3389%2Ffnagi.2015.00112" aria-label="Article reference 35" data-doi="10.3389/fnagi.2015.00112">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4460425" aria-label="PubMed Central reference 35">PubMed Central</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 35" href="http://scholar.google.com/scholar_lookup?&amp;title=Biomarkers%20of%20postoperative%20delirium%20and%20cognitive%20dysfunction&amp;journal=Front%20Aging%20Neurosci&amp;doi=10.3389%2Ffnagi.2015.00112&amp;publication_year=2015&amp;author=Androsova%2CG&amp;author=Krause%2CR&amp;author=Winterer%2CG&amp;author=Schneider%2CR">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="36."><p class="c-article-references__text" id="ref-CR36">Lagonigro E, Pansini A, Mone P, Guerra G, Komici K, Fantini C. The role of stress hyperglycemia on delirium onset. J Clin Med. 2025;14(2):407. <a href="https://doi.org/10.3390/jcm14020407" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3390/jcm14020407">https://doi.org/10.3390/jcm14020407</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.3390/jcm14020407" data-track-item_id="10.3390/jcm14020407" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3390%2Fjcm14020407" aria-label="Article reference 36" data-doi="10.3390/jcm14020407">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2MXis12htLg%3D" aria-label="CAS reference 36">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=39860413" aria-label="PubMed reference 36">PubMed</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11766312" aria-label="PubMed Central reference 36">PubMed Central</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 36" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20role%20of%20stress%20hyperglycemia%20on%20delirium%20onset&amp;journal=J%20Clin%20Med&amp;doi=10.3390%2Fjcm14020407&amp;volume=14&amp;issue=2&amp;publication_year=2025&amp;author=Lagonigro%2CE&amp;author=Pansini%2CA&amp;author=Mone%2CP&amp;author=Guerra%2CG&amp;author=Komici%2CK&amp;author=Fantini%2CC">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="37."><p class="c-article-references__text" id="ref-CR37">Wolfe RC. Perioperative implications of glucagon-like peptide-1 receptor agonists. J Perianesth Nurs. 2024;39(6):1108–10. <a href="https://doi.org/10.1016/j.jopan.2024.09.022" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/j.jopan.2024.09.022">https://doi.org/10.1016/j.jopan.2024.09.022</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.jopan.2024.09.022" data-track-item_id="10.1016/j.jopan.2024.09.022" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.jopan.2024.09.022" aria-label="Article reference 37" data-doi="10.1016/j.jopan.2024.09.022">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=39617519" aria-label="PubMed reference 37">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 37" href="http://scholar.google.com/scholar_lookup?&amp;title=Perioperative%20implications%20of%20glucagon-like%20peptide-1%20receptor%20agonists&amp;journal=J%20Perianesth%20Nurs&amp;doi=10.1016%2Fj.jopan.2024.09.022&amp;volume=39&amp;issue=6&amp;pages=1108-1110&amp;publication_year=2024&amp;author=Wolfe%2CRC">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="38."><p class="c-article-references__text" id="ref-CR38">A. H. Hulst. Glucose control therapies in the perioperative period. <a href="https://hdl.handle.net/11245.1/9f8b3eed-fbd4-4d84-96aa-593b390f447c" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://hdl.handle.net/11245.1/9f8b3eed-fbd4-4d84-96aa-593b390f447c">https://hdl.handle.net/11245.1/9f8b3eed-fbd4-4d84-96aa-593b390f447c</a></p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="39."><p class="c-article-references__text" id="ref-CR39">Olmo-García MID, et al. Glycemic variability in type 2 diabetes mellitus and acute coronary syndrome: liraglutide compared with insulin glargine: a pilot study. SAGE Publ. 2020. <a href="https://doi.org/10.1177/0300060520926063" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1177/0300060520926063">https://doi.org/10.1177/0300060520926063</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1177/0300060520926063" data-track-item_id="10.1177/0300060520926063" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1177%2F0300060520926063" aria-label="Article reference 39" data-doi="10.1177/0300060520926063">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 39" href="http://scholar.google.com/scholar_lookup?&amp;title=Glycemic%20variability%20in%20type%202%20diabetes%20mellitus%20and%20acute%20coronary%20syndrome%3A%20liraglutide%20compared%20with%20insulin%20glargine%3A%20a%20pilot%20study&amp;journal=SAGE%20Publ&amp;doi=10.1177%2F0300060520926063&amp;publication_year=2020&amp;author=Olmo-Garc%C3%ADa%2CMID">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="40."><p class="c-article-references__text" id="ref-CR40">Pinsky MR. Dysregulation of the immune response in severe sepsis. Elsevier BV. 2004;328(4):220–9. <a href="https://doi.org/10.1097/00000441-200410000-00005" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1097/00000441-200410000-00005">https://doi.org/10.1097/00000441-200410000-00005</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1097/00000441-200410000-00005" data-track-item_id="10.1097/00000441-200410000-00005" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1097%2F00000441-200410000-00005" aria-label="Article reference 40" data-doi="10.1097/00000441-200410000-00005">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 40" href="http://scholar.google.com/scholar_lookup?&amp;title=Dysregulation%20of%20the%20immune%20response%20in%20severe%20sepsis&amp;journal=Elsevier%20BV&amp;doi=10.1097%2F00000441-200410000-00005&amp;volume=328&amp;issue=4&amp;pages=220-229&amp;publication_year=2004&amp;author=Pinsky%2CMR">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="41."><p class="c-article-references__text" id="ref-CR41">Pool R, Gómez H, Kellum JA. Mechanisms of organ dysfunction in sepsis. Elsevier BV. 2017;34(1):63–80. <a href="https://doi.org/10.1016/j.ccc.2017.08.003" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/j.ccc.2017.08.003">https://doi.org/10.1016/j.ccc.2017.08.003</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.ccc.2017.08.003" data-track-item_id="10.1016/j.ccc.2017.08.003" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.ccc.2017.08.003" aria-label="Article reference 41" data-doi="10.1016/j.ccc.2017.08.003">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 41" href="http://scholar.google.com/scholar_lookup?&amp;title=Mechanisms%20of%20organ%20dysfunction%20in%20sepsis&amp;journal=Elsevier%20BV&amp;doi=10.1016%2Fj.ccc.2017.08.003&amp;volume=34&amp;issue=1&amp;pages=63-80&amp;publication_year=2017&amp;author=Pool%2CR&amp;author=G%C3%B3mez%2CH&amp;author=Kellum%2CJA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="42."><p class="c-article-references__text" id="ref-CR42">Sonneville R, et al. The spectrum of sepsis-associated encephalopathy: a clinical perspective. BioMed Central. 2013. <a href="https://doi.org/10.1186/s13054-023-04655-8" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1186/s13054-023-04655-8">https://doi.org/10.1186/s13054-023-04655-8</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1186/s13054-023-04655-8" data-track-item_id="10.1186/s13054-023-04655-8" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s13054-023-04655-8" aria-label="Article reference 42" data-doi="10.1186/s13054-023-04655-8">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 42" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20spectrum%20of%20sepsis-associated%20encephalopathy%3A%20a%20clinical%20perspective&amp;journal=BioMed%20Central&amp;doi=10.1186%2Fs13054-023-04655-8&amp;publication_year=2013&amp;author=Sonneville%2CR">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="43."><p class="c-article-references__text" id="ref-CR43">Piva S, Bertoni M, Gitti N, Rasulo F, Latronico N. Neurological complications of sepsis. Lippincott Williams Wilkins. 2023;29(2):75–84. <a href="https://doi.org/10.1097/mcc.0000000000001022" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1097/mcc.0000000000001022">https://doi.org/10.1097/mcc.0000000000001022</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1097/mcc.0000000000001022" data-track-item_id="10.1097/mcc.0000000000001022" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1097%2Fmcc.0000000000001022" aria-label="Article reference 43" data-doi="10.1097/mcc.0000000000001022">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 43" href="http://scholar.google.com/scholar_lookup?&amp;title=Neurological%20complications%20of%20sepsis&amp;journal=Lippincott%20Williams%20Wilkins&amp;doi=10.1097%2Fmcc.0000000000001022&amp;volume=29&amp;issue=2&amp;pages=75-84&amp;publication_year=2023&amp;author=Piva%2CS&amp;author=Bertoni%2CM&amp;author=Gitti%2CN&amp;author=Rasulo%2CF&amp;author=Latronico%2CN">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="44."><p class="c-article-references__text" id="ref-CR44">Barichello T, et al. Long-term cognitive outcomes after sepsis: a translational systematic review. Mol Neurobiol. 2019;56:186–251.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1007/s12035-018-1048-2" data-track-item_id="10.1007/s12035-018-1048-2" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s12035-018-1048-2" aria-label="Article reference 44" data-doi="10.1007/s12035-018-1048-2">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXotF2gsbs%3D" aria-label="CAS reference 44">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=29687346" aria-label="PubMed reference 44">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 44" href="http://scholar.google.com/scholar_lookup?&amp;title=Long-term%20cognitive%20outcomes%20after%20sepsis%3A%20a%20translational%20systematic%20review&amp;journal=Mol%20Neurobiol&amp;doi=10.1007%2Fs12035-018-1048-2&amp;volume=56&amp;pages=186-251&amp;publication_year=2019&amp;author=Barichello%2CT">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="45."><p class="c-article-references__text" id="ref-CR45">Yang F, et al. GLP-1 receptor: a new target for sepsis. Front Pharmacol. 2021;12: 706908. <a href="https://doi.org/10.3389/fphar.2021.706908" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3389/fphar.2021.706908">https://doi.org/10.3389/fphar.2021.706908</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.3389/fphar.2021.706908" data-track-item_id="10.3389/fphar.2021.706908" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3389%2Ffphar.2021.706908" aria-label="Article reference 45" data-doi="10.3389/fphar.2021.706908">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXit1SntbrE" aria-label="CAS reference 45">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34335269" aria-label="PubMed reference 45">PubMed</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316682" aria-label="PubMed Central reference 45">PubMed Central</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 45" href="http://scholar.google.com/scholar_lookup?&amp;title=GLP-1%20receptor%3A%20a%20new%20target%20for%20sepsis&amp;journal=Front%20Pharmacol&amp;doi=10.3389%2Ffphar.2021.706908&amp;volume=12&amp;publication_year=2021&amp;author=Yang%2CF">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="46."><p class="c-article-references__text" id="ref-CR46">Neves FS, et al. Brain-defective insulin signaling is associated to late cognitive impairment in post-septic mice. Mol Neurobiol. 2018;55(1):435–44. <a href="https://doi.org/10.1007/s12035-016-0307-3" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1007/s12035-016-0307-3">https://doi.org/10.1007/s12035-016-0307-3</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1007/s12035-016-0307-3" data-track-item_id="10.1007/s12035-016-0307-3" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s12035-016-0307-3" aria-label="Article reference 46" data-doi="10.1007/s12035-016-0307-3">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28XitVOjtrzO" aria-label="CAS reference 46">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27966074" aria-label="PubMed reference 46">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 46" href="http://scholar.google.com/scholar_lookup?&amp;title=Brain-defective%20insulin%20signaling%20is%20associated%20to%20late%20cognitive%20impairment%20in%20post-septic%20mice&amp;journal=Mol%20Neurobiol&amp;doi=10.1007%2Fs12035-016-0307-3&amp;volume=55&amp;issue=1&amp;pages=435-444&amp;publication_year=2018&amp;author=Neves%2CFS">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="47."><p class="c-article-references__text" id="ref-CR47">Yi H, et al. Activation of glucagon-like peptide-1 receptor in microglia exerts protective effects against sepsis-induced encephalopathy via attenuating endoplasmic reticulum stress-associated inflammation and apoptosis in a mouse model of sepsis. Exp Neurol. 2023;363: 114348. <a href="https://doi.org/10.1016/j.expneurol.2023.114348" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/j.expneurol.2023.114348">https://doi.org/10.1016/j.expneurol.2023.114348</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.expneurol.2023.114348" data-track-item_id="10.1016/j.expneurol.2023.114348" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.expneurol.2023.114348" aria-label="Article reference 47" data-doi="10.1016/j.expneurol.2023.114348">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXktV2jtb4%3D" aria-label="CAS reference 47">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=36813224" aria-label="PubMed reference 47">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 47" href="http://scholar.google.com/scholar_lookup?&amp;title=Activation%20of%20glucagon-like%20peptide-1%20receptor%20in%20microglia%20exerts%20protective%20effects%20against%20sepsis-induced%20encephalopathy%20via%20attenuating%20endoplasmic%20reticulum%20stress-associated%20inflammation%20and%20apoptosis%20in%20a%20mouse%20model%20of%20sepsis&amp;journal=Exp%20Neurol&amp;doi=10.1016%2Fj.expneurol.2023.114348&amp;volume=363&amp;publication_year=2023&amp;author=Yi%2CH">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="48."><p class="c-article-references__text" id="ref-CR48">Park SW, et al. Liraglutide activates mTORC1 signaling and AMPA receptors in rat hippocampal neurons under toxic conditions. Front Media. 2018. <a href="https://doi.org/10.3389/fnins.2018.00756" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3389/fnins.2018.00756">https://doi.org/10.3389/fnins.2018.00756</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.3389/fnins.2018.00756" data-track-item_id="10.3389/fnins.2018.00756" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3389%2Ffnins.2018.00756" aria-label="Article reference 48" data-doi="10.3389/fnins.2018.00756">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 48" href="http://scholar.google.com/scholar_lookup?&amp;title=Liraglutide%20activates%20mTORC1%20signaling%20and%20AMPA%20receptors%20in%20rat%20hippocampal%20neurons%20under%20toxic%20conditions&amp;journal=Front%20Media&amp;doi=10.3389%2Ffnins.2018.00756&amp;publication_year=2018&amp;author=Park%2CSW">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="49."><p class="c-article-references__text" id="ref-CR49">Garcı́a Arencibia M, Hochfeld WE, Toh PC, Rubinsztein DC. Autophagy, a guardian against neurodegeneration. Amsterdam: Elsevier; 2010.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.semcdb.2010.02.008" data-track-item_id="10.1016/j.semcdb.2010.02.008" data-track-value="book reference" data-track-action="book reference" href="https://doi.org/10.1016%2Fj.semcdb.2010.02.008" aria-label="Book reference 49" data-doi="10.1016/j.semcdb.2010.02.008">Book</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 49" href="http://scholar.google.com/scholar_lookup?&amp;title=Autophagy%2C%20a%20guardian%20against%20neurodegeneration&amp;doi=10.1016%2Fj.semcdb.2010.02.008&amp;publication_year=2010&amp;author=Garc%C4%B1%CC%81a%20Arencibia%2CM&amp;author=Hochfeld%2CWE&amp;author=Toh%2CPC&amp;author=Rubinsztein%2CDC">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="50."><p class="c-article-references__text" id="ref-CR50">Pérez-Monter C, Torre-Delgadillo A. Astrocyte pathophysiology in liver disease. IntechOpen. 2018. <a href="https://doi.org/10.5772/intechopen.72506" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.5772/intechopen.72506">https://doi.org/10.5772/intechopen.72506</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.5772/intechopen.72506" data-track-item_id="10.5772/intechopen.72506" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.5772%2Fintechopen.72506" aria-label="Article reference 50" data-doi="10.5772/intechopen.72506">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 50" href="http://scholar.google.com/scholar_lookup?&amp;title=Astrocyte%20pathophysiology%20in%20liver%20disease&amp;journal=IntechOpen&amp;doi=10.5772%2Fintechopen.72506&amp;publication_year=2018&amp;author=P%C3%A9rez-Monter%2CC&amp;author=Torre-Delgadillo%2CA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="51."><p class="c-article-references__text" id="ref-CR51">Swaminathan M, Ellul M, Cross T. Hepatic encephalopathy: current challenges and future prospects. Dove Med Press. 2018. <a href="https://doi.org/10.2147/hmer.s118964" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.2147/hmer.s118964">https://doi.org/10.2147/hmer.s118964</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.2147/hmer.s118964" data-track-item_id="10.2147/hmer.s118964" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.2147%2Fhmer.s118964" aria-label="Article reference 51" data-doi="10.2147/hmer.s118964">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 51" href="http://scholar.google.com/scholar_lookup?&amp;title=Hepatic%20encephalopathy%3A%20current%20challenges%20and%20future%20prospects&amp;journal=Dove%20Med%20Press&amp;doi=10.2147%2Fhmer.s118964&amp;publication_year=2018&amp;author=Swaminathan%2CM&amp;author=Ellul%2CM&amp;author=Cross%2CT">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="52."><p class="c-article-references__text" id="ref-CR52">S. Elwir and R. S. Rahimi. Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options. pp. 1–10, May 2017. <a href="https://doi.org/10.14218/jcth.2016.00069" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.14218/jcth.2016.00069">https://doi.org/10.14218/jcth.2016.00069</a>.</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="53."><p class="c-article-references__text" id="ref-CR53">Amodio P. Hepatic encephalopathy: diagnosis and management. Wiley. 2018;38(6):966–75. <a href="https://doi.org/10.1111/liv.13752" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1111/liv.13752">https://doi.org/10.1111/liv.13752</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/liv.13752" data-track-item_id="10.1111/liv.13752" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Fliv.13752" aria-label="Article reference 53" data-doi="10.1111/liv.13752">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 53" href="http://scholar.google.com/scholar_lookup?&amp;title=Hepatic%20encephalopathy%3A%20diagnosis%20and%20management&amp;journal=Wiley&amp;doi=10.1111%2Fliv.13752&amp;volume=38&amp;issue=6&amp;pages=966-975&amp;publication_year=2018&amp;author=Amodio%2CP">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="54."><p class="c-article-references__text" id="ref-CR54">Montagnese S, Bajaj JS. Impact of hepatic encephalopathy in cirrhosis on quality-of-life issues. Adis Springer Healthcare. 2019;79:11–6. <a href="https://doi.org/10.1007/s40265-018-1019-y" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1007/s40265-018-1019-y">https://doi.org/10.1007/s40265-018-1019-y</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1007/s40265-018-1019-y" data-track-item_id="10.1007/s40265-018-1019-y" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s40265-018-1019-y" aria-label="Article reference 54" data-doi="10.1007/s40265-018-1019-y">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 54" href="http://scholar.google.com/scholar_lookup?&amp;title=Impact%20of%20hepatic%20encephalopathy%20in%20cirrhosis%20on%20quality-of-life%20issues&amp;journal=Adis%20Springer%20Healthcare&amp;doi=10.1007%2Fs40265-018-1019-y&amp;volume=79&amp;pages=11-16&amp;publication_year=2019&amp;author=Montagnese%2CS&amp;author=Bajaj%2CJS">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="55."><p class="c-article-references__text" id="ref-CR55">Kjærgaard K, et al. Semaglutide reduces cognitive dysfunction in experimental non-alcoholic steatohepatitis through anti-inflammatory and neuroprotective effects. Am J Gastroenterol. 2023;118(9):S28–9. <a href="https://doi.org/10.14309/01.ajg.0000948452.01988.0c" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.14309/01.ajg.0000948452.01988.0c">https://doi.org/10.14309/01.ajg.0000948452.01988.0c</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.14309/01.ajg.0000948452.01988.0c" data-track-item_id="10.14309/01.ajg.0000948452.01988.0c" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.14309%2F01.ajg.0000948452.01988.0c" aria-label="Article reference 55" data-doi="10.14309/01.ajg.0000948452.01988.0c">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 55" href="http://scholar.google.com/scholar_lookup?&amp;title=Semaglutide%20reduces%20cognitive%20dysfunction%20in%20experimental%20non-alcoholic%20steatohepatitis%20through%20anti-inflammatory%20and%20neuroprotective%20effects&amp;journal=Am%20J%20Gastroenterol&amp;doi=10.14309%2F01.ajg.0000948452.01988.0c&amp;volume=118&amp;issue=9&amp;pages=S28-S29&amp;publication_year=2023&amp;author=Kj%C3%A6rgaard%2CK">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="56."><p class="c-article-references__text" id="ref-CR56">Elsaid MI, et al. Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease cirrhosis and type 2 diabetes. Aliment Pharmacol Ther. 2024;59(9):1096–110. <a href="https://doi.org/10.1111/apt.17925" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1111/apt.17925">https://doi.org/10.1111/apt.17925</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/apt.17925" data-track-item_id="10.1111/apt.17925" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Fapt.17925" aria-label="Article reference 56" data-doi="10.1111/apt.17925">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXnsVaksrs%3D" aria-label="CAS reference 56">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=38538967" aria-label="PubMed reference 56">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 56" href="http://scholar.google.com/scholar_lookup?&amp;title=Impacts%20of%20glucagon-like%20peptide-1%20receptor%20agonists%20on%20the%20risk%20of%20adverse%20liver%20outcomes%20in%20patients%20with%20metabolic%20dysfunction-associated%20steatotic%20liver%20disease%20cirrhosis%20and%20type%202%20diabetes&amp;journal=Aliment%20Pharmacol%20Ther&amp;doi=10.1111%2Fapt.17925&amp;volume=59&amp;issue=9&amp;pages=1096-1110&amp;publication_year=2024&amp;author=Elsaid%2CMI">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="57."><p class="c-article-references__text" id="ref-CR57">Passos PRC, Filho VOC, Noronha MM, Hyppolito EB, Saldanha EF, Motta RV. Influence of glucagon-like peptide-1 receptor agonists on hepatic events in type 2 diabetes: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2024. <a href="https://doi.org/10.1111/jgh.16752" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1111/jgh.16752">https://doi.org/10.1111/jgh.16752</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/jgh.16752" data-track-item_id="10.1111/jgh.16752" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Fjgh.16752" aria-label="Article reference 57" data-doi="10.1111/jgh.16752">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=39322970" aria-label="PubMed reference 57">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 57" href="http://scholar.google.com/scholar_lookup?&amp;title=Influence%20of%20glucagon-like%20peptide-1%20receptor%20agonists%20on%20hepatic%20events%20in%20type%202%20diabetes%3A%20a%20systematic%20review%20and%20meta-analysis&amp;journal=J%20Gastroenterol%20Hepatol&amp;doi=10.1111%2Fjgh.16752&amp;publication_year=2024&amp;author=Passos%2CPRC&amp;author=Filho%2CVOC&amp;author=Noronha%2CMM&amp;author=Hyppolito%2CEB&amp;author=Saldanha%2CEF&amp;author=Motta%2CRV">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="58."><p class="c-article-references__text" id="ref-CR58">Yen F-S, et al. Glucagon-like peptide-1 receptor agonist use in patients with liver cirrhosis and type 2 diabetes. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2024;22(6):1255-1264.e18. <a href="https://doi.org/10.1016/j.cgh.2023.06.004" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/j.cgh.2023.06.004">https://doi.org/10.1016/j.cgh.2023.06.004</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cgh.2023.06.004" data-track-item_id="10.1016/j.cgh.2023.06.004" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cgh.2023.06.004" aria-label="Article reference 58" data-doi="10.1016/j.cgh.2023.06.004">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXhsVCrs73I" aria-label="CAS reference 58">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 58" href="http://scholar.google.com/scholar_lookup?&amp;title=Glucagon-like%20peptide-1%20receptor%20agonist%20use%20in%20patients%20with%20liver%20cirrhosis%20and%20type%202%20diabetes&amp;journal=Clin%20Gastroenterol%20Hepatol%20Off%20Clin%20Pract%20J%20Am%20Gastroenterol%20Assoc&amp;doi=10.1016%2Fj.cgh.2023.06.004&amp;volume=22&amp;issue=6&amp;pages=1255-1264.e18&amp;publication_year=2024&amp;author=Yen%2CF-S">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="59."><p class="c-article-references__text" id="ref-CR59">Simon TG, Patorno E, Schneeweiss S. Glucagon-like peptide-1 receptor agonists and hepatic decompensation events in patients with cirrhosis and diabetes. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2022;20(6):1382-1393.e19. <a href="https://doi.org/10.1016/j.cgh.2021.07.010" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/j.cgh.2021.07.010">https://doi.org/10.1016/j.cgh.2021.07.010</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.cgh.2021.07.010" data-track-item_id="10.1016/j.cgh.2021.07.010" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.cgh.2021.07.010" aria-label="Article reference 59" data-doi="10.1016/j.cgh.2021.07.010">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3MXitlCntrvM" aria-label="CAS reference 59">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 59" href="http://scholar.google.com/scholar_lookup?&amp;title=Glucagon-like%20peptide-1%20receptor%20agonists%20and%20hepatic%20decompensation%20events%20in%20patients%20with%20cirrhosis%20and%20diabetes&amp;journal=Clin%20Gastroenterol%20Hepatol%20Off%20Clin%20Pract%20J%20Am%20Gastroenterol%20Assoc&amp;doi=10.1016%2Fj.cgh.2021.07.010&amp;volume=20&amp;issue=6&amp;pages=1382-1393.e19&amp;publication_year=2022&amp;author=Simon%2CTG&amp;author=Patorno%2CE&amp;author=Schneeweiss%2CS">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="60."><p class="c-article-references__text" id="ref-CR60">Kon K, Arai K, Uchiyama A, Fukada H, Yamashina S, Ikejima K. Glycine prevents steatohepatitis-associated heoatocarcinogenesis in hepatocyte-specific PTEN knockout mice through of lipid pofiles. Gastroenterology. 2024. <a href="https://doi.org/10.1016/S0016-5085(24)04221-5" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/S0016-5085(24)04221-5">https://doi.org/10.1016/S0016-5085(24)04221-5</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/S0016-5085(24)04221-5" data-track-item_id="10.1016/S0016-5085(24)04221-5" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2FS0016-5085%2824%2904221-5" aria-label="Article reference 60" data-doi="10.1016/S0016-5085(24)04221-5">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 60" href="http://scholar.google.com/scholar_lookup?&amp;title=Glycine%20prevents%20steatohepatitis-associated%20heoatocarcinogenesis%20in%20hepatocyte-specific%20PTEN%20knockout%20mice%20through%20of%20lipid%20pofiles&amp;journal=Gastroenterology&amp;doi=10.1016%2FS0016-5085%2824%2904221-5&amp;publication_year=2024&amp;author=Kon%2CK&amp;author=Arai%2CK&amp;author=Uchiyama%2CA&amp;author=Fukada%2CH&amp;author=Yamashina%2CS&amp;author=Ikejima%2CK">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="61."><p class="c-article-references__text" id="ref-CR61">Kutz A, Wexler DJ, Liu J, Paik JM, Patorno E. Association of GLP-1 receptor agonists and SGLT-2 inhibitors with major adverse cardiovascular events and serious liver events among patients with type 2. J Endocr. 2024. <a href="https://doi.org/10.1210/jendso/bvae163.555" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1210/jendso/bvae163.555">https://doi.org/10.1210/jendso/bvae163.555</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1210/jendso/bvae163.555" data-track-item_id="10.1210/jendso/bvae163.555" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1210%2Fjendso%2Fbvae163.555" aria-label="Article reference 61" data-doi="10.1210/jendso/bvae163.555">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 61" href="http://scholar.google.com/scholar_lookup?&amp;title=Association%20of%20GLP-1%20receptor%20agonists%20and%20SGLT-2%20inhibitors%20with%20major%20adverse%20cardiovascular%20events%20and%20serious%20liver%20events%20among%20patients%20with%20type%202&amp;journal=J%20Endocr&amp;doi=10.1210%2Fjendso%2Fbvae163.555&amp;publication_year=2024&amp;author=Kutz%2CA&amp;author=Wexler%2CDJ&amp;author=Liu%2CJ&amp;author=Paik%2CJM&amp;author=Patorno%2CE">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="62."><p class="c-article-references__text" id="ref-CR62">Trujillo S, Kamionkowski S, Walsh E, Davila J, Asaad I. Do weight loss medications reduce the risk of cirrhosis and HCC? Am J Gastroenterol. 2021;116(SUPPL):S547–8. <a href="https://doi.org/10.14309/01.ajg.0000778232.15515.30" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.14309/01.ajg.0000778232.15515.30">https://doi.org/10.14309/01.ajg.0000778232.15515.30</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.14309/01.ajg.0000778232.15515.30" data-track-item_id="10.14309/01.ajg.0000778232.15515.30" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.14309%2F01.ajg.0000778232.15515.30" aria-label="Article reference 62" data-doi="10.14309/01.ajg.0000778232.15515.30">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 62" href="http://scholar.google.com/scholar_lookup?&amp;title=Do%20weight%20loss%20medications%20reduce%20the%20risk%20of%20cirrhosis%20and%20HCC%3F&amp;journal=Am%20J%20Gastroenterol&amp;doi=10.14309%2F01.ajg.0000778232.15515.30&amp;volume=116&amp;issue=SUPPL&amp;pages=S547-S548&amp;publication_year=2021&amp;author=Trujillo%2CS&amp;author=Kamionkowski%2CS&amp;author=Walsh%2CE&amp;author=Davila%2CJ&amp;author=Asaad%2CI">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="63."><p class="c-article-references__text" id="ref-CR63">Peverelle M, Ng J, Peverelle J, Hirsch RD, Testro A. Liver decompensation after rapid weight loss from semaglutide in a patient with non-alcoholic steatohepatitis -associated cirrhosis. World J Gastroenterol. 2023;29(47):6165–7. <a href="https://doi.org/10.3748/wjg.v29.i47.6165" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3748/wjg.v29.i47.6165">https://doi.org/10.3748/wjg.v29.i47.6165</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.3748/wjg.v29.i47.6165" data-track-item_id="10.3748/wjg.v29.i47.6165" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3748%2Fwjg.v29.i47.6165" aria-label="Article reference 63" data-doi="10.3748/wjg.v29.i47.6165">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=38186682" aria-label="PubMed reference 63">PubMed</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10768411" aria-label="PubMed Central reference 63">PubMed Central</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 63" href="http://scholar.google.com/scholar_lookup?&amp;title=Liver%20decompensation%20after%20rapid%20weight%20loss%20from%20semaglutide%20in%20a%20patient%20with%20non-alcoholic%20steatohepatitis%20-associated%20cirrhosis&amp;journal=World%20J%20Gastroenterol&amp;doi=10.3748%2Fwjg.v29.i47.6165&amp;volume=29&amp;issue=47&amp;pages=6165-6167&amp;publication_year=2023&amp;author=Peverelle%2CM&amp;author=Ng%2CJ&amp;author=Peverelle%2CJ&amp;author=Hirsch%2CRD&amp;author=Testro%2CA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="64."><p class="c-article-references__text" id="ref-CR64">Deng Y, Li K, Li A, Hu W, Hu W. Advances in the treatment of hepatogenous diabetes: a review. Med U S. 2023;102(46):E36068. <a href="https://doi.org/10.1097/MD.0000000000036068" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1097/MD.0000000000036068">https://doi.org/10.1097/MD.0000000000036068</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1097/MD.0000000000036068" data-track-item_id="10.1097/MD.0000000000036068" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1097%2FMD.0000000000036068" aria-label="Article reference 64" data-doi="10.1097/MD.0000000000036068">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB3sXitl2gs73L" aria-label="CAS reference 64">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 64" href="http://scholar.google.com/scholar_lookup?&amp;title=Advances%20in%20the%20treatment%20of%20hepatogenous%20diabetes%3A%20a%20review&amp;journal=Med%20U%20S&amp;doi=10.1097%2FMD.0000000000036068&amp;volume=102&amp;issue=46&amp;publication_year=2023&amp;author=Deng%2CY&amp;author=Li%2CK&amp;author=Li%2CA&amp;author=Hu%2CW&amp;author=Hu%2CW">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="65."><p class="c-article-references__text" id="ref-CR65">A. Yelam and PC Bollu. 2018. Delayed Hypoxic Reversible Leukoencephalopathy Syndrome. Cureus Inc. <a href="https://doi.org/10.7759/cureus.2702" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.7759/cureus.2702">https://doi.org/10.7759/cureus.2702</a>.</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="66."><p class="c-article-references__text" id="ref-CR66">Lemyre B, Chau V. Hypothermia for newborns with hypoxic-ischemic encephalopathy. Oxford Univ Press. 2018;23(4):285–91. <a href="https://doi.org/10.1093/pch/pxy028" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1093/pch/pxy028">https://doi.org/10.1093/pch/pxy028</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/pch/pxy028" data-track-item_id="10.1093/pch/pxy028" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Fpch%2Fpxy028" aria-label="Article reference 66" data-doi="10.1093/pch/pxy028">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 66" href="http://scholar.google.com/scholar_lookup?&amp;title=Hypothermia%20for%20newborns%20with%20hypoxic-ischemic%20encephalopathy&amp;journal=Oxford%20Univ%20Press&amp;doi=10.1093%2Fpch%2Fpxy028&amp;volume=23&amp;issue=4&amp;pages=285-291&amp;publication_year=2018&amp;author=Lemyre%2CB&amp;author=Chau%2CV">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="67."><p class="c-article-references__text" id="ref-CR67">Hölscher C. Novel dual GLP-1/GIP receptor agonists show neuroprotective effects in Alzheimer’s and Parkinson’s disease models. Elsevier BV. 2018;136:251–9. <a href="https://doi.org/10.1016/j.neuropharm.2018.01.040" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/j.neuropharm.2018.01.040">https://doi.org/10.1016/j.neuropharm.2018.01.040</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.neuropharm.2018.01.040" data-track-item_id="10.1016/j.neuropharm.2018.01.040" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.neuropharm.2018.01.040" aria-label="Article reference 67" data-doi="10.1016/j.neuropharm.2018.01.040">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXisVSgsLk%3D" aria-label="CAS reference 67">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 67" href="http://scholar.google.com/scholar_lookup?&amp;title=Novel%20dual%20GLP-1%2FGIP%20receptor%20agonists%20show%20neuroprotective%20effects%20in%20Alzheimer%E2%80%99s%20and%20Parkinson%E2%80%99s%20disease%20models&amp;journal=Elsevier%20BV&amp;doi=10.1016%2Fj.neuropharm.2018.01.040&amp;volume=136&amp;pages=251-259&amp;publication_year=2018&amp;author=H%C3%B6lscher%2CC">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="68."><p class="c-article-references__text" id="ref-CR68">Zhao L, et al. Protective effect of rhGLP-1 (7–36) on brain ischemia/reperfusion damage in diabetic rats. Elsevier BV. 2015;1602:153–9. <a href="https://doi.org/10.1016/j.brainres.2015.01.014" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/j.brainres.2015.01.014">https://doi.org/10.1016/j.brainres.2015.01.014</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.brainres.2015.01.014" data-track-item_id="10.1016/j.brainres.2015.01.014" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.brainres.2015.01.014" aria-label="Article reference 68" data-doi="10.1016/j.brainres.2015.01.014">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXhsVamsL0%3D" aria-label="CAS reference 68">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 68" href="http://scholar.google.com/scholar_lookup?&amp;title=Protective%20effect%20of%20rhGLP-1%20%287%E2%80%9336%29%20on%20brain%20ischemia%2Freperfusion%20damage%20in%20diabetic%20rats&amp;journal=Elsevier%20BV&amp;doi=10.1016%2Fj.brainres.2015.01.014&amp;volume=1602&amp;pages=153-159&amp;publication_year=2015&amp;author=Zhao%2CL">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="69."><p class="c-article-references__text" id="ref-CR69">Rocha-Ferreira E, et al. Neuroprotective exendin-4 enhances hypothermia therapy in a model of hypoxic-ischaemic encephalopathy. Brain J Neurol. 2018;141(10):2925–42. <a href="https://doi.org/10.1093/brain/awy220" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1093/brain/awy220">https://doi.org/10.1093/brain/awy220</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1093/brain/awy220" data-track-item_id="10.1093/brain/awy220" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1093%2Fbrain%2Fawy220" aria-label="Article reference 69" data-doi="10.1093/brain/awy220">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 69" href="http://scholar.google.com/scholar_lookup?&amp;title=Neuroprotective%20exendin-4%20enhances%20hypothermia%20therapy%20in%20a%20model%20of%20hypoxic-ischaemic%20encephalopathy&amp;journal=Brain%20J%20Neurol&amp;doi=10.1093%2Fbrain%2Fawy220&amp;volume=141&amp;issue=10&amp;pages=2925-2942&amp;publication_year=2018&amp;author=Rocha-Ferreira%2CE">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="70."><p class="c-article-references__text" id="ref-CR70">Xie Z, et al. Exendin-4 attenuates neuronal death via GLP-1R/PI3K/Akt pathway in early brain injury after subarachnoid hemorrhage in rats. Neuropharmacology. 2018;128:142–51. <a href="https://doi.org/10.1016/j.neuropharm.2017.09.040" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/j.neuropharm.2017.09.040">https://doi.org/10.1016/j.neuropharm.2017.09.040</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.neuropharm.2017.09.040" data-track-item_id="10.1016/j.neuropharm.2017.09.040" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.neuropharm.2017.09.040" aria-label="Article reference 70" data-doi="10.1016/j.neuropharm.2017.09.040">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2sXhs1Knt7vF" aria-label="CAS reference 70">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=28986282" aria-label="PubMed reference 70">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 70" href="http://scholar.google.com/scholar_lookup?&amp;title=Exendin-4%20attenuates%20neuronal%20death%20via%20GLP-1R%2FPI3K%2FAkt%20pathway%20in%20early%20brain%20injury%20after%20subarachnoid%20hemorrhage%20in%20rats&amp;journal=Neuropharmacology&amp;doi=10.1016%2Fj.neuropharm.2017.09.040&amp;volume=128&amp;pages=142-151&amp;publication_year=2018&amp;author=Xie%2CZ">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="71."><p class="c-article-references__text" id="ref-CR71">S. Kim et al. Anti-inflammatory Effect of Glucagon Like Peptide-1 Receptor Agonist, Exendin-4, through Modulation of IB1/JIP1 Expression and JNK Signaling in Stroke,” vol. 26, no. 4, pp. 227–239, Aug. 2017, <a href="https://doi.org/10.5607/en.2017.26.4.227" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.5607/en.2017.26.4.227">https://doi.org/10.5607/en.2017.26.4.227</a>.</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="72."><p class="c-article-references__text" id="ref-CR72">Teramoto S, et al. Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral Ischemia. Sage Publ. 2011;31(8):1696–705. <a href="https://doi.org/10.1038/jcbfm.2011.51" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1038/jcbfm.2011.51">https://doi.org/10.1038/jcbfm.2011.51</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/jcbfm.2011.51" data-track-item_id="10.1038/jcbfm.2011.51" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fjcbfm.2011.51" aria-label="Article reference 72" data-doi="10.1038/jcbfm.2011.51">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3MXps1OmtL0%3D" aria-label="CAS reference 72">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 72" href="http://scholar.google.com/scholar_lookup?&amp;title=Exendin-4%2C%20a%20glucagon-like%20peptide-1%20receptor%20agonist%2C%20provides%20neuroprotection%20in%20mice%20transient%20focal%20cerebral%20Ischemia&amp;journal=Sage%20Publ&amp;doi=10.1038%2Fjcbfm.2011.51&amp;volume=31&amp;issue=8&amp;pages=1696-1705&amp;publication_year=2011&amp;author=Teramoto%2CS">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="73."><p class="c-article-references__text" id="ref-CR73">Li Y, Gong M. Analysis of the neuroprotective effect of GLP-1 receptor agonist peptide on cerebral ischemia-reperfusion injury by quantitative proteomics mass spectrometry. Cambridge: Wiley; 2021.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/brb3.2190" data-track-item_id="10.1002/brb3.2190" data-track-value="book reference" data-track-action="book reference" href="https://doi.org/10.1002%2Fbrb3.2190" aria-label="Book reference 73" data-doi="10.1002/brb3.2190">Book</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 73" href="http://scholar.google.com/scholar_lookup?&amp;title=Analysis%20of%20the%20neuroprotective%20effect%20of%20GLP-1%20receptor%20agonist%20peptide%20on%20cerebral%20ischemia-reperfusion%20injury%20by%20quantitative%20proteomics%20mass%20spectrometry&amp;doi=10.1002%2Fbrb3.2190&amp;publication_year=2021&amp;author=Li%2CY&amp;author=Gong%2CM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="74."><p class="c-article-references__text" id="ref-CR74">Victor S, Rocha-Ferreira E, Rahim A, Hagberg H, Edwards D. New possibilities for neuroprotection in neonatal hypoxic-ischemic encephalopathy. Eur J Pediatr. 2022;181(3):875–87. <a href="https://doi.org/10.1007/s00431-021-04320-8" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1007/s00431-021-04320-8">https://doi.org/10.1007/s00431-021-04320-8</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1007/s00431-021-04320-8" data-track-item_id="10.1007/s00431-021-04320-8" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s00431-021-04320-8" aria-label="Article reference 74" data-doi="10.1007/s00431-021-04320-8">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34820702" aria-label="PubMed reference 74">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 74" href="http://scholar.google.com/scholar_lookup?&amp;title=New%20possibilities%20for%20neuroprotection%20in%20neonatal%20hypoxic-ischemic%20encephalopathy&amp;journal=Eur%20J%20Pediatr&amp;doi=10.1007%2Fs00431-021-04320-8&amp;volume=181&amp;issue=3&amp;pages=875-887&amp;publication_year=2022&amp;author=Victor%2CS&amp;author=Rocha-Ferreira%2CE&amp;author=Rahim%2CA&amp;author=Hagberg%2CH&amp;author=Edwards%2CD">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="75."><p class="c-article-references__text" id="ref-CR75">Nutma S, Le Feber J, Hofmeijer J. Neuroprotective treatment of post-anoxic encephalopathy: a review of clinical evidence. Front Neurol. 2021;12: 614698. <a href="https://doi.org/10.3389/fneur.2021.614698" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3389/fneur.2021.614698">https://doi.org/10.3389/fneur.2021.614698</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.3389/fneur.2021.614698" data-track-item_id="10.3389/fneur.2021.614698" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3389%2Ffneur.2021.614698" aria-label="Article reference 75" data-doi="10.3389/fneur.2021.614698">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=33679581" aria-label="PubMed reference 75">PubMed</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930064" aria-label="PubMed Central reference 75">PubMed Central</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 75" href="http://scholar.google.com/scholar_lookup?&amp;title=Neuroprotective%20treatment%20of%20post-anoxic%20encephalopathy%3A%20a%20review%20of%20clinical%20evidence&amp;journal=Front%20Neurol&amp;doi=10.3389%2Ffneur.2021.614698&amp;volume=12&amp;publication_year=2021&amp;author=Nutma%2CS&amp;author=Feber%2CJ&amp;author=Hofmeijer%2CJ">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="76."><p class="c-article-references__text" id="ref-CR76">Wiberg S, et al. GLP-1 analogues for neuroprotection after out-of-hospital cardiac arrest: study protocol for a randomized controlled trial. Trials. 2016;17(1):304. <a href="https://doi.org/10.1186/s13063-016-1421-2" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1186/s13063-016-1421-2">https://doi.org/10.1186/s13063-016-1421-2</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1186/s13063-016-1421-2" data-track-item_id="10.1186/s13063-016-1421-2" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1186/s13063-016-1421-2" aria-label="Article reference 76" data-doi="10.1186/s13063-016-1421-2">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXpslWktw%3D%3D" aria-label="CAS reference 76">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=27363489" aria-label="PubMed reference 76">PubMed</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929765" aria-label="PubMed Central reference 76">PubMed Central</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 76" href="http://scholar.google.com/scholar_lookup?&amp;title=GLP-1%20analogues%20for%20neuroprotection%20after%20out-of-hospital%20cardiac%20arrest%3A%20study%20protocol%20for%20a%20randomized%20controlled%20trial&amp;journal=Trials&amp;doi=10.1186%2Fs13063-016-1421-2&amp;volume=17&amp;issue=1&amp;publication_year=2016&amp;author=Wiberg%2CS">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="77."><p class="c-article-references__text" id="ref-CR77">Sima AAF. Encephalopathies: the emerging diabetic complications. Acta Diabetol. 2010;47(4):279–93. <a href="https://doi.org/10.1007/s00592-010-0218-0" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1007/s00592-010-0218-0">https://doi.org/10.1007/s00592-010-0218-0</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1007/s00592-010-0218-0" data-track-item_id="10.1007/s00592-010-0218-0" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s00592-010-0218-0" aria-label="Article reference 77" data-doi="10.1007/s00592-010-0218-0">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3cXhtlClu7nJ" aria-label="CAS reference 77">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=20798963" aria-label="PubMed reference 77">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 77" href="http://scholar.google.com/scholar_lookup?&amp;title=Encephalopathies%3A%20the%20emerging%20diabetic%20complications&amp;journal=Acta%20Diabetol&amp;doi=10.1007%2Fs00592-010-0218-0&amp;volume=47&amp;issue=4&amp;pages=279-293&amp;publication_year=2010&amp;author=Sima%2CAAF">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="78."><p class="c-article-references__text" id="ref-CR78">Kimura R, et al. Glucagon-like peptide-1 (GLP-1) protects against methylglyoxal-induced PC12 cell apoptosis through the PI3K/Akt/mTOR/GCLc/redox signaling pathway. Neuroscience. 2009;162(4):1212–9. <a href="https://doi.org/10.1016/j.neuroscience.2009.05.025" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/j.neuroscience.2009.05.025">https://doi.org/10.1016/j.neuroscience.2009.05.025</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.neuroscience.2009.05.025" data-track-item_id="10.1016/j.neuroscience.2009.05.025" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.neuroscience.2009.05.025" aria-label="Article reference 78" data-doi="10.1016/j.neuroscience.2009.05.025">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD1MXps1aitbg%3D" aria-label="CAS reference 78">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=19463904" aria-label="PubMed reference 78">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 78" href="http://scholar.google.com/scholar_lookup?&amp;title=Glucagon-like%20peptide-1%20%28GLP-1%29%20protects%20against%20methylglyoxal-induced%20PC12%20cell%20apoptosis%20through%20the%20PI3K%2FAkt%2FmTOR%2FGCLc%2Fredox%20signaling%20pathway&amp;journal=Neuroscience&amp;doi=10.1016%2Fj.neuroscience.2009.05.025&amp;volume=162&amp;issue=4&amp;pages=1212-1219&amp;publication_year=2009&amp;author=Kimura%2CR">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="79."><p class="c-article-references__text" id="ref-CR79">Wątroba M, Grabowska AD, Szukiewicz D. Chemokine CX3CL1 (fractalkine) signaling and diabetic encephalopathy. Int J Mol Sci. 2024;25(14):7527. <a href="https://doi.org/10.3390/ijms25147527" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3390/ijms25147527">https://doi.org/10.3390/ijms25147527</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.3390/ijms25147527" data-track-item_id="10.3390/ijms25147527" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3390%2Fijms25147527" aria-label="Article reference 79" data-doi="10.3390/ijms25147527">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXitVChurfJ" aria-label="CAS reference 79">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=39062768" aria-label="PubMed reference 79">PubMed</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11277241" aria-label="PubMed Central reference 79">PubMed Central</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 79" href="http://scholar.google.com/scholar_lookup?&amp;title=Chemokine%20CX3CL1%20%28fractalkine%29%20signaling%20and%20diabetic%20encephalopathy&amp;journal=Int%20J%20Mol%20Sci&amp;doi=10.3390%2Fijms25147527&amp;volume=25&amp;issue=14&amp;publication_year=2024&amp;author=W%C4%85troba%2CM&amp;author=Grabowska%2CAD&amp;author=Szukiewicz%2CD">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="80."><p class="c-article-references__text" id="ref-CR80">Xourgia E, Papazafiropoulou A, Melidonis A. Antidiabetic treatment on memory and spatial learning: from the pancreas to the neuron. World J Diabetes. 2019;10(3):169–80. <a href="https://doi.org/10.4239/wjd.v10.i3.169" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.4239/wjd.v10.i3.169">https://doi.org/10.4239/wjd.v10.i3.169</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.4239/wjd.v10.i3.169" data-track-item_id="10.4239/wjd.v10.i3.169" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.4239%2Fwjd.v10.i3.169" aria-label="Article reference 80" data-doi="10.4239/wjd.v10.i3.169">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=30891152" aria-label="PubMed reference 80">PubMed</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422855" aria-label="PubMed Central reference 80">PubMed Central</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 80" href="http://scholar.google.com/scholar_lookup?&amp;title=Antidiabetic%20treatment%20on%20memory%20and%20spatial%20learning%3A%20from%20the%20pancreas%20to%20the%20neuron&amp;journal=World%20J%20Diabetes&amp;doi=10.4239%2Fwjd.v10.i3.169&amp;volume=10&amp;issue=3&amp;pages=169-180&amp;publication_year=2019&amp;author=Xourgia%2CE&amp;author=Papazafiropoulou%2CA&amp;author=Melidonis%2CA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="81."><p class="c-article-references__text" id="ref-CR81">Soares E, Nunes S, Reis F, Pereira FC. Diabetic encephalopathy: the role of oxidative stress and inflammation in type 2 diabetes. Int J Interferon Cytokine Mediat Res. 2012;4(1):75–85. <a href="https://doi.org/10.2147/IJICMR.S29322" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.2147/IJICMR.S29322">https://doi.org/10.2147/IJICMR.S29322</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.2147/IJICMR.S29322" data-track-item_id="10.2147/IJICMR.S29322" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.2147%2FIJICMR.S29322" aria-label="Article reference 81" data-doi="10.2147/IJICMR.S29322">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 81" href="http://scholar.google.com/scholar_lookup?&amp;title=Diabetic%20encephalopathy%3A%20the%20role%20of%20oxidative%20stress%20and%20inflammation%20in%20type%202%20diabetes&amp;journal=Int%20J%20Interferon%20Cytokine%20Mediat%20Res&amp;doi=10.2147%2FIJICMR.S29322&amp;volume=4&amp;issue=1&amp;pages=75-85&amp;publication_year=2012&amp;author=Soares%2CE&amp;author=Nunes%2CS&amp;author=Reis%2CF&amp;author=Pereira%2CFC">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="82."><p class="c-article-references__text" id="ref-CR82">Mansur RB, et al. Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: a pilot, open-label study. Elsevier. 2016;207:114–20. <a href="https://doi.org/10.1016/j.jad.2016.09.056" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/j.jad.2016.09.056">https://doi.org/10.1016/j.jad.2016.09.056</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.jad.2016.09.056" data-track-item_id="10.1016/j.jad.2016.09.056" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.jad.2016.09.056" aria-label="Article reference 82" data-doi="10.1016/j.jad.2016.09.056">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28Xhs1GnsrnF" aria-label="CAS reference 82">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 82" href="http://scholar.google.com/scholar_lookup?&amp;title=Liraglutide%20promotes%20improvements%20in%20objective%20measures%20of%20cognitive%20dysfunction%20in%20individuals%20with%20mood%20disorders%3A%20a%20pilot%2C%20open-label%20study&amp;journal=Elsevier&amp;doi=10.1016%2Fj.jad.2016.09.056&amp;volume=207&amp;pages=114-120&amp;publication_year=2016&amp;author=Mansur%2CRB">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="83."><p class="c-article-references__text" id="ref-CR83">Bayard M, McIntyre J, Hill KR, Woodside JR. Alcohol withdrawal syndrome. Informa. 2000. <a href="https://doi.org/10.1201/9781420036961-14" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1201/9781420036961-14">https://doi.org/10.1201/9781420036961-14</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1201/9781420036961-14" data-track-item_id="10.1201/9781420036961-14" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1201%2F9781420036961-14" aria-label="Article reference 83" data-doi="10.1201/9781420036961-14">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 83" href="http://scholar.google.com/scholar_lookup?&amp;title=Alcohol%20withdrawal%20syndrome&amp;journal=Informa&amp;doi=10.1201%2F9781420036961-14&amp;publication_year=2000&amp;author=Bayard%2CM&amp;author=McIntyre%2CJ&amp;author=Hill%2CKR&amp;author=Woodside%2CJR">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="84."><p class="c-article-references__text" id="ref-CR84">Jesse S, et al. Alcohol withdrawal syndrome: mechanisms, manifestations, and management. Wiley. 2016;135(1):4–16. <a href="https://doi.org/10.1111/ane.12671" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1111/ane.12671">https://doi.org/10.1111/ane.12671</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1111/ane.12671" data-track-item_id="10.1111/ane.12671" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1111%2Fane.12671" aria-label="Article reference 84" data-doi="10.1111/ane.12671">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 84" href="http://scholar.google.com/scholar_lookup?&amp;title=Alcohol%20withdrawal%20syndrome%3A%20mechanisms%2C%20manifestations%2C%20and%20management&amp;journal=Wiley&amp;doi=10.1111%2Fane.12671&amp;volume=135&amp;issue=1&amp;pages=4-16&amp;publication_year=2016&amp;author=Jesse%2CS">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="85."><p class="c-article-references__text" id="ref-CR85">Vale A. The management of alcohol withdrawal. Amsterdam: Elsevier Ltd; 2006.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1053/j.mpmed.2006.07.001" data-track-item_id="10.1053/j.mpmed.2006.07.001" data-track-value="book reference" data-track-action="book reference" href="https://doi.org/10.1053%2Fj.mpmed.2006.07.001" aria-label="Book reference 85" data-doi="10.1053/j.mpmed.2006.07.001">Book</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 85" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20management%20of%20alcohol%20withdrawal&amp;doi=10.1053%2Fj.mpmed.2006.07.001&amp;publication_year=2006&amp;author=Vale%2CA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="86."><p class="c-article-references__text" id="ref-CR86">Gonçalves MCB, Félix F, Romão J, André R, Sereijo C, Ismail F. Seizures and alcohol withdrawal: a literature review. Camb Univ Press. 2022. <a href="https://doi.org/10.1192/j.eurpsy.2022.2143" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1192/j.eurpsy.2022.2143">https://doi.org/10.1192/j.eurpsy.2022.2143</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1192/j.eurpsy.2022.2143" data-track-item_id="10.1192/j.eurpsy.2022.2143" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1192%2Fj.eurpsy.2022.2143" aria-label="Article reference 86" data-doi="10.1192/j.eurpsy.2022.2143">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 86" href="http://scholar.google.com/scholar_lookup?&amp;title=Seizures%20and%20alcohol%20withdrawal%3A%20a%20literature%20review&amp;journal=Camb%20Univ%20Press&amp;doi=10.1192%2Fj.eurpsy.2022.2143&amp;publication_year=2022&amp;author=Gon%C3%A7alves%2CMCB&amp;author=F%C3%A9lix%2CF&amp;author=Rom%C3%A3o%2CJ&amp;author=Andr%C3%A9%2CR&amp;author=Sereijo%2CC&amp;author=Ismail%2CF">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="87."><p class="c-article-references__text" id="ref-CR87">Kaye AD, et al. The role of glucagon-like peptide-1 agonists in the treatment of multiple sclerosis: a narrative review. Cureus. 2024. <a href="https://doi.org/10.7759/cureus.67232" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.7759/cureus.67232">https://doi.org/10.7759/cureus.67232</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.7759/cureus.67232" data-track-item_id="10.7759/cureus.67232" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.7759%2Fcureus.67232" aria-label="Article reference 87" data-doi="10.7759/cureus.67232">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=39840162" aria-label="PubMed reference 87">PubMed</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11745841" aria-label="PubMed Central reference 87">PubMed Central</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 87" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20role%20of%20glucagon-like%20peptide-1%20agonists%20in%20the%20treatment%20of%20multiple%20sclerosis%3A%20a%20narrative%20review&amp;journal=Cureus&amp;doi=10.7759%2Fcureus.67232&amp;publication_year=2024&amp;author=Kaye%2CAD">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="88."><p class="c-article-references__text" id="ref-CR88">Mirijello A, et al. Identification and management of alcohol withdrawal syndrome. Adis Springer Healthcare. 2015;75(4):353–65. <a href="https://doi.org/10.1007/s40265-015-0358-1" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1007/s40265-015-0358-1">https://doi.org/10.1007/s40265-015-0358-1</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1007/s40265-015-0358-1" data-track-item_id="10.1007/s40265-015-0358-1" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s40265-015-0358-1" aria-label="Article reference 88" data-doi="10.1007/s40265-015-0358-1">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2MXltVWltrw%3D" aria-label="CAS reference 88">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 88" href="http://scholar.google.com/scholar_lookup?&amp;title=Identification%20and%20management%20of%20alcohol%20withdrawal%20syndrome&amp;journal=Adis%20Springer%20Healthcare&amp;doi=10.1007%2Fs40265-015-0358-1&amp;volume=75&amp;issue=4&amp;pages=353-365&amp;publication_year=2015&amp;author=Mirijello%2CA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="89."><p class="c-article-references__text" id="ref-CR89">Mahajan R, Singh R, Bansal P, Bala R. Use of propofol as adjuvant therapy in refractory delirium tremens. Medknow. 2010;19(1):58–58. <a href="https://doi.org/10.4103/0972-6748.77641" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.4103/0972-6748.77641">https://doi.org/10.4103/0972-6748.77641</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.4103/0972-6748.77641" data-track-item_id="10.4103/0972-6748.77641" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.4103%2F0972-6748.77641" aria-label="Article reference 89" data-doi="10.4103/0972-6748.77641">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 89" href="http://scholar.google.com/scholar_lookup?&amp;title=Use%20of%20propofol%20as%20adjuvant%20therapy%20in%20refractory%20delirium%20tremens&amp;journal=Medknow&amp;doi=10.4103%2F0972-6748.77641&amp;volume=19&amp;issue=1&amp;pages=58-58&amp;publication_year=2010&amp;author=Mahajan%2CR&amp;author=Singh%2CR&amp;author=Bansal%2CP&amp;author=Bala%2CR">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="90."><p class="c-article-references__text" id="ref-CR90">Trevisan L, Boutros NN, Petrakis IL, Krystal JH. Complications of alcohol withdrawal: pathophysiological insights. Natl Inst Health. 1998;22(1):61–6.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:STN:280:DC%2BD2M%2FnslOmsQ%3D%3D" aria-label="CAS reference 90">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 90" href="http://scholar.google.com/scholar_lookup?&amp;title=Complications%20of%20alcohol%20withdrawal%3A%20pathophysiological%20insights&amp;journal=Natl%20Inst%20Health&amp;volume=22&amp;issue=1&amp;pages=61-66&amp;publication_year=1998&amp;author=Trevisan%2CL&amp;author=Boutros%2CNN&amp;author=Petrakis%2CIL&amp;author=Krystal%2CJH">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="91."><p class="c-article-references__text" id="ref-CR91">Abulseoud OA, Çamsarı UM, Ruby CL, Kasasbeh A, Choi S, Choi D-S. Attenuation of ethanol withdrawal by ceftriaxone-induced upregulation of glutamate transporter EAAT2. Springer Nat. 2014;39(7):1674–84. <a href="https://doi.org/10.1038/npp.2014.14" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1038/npp.2014.14">https://doi.org/10.1038/npp.2014.14</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/npp.2014.14" data-track-item_id="10.1038/npp.2014.14" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnpp.2014.14" aria-label="Article reference 91" data-doi="10.1038/npp.2014.14">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXjtVKisbw%3D" aria-label="CAS reference 91">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 91" href="http://scholar.google.com/scholar_lookup?&amp;title=Attenuation%20of%20ethanol%20withdrawal%20by%20ceftriaxone-induced%20upregulation%20of%20glutamate%20transporter%20EAAT2&amp;journal=Springer%20Nat&amp;doi=10.1038%2Fnpp.2014.14&amp;volume=39&amp;issue=7&amp;pages=1674-1684&amp;publication_year=2014&amp;author=Abulseoud%2COA&amp;author=%C3%87amsar%C4%B1%2CUM&amp;author=Ruby%2CCL&amp;author=Kasasbeh%2CA&amp;author=Choi%2CS&amp;author=Choi%2CD-S">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="92."><p class="c-article-references__text" id="ref-CR92">Bauer J, et al. Craving in alcohol-dependent patients after detoxification is related to glutamatergic dysfunction in the nucleus accumbens and the anterior cingulate cortex. Springer Nat. 2013;38(8):1401–8. <a href="https://doi.org/10.1038/npp.2013.45" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1038/npp.2013.45">https://doi.org/10.1038/npp.2013.45</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/npp.2013.45" data-track-item_id="10.1038/npp.2013.45" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fnpp.2013.45" aria-label="Article reference 92" data-doi="10.1038/npp.2013.45">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC3sXps1Crt7Y%3D" aria-label="CAS reference 92">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 92" href="http://scholar.google.com/scholar_lookup?&amp;title=Craving%20in%20alcohol-dependent%20patients%20after%20detoxification%20is%20related%20to%20glutamatergic%20dysfunction%20in%20the%20nucleus%20accumbens%20and%20the%20anterior%20cingulate%20cortex&amp;journal=Springer%20Nat&amp;doi=10.1038%2Fnpp.2013.45&amp;volume=38&amp;issue=8&amp;pages=1401-1408&amp;publication_year=2013&amp;author=Bauer%2CJ">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="93."><p class="c-article-references__text" id="ref-CR93">Dixit D, et al. Management of acute alcohol withdrawal syndrome in critically Ill patients. Wiley. 2016;36(7):797–822. <a href="https://doi.org/10.1002/phar.1770" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1002/phar.1770">https://doi.org/10.1002/phar.1770</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/phar.1770" data-track-item_id="10.1002/phar.1770" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fphar.1770" aria-label="Article reference 93" data-doi="10.1002/phar.1770">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC28Xht1SmtL3N" aria-label="CAS reference 93">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 93" href="http://scholar.google.com/scholar_lookup?&amp;title=Management%20of%20acute%20alcohol%20withdrawal%20syndrome%20in%20critically%20Ill%20patients&amp;journal=Wiley&amp;doi=10.1002%2Fphar.1770&amp;volume=36&amp;issue=7&amp;pages=797-822&amp;publication_year=2016&amp;author=Dixit%2CD">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="94."><p class="c-article-references__text" id="ref-CR94">Elliott DY. Caring for hospitalized patients with alcohol withdrawal syndrome. Lippincott Williams Wilkins. 2019;14(5):18–30. <a href="https://doi.org/10.1097/01.ccn.0000578828.37034.c2" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1097/01.ccn.0000578828.37034.c2">https://doi.org/10.1097/01.ccn.0000578828.37034.c2</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1097/01.ccn.0000578828.37034.c2" data-track-item_id="10.1097/01.ccn.0000578828.37034.c2" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1097%2F01.ccn.0000578828.37034.c2" aria-label="Article reference 94" data-doi="10.1097/01.ccn.0000578828.37034.c2">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 94" href="http://scholar.google.com/scholar_lookup?&amp;title=Caring%20for%20hospitalized%20patients%20with%20alcohol%20withdrawal%20syndrome&amp;journal=Lippincott%20Williams%20Wilkins&amp;doi=10.1097%2F01.ccn.0000578828.37034.c2&amp;volume=14&amp;issue=5&amp;pages=18-30&amp;publication_year=2019&amp;author=Elliott%2CDY">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="95."><p class="c-article-references__text" id="ref-CR95">Maldonado JR. Novel algorithms for the prophylaxis and management of alcohol withdrawal syndromes-beyond benzodiazepines. Elsevier BV. 2017;33(3):559–99. <a href="https://doi.org/10.1016/j.ccc.2017.03.012" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/j.ccc.2017.03.012">https://doi.org/10.1016/j.ccc.2017.03.012</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.ccc.2017.03.012" data-track-item_id="10.1016/j.ccc.2017.03.012" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.ccc.2017.03.012" aria-label="Article reference 95" data-doi="10.1016/j.ccc.2017.03.012">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 95" href="http://scholar.google.com/scholar_lookup?&amp;title=Novel%20algorithms%20for%20the%20prophylaxis%20and%20management%20of%20alcohol%20withdrawal%20syndromes-beyond%20benzodiazepines&amp;journal=Elsevier%20BV&amp;doi=10.1016%2Fj.ccc.2017.03.012&amp;volume=33&amp;issue=3&amp;pages=559-599&amp;publication_year=2017&amp;author=Maldonado%2CJR">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="96."><p class="c-article-references__text" id="ref-CR96">McPheeters M, O’Connor EA, Riley S. Naltrexone, acamprosate show strongest results in review of alcohol use disorder treatments. Wiley. 2024;35(3):4–4. <a href="https://doi.org/10.1002/pu.31133" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1002/pu.31133">https://doi.org/10.1002/pu.31133</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1002/pu.31133" data-track-item_id="10.1002/pu.31133" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1002%2Fpu.31133" aria-label="Article reference 96" data-doi="10.1002/pu.31133">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 96" href="http://scholar.google.com/scholar_lookup?&amp;title=Naltrexone%2C%20acamprosate%20show%20strongest%20results%20in%20review%20of%20alcohol%20use%20disorder%20treatments&amp;journal=Wiley&amp;doi=10.1002%2Fpu.31133&amp;volume=35&amp;issue=3&amp;pages=4-4&amp;publication_year=2024&amp;author=McPheeters%2CM&amp;author=O%E2%80%99Connor%2CEA&amp;author=Riley%2CS">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="97."><p class="c-article-references__text" id="ref-CR97">Rizk JG, Saini J, Kim K, Pathan U, Qato DM. County-level factors associated with a mismatch between opioid overdose mortality and availability of opioid treatment facilities. Public Libr Sci. 2024. <a href="https://doi.org/10.1371/journal.pone.0301863" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1371/journal.pone.0301863">https://doi.org/10.1371/journal.pone.0301863</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1371/journal.pone.0301863" data-track-item_id="10.1371/journal.pone.0301863" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1371%2Fjournal.pone.0301863" aria-label="Article reference 97" data-doi="10.1371/journal.pone.0301863">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 97" href="http://scholar.google.com/scholar_lookup?&amp;title=County-level%20factors%20associated%20with%20a%20mismatch%20between%20opioid%20overdose%20mortality%20and%20availability%20of%20opioid%20treatment%20facilities&amp;journal=Public%20Libr%20Sci&amp;doi=10.1371%2Fjournal.pone.0301863&amp;publication_year=2024&amp;author=Rizk%2CJG&amp;author=Saini%2CJ&amp;author=Kim%2CK&amp;author=Pathan%2CU&amp;author=Qato%2CDM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="98."><p class="c-article-references__text" id="ref-CR98">Swift RM. Emerging approaches to managing alcohol dependence. Oxford: Oxford University Press; 2007.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.2146/ajhp060644" data-track-item_id="10.2146/ajhp060644" data-track-value="book reference" data-track-action="book reference" href="https://doi.org/10.2146%2Fajhp060644" aria-label="Book reference 98" data-doi="10.2146/ajhp060644">Book</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 98" href="http://scholar.google.com/scholar_lookup?&amp;title=Emerging%20approaches%20to%20managing%20alcohol%20dependence&amp;doi=10.2146%2Fajhp060644&amp;publication_year=2007&amp;author=Swift%2CRM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="99."><p class="c-article-references__text" id="ref-CR99">Grieco M, et al. Glucagon-like peptide-1: a focus on neurodegenerative diseases. Frontiers Media. 2019. <a href="https://doi.org/10.3389/fnins.2019.01112" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3389/fnins.2019.01112">https://doi.org/10.3389/fnins.2019.01112</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.3389/fnins.2019.01112" data-track-item_id="10.3389/fnins.2019.01112" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3389%2Ffnins.2019.01112" aria-label="Article reference 99" data-doi="10.3389/fnins.2019.01112">Article</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 99" href="http://scholar.google.com/scholar_lookup?&amp;title=Glucagon-like%20peptide-1%3A%20a%20focus%20on%20neurodegenerative%20diseases&amp;journal=Frontiers%20Media&amp;doi=10.3389%2Ffnins.2019.01112&amp;publication_year=2019&amp;author=Grieco%2CM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="100."><p class="c-article-references__text" id="ref-CR100">Jerlhag E. GLP-1 signaling and alcohol-mediated behaviors; preclinical and clinical evidence. Elsevier BV. 2018;136:343–9. <a href="https://doi.org/10.1016/j.neuropharm.2018.01.013" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/j.neuropharm.2018.01.013">https://doi.org/10.1016/j.neuropharm.2018.01.013</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.neuropharm.2018.01.013" data-track-item_id="10.1016/j.neuropharm.2018.01.013" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.neuropharm.2018.01.013" aria-label="Article reference 100" data-doi="10.1016/j.neuropharm.2018.01.013">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXhtFKktbg%3D" aria-label="CAS reference 100">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 100" href="http://scholar.google.com/scholar_lookup?&amp;title=GLP-1%20signaling%20and%20alcohol-mediated%20behaviors%3B%20preclinical%20and%20clinical%20evidence&amp;journal=Elsevier%20BV&amp;doi=10.1016%2Fj.neuropharm.2018.01.013&amp;volume=136&amp;pages=343-349&amp;publication_year=2018&amp;author=Jerlhag%2CE">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="101."><p class="c-article-references__text" id="ref-CR101">Sharma AN, Pise A, Sharma JN, Shukla P. Glucagon-like peptide-1 (GLP-1) receptor agonist prevents development of tolerance to anti-anxiety effect of ethanol and withdrawal-induced anxiety in rats. Metab Brain Dis. 2015;30(3):719–30. <a href="https://doi.org/10.1007/s11011-014-9627-z" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1007/s11011-014-9627-z">https://doi.org/10.1007/s11011-014-9627-z</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1007/s11011-014-9627-z" data-track-item_id="10.1007/s11011-014-9627-z" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s11011-014-9627-z" aria-label="Article reference 101" data-doi="10.1007/s11011-014-9627-z">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC2cXhvFSnu7bE" aria-label="CAS reference 101">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=25380665" aria-label="PubMed reference 101">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 101" href="http://scholar.google.com/scholar_lookup?&amp;title=Glucagon-like%20peptide-1%20%28GLP-1%29%20receptor%20agonist%20prevents%20development%20of%20tolerance%20to%20anti-anxiety%20effect%20of%20ethanol%20and%20withdrawal-induced%20anxiety%20in%20rats&amp;journal=Metab%20Brain%20Dis&amp;doi=10.1007%2Fs11011-014-9627-z&amp;volume=30&amp;issue=3&amp;pages=719-730&amp;publication_year=2015&amp;author=Sharma%2CAN&amp;author=Pise%2CA&amp;author=Sharma%2CJN&amp;author=Shukla%2CP">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="102."><p class="c-article-references__text" id="ref-CR102">Breese GR, Overstreet DH, Knapp DJ, Navarro M. Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist. Springer Nat. 2005;30(9):1662–9. <a href="https://doi.org/10.1038/sj.npp.1300706" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1038/sj.npp.1300706">https://doi.org/10.1038/sj.npp.1300706</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1038/sj.npp.1300706" data-track-item_id="10.1038/sj.npp.1300706" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1038%2Fsj.npp.1300706" aria-label="Article reference 102" data-doi="10.1038/sj.npp.1300706">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD2MXotFegtbk%3D" aria-label="CAS reference 102">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 102" href="http://scholar.google.com/scholar_lookup?&amp;title=Prior%20multiple%20ethanol%20withdrawals%20enhance%20stress-induced%20anxiety-like%20behavior%3A%20inhibition%20by%20CRF1-%20and%20benzodiazepine-receptor%20antagonists%20and%20a%205-HT1a-receptor%20agonist&amp;journal=Springer%20Nat&amp;doi=10.1038%2Fsj.npp.1300706&amp;volume=30&amp;issue=9&amp;pages=1662-1669&amp;publication_year=2005&amp;author=Breese%2CGR&amp;author=Overstreet%2CDH&amp;author=Knapp%2CDJ&amp;author=Navarro%2CM">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="103."><p class="c-article-references__text" id="ref-CR103">Jerlhag E. The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies. Front Pharmacol. 2023. <a href="https://doi.org/10.3389/fphar.2023.1063033" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3389/fphar.2023.1063033">https://doi.org/10.3389/fphar.2023.1063033</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.3389/fphar.2023.1063033" data-track-item_id="10.3389/fphar.2023.1063033" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3389%2Ffphar.2023.1063033" aria-label="Article reference 103" data-doi="10.3389/fphar.2023.1063033">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=37719854" aria-label="PubMed reference 103">PubMed</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500129" aria-label="PubMed Central reference 103">PubMed Central</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 103" href="http://scholar.google.com/scholar_lookup?&amp;title=The%20therapeutic%20potential%20of%20glucagon-like%20peptide-1%20for%20persons%20with%20addictions%20based%20on%20findings%20from%20preclinical%20and%20clinical%20studies&amp;journal=Front%20Pharmacol&amp;doi=10.3389%2Ffphar.2023.1063033&amp;publication_year=2023&amp;author=Jerlhag%2CE">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="104."><p class="c-article-references__text" id="ref-CR104">Celik M, Gold MS, Fuehrlein B. A narrative review of current and emerging trends in the treatment of alcohol use disorder. Brain Sci. 2024;14(3):294. <a href="https://doi.org/10.3390/brainsci14030294" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.3390/brainsci14030294">https://doi.org/10.3390/brainsci14030294</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.3390/brainsci14030294" data-track-item_id="10.3390/brainsci14030294" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.3390%2Fbrainsci14030294" aria-label="Article reference 104" data-doi="10.3390/brainsci14030294">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB2cXosVyrtr8%3D" aria-label="CAS reference 104">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=38539681" aria-label="PubMed reference 104">PubMed</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10969323" aria-label="PubMed Central reference 104">PubMed Central</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 104" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20narrative%20review%20of%20current%20and%20emerging%20trends%20in%20the%20treatment%20of%20alcohol%20use%20disorder&amp;journal=Brain%20Sci&amp;doi=10.3390%2Fbrainsci14030294&amp;volume=14&amp;issue=3&amp;publication_year=2024&amp;author=Celik%2CM&amp;author=Gold%2CMS&amp;author=Fuehrlein%2CB">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="105."><p class="c-article-references__text" id="ref-CR105">Jerlhag E. Alcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1. Elsevier BV. 2019;1727:146562–146562. <a href="https://doi.org/10.1016/j.brainres.2019.146562" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/j.brainres.2019.146562">https://doi.org/10.1016/j.brainres.2019.146562</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.brainres.2019.146562" data-track-item_id="10.1016/j.brainres.2019.146562" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.brainres.2019.146562" aria-label="Article reference 105" data-doi="10.1016/j.brainres.2019.146562">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1MXitlSqtrjJ" aria-label="CAS reference 105">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 105" href="http://scholar.google.com/scholar_lookup?&amp;title=Alcohol-mediated%20behaviours%20and%20the%20gut-brain%20axis%3B%20with%20focus%20on%20glucagon-like%20peptide-1&amp;journal=Elsevier%20BV&amp;doi=10.1016%2Fj.brainres.2019.146562&amp;volume=1727&amp;pages=146562-146562&amp;publication_year=2019&amp;author=Jerlhag%2CE">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="106."><p class="c-article-references__text" id="ref-CR106">Thomsen M, Holst JJ, Molander A, Línnet K, Ptito M, Fink-Jensen A. Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys. Springer Sci Media. 2018;236(2):603–11. <a href="https://doi.org/10.1007/s00213-018-5089-z" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1007/s00213-018-5089-z">https://doi.org/10.1007/s00213-018-5089-z</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="noopener" data-track-label="10.1007/s00213-018-5089-z" data-track-item_id="10.1007/s00213-018-5089-z" data-track-value="article reference" data-track-action="article reference" href="https://link.springer.com/doi/10.1007/s00213-018-5089-z" aria-label="Article reference 106" data-doi="10.1007/s00213-018-5089-z">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BC1cXitVyiu7fM" aria-label="CAS reference 106">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 106" href="http://scholar.google.com/scholar_lookup?&amp;title=Effects%20of%20glucagon-like%20peptide%201%20analogs%20on%20alcohol%20intake%20in%20alcohol-preferring%20vervet%20monkeys&amp;journal=Springer%20Sci%20Media&amp;doi=10.1007%2Fs00213-018-5089-z&amp;volume=236&amp;issue=2&amp;pages=603-611&amp;publication_year=2018&amp;author=Thomsen%2CM&amp;author=Holst%2CJJ&amp;author=Molander%2CA&amp;author=L%C3%ADnnet%2CK&amp;author=Ptito%2CM&amp;author=Fink-Jensen%2CA">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="107."><p class="c-article-references__text" id="ref-CR107">M. R. Shen, K. Owusu-Boaitey, L. M. Holsen, and J. Suzuki, “The Efficacy of GLP-1 Agonists in Treating Substance Use Disorder in Patients: A Scoping Review.” Jan. 2024.</p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="108."><p class="c-article-references__text" id="ref-CR108">Kopp KO, Glotfelty EJ, Li Y, Greig NH. Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment. Elsevier BV. 2022;186:106550–106550. <a href="https://doi.org/10.1016/j.phrs.2022.106550" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1016/j.phrs.2022.106550">https://doi.org/10.1016/j.phrs.2022.106550</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1016/j.phrs.2022.106550" data-track-item_id="10.1016/j.phrs.2022.106550" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1016%2Fj.phrs.2022.106550" aria-label="Article reference 108" data-doi="10.1016/j.phrs.2022.106550">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XjtVWitL%2FL" aria-label="CAS reference 108">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 108" href="http://scholar.google.com/scholar_lookup?&amp;title=Glucagon-like%20peptide-1%20%28GLP-1%29%20receptor%20agonists%20and%20neuroinflammation%3A%20Implications%20for%20neurodegenerative%20disease%20treatment&amp;journal=Elsevier%20BV&amp;doi=10.1016%2Fj.phrs.2022.106550&amp;volume=186&amp;pages=106550-106550&amp;publication_year=2022&amp;author=Kopp%2CKO&amp;author=Glotfelty%2CEJ&amp;author=Li%2CY&amp;author=Greig%2CNH">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="109."><p class="c-article-references__text" id="ref-CR109">Cheng L-Z, Li W, Chen Y-X, Lin Y-J, Miao Y. Autophagy and diabetic encephalopathy: mechanistic insights and potential therapeutic implications. Aging Dis. 2022;13(2):447–57. <a href="https://doi.org/10.14336/AD.2021.0823" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.14336/AD.2021.0823">https://doi.org/10.14336/AD.2021.0823</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.14336/AD.2021.0823" data-track-item_id="10.14336/AD.2021.0823" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.14336%2FAD.2021.0823" aria-label="Article reference 109" data-doi="10.14336/AD.2021.0823">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=35371595" aria-label="PubMed reference 109">PubMed</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed central reference" data-track-action="pubmed central reference" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947837" aria-label="PubMed Central reference 109">PubMed Central</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 109" href="http://scholar.google.com/scholar_lookup?&amp;title=Autophagy%20and%20diabetic%20encephalopathy%3A%20mechanistic%20insights%20and%20potential%20therapeutic%20implications&amp;journal=Aging%20Dis&amp;doi=10.14336%2FAD.2021.0823&amp;volume=13&amp;issue=2&amp;pages=447-457&amp;publication_year=2022&amp;author=Cheng%2CL-Z&amp;author=Li%2CW&amp;author=Chen%2CY-X&amp;author=Lin%2CY-J&amp;author=Miao%2CY">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="110."><p class="c-article-references__text" id="ref-CR110">Hui H, Nourparvar A, Zhao X, Perfetti R. Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5′-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway. Oxf Univ Press. 2003;144(4):1444–55. <a href="https://doi.org/10.1210/en.2002-220897" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1210/en.2002-220897">https://doi.org/10.1210/en.2002-220897</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1210/en.2002-220897" data-track-item_id="10.1210/en.2002-220897" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1210%2Fen.2002-220897" aria-label="Article reference 110" data-doi="10.1210/en.2002-220897">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BD3sXisVegsbk%3D" aria-label="CAS reference 110">CAS</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 110" href="http://scholar.google.com/scholar_lookup?&amp;title=Glucagon-like%20peptide-1%20inhibits%20apoptosis%20of%20insulin-secreting%20cells%20via%20a%20cyclic%205%E2%80%B2-adenosine%20monophosphate-dependent%20protein%20kinase%20A-%20and%20a%20phosphatidylinositol%203-kinase-dependent%20pathway&amp;journal=Oxf%20Univ%20Press&amp;doi=10.1210%2Fen.2002-220897&amp;volume=144&amp;issue=4&amp;pages=1444-1455&amp;publication_year=2003&amp;author=Hui%2CH&amp;author=Nourparvar%2CA&amp;author=Zhao%2CX&amp;author=Perfetti%2CR">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="111."><p class="c-article-references__text" id="ref-CR111">Kobara M, Toba H, Nakata T. A glucagon-like peptide 1 analog protects mitochondria and attenuates hypoxia-reoxygenation injury in cultured cardiomyocytes. J Cardiovasc Pharmacol. 2022;79(4):568–76. <a href="https://doi.org/10.1097/FJC.0000000000001218" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="10.1097/FJC.0000000000001218">https://doi.org/10.1097/FJC.0000000000001218</a>.</p><p class="c-article-references__links u-hide-print"><a data-track="click_references" rel="nofollow noopener" data-track-label="10.1097/FJC.0000000000001218" data-track-item_id="10.1097/FJC.0000000000001218" data-track-value="article reference" data-track-action="article reference" href="https://doi.org/10.1097%2FFJC.0000000000001218" aria-label="Article reference 111" data-doi="10.1097/FJC.0000000000001218">Article</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="cas reference" data-track-action="cas reference" href="/articles/cas-redirect/1:CAS:528:DC%2BB38XptVaqtL0%3D" aria-label="CAS reference 111">CAS</a> 
    <a data-track="click_references" rel="nofollow noopener" data-track-label="link" data-track-item_id="link" data-track-value="pubmed reference" data-track-action="pubmed reference" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&amp;db=PubMed&amp;dopt=Abstract&amp;list_uids=34983916" aria-label="PubMed reference 111">PubMed</a> 
    <a data-track="click_references" data-track-action="google scholar reference" data-track-value="google scholar reference" data-track-label="link" data-track-item_id="link" rel="nofollow noopener" aria-label="Google Scholar reference 111" href="http://scholar.google.com/scholar_lookup?&amp;title=A%20glucagon-like%20peptide%201%20analog%20protects%20mitochondria%20and%20attenuates%20hypoxia-reoxygenation%20injury%20in%20cultured%20cardiomyocytes&amp;journal=J%20Cardiovasc%20Pharmacol&amp;doi=10.1097%2FFJC.0000000000001218&amp;volume=79&amp;issue=4&amp;pages=568-576&amp;publication_year=2022&amp;author=Kobara%2CM&amp;author=Toba%2CH&amp;author=Nakata%2CT">
                    Google Scholar</a> 
                </p></li><li class="c-article-references__item js-c-reading-companion-references-item" data-counter="112."><p class="c-article-references__text" id="ref-CR112">I. S. D. T. Y. L. N. H. G. Salcedo, “Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders,” vol. undefined, no. undefined. Apr. 2012. <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419902/" data-track="click_references" data-track-action="external reference" data-track-value="external reference" data-track-label="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419902/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419902/</a></p></li></ol><p class="c-article-references__download u-hide-print"><a data-track="click" data-track-action="download citation references" data-track-label="link" rel="nofollow" href="https://citation-needed.springer.com/v2/references/10.1007/s44337-025-00428-0?format=refman&amp;flavour=references">Download references<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-download-medium"></use></svg></a></p></div></div></div></section></div><section data-title="Acknowledgements"><div class="c-article-section" id="Ack1-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Ack1">Acknowledgements</h2><div class="c-article-section__content" id="Ack1-content"><p>Not applicable.</p></div></div></section><section data-title="Funding"><div class="c-article-section" id="Fun-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Fun">Funding</h2><div class="c-article-section__content" id="Fun-content"><p>No funds, grants, or other support was received.</p></div></div></section><section aria-labelledby="author-information" data-title="Author information"><div class="c-article-section" id="author-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="author-information">Author information</h2><div class="c-article-section__content" id="author-information-content"><h3 class="c-article__sub-heading" id="affiliations">Authors and Affiliations</h3><ol class="c-article-author-affiliation__list"><li id="Aff1"><p class="c-article-author-affiliation__address">University of Hawaii John A. Burns School of Medicine Honolulu, Hawaii, HI, 96813, USA</p><p class="c-article-author-affiliation__authors-list">Francisco Mercado, Michaela Kop &amp; Michelle Trinh</p></li><li id="Aff2"><p class="c-article-author-affiliation__address">Tripler Army Medical Center, Honolulu, HI, USA</p><p class="c-article-author-affiliation__authors-list">Francisco Mercado</p></li></ol><div class="u-js-hide u-hide-print" data-test="author-info"><span class="c-article__sub-heading">Authors</span><ol class="c-article-authors-search u-list-reset"><li id="auth-Francisco-Mercado-Aff1-Aff2"><span class="c-article-authors-search__title u-h3 js-search-name">Francisco Mercado</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?sortBy=newestFirst&amp;dc.creator=Francisco%20Mercado" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">Search author on:</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Francisco%20Mercado" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Francisco%20Mercado%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Michaela-Kop-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Michaela Kop</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?sortBy=newestFirst&amp;dc.creator=Michaela%20Kop" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">Search author on:</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Michaela%20Kop" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Michaela%20Kop%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li><li id="auth-Michelle-Trinh-Aff1"><span class="c-article-authors-search__title u-h3 js-search-name">Michelle Trinh</span><div class="c-article-authors-search__list"><div class="c-article-authors-search__item c-article-authors-search__list-item--left"><a href="/search?sortBy=newestFirst&amp;dc.creator=Michelle%20Trinh" class="c-article-button" data-track="click" data-track-action="author link - publication" data-track-label="link" rel="nofollow">View author publications</a></div><div class="c-article-authors-search__item c-article-authors-search__list-item--right"><p class="search-in-title-js c-article-authors-search__text"><span class="c-article-authors-search__links-text">Search author on:</span><span class="c-article-identifiers"><a class="c-article-identifiers__item" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&amp;term=Michelle%20Trinh" data-track="click" data-track-action="author link - pubmed" data-track-label="link" rel="nofollow">PubMed</a><span class="u-hide"> </span><a class="c-article-identifiers__item" href="https://scholar.google.co.uk/scholar?as_q=&amp;num=10&amp;btnG=Search+Scholar&amp;as_epq=&amp;as_oq=&amp;as_eq=&amp;as_occt=any&amp;as_sauthors=%22Michelle%20Trinh%22&amp;as_publication=&amp;as_ylo=&amp;as_yhi=&amp;as_allsubj=all&amp;hl=en" data-track="click" data-track-action="author link - scholar" data-track-label="link" rel="nofollow">Google Scholar</a></span></p></div></div></li></ol></div><h3 class="c-article__sub-heading" id="contributions">Contributions</h3><p>FM conceived the study, conducted the literature review, drafted and revised the manuscript, and supervised the overall process. MT and MK reviewed the manuscript, screened the articles, extracted data, created and modified the diagram, and ensured the completeness of the references.</p><h3 class="c-article__sub-heading" id="corresponding-author">Corresponding author</h3><p id="corresponding-author-list">Correspondence to
                <a id="corresp-c1" aria-label="email Francisco Mercado" href="mailto:fsmerc425@hotmail.com">Francisco Mercado</a>.</p></div></div></section><section data-title="Ethics declarations"><div class="c-article-section" id="ethics-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="ethics">Ethics declarations</h2><div class="c-article-section__content" id="ethics-content">
              
              
                <h3 class="c-article__sub-heading" id="FPar1">Ethical approval and consent to participate</h3>
                <p>Ethical approval was not necessary for this scoping review since it reviews existing literature and does not involve collecting new data from human participants. Consent to participate was not necessary for this scoping review, as it is a review of the existing literature and does not involve collecting new data from human participants.</p>
              
              
                <h3 class="c-article__sub-heading" id="FPar2">Consent for publication</h3>
                <p>Consent to publish was not necessary for this scoping review since it did not include identifiable personal data.</p>
              
              
                <h3 class="c-article__sub-heading" id="FPar3">Competing interests</h3>
                <p>The authors declare no competing interests.</p>
              
            </div></div></section><section data-title="Additional information"><div class="c-article-section" id="additional-information-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="additional-information">Additional information</h2><div class="c-article-section__content" id="additional-information-content"><h3 class="c-article__sub-heading">Publisher's Note</h3><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div></section><section data-title="Supplementary Information"><div class="c-article-section" id="Sec12-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="Sec12">Supplementary Information</h2><div class="c-article-section__content" id="Sec12-content"><div data-test="supplementary-info"><div id="figshareContainer" class="c-article-figshare-container" data-test="figshare-container"></div><p>Below is the link to the electronic supplementary material.</p><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM1"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="supplementary material 1." href="https://static-content.springer.com/esm/art%3A10.1007%2Fs44337-025-00428-0/MediaObjects/44337_2025_428_MOESM1_ESM.docx" data-supp-info-image="">Supplementary material 1.</a></h3></div><div class="c-article-supplementary__item" data-test="supp-item" id="MOESM2"><h3 class="c-article-supplementary__title u-h3"><a class="print-link" data-track="click" data-track-action="view supplementary info" data-test="supp-info-link" data-track-label="supplementary material 2." href="https://static-content.springer.com/esm/art%3A10.1007%2Fs44337-025-00428-0/MediaObjects/44337_2025_428_MOESM2_ESM.docx" data-supp-info-image="">Supplementary material 2.</a></h3></div></div></div></div></section><section data-title="Rights and permissions"><div class="c-article-section" id="rightslink-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="rightslink">Rights and permissions</h2><div class="c-article-section__content" id="rightslink-content">
                <p><b>Open Access</b>  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="http://creativecommons.org/licenses/by/4.0/" rel="license">http://creativecommons.org/licenses/by/4.0/</a>.</p>
              <p class="c-article-rights"><a data-track="click" data-track-action="view rights and permissions" data-track-label="link" href="https://s100.copyright.com/AppDispatchServlet?title=GLP-1%20receptor%20agonists%20in%20delirium%20and%20encephalopathies%3A%20a%20neuroprotective%20scoping%20review&amp;author=Francisco%20Mercado%20et%20al&amp;contentID=10.1007%2Fs44337-025-00428-0&amp;copyright=This%20is%20a%20U.S.%20Government%20work%20and%20not%20under%20copyright%20protection%20in%20the%20US%3B%20foreign%20copyright%20protection%20may%20apply&amp;publication=3004-8885&amp;publicationDate=2025-07-31&amp;publisherName=SpringerNature&amp;orderBeanReset=true&amp;oa=CC%20BY">Reprints and permissions</a></p></div></div></section><section aria-labelledby="article-info" data-title="About this article"><div class="c-article-section" id="article-info-section"><h2 class="c-article-section__title js-section-title js-c-reading-companion-sections-item" id="article-info">About this article</h2><div class="c-article-section__content" id="article-info-content"><div class="c-bibliographic-information"><div class="u-hide-print c-bibliographic-information__column c-bibliographic-information__column--border"><a data-crossmark="10.1007/s44337-025-00428-0" target="_blank" rel="noopener" href="https://crossmark.crossref.org/dialog/?doi=10.1007/s44337-025-00428-0" data-track="click" data-track-action="Click Crossmark" data-track-label="link" data-test="crossmark"><img loading="lazy" width="57" height="81" alt="Check for updates. Verify currency and authenticity via CrossMark" src="data:image/svg+xml;base64,<svg height="81" width="57" xmlns="http://www.w3.org/2000/svg"><g fill="none" fill-rule="evenodd"><path d="m17.35 35.45 21.3-14.2v-17.03h-21.3" fill="#989898"/><path d="m38.65 35.45-21.3-14.2v-17.03h21.3" fill="#747474"/><path d="m28 .5c-12.98 0-23.5 10.52-23.5 23.5s10.52 23.5 23.5 23.5 23.5-10.52 23.5-23.5c0-6.23-2.48-12.21-6.88-16.62-4.41-4.4-10.39-6.88-16.62-6.88zm0 41.25c-9.8 0-17.75-7.95-17.75-17.75s7.95-17.75 17.75-17.75 17.75 7.95 17.75 17.75c0 4.71-1.87 9.22-5.2 12.55s-7.84 5.2-12.55 5.2z" fill="#535353"/><path d="m41 36c-5.81 6.23-15.23 7.45-22.43 2.9-7.21-4.55-10.16-13.57-7.03-21.5l-4.92-3.11c-4.95 10.7-1.19 23.42 8.78 29.71 9.97 6.3 23.07 4.22 30.6-4.86z" fill="#9c9c9c"/><path d="m.2 58.45c0-.75.11-1.42.33-2.01s.52-1.09.91-1.5c.38-.41.83-.73 1.34-.94.51-.22 1.06-.32 1.65-.32.56 0 1.06.11 1.51.35.44.23.81.5 1.1.81l-.91 1.01c-.24-.24-.49-.42-.75-.56-.27-.13-.58-.2-.93-.2-.39 0-.73.08-1.05.23-.31.16-.58.37-.81.66-.23.28-.41.63-.53 1.04-.13.41-.19.88-.19 1.39 0 1.04.23 1.86.68 2.46.45.59 1.06.88 1.84.88.41 0 .77-.07 1.07-.23s.59-.39.85-.68l.91 1c-.38.43-.8.76-1.28.99-.47.22-1 .34-1.58.34-.59 0-1.13-.1-1.64-.31-.5-.2-.94-.51-1.31-.91-.38-.4-.67-.9-.88-1.48-.22-.59-.33-1.26-.33-2.02zm8.4-5.33h1.61v2.54l-.05 1.33c.29-.27.61-.51.96-.72s.76-.31 1.24-.31c.73 0 1.27.23 1.61.71.33.47.5 1.14.5 2.02v4.31h-1.61v-4.1c0-.57-.08-.97-.25-1.21-.17-.23-.45-.35-.83-.35-.3 0-.56.08-.79.22-.23.15-.49.36-.78.64v4.8h-1.61zm7.37 6.45c0-.56.09-1.06.26-1.51.18-.45.42-.83.71-1.14.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.36c.07.62.29 1.1.65 1.44.36.33.82.5 1.38.5.29 0 .57-.04.83-.13s.51-.21.76-.37l.55 1.01c-.33.21-.69.39-1.09.53-.41.14-.83.21-1.26.21-.48 0-.92-.08-1.34-.25-.41-.16-.76-.4-1.07-.7-.31-.31-.55-.69-.72-1.13-.18-.44-.26-.95-.26-1.52zm4.6-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.07.45-.31.29-.5.73-.58 1.3zm2.5.62c0-.57.09-1.08.28-1.53.18-.44.43-.82.75-1.13s.69-.54 1.1-.71c.42-.16.85-.24 1.31-.24.45 0 .84.08 1.17.23s.61.34.85.57l-.77 1.02c-.19-.16-.38-.28-.56-.37-.19-.09-.39-.14-.61-.14-.56 0-1.01.21-1.35.63-.35.41-.52.97-.52 1.67 0 .69.17 1.24.51 1.66.34.41.78.62 1.32.62.28 0 .54-.06.78-.17.24-.12.45-.26.64-.42l.67 1.03c-.33.29-.69.51-1.08.65-.39.15-.78.23-1.18.23-.46 0-.9-.08-1.31-.24-.4-.16-.75-.39-1.05-.7s-.53-.69-.7-1.13c-.17-.45-.25-.96-.25-1.53zm6.91-6.45h1.58v6.17h.05l2.54-3.16h1.77l-2.35 2.8 2.59 4.07h-1.75l-1.77-2.98-1.08 1.23v1.75h-1.58zm13.69 1.27c-.25-.11-.5-.17-.75-.17-.58 0-.87.39-.87 1.16v.75h1.34v1.27h-1.34v5.6h-1.61v-5.6h-.92v-1.2l.92-.07v-.72c0-.35.04-.68.13-.98.08-.31.21-.57.4-.79s.42-.39.71-.51c.28-.12.63-.18 1.04-.18.24 0 .48.02.69.07.22.05.41.1.57.17zm.48 5.18c0-.57.09-1.08.27-1.53.17-.44.41-.82.72-1.13.3-.31.65-.54 1.04-.71.39-.16.8-.24 1.23-.24s.84.08 1.24.24c.4.17.74.4 1.04.71s.54.69.72 1.13c.19.45.28.96.28 1.53s-.09 1.08-.28 1.53c-.18.44-.42.82-.72 1.13s-.64.54-1.04.7-.81.24-1.24.24-.84-.08-1.23-.24-.74-.39-1.04-.7c-.31-.31-.55-.69-.72-1.13-.18-.45-.27-.96-.27-1.53zm1.65 0c0 .69.14 1.24.43 1.66.28.41.68.62 1.18.62.51 0 .9-.21 1.19-.62.29-.42.44-.97.44-1.66 0-.7-.15-1.26-.44-1.67-.29-.42-.68-.63-1.19-.63-.5 0-.9.21-1.18.63-.29.41-.43.97-.43 1.67zm6.48-3.44h1.33l.12 1.21h.05c.24-.44.54-.79.88-1.02.35-.24.7-.36 1.07-.36.32 0 .59.05.78.14l-.28 1.4-.33-.09c-.11-.01-.23-.02-.38-.02-.27 0-.56.1-.86.31s-.55.58-.77 1.1v4.2h-1.61zm-47.87 15h1.61v4.1c0 .57.08.97.25 1.2.17.24.44.35.81.35.3 0 .57-.07.8-.22.22-.15.47-.39.73-.73v-4.7h1.61v6.87h-1.32l-.12-1.01h-.04c-.3.36-.63.64-.98.86-.35.21-.76.32-1.24.32-.73 0-1.27-.24-1.61-.71-.33-.47-.5-1.14-.5-2.02zm9.46 7.43v2.16h-1.61v-9.59h1.33l.12.72h.05c.29-.24.61-.45.97-.63.35-.17.72-.26 1.1-.26.43 0 .81.08 1.15.24.33.17.61.4.84.71.24.31.41.68.53 1.11.13.42.19.91.19 1.44 0 .59-.09 1.11-.25 1.57-.16.47-.38.85-.65 1.16-.27.32-.58.56-.94.73-.35.16-.72.25-1.1.25-.3 0-.6-.07-.9-.2s-.59-.31-.87-.56zm0-2.3c.26.22.5.37.73.45.24.09.46.13.66.13.46 0 .84-.2 1.15-.6.31-.39.46-.98.46-1.77 0-.69-.12-1.22-.35-1.61-.23-.38-.61-.57-1.13-.57-.49 0-.99.26-1.52.77zm5.87-1.69c0-.56.08-1.06.25-1.51.16-.45.37-.83.65-1.14.27-.3.58-.54.93-.71s.71-.25 1.08-.25c.39 0 .73.07 1 .2.27.14.54.32.81.55l-.06-1.1v-2.49h1.61v9.88h-1.33l-.11-.74h-.06c-.25.25-.54.46-.88.64-.33.18-.69.27-1.06.27-.87 0-1.56-.32-2.07-.95s-.76-1.51-.76-2.65zm1.67-.01c0 .74.13 1.31.4 1.7.26.38.65.58 1.15.58.51 0 .99-.26 1.44-.77v-3.21c-.24-.21-.48-.36-.7-.45-.23-.08-.46-.12-.7-.12-.45 0-.82.19-1.13.59-.31.39-.46.95-.46 1.68zm6.35 1.59c0-.73.32-1.3.97-1.71.64-.4 1.67-.68 3.08-.84 0-.17-.02-.34-.07-.51-.05-.16-.12-.3-.22-.43s-.22-.22-.38-.3c-.15-.06-.34-.1-.58-.1-.34 0-.68.07-1 .2s-.63.29-.93.47l-.59-1.08c.39-.24.81-.45 1.28-.63.47-.17.99-.26 1.54-.26.86 0 1.51.25 1.93.76s.63 1.25.63 2.21v4.07h-1.32l-.12-.76h-.05c-.3.27-.63.48-.98.66s-.73.27-1.14.27c-.61 0-1.1-.19-1.48-.56-.38-.36-.57-.85-.57-1.46zm1.57-.12c0 .3.09.53.27.67.19.14.42.21.71.21.28 0 .54-.07.77-.2s.48-.31.73-.56v-1.54c-.47.06-.86.13-1.18.23-.31.09-.57.19-.76.31s-.33.25-.41.4c-.09.15-.13.31-.13.48zm6.29-3.63h-.98v-1.2l1.06-.07.2-1.88h1.34v1.88h1.75v1.27h-1.75v3.28c0 .8.32 1.2.97 1.2.12 0 .24-.01.37-.04.12-.03.24-.07.34-.11l.28 1.19c-.19.06-.4.12-.64.17-.23.05-.49.08-.76.08-.4 0-.74-.06-1.02-.18-.27-.13-.49-.3-.67-.52-.17-.21-.3-.48-.37-.78-.08-.3-.12-.64-.12-1.01zm4.36 2.17c0-.56.09-1.06.27-1.51s.41-.83.71-1.14c.29-.3.63-.54 1.01-.71.39-.17.78-.25 1.18-.25.47 0 .88.08 1.23.24.36.16.65.38.89.67s.42.63.54 1.03c.12.41.18.84.18 1.32 0 .32-.02.57-.07.76h-4.37c.08.62.29 1.1.65 1.44.36.33.82.5 1.38.5.3 0 .58-.04.84-.13.25-.09.51-.21.76-.37l.54 1.01c-.32.21-.69.39-1.09.53s-.82.21-1.26.21c-.47 0-.92-.08-1.33-.25-.41-.16-.77-.4-1.08-.7-.3-.31-.54-.69-.72-1.13-.17-.44-.26-.95-.26-1.52zm4.61-.62c0-.55-.11-.98-.34-1.28-.23-.31-.58-.47-1.06-.47-.41 0-.77.15-1.08.45-.31.29-.5.73-.57 1.3zm3.01 2.23c.31.24.61.43.92.57.3.13.63.2.98.2.38 0 .65-.08.83-.23s.27-.35.27-.6c0-.14-.05-.26-.13-.37-.08-.1-.2-.2-.34-.28-.14-.09-.29-.16-.47-.23l-.53-.22c-.23-.09-.46-.18-.69-.3-.23-.11-.44-.24-.62-.4s-.33-.35-.45-.55c-.12-.21-.18-.46-.18-.75 0-.61.23-1.1.68-1.49.44-.38 1.06-.57 1.83-.57.48 0 .91.08 1.29.25s.71.36.99.57l-.74.98c-.24-.17-.49-.32-.73-.42-.25-.11-.51-.16-.78-.16-.35 0-.6.07-.76.21-.17.15-.25.33-.25.54 0 .14.04.26.12.36s.18.18.31.26c.14.07.29.14.46.21l.54.19c.23.09.47.18.7.29s.44.24.64.4c.19.16.34.35.46.58.11.23.17.5.17.82 0 .3-.06.58-.17.83-.12.26-.29.48-.51.68-.23.19-.51.34-.84.45-.34.11-.72.17-1.15.17-.48 0-.95-.09-1.41-.27-.46-.19-.86-.41-1.2-.68z" fill="#535353"/></g></svg>"></a></div><div class="c-bibliographic-information__column"><h3 class="c-article__sub-heading" id="citeas">Cite this article</h3><p class="c-bibliographic-information__citation">Mercado, F., Kop, M. &amp; Trinh, M. GLP-1 receptor agonists in delirium and encephalopathies: a neuroprotective scoping review.
                    <i>Discov Med</i> <b>2</b>, 207 (2025). https://doi.org/10.1007/s44337-025-00428-0</p><p class="c-bibliographic-information__download-citation u-hide-print"><a data-test="citation-link" data-track="click" data-track-action="download article citation" data-track-label="link" data-track-external="" rel="nofollow" href="https://citation-needed.springer.com/v2/references/10.1007/s44337-025-00428-0?format=refman&amp;flavour=citation">Download citation<svg width="16" height="16" focusable="false" role="img" aria-hidden="true" class="u-icon"><use xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="#icon-eds-i-download-medium"></use></svg></a></p><ul class="c-bibliographic-information__list" data-test="publication-history"><li class="c-bibliographic-information__list-item"><p>Received<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2025-04-14">14 April 2025</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Accepted<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2025-07-10">10 July 2025</time></span></p></li><li class="c-bibliographic-information__list-item"><p>Published<span class="u-hide">: </span><span class="c-bibliographic-information__value"><time datetime="2025-07-31">31 July 2025</time></span></p></li><li class="c-bibliographic-information__list-item c-bibliographic-information__list-item--full-width"><p><abbr title="Digital Object Identifier">DOI</abbr><span class="u-hide">: </span><span class="c-bibliographic-information__value">https://doi.org/10.1007/s44337-025-00428-0</span></p></li></ul><div data-component="share-box"><div class="c-article-share-box u-display-none" hidden=""><h3 class="c-article__sub-heading">Share this article</h3><p class="c-article-share-box__description">Anyone you share the following link with will be able to read this content:</p><button class="js-get-share-url c-article-share-box__button" type="button" id="get-share-url" data-track="click" data-track-label="button" data-track-external="" data-track-action="get shareable link">Get shareable link</button><div class="js-no-share-url-container u-display-none" hidden=""><p class="js-c-article-share-box__no-sharelink-info c-article-share-box__no-sharelink-info">Sorry, a shareable link is not currently available for this article.</p></div><div class="js-share-url-container u-display-none" hidden=""><p class="js-share-url c-article-share-box__only-read-input" id="share-url" data-track="click" data-track-label="button" data-track-action="select share url"></p><button class="js-copy-share-url c-article-share-box__button--link-like" type="button" id="copy-share-url" data-track="click" data-track-label="button" data-track-action="copy share url" data-track-external="">Copy shareable link to clipboard</button></div><p class="js-c-article-share-box__additional-info c-article-share-box__additional-info">
                            Provided by the Springer Nature SharedIt content-sharing initiative
                        </p></div></div><h3 class="c-article__sub-heading">Keywords</h3><ul class="c-article-subject-list"><li class="c-article-subject-list__subject"><span><a href="/search?query=Glucagon-like%20peptide-1%20receptor%20agonists%20%28GLP-1%20RA%20or%20GLP-1%20RAs%29&amp;facet-discipline=&#34;Biomedicine&#34;" data-track="click" data-track-action="view keyword" data-track-label="link">Glucagon-like peptide-1 receptor agonists (GLP-1 RA or GLP-1 RAs)</a></span></li><li class="c-article-subject-list__subject"><span><a href="/search?query=Delirium&amp;facet-discipline=&#34;Biomedicine&#34;" data-track="click" data-track-action="view keyword" data-track-label="link">Delirium</a></span></li><li class="c-article-subject-list__subject"><span><a href="/search?query=Encephalopathy&amp;facet-discipline=&#34;Biomedicine&#34;" data-track="click" data-track-action="view keyword" data-track-label="link">Encephalopathy</a></span></li><li class="c-article-subject-list__subject"><span><a href="/search?query=Neuroprotection&amp;facet-discipline=&#34;Biomedicine&#34;" data-track="click" data-track-action="view keyword" data-track-label="link">Neuroprotection</a></span></li><li class="c-article-subject-list__subject"><span><a href="/search?query=Neurodegenerative%20diseases&amp;facet-discipline=&#34;Biomedicine&#34;" data-track="click" data-track-action="view keyword" data-track-label="link">Neurodegenerative diseases</a></span></li><li class="c-article-subject-list__subject"><span><a href="/search?query=Neuroinflammation&amp;facet-discipline=&#34;Biomedicine&#34;" data-track="click" data-track-action="view keyword" data-track-label="link">Neuroinflammation</a></span></li><li class="c-article-subject-list__subject"><span><a href="/search?query=Cognitive%20impairment&amp;facet-discipline=&#34;Biomedicine&#34;" data-track="click" data-track-action="view keyword" data-track-label="link">Cognitive impairment</a></span></li></ul><div data-component="article-info-list"></div></div></div></div></div></section>

                    
    <div id="researcher-profile-container">
        <h3>Profiles</h3>
        <ol>
            
                <li data-test="researcher-profile-data"  data-profile-index="0">
                    <span data-test="researcher-profile-name">Francisco Mercado</span>
                    <a class="js-cta-popup-link c-article-authors-search__cta-link" href="/researchers/88460155SN" data-track="click_view_profile" data-test="researcher-profile-link">
                        <span class="eds-c-button eds-c-button--primary">
                            <svg class="c-article-authors-search__cta-icon" aria-hidden="true" focusable="false" width="24" height="24">
                                <use xlink:href="#icon-eds-i-user-single-medium"></use>
                            </svg><span>View author profile</span>
                        </span>
                    </a>
                </li>
            
        </ol>
    </div>


                    
                </div>
            </main>

            <div class="c-article-sidebar u-text-sm u-hide-print l-with-sidebar__sidebar" id="sidebar"
                 data-container-type="reading-companion" data-track-component="reading companion">
                <aside aria-label="reading companion">
                    

                    
                        
    <div class="app-card-service" data-test="article-checklist-banner">
        <div>
            <a class="app-card-service__link" data-track="click_presubmission_checklist" data-track-context="article page top of reading companion" data-track-category="pre-submission-checklist" data-track-action="clicked article page checklist banner test 2 old version" data-track-label="link" href="https://beta.springernature.com/pre-submission?journalId=44337"
            data-test="article-checklist-banner-link">
            <span class="app-card-service__link-text">Use our pre-submission checklist</span>
            <svg class="app-card-service__link-icon" aria-hidden="true" focusable="false"><use xlink:href="#icon-eds-i-arrow-right-small"></use></svg>
            </a>
            <p class="app-card-service__description">Avoid common mistakes on your manuscript.</p>
        </div>
        <div class="app-card-service__icon-container">
            <svg class="app-card-service__icon" aria-hidden="true" focusable="false">
                <use xlink:href="#icon-eds-i-clipboard-check-medium"></use>
            </svg>
        </div>
    </div>

                    

                    
                        <div data-test="collections">
                            
    

                        </div>
                    

                    <div data-test="editorial-summary">
                        
                    </div>

                    <div class="c-reading-companion">
                        <div class="c-reading-companion__sticky" data-component="reading-companion-sticky"
                             data-test="reading-companion-sticky">
                            
                            
                                
                                    
                                
                            
                            <div
                                class="c-reading-companion__panel c-reading-companion__sections c-reading-companion__panel--active"
                                id="tabpanel-sections">
                                <div class="u-lazy-ad-wrapper u-mt-16 u-hide"
                                     data-component-mpu><div class="c-ad c-ad--300x250">
    <div class="c-ad__inner">
        <p class="c-ad__label">Advertisement</p>
        <div id="div-gpt-ad-MPU1"
             class="div-gpt-ad grade-c-hide"
             data-pa11y-ignore
             data-gpt
             data-gpt-unitpath="/270604982/springerlink/44337/article"
             data-gpt-sizes="300x250" data-test="MPU1-ad"
             data-gpt-targeting="pos=MPU1;articleid=s44337-025-00428-0;">
        </div>
    </div>
</div>

<script>
    window.SN = window.SN || {};
    window.SN.libs = window.SN.libs || {};
    window.SN.libs.ads = window.SN.libs.ads || {};
    window.SN.libs.ads.slotConfig = window.SN.libs.ads.slotConfig || {};
    window.SN.libs.ads.slotConfig['MPU1'] = {
        'pos': 'MPU1',
        'type': 'MPU1',
    };
    window.SN.libs.ads.slotConfig['unitPath'] = '/270604982/springerlink/44337/article';
</script>

</div>
                            </div>
                            <div
                                class="c-reading-companion__panel c-reading-companion__figures c-reading-companion__panel--full-width"
                                id="tabpanel-figures"></div>
                            <div
                                class="c-reading-companion__panel c-reading-companion__references c-reading-companion__panel--full-width"
                                id="tabpanel-references"></div>
                        </div>
                    </div>
                </aside>
            </div>
        </div>
    </article>
    <div class="app-elements" data-test="footer">
    <nav aria-label="expander navigation">



    
        <div class="eds-c-header__expander eds-c-header__expander--search" id="eds-c-header-popup-search">
            <h2 class="eds-c-header__heading">Search</h2>
            <div class="u-container">
                <search class="eds-c-header__search" role="search" aria-label="Search from the header">
                    <form method="GET" action="//link.springer.com/search"
                        
                            data-test="header-search"
                        
                            data-track="search"
                        
                            data-track-context="search from header"
                        
                            data-track-action="submit search form"
                        
                            data-track-category="unified header"
                        
                            data-track-label="form"
                        
					>
                        <label for="eds-c-header-search" class="eds-c-header__search-label">Search by keyword or author</label>
                        <div class="eds-c-header__search-container">
                            <input id="eds-c-header-search" class="eds-c-header__search-input" autocomplete="off" name="query" type="search" value="" required>
                            <button class="eds-c-header__search-button" type="submit">
                                <svg class="eds-c-header__icon" aria-hidden="true" focusable="false">
                                    <use xlink:href="#icon-eds-i-search-medium"></use>
                                </svg>
                                <span class="u-visually-hidden">Search</span>
                            </button>
                        </div>
                    </form>
                </search>
            </div>
        </div>
    


<div class="eds-c-header__expander eds-c-header__expander--menu" id="eds-c-header-nav">
    
        <h2 class="eds-c-header__heading">Navigation</h2>
        <ul class="eds-c-header__list">
            
                <li class="eds-c-header__list-item">
                   <a class="eds-c-header__link" href="https://link.springer.com/journals/"
                        
                            data-track="nav_find_a_journal"
                        
                            data-track-context="unified header"
                        
                            data-track-action="click find a journal"
                        
                            data-track-category="unified header"
                        
                            data-track-label="link"
                        
					>
                        Find a journal
                    </a>
                </li>
            
                <li class="eds-c-header__list-item">
                   <a class="eds-c-header__link" href="https://www.springernature.com/gp/authors"
                        
                            data-track="nav_how_to_publish"
                        
                            data-track-context="unified header"
                        
                            data-track-action="click publish with us link"
                        
                            data-track-category="unified header"
                        
                            data-track-label="link"
                        
					>
                        Publish with us
                    </a>
                </li>
            
                <li class="eds-c-header__list-item">
                   <a class="eds-c-header__link" href="https://link.springernature.com/home/"
                        
                            data-track="nav_track_your_research"
                        
                            data-track-context="unified header"
                        
                            data-track-action="click track your research"
                        
                            data-track-category="unified header"
                        
                            data-track-label="link"
                        
					>
                        Track your research
                    </a>
                </li>
            
        </ul>
    
</div>
</nav>
    <footer >
	<div class="eds-c-footer"
		
	>
		
			
				<div class="eds-c-footer__container">
		<div class="eds-c-footer__grid eds-c-footer__group--separator">
			
			<div class="eds-c-footer__group">
				<h3 class="eds-c-footer__heading">Discover content</h3>
				<ul class="eds-c-footer__list">
					
						<li class="eds-c-footer__item"><a class="eds-c-footer__link" href="https://link.springer.com/journals/a/1" data-track="nav_journals_a_z" data-track-action="journals a-z" data-track-context="unified footer" data-track-label="link">Journals A-Z</a></li>
					
						<li class="eds-c-footer__item"><a class="eds-c-footer__link" href="https://link.springer.com/books/a/1" data-track="nav_books_a_z" data-track-action="books a-z" data-track-context="unified footer" data-track-label="link">Books A-Z</a></li>
					
				</ul>
			</div>
			
			<div class="eds-c-footer__group">
				<h3 class="eds-c-footer__heading">Publish with us</h3>
				<ul class="eds-c-footer__list">
					
						<li class="eds-c-footer__item"><a class="eds-c-footer__link" href="https://link.springer.com/journals" data-track="nav_journal_finder" data-track-action="journal finder" data-track-context="unified footer" data-track-label="link">Journal finder</a></li>
					
						<li class="eds-c-footer__item"><a class="eds-c-footer__link" href="https://www.springernature.com/gp/authors" data-track="nav_publish_your_research" data-track-action="publish your research" data-track-context="unified footer" data-track-label="link">Publish your research</a></li>
					
						<li class="eds-c-footer__item"><a class="eds-c-footer__link" href="https://authorservices.springernature.com/go/sn/?utm_source&#x3D;SNLinkfooter&amp;utm_medium&#x3D;Web&amp;utm_campaign&#x3D;SNReferral" data-track="nav_language_editing" data-track-action="language editing" data-track-context="unified footer" data-track-label="link">Language editing</a></li>
					
						<li class="eds-c-footer__item"><a class="eds-c-footer__link" href="https://www.springernature.com/gp/open-science/about/the-fundamentals-of-open-access-and-open-research" data-track="nav_open_access_publishing" data-track-action="open access publishing" data-track-context="unified footer" data-track-label="link">Open access publishing</a></li>
					
				</ul>
			</div>
			
			<div class="eds-c-footer__group">
				<h3 class="eds-c-footer__heading">Products and services</h3>
				<ul class="eds-c-footer__list">
					
						<li class="eds-c-footer__item"><a class="eds-c-footer__link" href="https://www.springernature.com/gp/products" data-track="nav_our_products" data-track-action="our products" data-track-context="unified footer" data-track-label="link">Our products</a></li>
					
						<li class="eds-c-footer__item"><a class="eds-c-footer__link" href="https://www.springernature.com/gp/librarians" data-track="nav_librarians" data-track-action="librarians" data-track-context="unified footer" data-track-label="link">Librarians</a></li>
					
						<li class="eds-c-footer__item"><a class="eds-c-footer__link" href="https://www.springernature.com/gp/societies" data-track="nav_societies" data-track-action="societies" data-track-context="unified footer" data-track-label="link">Societies</a></li>
					
						<li class="eds-c-footer__item"><a class="eds-c-footer__link" href="https://www.springernature.com/gp/partners" data-track="nav_partners_and_advertisers" data-track-action="partners and advertisers" data-track-context="unified footer" data-track-label="link">Partners and advertisers</a></li>
					
				</ul>
			</div>
			
			<div class="eds-c-footer__group">
				<h3 class="eds-c-footer__heading">Our brands</h3>
				<ul class="eds-c-footer__list">
					
						<li class="eds-c-footer__item"><a class="eds-c-footer__link" href="https://www.springer.com/" data-track="nav_imprint_Springer" data-track-action="Springer" data-track-context="unified footer" data-track-label="link">Springer</a></li>
					
						<li class="eds-c-footer__item"><a class="eds-c-footer__link" href="https://www.nature.com/" data-track="nav_imprint_Nature_Portfolio" data-track-action="Nature Portfolio" data-track-context="unified footer" data-track-label="link">Nature Portfolio</a></li>
					
						<li class="eds-c-footer__item"><a class="eds-c-footer__link" href="https://link.springer.com/brands/bmc" data-track="nav_imprint_BMC" data-track-action="BMC" data-track-context="unified footer" data-track-label="link">BMC</a></li>
					
						<li class="eds-c-footer__item"><a class="eds-c-footer__link" href="https://www.palgrave.com/" data-track="nav_imprint_Palgrave_Macmillan" data-track-action="Palgrave Macmillan" data-track-context="unified footer" data-track-label="link">Palgrave Macmillan</a></li>
					
						<li class="eds-c-footer__item"><a class="eds-c-footer__link" href="https://www.apress.com/" data-track="nav_imprint_Apress" data-track-action="Apress" data-track-context="unified footer" data-track-label="link">Apress</a></li>
					
						<li class="eds-c-footer__item"><a class="eds-c-footer__link" href="https://link.springer.com/brands/discover" data-track="nav_imprint_Discover" data-track-action="Discover" data-track-context="unified footer" data-track-label="link">Discover</a></li>
					
				</ul>
			</div>
			
		</div>
	</div>

		
		
		<div class="eds-c-footer__container">
	
		<nav aria-label="footer navigation">
			<ul class="eds-c-footer__links">
				
					<li class="eds-c-footer__item">
						
						
							<button class="eds-c-footer__link" data-cc-action="preferences"
								 data-track="dialog_manage_cookies" data-track-action="Manage cookies" data-track-context="unified footer" data-track-label="link"><span class="eds-c-footer__button-text">Your privacy choices/Manage cookies</span></button>
						
					</li>
				
					<li class="eds-c-footer__item">
						
							<a class="eds-c-footer__link" href="https://www.springernature.com/gp/legal/ccpa"
								 data-track="nav_california_privacy_statement" data-track-action="california privacy statement" data-track-context="unified footer" data-track-label="link">Your US state privacy rights</a>
						
						
					</li>
				
					<li class="eds-c-footer__item">
						
							<a class="eds-c-footer__link" href="https://www.springernature.com/gp/info/accessibility"
								 data-track="nav_accessibility_statement" data-track-action="accessibility statement" data-track-context="unified footer" data-track-label="link">Accessibility statement</a>
						
						
					</li>
				
					<li class="eds-c-footer__item">
						
							<a class="eds-c-footer__link" href="https://link.springer.com/termsandconditions"
								 data-track="nav_terms_and_conditions" data-track-action="terms and conditions" data-track-context="unified footer" data-track-label="link">Terms and conditions</a>
						
						
					</li>
				
					<li class="eds-c-footer__item">
						
							<a class="eds-c-footer__link" href="https://link.springer.com/privacystatement"
								 data-track="nav_privacy_policy" data-track-action="privacy policy" data-track-context="unified footer" data-track-label="link">Privacy policy</a>
						
						
					</li>
				
					<li class="eds-c-footer__item">
						
							<a class="eds-c-footer__link" href="https://support.springernature.com/en/support/home"
								 data-track="nav_help_and_support" data-track-action="help and support" data-track-context="unified footer" data-track-label="link">Help and support</a>
						
						
					</li>
				
					<li class="eds-c-footer__item">
						
							<a class="eds-c-footer__link" href="https://link.springer.com/legal-notice"
								 data-track="nav_legal_notice" data-track-action="legal notice" data-track-context="unified footer" data-track-label="link">Legal notice</a>
						
						
					</li>
				
					<li class="eds-c-footer__item">
						
							<a class="eds-c-footer__link" href="https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations"
								 data-track-action="cancel contracts here">Cancel contracts here</a>
						
						
					</li>
				
			</ul>
		</nav>
	
	
		
			<div class="eds-c-footer__user">
				<p class="eds-c-footer__user-info">
					
					<span data-test="footer-user-ip">173.68.96.214</span>
				</p>
				<p class="eds-c-footer__user-info" data-test="footer-business-partners">Not affiliated</p>
			</div>
		
	
	
		<a href="https://www.springernature.com/" class="eds-c-footer__link">
			<img src="/oscar-static/images/logo-springernature-white-19dd4ba190.svg" alt="Springer Nature" loading="lazy" width="200" height="20"/>
		</a>
	
	<p class="eds-c-footer__legal" data-test="copyright">&copy; 2025 Springer Nature</p>
</div>

	</div>
</footer>
</div>


    </body>
</html>


